
<html lang="en"     class="pb-page"  data-request-id="9f5941c0-50c1-494e-8ab1-969409c0ccf2"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2010.53.issue-6;article:article:10.1021/jm9015526;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor" /></meta><meta name="dc.Creator" content="John A.  McCauley" /></meta><meta name="dc.Creator" content="Charles J.  McIntyre" /></meta><meta name="dc.Creator" content="Michael T.  Rudd" /></meta><meta name="dc.Creator" content="Kevin T.  Nguyen" /></meta><meta name="dc.Creator" content="Joseph J.  Romano" /></meta><meta name="dc.Creator" content="John W.  Butcher" /></meta><meta name="dc.Creator" content="Kevin F.  Gilbert" /></meta><meta name="dc.Creator" content="Kimberly J.  Bush" /></meta><meta name="dc.Creator" content="M. Katharine  Holloway" /></meta><meta name="dc.Creator" content="John  Swestock" /></meta><meta name="dc.Creator" content="Bang-Lin  Wan" /></meta><meta name="dc.Creator" content="Steven S.  Carroll" /></meta><meta name="dc.Creator" content="Jillian M.  DiMuzio" /></meta><meta name="dc.Creator" content="Donald J.  Graham" /></meta><meta name="dc.Creator" content="Steven W.  Ludmerer" /></meta><meta name="dc.Creator" content="Shi-Shan  Mao" /></meta><meta name="dc.Creator" content="Mark W.  Stahlhut" /></meta><meta name="dc.Creator" content="Christine M.  Fandozzi" /></meta><meta name="dc.Creator" content="Nicole  Trainor" /></meta><meta name="dc.Creator" content="David B.  Olsen" /></meta><meta name="dc.Creator" content="Joseph P.  Vacca" /></meta><meta name="dc.Creator" content="Nigel J.  Liverton" /></meta><meta name="dc.Description" content="A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, th..." /></meta><meta name="Description" content="A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, th..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 17, 2010" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm9015526" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2010 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm9015526" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm9015526" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm9015526" /></link>
        
    
    

<title>Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm9015526" /></meta><meta property="og:title" content="Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0010.jpeg" /></meta><meta property="og:description" content="A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compounds via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing. These studies led to the identification of clinical candidate 35b (vaniprevir, MK-7009), which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm9015526"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm9015526">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm9015526&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm9015526&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm9015526&amp;href=/doi/10.1021/jm9015526" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2010</span><span class="cit-fg-volume">, 53</span><span class="cit-fg-issue">, 6</span><span class="cit-fg-pageRange">, 2443-2463</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/53/6" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm901388c" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm901613f" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+A.++McCauley">John A. McCauley</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles+J.++McIntyre">Charles J. McIntyre</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+T.++Rudd">Michael T. Rudd</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+T.++Nguyen">Kevin T. Nguyen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+J.++Romano">Joseph J. Romano</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+W.++Butcher">John W. Butcher</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kevin+F.++Gilbert">Kevin F. Gilbert</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kimberly+J.++Bush">Kimberly J. Bush</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=M.+Katharine++Holloway">M. Katharine Holloway</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John++Swestock">John Swestock</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Bang-Lin++Wan">Bang-Lin Wan</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+S.++Carroll">Steven S. Carroll</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jillian+M.++DiMuzio">Jillian M. DiMuzio</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Donald+J.++Graham">Donald J. Graham</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven+W.++Ludmerer">Steven W. Ludmerer</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shi-Shan++Mao">Shi-Shan Mao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+W.++Stahlhut">Mark W. Stahlhut</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine+M.++Fandozzi">Christine M. Fandozzi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nicole++Trainor">Nicole Trainor</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=David+B.++Olsen">David B. Olsen</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Joseph+P.++Vacca">Joseph P. Vacca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nigel+J.++Liverton">Nigel J. Liverton</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-symbol">†</span> <span class="aff-text">Department of Medicinal Chemistry</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">‡</span> <span class="aff-text">Department of Molecular Systems</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">§</span> <span class="aff-text">Department of Antiviral Research</span></div><div class="aff-info" id="aff4"><span class="aff-symbol">∥</span> <span class="aff-text">Department of Drug Metabolism</span></div><div class="aff-info" id="aff5"><span class="aff-text">Merck Research Laboratories, West Point, Pennsylvania, 19486</span></div><div class="corresp-info"><strong>*</strong>To whom correspondence should be addressed. Phone: 215-652-4133. Fax: 215-652-3971. E-mail: <a href="/cdn-cgi/l/email-protection#90fafff8fecffdf3f3f1e5fcf5e9d0fdf5e2f3fbbef3fffd"><span class="__cf_email__" data-cfemail="791316111726141a1a180c151c0039141c0b1a12571a1614">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm9015526&amp;href=/doi/10.1021%2Fjm9015526" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2010</span></span><span class="cit-volume">, 53</span><span class="cit-issue">, 6</span><span class="cit-pageRange">, 2443–2463</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 17, 2010</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>19 October 2009</li><li><span class="item_label"><b>Published</b> online</span>17 February 2010</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 March 2010</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm9015526" title="DOI URL">https://doi.org/10.1021/jm9015526</a></div><div class="article_header-article-copyright"><strong>Copyright © 2010 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2443%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DJohn%2BA.%2BMcCauley%252C%2BCharles%2BJ.%2BMcIntyre%252C%2BMichael%2BT.%2BRudd%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D53%26issueNum%3D6%26contentID%3Djm9015526%26title%3DDiscovery%2Bof%2BVaniprevir%2B%2528MK-7009%2529%252C%2Ba%2BMacrocyclic%2BHepatitis%2BC%2BVirus%2BNS3%252F4a%2BProtease%2BInhibitor%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2463%26publicationDate%3DMarch%2B2010">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm9015526"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">5242</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">121</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm9015526" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Discovery of Vaniprevir (MK-7009), a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;A. McCauley&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;J. McIntyre&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;T. Rudd&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;T. Nguyen&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;J. Romano&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;W. Butcher&quot;},{&quot;first_name&quot;:&quot;Kevin&quot;,&quot;last_name&quot;:&quot;F. Gilbert&quot;},{&quot;first_name&quot;:&quot;Kimberly&quot;,&quot;last_name&quot;:&quot;J. Bush&quot;},{&quot;first_name&quot;:&quot;M.&quot;,&quot;last_name&quot;:&quot;Katharine Holloway&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;Swestock&quot;},{&quot;first_name&quot;:&quot;Bang-Lin&quot;,&quot;last_name&quot;:&quot;Wan&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;S. Carroll&quot;},{&quot;first_name&quot;:&quot;Jillian&quot;,&quot;last_name&quot;:&quot;M. DiMuzio&quot;},{&quot;first_name&quot;:&quot;Donald&quot;,&quot;last_name&quot;:&quot;J. Graham&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;W. Ludmerer&quot;},{&quot;first_name&quot;:&quot;Shi-Shan&quot;,&quot;last_name&quot;:&quot;Mao&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;W. Stahlhut&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;M. Fandozzi&quot;},{&quot;first_name&quot;:&quot;Nicole&quot;,&quot;last_name&quot;:&quot;Trainor&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;B. Olsen&quot;},{&quot;first_name&quot;:&quot;Joseph&quot;,&quot;last_name&quot;:&quot;P. Vacca&quot;},{&quot;first_name&quot;:&quot;Nigel&quot;,&quot;last_name&quot;:&quot;J. Liverton&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2010&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;17&quot;,&quot;issue&quot;:&quot;6&quot;,&quot;volume&quot;:&quot;53&quot;,&quot;pages&quot;:&quot;2443-2463&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm9015526&quot;},&quot;abstract&quot;:&quot;A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compounds via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing. These studies led to the identification of clinical candidate 35b (vaniprevir, MK-7009), which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9015526&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9015526" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9015526&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9015526" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm9015526&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9015526" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm9015526&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm9015526&amp;href=/doi/10.1021/jm9015526" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm9015526" /></input><a href="/doi/pdf/10.1021/jm9015526" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm9015526&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm9015526%26sid%3Dliteratum%253Aachs%26pmid%3D20163176%26genre%3Darticle%26aulast%3DMcCauley%26date%3D2010%26atitle%3DDiscovery%2Bof%2BVaniprevir%2B%2528MK-7009%2529%252C%2Ba%2BMacrocyclic%2BHepatitis%2BC%2BVirus%2BNS3%252F4a%2BProtease%2BInhibitor%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D53%26issue%3D6%26spage%3D2443%26epage%3D2463%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=291456" title="Hydrocarbons">Hydrocarbons</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=291089" title="Plasma">Plasma</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/53/6" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A new class of HCV NS3/4a protease inhibitors which contain a P2 to P4 macrocyclic constraint was designed using a molecular-modeling derived strategy. Exploration of the P2 heterocyclic region, the P2 to P4 linker, and the P1 side chain of this class of compounds via a modular synthetic strategy allowed for the optimization of enzyme potency, cellular activity, and rat liver exposure following oral dosing. These studies led to the identification of clinical candidate <b>35b</b> (vaniprevir, MK-7009), which is active against both the genotype 1 and genotype 2 NS3/4a protease enzymes and has good plasma exposure and excellent liver exposure in multiple species.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_17262" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_17262" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hepatitis C virus (HCV<a class="ref internalNav" href="#fn9" aria-label="a">a</a><div class="NLM_fn" id="fn9">a<p class="last">Abbreviations: APCI, atmospheric pressure chemical ionization; Boc, <i>t</i>-butoxycarbonyl; CDI, carbonyldiimazole; DCE, 1,2-dichloroethane; DIPEA, diisopropylethylamine; DMAP, 4-dimethylamino pyridine; DMEM, Dulbecco’s modified eagle’s medium; DMF, dimethylformamide; DMSO, dimethyl sulfoxide; DTT, dithiothreitol; ESI, electrospray ionization; EtOAc, ethyl acetate; EtOH, ethanol; FBS, fetal bovine serum; FTICR, Fourier transform ion cyclotron resonance; HATU, <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl uronium hexafluorophosphate; HCV, hepatitis C virus; HEPES, 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid sodium salt; LAH, lithium aluminum hydride; MES, 2-(<i>N</i>-morpholino)ethanesulfonic acid; MeCN, acetonitrile; MeOH, methanol; NBS, <i>N</i>-bromosuccinimide; NHS, normal human serum; PEG400, polyethyleneglycol 400; RCM, ring-closing metathesis; RT, room temperature; SAR, structure−activity relationship; TEA, triethylamine; TFA, trifluoroacetic acid; THF, tetrahydrofuran; TRF, time-resolved fluorescence; Zhan 1b catalyst, [1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene[2-(<i>i</i>-propoxy)-5-(<i>N</i>,<i>N</i>-dimethylaminosulfonyl)phenyl] methyleneruthenium(II) dichloride].</p></div>) is a chronic infection that affects an estimated 130−170 million people worldwide.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> The positive RNA strand <i>Flaviviridae</i> family virus replicates primarily in the liver, and while disease progression is typically a slow process, a significant fraction of those infected develop serious liver disease including cirrhosis and hepatocellular carcinoma.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> HCV is currently a leading cause of death in HIV coinfected patients<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> and is the most common indication for liver transplantation.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> HCV displays a high degree of genetic heterogeneity and can be classified into six major genotypes that have different geographic distributions: genotypes 1, 2, and 3 account for more than 90% of the infections in the developed world, with genotype 1 being predominant (∼70%) in the U.S., Europe and Japan. Current standard treatment for HCV is based on combination therapy with pegylated interferon-α and ribavirin.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Pegylated interferon is dosed by once weekly injection and ribavirin orally. Duration of therapy and response rates are genotype-dependent. Sustained viral response is seen in ∼45% of HCV genotype 1-infected patients treated for 48 weeks and in ∼80% of genotype 2- and 3-infected patients treated for 24 weeks. Pegylated interferon and ribavirin therapy is also associated with a number of serious side effects, which limit the number of patients who may be treated.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">There is a compelling medical need for new oral therapeutic agents with improved efficacy and tolerability. Several promising antiviral targets for HCV have emerged in recent years,<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> with NS3/4a protease inhibitors showing perhaps the most dramatic antiviral effects.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Clinical proof-of-concept for this mechanism was first achieved with BILN-2061 (<b>1</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), a rapidly reversible NS3 inhibitor.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Other compounds have entered clinical trials, including the slowly reversible covalent binders <b>2</b> (telaprevir, VX-950)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> and <b>3</b> (boceprevir, SCH 503034)<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> and the rapidly reversible inhibitors <b>4</b> (ITMN-191)<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and <b>5</b> (TMC 435350).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS3/4a protease inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We have recently disclosed a molecular-modeling derived strategy that led us to design HCV NS3/4a protease inhibitors which contain the P2 to P4 macrocyclic constraint.<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> This strategy arose from an analysis of the full crystal structure of NS3 with and without inhibitors docked in the active site.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> A key observation was that in the absence of inhibitor, the C-terminus of the helicase domain occupies the protease active site. The side chain of Glu628 in this C-terminal region was the inspiration for, and occupies the same space as, the P2 to P4 linker in this class of inhibitors. With our P2 to P4 macrocyclization strategy validated by the attractive potency and pharmacokinetic profile of compound <b>6</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>),<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> we set out to explore the P2 heterocyclic portion of this class of compounds. In the literature, there was a significant variety of substituents in the P2 region which could be broken into two main classes. First were the directly linked heterocycles such as <b>1</b> and <b>5</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>) and <b>7</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>)<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> and second were those linked through a carbamate, including <b>4</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>), <b>8</b>, and <b>9</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> In both of these classes, the P2 group ranged from the relatively simple to the very complex. Our modular synthetic approach, which relies on a key ring-closing metathesis (RCM) reaction,<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> allowed for the rapid exploration of a number of regions of these molecules, and herein, we report studies that led to the identification of a clinical candidate.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. P2 substituents employed in representative HCV NS3/4a protease inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62808" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62808" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds <b>12a</b>−<b>c</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>) could be prepared by reaction of 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidine-1,2-dicarboxylate (<b>11</b>)<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> first with carbonyldiimidazole (CDI), then by treatment with the ortho-, meta- and para-isomers of <i>N</i>-methyl-bromobenzylamine (<b>10a</b>−<b>c</b>), followed by vinylation with vinyltributyltin via palladium catalysis. Removal of the <i>t</i>-butoxycarbonyl (Boc) protecting group and amide formation under standard conditions with carboxylic acid <b>13</b> provided RCM precursors <b>14a</b>−<b>c</b>. Exposure of dilute solutions (3 mM) of the bis-olefins to the Zhan 1b catalyst [1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene[2-(<i>i</i>-propoxy)-5-(<i>N</i>,<i>N</i>-dimethylaminosulfonyl)phenyl] methyleneruthenium(II) dichloride]<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> in dichloroethane (DCE) at 70 °C provided macrocycles <b>15a</b> and <b>15b</b> cleanly via the RCM reaction and with selective (>10:1) formation of the trans olefins.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Compound <b>14c</b>, however, did not cyclize to give the desired product and, under forcing conditions, decomposed. We attribute this reaction failure to the strain associated with having a 1,4-substituted phenyl contained in a potentially rigid macrocycle. Compounds <b>15a</b> and <b>15b</b> were converted to <b>17a</b> and <b>17b</b>, respectively, by hydrolysis of the methyl ester and amide coupling with the vinyl P1 fragment <b>16</b>.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a></div><figure id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11</b>, carbonyldiimidazole, DMF; <b>10a</b>−<b>c</b>, DIPEA, 50 °C; (b) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C; (c) HCl, dioxane; (d) <b>13</b>, HATU, DIPEA, DMAP, DMF; (e) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼3 mM, 70 °C; (f) LiOH, THF, MeOH, H<sub>2</sub>O; (g) <b>16</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><div class="NLM_p">Access to the intermediate required for the 5-tetrahydroisoquinoline P2 macrocycle (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>) started with the coupling of 5-bromotetrahydroisoquinoline (<b>18a</b>) to <b>11</b> through a CDI mediated carbamate formation followed by vinylation yielding <b>19a</b>. The 8-linked isomer synthesis began with demethylation of 8-methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (<b>18b</b>) to give the corresponding phenol,<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> which could be coupled to <b>11</b> in a similar manner. Installation of the vinyl group through the intermediate triflate provided <b>19b</b>. The linker region was installed via amide formation with <b>13</b> to give RCM precursors <b>20a</b> and <b>20b</b>. RCM with the Zhan 1b catalyst<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> formed the <i>trans</i>-olefins selectively and yielded the macrocycles (<b>21a</b> and <b>21b</b>), which could be further elaborated to <b>22a</b> and <b>22b</b> via hydrolysis and attachment of the P1 side chain (<b>16</b>).</div><figure id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11</b>, carbonyldiimidazole, DMF; <b>18a</b>, DIPEA, 50 °C; (b) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 75%; (c) HBr/H<sub>2</sub>O, 120 °C, 81%; (d) carbonyldiimidazole, DMF; <b>18c</b>, DIPEA, 50 °C, 69%; (e) Tf<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 69%; (f) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, toluene, 25 °C, 74%; (g) HCl, dioxane; (h) <b>13</b>, HATU, DIPEA, DMAP, DMF; (i) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼3 mM, 70 °C; (j) LiOH, THF, MeOH, H<sub>2</sub>O; (k) <b>16</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><div class="NLM_p">The isoindoline P2 synthesis starts with 3-bromo-<i>o</i>-xylene (<b>23</b>), which was dibrominated with <i>N</i>-bromosuccinimde (NBS) and benzoyl peroxide (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>).<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Displacement of the bromines with benzylamine with concomitant ring closure gave 2-benzyl-4-bromoisoindoline. Installation of the vinyl group and removal of the benzyl protective group with 1-chloroethyl chloroformate<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> and methanol (MeOH) provided the required P2 heterocycle (<b>24</b>). Standard carbamate forming conditions and removal of the Boc protecting group gave key intermediate <b>25</b> as the hydrochloride salt, which is a stable white powder. Compound <b>25</b> was coupled to a variety of linker acids <b>13</b> and <b>26b</b>−<b>i</b> as shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a> to form bis-olefins <b>27a</b>−<b>i</b>. The Zhan 1b metathesis catalyst<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> was used to affect macrocyclization providing <b>28a</b>−<b>i</b> selectively as trans isomers. These intermediates were transformed to the ultimate targets by hydrolysis and amide formation with <b>16</b> to give a series of compounds that contained both the ring and side chain olefins and varied with regard to macrocycle size and P3 substituent (<b>29a</b>−<b>i</b>).</div><figure id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>, reflux, 92%; (b) K<sub>2</sub>CO<sub>3</sub>, benzylamine, MeCN, 77 °C, 50%; (c) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 83%; (d) 1-chloroethyl chloroformate, DCE, reflux; MeOH, reflux, 86%; (e) <b>11</b>, carbonyldiimidazole, DMF; <b>24</b>, 60 °C, 81%; (f) HCl, dioxane, 90%; (g) <b>13</b>, <b>26b</b>−<b>i</b>, HATU, DIPEA, DMF; (h) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼5 mM, 75 °C; (i) LiOH, THF, MeOH, H<sub>2</sub>O; (j) <b>16</b>, HATU, DIPEA, DMF.</p></p></figure><div class="NLM_p">Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a> describes the synthesis of a series of macrocycles similar to <b>29a</b> but with varying levels of saturation of the olefins contained in the macrocycle and the P1 side chain. Compound <b>31a</b> was prepared by hydrogenation of <b>28a</b>, followed by hydrolysis and coupling to the vinyl P1 side chain <b>16</b>. Macrocycle <b>31b</b> was prepared directly from <b>28a</b> by hydrolysis and addition of the ethyl P1 side chain <b>30</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> whereas <b>28a</b> first underwent reduction of the macrocyclic olefin before the final hydrolysis and ethyl P1 (<b>30</b>) coupling steps to give <b>31c</b>.</div><figure id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, 10% Pd/C, EtOAc; (b) LiOH·H<sub>2</sub>O, THF, MeOH, H<sub>2</sub>O; (c) <b>16</b>, HATU, DIPEA, DMAP, DMF; (d) <b>30</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><div class="NLM_p">A second series of isoindoline P2 compounds containing a saturated linker and the ethyl cyclopropane P1 side chain was prepared using similar chemistry (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Amine hydrochloride <b>25</b> was coupled with a series of acids (<b>26h</b> and <b>32b</b>−<b>i</b>) to provide <b>27h</b> and <b>33b</b>−<b>i</b> which was then cyclized to give <b>28h</b> and <b>34b</b>−<b>i</b>. The newly formed olefin could be hydrogenated and the synthesis completed via hydrolysis and addition of the saturated P1 side chain <b>30</b> to give compounds <b>35a</b>−<b>i</b>.</div><figure id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>26h</b>, <b>32b</b>−<b>i</b>, HATU, DIPEA, DMF; (b) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> CH<sub>2</sub>Cl<sub>2</sub>, ∼3 mM; (c) H<sub>2</sub>, 10% Pd/C, EtOH, EtOAc; (d) LiOH·H<sub>2</sub>O, THF, MeOH, H<sub>2</sub>O; (e) <b>30</b>, HATU, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33861" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33861" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Compounds were evaluated in an enzyme binding assay using the genotype 1b NS3/4a enzyme and selected compounds were also tested versus the genotype 2a enzyme with results reported as <i>K</i><sub>i</sub> values.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The cellular activity was determined using the replicon system expressing genotypes 1b or 2a, and compounds were tested in the presence of 10% fetal bovine serum (FBS) and 50% normal human serum (NHS).<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Initial pharmacokinetic analysis focused on liver concentration of compounds in rats after a single 5 mg/kg oral dose.</div><div class="NLM_p">For one of our initial efforts aimed at exploring the P2 region of our novel macrocycles, we chose to explore simple benzylamine derived carbamates. The 2-linked isomer <b>17a</b> had modest activity in both the 1b enzyme and cellular replicon assays (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). This level of activity could be greatly improved by moving the linker to the three position as in compound <b>17b</b>, resulting in a 3.5-fold increase in replicon activity. This level of activity led us to constrain the P2 region of the compounds by cyclizing to the two corresponding isomers of tetrahydroisoquinoline <b>22a</b> and <b>22b</b>, which demonstrated an even greater difference in 1b enzyme potency of >50-fold. Further constraint of <b>22b</b> to the isoindoline (<b>29a</b>) led to a highly potent compound with 50 pM activity versus the genotype 1b enzyme and 7 nM activity in the replicon assay. Compound <b>29a</b> also showed liver exposure in rat of 910 nM at the 4 h time point following a single 5 mg/kg oral dose. As previously communicated, we have used rat liver concentration as the primary pharmacokinetic readout for evaluating compounds.<a onclick="showRef(event, 'ref14 ref20'); return false;" href="javascript:void(0);" class="ref ref14 ref20">(14, 20)</a> On the basis of these data, <b>29a</b> became an important lead and our focus turned toward evaluating structure−activity relationships (SAR) in other parts of the molecule while leaving the P2 isoindoline intact.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. In Vitro Activity</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center" char="±"> </th><th colspan="2" align="center" char="±">1b replicon IC<sub>50</sub><br /></br>(nM)<a class="ref internalNav" href="#t1fn2" aria-label="b">b</a></th><th align="center" char="±"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center" char="±">1b <i>K</i><sub>i</sub><br /></br>(nM)<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th align="center" char="±">10% FBS</th><th align="center" char="±">50% NHS</th><th align="center" char="±">rat [liver] <br /></br>@ 4 h (μM)<a class="ref internalNav" href="#t1fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>17a</b></td><td align="char" char="±">1.60 ± 0.93</td><td align="char" char="±">98 ± 72</td><td align="char" char="±">610 ± 60</td><td align="char" char="±">nd</td></tr><tr valign="top"><td align="left"><b>17b</b></td><td align="char" char="±">0.14 ± 0.06</td><td align="char" char="±">28 ± 4</td><td align="char" char="±">42 ± 5</td><td align="char" char="±">0.45 ± 0.14</td></tr><tr valign="top"><td align="left"><b>22a</b></td><td align="char" char="±">8.30 ± 1.23</td><td align="char" char="±">730 ± 82</td><td align="char" char="±">2900 ± 900</td><td align="char" char="±">nd</td></tr><tr valign="top"><td align="left"><b>22b</b></td><td align="char" char="±">0.15 ± 0.05</td><td align="char" char="±">26 ± 4</td><td align="char" char="±">140 ± 19</td><td align="char" char="±">3.5 ± 0.2</td></tr><tr valign="top"><td align="left"><b>29a</b></td><td align="char" char="±">0.05 ± 0.01</td><td align="char" char="±">7 ± 2</td><td align="char" char="±">32 ± 4</td><td align="char" char="±">0.91 ± 0.65</td></tr><tr valign="top"><td align="left"><b>29b</b></td><td align="char" char="±">0.05 ± 0.01</td><td align="char" char="±">6 ± 3</td><td align="char" char="±">26 ± 1</td><td align="char" char="±">0.46 ± 0.32</td></tr><tr valign="top"><td align="left"><b>29c</b></td><td align="char" char="±">0.04 ± 0.01</td><td align="char" char="±">12 ± 3</td><td align="char" char="±">28 ± 3</td><td align="char" char="±">0.44 ± 0.13</td></tr><tr valign="top"><td align="left"><b>29d</b></td><td align="char" char="±">0.02 ± 0.01</td><td align="char" char="±">3 ± 1</td><td align="char" char="±">24 ± 4</td><td align="char" char="±">2.8 ± 0.8</td></tr><tr valign="top"><td align="left"><b>29e</b></td><td align="char" char="±">0.06 ± 0.01</td><td align="char" char="±">4 ± 1</td><td align="char" char="±">38 ± 3</td><td align="char" char="±">1.6 ± 0.5</td></tr><tr valign="top"><td align="left"><b>29f</b></td><td align="char" char="±">0.04 ± 0.01</td><td align="char" char="±">4 ± 1</td><td align="char" char="±">23 ± 5</td><td align="char" char="±">nd</td></tr><tr valign="top"><td align="left"><b>29g</b></td><td align="char" char="±">0.10 ± 0.03</td><td align="char" char="±">16 ± 3</td><td align="char" char="±">390 ± 65</td><td align="char" char="±">nd</td></tr><tr valign="top"><td align="left"><b>29h</b></td><td align="char" char="±">0.03 ± 0.01</td><td align="char" char="±">5.0 ± 0.3</td><td align="char" char="±">19 ± 4</td><td align="char" char="±">0.23 ± 0.12</td></tr><tr valign="top"><td align="left"><b>29i</b></td><td align="char" char="±"><0.02 ± 0</td><td align="char" char="±">3.0 ± 0</td><td align="char" char="±">23 ± 1</td><td align="char" char="±">0.14 ± 0.05</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>a</sup><p class="last">NS3/4a protease time-resolved fluorescence assay, mean ± standard deviation of at least <i>n</i> = 3 measurements.</p></div><div class="footnote" id="t1fn2"><sup>b</sup><p class="last">Cell-based replicon assay, mean ± standard deviation of at least <i>n</i> = 3 measurements.</p></div><div class="footnote" id="t1fn3"><sup>c</sup><p class="last">Liver levels from PK experiments carried out as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">The investigation of the role of the P3 amino acid side chain was carried out via the synthesis of the series of compounds <b>29a</b>−<b>29f</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Very little difference in potency was seen with various alkyl and cycloalkyl substituents. Rat liver concentrations after oral dosing were again similar for this series of compounds, with a slight trend toward increased liver exposure for the most lipophilic substituents. For example, cyclohexyl derivatives <b>29d</b> and <b>29e</b> showed 2.8 and 1.6 μM liver concentrations in rat liver at 4 h, while the isopropyl derivative <b>29c</b> showed a ∼5-fold lower concentration at 0.44 μM. All three compounds, however, showed comparable enzyme and cellular activity. Contraction of the macrocyclic ring constraint by one carbon gave <b>29g</b> and led to a decrease in potency as well as cellular activity. Expansion of the linker by 1 and 2 carbons to the 6-carbon linked <b>29h</b> and 7-carbon linked <b>29i</b> gave overall profiles similar to the lead <b>29a</b>. The SAR summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> showed that there was good flexibility with regard to the P3 substituent and that a linker of 5 to at least 7 carbons was also tolerated. However, none of these changes led to a dramatic increase in activity or liver exposure.</div><div class="NLM_p">We then undertook a study of the effect of saturation of each of the two olefins present in <b>29a</b>. Reduction of the macrocyclic olefin provided <b>31a</b>, which had a virtually identical potency and pharmacokinetic profile to that of <b>29a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Saturation of the P1 vinyl group to the P1 ethyl (<b>31b</b>) led to a ∼4-fold increase in rat liver concentration, but this was accompanied by a ∼10-fold loss in potency. The fully saturated compound (<b>31c</b>) however, maintained much of the potency of <b>29a</b> but now showed improved liver exposure (10.7 μM) at a 5 mg/kg oral dose to rats. We were encourged by this result; however, upon further profiling of <b>31c</b>, we found that the replicon activity, when measured against the genotype 2a system, was suboptimal. In fact, only <b>31a</b> in this series was below 100 nM in the genotype 2a replicon assay.</div><div class="NLM_p">Knowing that there was flexibility with regard to macrocyclic ring size (vide supra), we expanded the ring of <b>31c</b> by one carbon to give <b>35a</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). This change gave a small boost in genotype 1b replicon activity but fortunately led to a greater than 10-fold increase in genotype 2a replicon activity. Somewhat unexpectedly, the liver exposure seen with <b>35a</b> was about 5-fold lower than <b>31c</b> even though the structures only differ by one methylene unit in the linker. In an attempt to regain liver exposure, we sought to introduce added lipophilicity on the linker. Installation of a dimethyl group β to the carbamate oxygen gave compound <b>35b</b>, which showed a concentration of 9.9 μM in rat liver at 4 h following a 5 mg/kg oral dose. Furthermore, replicon activity at both genotypes 1b and 2a was under 10 nM in the presence of 10% FBS and in the presence of 50% NHS the genotype 1b replicon activity showed a very small protein shift to 19 nM. A series of spiro-cycloalkyl substituents, from cyclopropane to cyclohexane (<b>35c</b>−<b>f</b>), showed that increasing the steric bulk and lipophilicity in this region of the molecule led to a decrease in enzyme potency and a marked erosion in replicon activity in the presence of 50% human serum (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Liver exposure, however, was affected in a less predictable manner. The change from a dimethyl substituent (<b>35b</b>) to a spiro-cyclohexyl group (<b>35f</b>) increased liver exposure by 2.5-fold but decreased replicon activity in the presence of 50% NHS by 50-fold. Although it has reduced potency, the spiro-cyclobutyl compound (<b>35d</b>) showed remarkable rat liver exposure of >40 μM after the 5 mg/kg oral dose and illustrates the difficulty of predicting this parameter.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. In Vitro Activity</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col></colgroup><thead><tr valign="top"><th align="center"> </th><th align="center" char="±"> </th><th align="center" char="±"> </th><th colspan="3" align="center" char="±">replicon IC<sub>50</sub> (nM)<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th align="center" char="±"> </th></tr><tr valign="top"><th align="center">compd</th><th align="center" char="±">1b <i>K</i><sub>i</sub><br /></br>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="center" char="±">2a <i>K</i><sub>i</sub><br /></br>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a></th><th align="center" char="±">1b 10% FBS</th><th align="center" char="±">1b 50% NHS</th><th align="center" char="±">2a 10% FBS</th><th align="center" char="±">rat [liver] @ 4 h (μM)<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th></tr></thead><tbody><tr valign="top"><td align="left"><b>29a</b></td><td align="char" char="±">0.05 ± 0.01</td><td align="char" char="±">2.6 ± 0.9</td><td align="char" char="±">7 ± 2</td><td align="char" char="±">32 ± 4</td><td align="char" char="±">150 ± 20</td><td align="char" char="±">0.91 ± 0.65</td></tr><tr valign="top"><td align="left"><b>31a</b></td><td align="char" char="±">0.04 ± 0.01</td><td align="char" char="±">0.9 ± 0.1</td><td align="char" char="±">7 ± 0</td><td align="char" char="±">27 ± 5</td><td align="char" char="±">66 ± 16</td><td align="char" char="±">0.52 ± 0.01</td></tr><tr valign="top"><td align="left"><b>31b</b></td><td align="char" char="±">0.45 ± 0.07</td><td align="char" char="±">19 ± 5</td><td align="char" char="±">29 ± 8</td><td align="char" char="±">110 ± 16</td><td align="char" char="±">720 ± 110</td><td align="char" char="±">3.8 ± 1.2</td></tr><tr valign="top"><td align="left"><b>31c</b></td><td align="char" char="±">0.18 ± 0.07</td><td align="char" char="±">4.0 ± 0.8</td><td align="char" char="±">10 ± 2</td><td align="char" char="±">35 ± 20</td><td align="char" char="±">140 ± 40</td><td align="char" char="±">10.7 ± 0.5</td></tr><tr valign="top"><td align="left"><b>35a</b></td><td align="char" char="±">0.06 ± 0.01</td><td align="char" char="±">0.9 ± 0.2</td><td align="char" char="±">5.0 ± 0.3</td><td align="char" char="±">27 ± 11</td><td align="char" char="±">13 ± 2</td><td align="char" char="±">1.9 ± 0.8</td></tr><tr valign="top"><td align="left"><b>35b</b></td><td align="char" char="±">0.05 ± 0.01</td><td align="char" char="±">0.9 ± 0.3</td><td align="char" char="±">3.0 ± 1.0</td><td align="char" char="±">19 ± 6</td><td align="char" char="±">9.0 ± 2.6</td><td align="char" char="±">9.9 ± 5.4</td></tr><tr valign="top"><td align="left"><b>35c</b></td><td align="char" char="±">0.10 ± 0.03</td><td align="char" char="±">4.3 ± 0.5</td><td align="char" char="±">6 ± 1</td><td align="char" char="±">41 ± 15</td><td align="char" char="±">35 ± 4</td><td align="char" char="±">4.6 ± 2.0</td></tr><tr valign="top"><td align="left"><b>35d</b></td><td align="char" char="±">0.09 ± 0.02</td><td align="char" char="±">3.6 ± 1.0</td><td align="char" char="±">3.0 ± 0.6</td><td align="char" char="±">30 ± 9</td><td align="char" char="±">20 ± 9</td><td align="char" char="±">45 ± 8</td></tr><tr valign="top"><td align="left"><b>35e</b></td><td align="char" char="±">0.09 ± 0.01</td><td align="char" char="±">5.1 ± 0.2</td><td align="char" char="±">7 ± 1</td><td align="char" char="±">85 ± 47</td><td align="char" char="±">20 ± 3</td><td align="char" char="±">6.6 ± 2.9</td></tr><tr valign="top"><td align="left"><b>35f</b></td><td align="char" char="±">1.22 ± 0.39</td><td align="char" char="±">63 ± 8</td><td align="char" char="±">43 ± 14</td><td align="char" char="±">860 ± 60</td><td align="char" char="±">270 ± 90</td><td align="char" char="±">25 ± 16</td></tr><tr valign="top"><td align="left"><b>35g</b></td><td align="char" char="±">0.09 ± 0.02</td><td align="char" char="±">nd</td><td align="char" char="±">16 ± 12</td><td align="char" char="±">75 ± 21</td><td align="char" char="±">nd</td><td align="char" char="±">7.5 ± 2.1</td></tr><tr valign="top"><td align="left"><b>35h</b></td><td align="char" char="±">0.08 ± 0.02</td><td align="char" char="±">nd</td><td align="char" char="±">10 ± 1</td><td align="char" char="±">90 ± 9</td><td align="char" char="±">nd</td><td align="char" char="±">2.0 ± 0.5</td></tr><tr valign="top"><td align="left"><b>35i</b></td><td align="char" char="±">0.30 ± 0.09</td><td align="char" char="±">nd</td><td align="char" char="±">16 ± 6</td><td align="char" char="±">180 ± 40</td><td align="char" char="±">nd</td><td align="char" char="±">13 ± 9.5</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">NS3/4a protease time-resolved fluorescence assay, mean ± standard deviation of at least <i>n</i> = 3 measurements.</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">Cell-based replicon assay, mean ± standard deviation of at least <i>n</i> = 3 measurements.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">Liver levels from PK experiments carried out as described in the <a class="ref internalNav" href="#sec4" aria-label="Experimental Section">Experimental Section</a>.</p></div></div></div><div class="NLM_p">Next, we sought to revisit the P3 amino acid side chain as in <b>29a</b>−<b>f</b> where varying the P3 group had little effect on activity but modulated liver exposure. In the case of compounds <b>35g</b>−<b>i</b>, however, larger more lipophilic P3 groups were not tolerated. For example, the cyclohexyl substituent used in compound <b>35g</b> led to good liver exposure, but this change was accompanied by a 4-fold loss in the serum-shifted replicon IC<sub>50</sub>. This result is in contrast to the result with <b>29d</b>, which did not suffer a loss in activity with the P3 cyclohexyl group. The requirement for liver exposure needs to be carefully balanced with cellular activity. Perhaps the increase in lipophilicity of the linker that gives compounds <b>35b</b>−<b>i</b> good liver exposure precludes a further increase in lipophilicity at P3. On the basis of the exploration of the macrocyclic scaffold in the P2 isoindoline series, we concluded that <b>35b</b> was an optimal compound in this series and was subsequently selected for further development.</div><div class="NLM_p">The pharmacokinetic properties of compound <b>35b</b> were evaluated in multiple species (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). In rat, <b>35b</b> showed a plasma clearance of 74 mL/min/kg and a plasma half-life of ∼1 h. When dosed orally at 5 mg/kg, the plasma exposure of <b>35b</b> was modest with an AUC of 0.1 μM·h. In contrast to the plasma exposure data, the liver exposure of the compound is quite good and <b>35b</b> remains in liver 24 h after a single 5 mg/kg oral dose. At 24 h, the liver concentration of <b>35b</b> is 0.4 μM, which is 130-fold greater than the replicon IC<sub>50</sub> (10% FBS) and is >20-fold higher than the IC<sub>50</sub> in the replicon assay in the presence of 50% NHS.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Pharmacokinetic Parameters for <b>35b</b><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0009.gif" alt="" id="fx2" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="char" char="±" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top"><th align="center">species</th><th align="center" char="±">Cl <br /></br>(mL/min/kg)</th><th align="center" char="±"><i>V</i><sub>d</sub><br /></br>(L/kg)</th><th align="center" char="±"><i>T</i><sub>1/2</sub> (h)</th><th align="center">PO <i>C</i><sub>max</sub><br /></br>(μM)</th><th align="center">PO AUC <br /></br>(μM·h)</th><th align="center">PO [liver] <br /></br>2 h (μM)</th><th align="center">PO [liver] <br /></br>24 h (μM)</th></tr></thead><tbody><tr valign="top"><td align="left">rat</td><td align="char" char="±">74 ± 9</td><td align="char" char="±">1.9 ± 1.6</td><td align="char" char="±">0.9 ± 0.7</td><td align="left">0−0.1</td><td align="left">0−0.1</td><td align="left">9.9 @ 4 h</td><td align="left">0.4</td></tr><tr valign="top"><td align="left">dog</td><td align="char" char="±">11 ± 2</td><td align="char" char="±">0.3 ± 0.1</td><td align="char" char="±">1.2 ± 0</td><td align="left">0.5 ± 0.2</td><td align="left">1.2 ± 0.4</td><td align="left">34</td><td align="left">0.5</td></tr><tr valign="top"><td align="left">rhesus</td><td align="char" char="±">18 ± 2</td><td align="char" char="±">0.4 ± 0.1</td><td align="char" char="±">1.3 ± 0.2</td><td align="left">0.01−0.2</td><td align="left">0.05−0.2</td><td align="left">3</td><td align="left">nd</td></tr><tr valign="top"><td align="left">chimpanzee</td><td align="char" char="±">nd</td><td align="char" char="±">nd</td><td align="char" char="±">nd</td><td align="left">0.9</td><td align="left">5.2</td><td align="left">nd</td><td align="left">31 @ 12 h</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">Rat, dog, and rhesus iv (2 mg/kg, <i>n</i> = 3, DMSO), po (5 mg/kg, <i>n</i> = 3, PEG400), chimpanzee (po, 10 mg/kg, <i>n</i> = 2, chocolate milk).</p></div></div></div><div class="NLM_p">When dosed to dogs, the plasma pharmacokinetics of <b>35b</b> were greatly improved (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). The compound shows moderate clearance of 11 mL/min/kg and a 1.2 h half-life after iv dosing and has good plasma exposure (AUC = 1.2 μM·h) after a 5 mg/kg oral dose. Dog liver biopsy studies showed that the liver concentrations of <b>35b</b> after the 5 mg/kg oral dose are 34 and 0.5 μM at the 2 and 24 h time points, respectively. Similar to its behavior in rats, <b>35b</b> demonstrates effective partitioning into liver tissue and maintains high liver concentration, relative to potency, 24 h after oral dosing in dogs. In contrast to rat, <b>35b</b> demonstrates good plasma exposure after dosing a 5 mg/kg oral dose in dogs.</div><div class="NLM_p last">Rhesus pharmacokinetic parameters were generally similar to that of rat and characterized by good liver exposure and poor plasma exposure after a 5 mg/kg oral dose (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). As a prelude to efficacy experiments which will be described elsewhere, we dosed <b>35b</b> to chimpanzees to evaluate plasma and liver pharmacokinetics. Following an oral dose of 10 mg/kg in chimpanzees, <b>35b</b> shows excellent plasma exposure with an AUC of 5.2 μM·h and a <i>C</i><sub>max</sub> of 0.9 μM. Furthermore, a liver biopsy at this dose level shows a liver concentration of 31 μM at 12 h postdose for <b>35b</b>. This concentration is >1500-fold greater than the serum-shifted replicon IC<sub>50</sub> and clearly supported a dosing regimen of, at most, twice per day in chimpanzees.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_45270" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_45270" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Investigation of a series of P2−P4 macrocycles containing a hydroxy-proline carbamate led to the identification of 3-linked isoindoline as a promising P2 substituent for a new class of HCV NS3/4a protease inhibitors. Optimization of this series, including exploration of linker length and P3 amino acid side chains, showed that a number of different compounds maintained good activity versus the genotype 1b enzyme but that rat liver exposure was modest. Through a study of the effects of saturation of the macrocyclic and P1 side chain olefin, it was discovered that the fully saturated compounds preferentially partitioned into rat liver and provided high liver concentrations. Further optimization of the fully reduced compounds with regard to linker length and substitution was performed in an effort to maintain rat liver exposure and achieve balanced activity against both the 1b and 2a genotypes of NS3/4a protease, and these efforts led to the identification of <b>35b</b>. Compound <b>35b</b> shows good to excellent liver exposure across species and poor plasma exposure in rats and rhesus following a 5 mg/kg oral dose. In contrast, good plasma exposure was observed in dogs. In chimpanzees, at a 10 mg/kg oral dose, excellent plasma and liver exposure were observed with a liver concentration at 12 h 1500-fold greater than the serum-shifted replicon IC<sub>50</sub>. Further studies of <b>35b</b> (vaniprevir, MK-7009), including clinical investigations of the pharmacokinetic and efficacy profile, are ongoing.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i8">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_15412" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_15412" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> General</h3><div class="NLM_p last">All reagents and solvents were of commercial quality and used without further purification unless indicated otherwise. All reactions were carried out under an inert atmosphere of nitrogen. <sup>1</sup>H NMR spectra were obtained on a Varian Unity Inova 400 spectrometer or a Varian Unity Inova 500 spectrometer. Chemical shifts are reported in parts per million relative to TMS as internal standard. Samples provided for accurate mass measurement were taken up in acetonitrile:water (50/50). The solutions were analyzed by use of electrospray ionization (ESI) or atmospheric pressure chemical ionization (APCI) on either a Bruker Daltonics 3T or 7T Fourier transform ion cyclotron resonance (FTICR) mass spectrometer. External calibration was accomplished with polypropylene glycol (425 or 750). Elemental analyses were performed by Quantitative Technologies Inc., Whitehouse, NJ, and Robertson Microlit Laboratories, Madison, NJ. Silica gel chromatography was carried out with an ISCO CombiFlash Sg 100c or ISCO CombiFlash Companion purification system using ISCO silica gel RediSep or Analytical Sales and Products Aspire FlashReady cartridges. Preparative reverse-phase HPLC was performed using a Gilson 215 liquid handler and a Phenomenex Luna C18 column (150 mm × 20 mm i.d.) with a linear gradient over 15 min (95:5 to 0:100 H<sub>2</sub>O containing 0.15% trifluoroacetic acid:acetonitrile). Compound purity was determined to be >95% by analytical HPLC analysis on an Agilent 1090 HPLC with binary pump and diode array detector with area quantification performed at 214 nm (Method 1: Zorbax RX-C18, 75 mm × 4.6 mm, 3.5 μM, 98% A/2% B to 100% B over 5.5 min then 100% B to 6.0 min (A = 0.1% H<sub>3</sub>PO<sub>4</sub>/water v/v; B = acetonitrile). Method 2: Luna C8(2), 75 mm × 4.6 mm, 3 μM, 98% A/2% B to 100% B over 5.5 min then 100% B to 6.0 min (A = 0.1% H<sub>3</sub>PO<sub>4</sub>/water v/v; B = acetonitrile)).</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Enzymatic Assays</h3><div class="NLM_p last">Compound inhibitory potencies were determined with use of a time-resolved fluorescence assay for NS3/4A protease activity.<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> The NS3 protease assay was performed in a final volume of 100 μL in assay buffer containing 50 mM 4-(2-hydroxyethyl)piperazine-1-ethanesulfonic acid sodium salt (HEPES), pH 7.5, 150 mM NaCl, 15% glycerol, 0.15% Triton X-100, 10 mM dithiothreitol (DTT), and 0.1% PEG8000. The NS3 protease was preincubated with various concentrations of inhibitors in dimethyl sulfoxide (DMSO) for 30 min. The reaction was initiated by adding the time-resolved fluorescence (TRF) peptide substrate (final concentration 100 nM). NS3 mediated hydrolysis of the substrate was quenched after 1 h at RT with 100 μL of 500 mM 2-(<i>N</i>-morpholino)ethanesulfonic acid (MES), pH 5.5. Product fluorescence was detected using either a Victor V2 or Fusion fluorophotometer (Perkin-Elmer Life and Analytical Sciences) with excitation at 340 nm and emission at 615 nm with a 400 μs delay. The inhibition constants were derived using a standard four-parameter fit to the data. Full length NS3/4A protease with the sequence from genotype 1b (BK strain) and genotype 2a (JFH strain) was overexpressed in and purified from <i>E. coli</i>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> Replicon Assay</h3><div class="NLM_p last">Inhibition of viral replication was determined with use of the HCV bicistronic replicon assay<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> adapted for quantitative analysis using in situ hybridization.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Huh-7 cells that were stably transfected with HCV replicon RNA (genotype 1b con1 sequence;<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> genotype 2a JFH sequence<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a>) were seeded into 96-well plates impregnated with scintillant (Cytostar-T, GE Healthcare) at a density of 20000 cells per well and incubated at 37 °C/5%CO<sub>2</sub> for 24 h in the presence of Dulbecco’s modified eagle’s medium (DMEM) supplemented with either 10% FBS or 50% NHS. Compound in DMSO was added to 1%, and incubated for a further 24 h. Cells were fixed by treatment with 10% formaldehyde and permeabilized by treatment with 0.25% Triton X100. A radiolabeled RNA probe that hybridizes to the neomycin resistance gene of the replicon was added and hybridized at 50 °C for 18 h, followed by RNase A treatment to remove unhybridized probe and washing. The plate was then counted in a Topcount NXT (Packard). The inhibition constants were derived using a standard four-parameter fit to the data.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Pharmacokinetics</h3><div class="NLM_p">Pharmacokinetic characterization of test agents was conducted in conscious male Sprague−Dawley rats (300−500 g; <i>n</i> = 2−3/study) or male and female beagle dogs (13−15 kg; <i>n</i> = 3/study) or male rhesus (4−6 kg, <i>n</i> = 3/study) or chimpanzees (∼60 kg; 1 male and 1 female). The housing, maintenance, and care of the chimpanzees (<i>Pan troglodytes</i>) used in the study were in compliance with all relevant guidelines and requirements at Merck Research Laboratories, and at New Iberia Research Center (University of Louisiana at Lafayette). The study protocols were reviewed and approved by the Institutional Animal Care and Use Committees at both sites. Compounds were dosed intravenously to fasted rats, dogs, and rhesus monkeys. Compounds in DMSO were administered as a bolus (1.0, 0.1, 0.1 mL/kg respectively) in DMSO. For oral studies in rat, dog, and rhesus, compounds were dosed as a solution in polyethyleneglycol 400 (PEG400) (2.0 mL/kg). Two chimpanzees were dosed orally by voluntary ingestion of test agent in a chocolate milk vehicle (Nestle brand, 0.67 mL/kg). Typical doses were 2 mg/kg iv and 5 mg/kg po to rats, 1 mg/kg iv and 5 mg/kg po to dogs, and 1 mg/kg iv and 5 mg/kg po to rhesus and 10 mg/kg po to chimpanzees. Blood samples for the determination of test agent plasma concentration were obtained at multiple time points up to 24 h after single dose test agent administration. Liver samples were taken at terminal time points for rats and as liver biopsies in dog, rhesus monkey, and chimpanzee. Liver samples were homogenized in buffer prior to analysis. Plasma and liver samples were analyzed using liquid−liquid extraction and LC/MS with appropriate standards and QCs. Pharmacokinetic parameters were calculated using Watson software.</div><div class="NLM_p last">All procedures related to the use of animals in these studies were reviewed and approved by the Institutional Animal Care and Use Committee at Merck Research Laboratories at West Point and conform with the Guide for the Care and Use of Laboratory Animals (Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, 1996).</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> 1-<i>tert</i>-Butyl 2-Methyl (2<i>S</i>,4<i>R</i>)-4-({[Methyl(2-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12a</b>)</h3><div class="NLM_p">To a 0 °C solution of 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidine-1,2-dicarboxylate (<b>11</b>) (2.00 g, 8.15 mmol) in dimethylformamide (DMF) (16 mL) under nitrogen was added CDI (1.32 g, 8.15 mmol) and the mixture was stirred at RT for 2 h. 2-Bromo-<i>N</i>-methylbenzylamine (<b>10a</b>) (1.63 g, 8.15 mmol) and diisopropylethyl amine (DIPEA) (1.42 mL, 8.15 mmol) were added, and the reaction mixture was heated to 50 °C and stirred for 18 h. The reaction mixture was diluted with ethyl acetate (EtOAc) (50 mL), washed with 10% KHSO<sub>4</sub> (50 mL), 10% NaHCO<sub>3</sub> (50 mL), and brine (50 mL). The organic extract was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 30−60% EtOAc in hexanes) to yield 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-({[(2-bromobenzyl)(methyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate as a clear oil (1.80 g, 47% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 7.8 Hz, 1 H), 7.31 (t, <i>J</i> = 7.5 Hz, 1 H), 7.24−7.06 (m, 2 H), 5.28 (m, 1 H), 4.55 (m, 2 H), 4.30−4.00 (m, 1 H), 3.70−3.50 (m, 5 H), 2.90 (m, 3 H), 2.50−2.10 (m, 2 H), 1.40 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 471.1117 [(M + H)<sup>+</sup>; calcd for C<sub>20</sub>H<sub>28</sub>BrN<sub>2</sub>O<sub>6</sub>: 471.1125].</div><div class="NLM_p last">A solution of the above bromide (1.60 g, 3.39 mmol) in toluene (20 mL) was degassed with nitrogen for 30 min. Vinyltributyltin (1.20 mL, 4.07 mmol) and Pd(PPh<sub>3</sub>)<sub>4</sub> (0.39 g, 0.34 mmol) were added, and the reaction mixture was heated to 100 °C and stirred for 3 h. The reaction mixture was cooled, concentrated, and purified by silica gel chromatography (gradient elution, 20−60% EtOAc in hexanes) to provide <b>12a</b> as a clear oil (1.40 g, 99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60−7.43 (m, 1 H), 7.30−6.80 (m, 3 H), 5.62 (dd, <i>J</i> = 7.3, 1.2 Hz, 1 H), 5.30 (m, 2 H), 4.70−4.10 (m, 4 H), 3.90−3.60 (m, 5 H), 3.00−2.10 (m, 5 H), 1.41 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 419.2183 [(M + H)<sup>+</sup>; calcd for C<sub>22</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub>: 419.2177].</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> 1-<i>tert</i>-Butyl 2-Methyl (2<i>S</i>,4<i>R</i>)-4-({[Methyl(3-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>12a</b> with 3-bromo-<i>N</i>-methylbenzylamine (<b>10b</b>) provided <b>12b</b> (60% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.37−7.26 (m, 2 H), 7.21−7.00 (m, 2 H), 6.71 (dd, <i>J</i> = 17.6, 10.9 Hz, 1 H), 5.75 (d, <i>J</i> = 17.6 Hz, 1 H), 5.34−5.21 (m, 2 H), 4.49−4.28 (m, 3 H), 3.74 (s, 6 H), 3.01−2.71 (m, 3 H), 1.48−1.36 (m, 10 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 419.2183 [(M + H)<sup>+</sup>; calcd for C<sub>22</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub>: 419.2177].</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> 1-<i>tert</i>-Butyl 2-Methyl (2<i>S</i>,4<i>R</i>)-4-({[Methyl(4-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>12a</b> with 4-bromo-<i>N</i>-methylbenzylamine (<b>10c</b>) provided <b>12c</b> (67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.41−7.34 (m, 2 H), 7.24−7.08 (m, 2 H), 6.70 (dd, <i>J</i> = 17.6, 10.9 Hz, 1 H), 5.74 (d, <i>J</i> = 17.6 Hz, 1 H), 5.29 (s, 1 H), 5.24 (d, <i>J</i> = 10.9 Hz, 1 H), 4.50−4.27 (m, 3 H), 3.81−3.67 (m, 4 H), 2.99−2.71 (m, 3 H), 2.47−2.34 (m, 1 H), 2.30−2.07 (m, 1 H), 1.46−1.26 (m, 10 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 419.2183 [(M+H)<sup>+</sup>; calcd for C<sub>22</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub>: 419.2177].</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valine (<b>13</b>)</h3><div class="NLM_p last">DIPEA (9.85 g, 76.2 mmol) was added dropwise to a 0 °C solution of 4-penten-1-ol (7.22 g, 83.9 mmol) and triphosgene (11.3 g, 38.1 mmol) in dioxane (160 mL). The resulting white suspension was stirred for 5 min at 0 °C and then allowed to warm to room temperature (RT) over 1 h. The suspension was recooled to 0 °C and 1 N NaOH (76.2 mL, 76.2 mmol) and <span class="smallcaps smallerCapital">l</span>-<i>tert</i>-butylglycine (10.0 g, 76.2 mmol) were added. The reaction mixture was allowed to warm to RT and stirred for 18 h. The dioxane was removed in vacuo, and the reaction mixture was basified to pH 12 with 1 N NaOH and washed with CH<sub>2</sub>Cl<sub>2</sub>. The aqueous phase was acidified to ∼pH 1 with 6 N HCl and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 150 mL). The organic layers were dried over MgSO<sub>4</sub> and concentrated to give <b>13</b> as a tan oil (13.7 g, 74% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.80 (m, 1 H), 5.20 (br d, <i>J</i> = 9.7 Hz, 1 H), 5.03 (dd, <i>J</i> = 17.2, 1.7 Hz, 1 H), 4.98 (dd, <i>J</i> = 10.2, 1.7 Hz, 1 H), 4.19 (br d, <i>J</i> = 9.4 Hz, 1 H), 4.09 (apparent t, <i>J</i> = 7.1 Hz, 2 H), 2.15−2.09 (m, 2 H), 1.76−1.69 (m, 2 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 244.1541 [(M + H)<sup>+</sup>; calcd for C<sub>12</sub>H<sub>22</sub>NO<sub>4</sub>: 244.1543].</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({[methyl(2-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>14a</b>)</h3><div class="NLM_p">A solution of 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-({[methyl(2-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12a</b>) (1.30 g, 3.11 mmol) in HCl/dioxane (4 M, 50 mL) was stirred at RT for 24 h. The reaction mixture was concentrated, triturated in ether/hexane, and concentrated to give methyl (4<i>R</i>)-4-({[methyl(2-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate hydrochloride as a white solid (1.1 g, 100% yield).</div><div class="NLM_p last">To a mixture of the above amine hydrochloride (1.17 g, 3.29 mmol), 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valine (<b>13</b>) (800 mg, 3.29 mmol), 4-dimethylamino pyridine (DMAP) (201 mg, 1.64 mmol), and DIPEA (1.73 mL, 9.86 mmol) in DMF (5 mL) was added <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyl uronium hexafluorophosphate (HATU) (1.63 g, 4.27 mmol). The reaction mixture was stirred at RT for 24 h, diluted with aq KHSO<sub>4</sub>, and extracted with EtOAc. The organic layer was washed with NaHCO<sub>3</sub> and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 20% to 60% EtOAc in hexanes) to yield <b>14a</b> as a clear oil (800 mg, 45% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.60−7.40 (m, 1 H), 7.20−6.80 (m, 4 H), 5.77 (m, 1 H), 5.62 (d, <i>J</i> = 17.3 Hz, 1 H), 5.32 (m, 3 H), 4.98 (m, 2 H), 4.70−4.20 (m, 4 H), 4.00 (m, 4 H), 3.72 (m, 4 H), 2.85−2.00 (m, 6 H), 1.65 (m, 2 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 544.2992 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 544.3017].</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({[methyl(3-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>14b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>14a</b> with 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-({[methyl(3-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12b</b>) provided <b>14b</b> (51% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.36−7.25 (m, 2 H), 7.19−7.00 (m, 2 H), 6.71 (dd, <i>J</i> = 17.6, 11.0 Hz, 1 H), 5.75 (d, <i>J</i> = 17.3 Hz, 2 H), 5.40−5.29 (m, 2 H), 5.27 (d, <i>J</i> = 11.0 Hz, 1 H), 5.04−4.92 (m, 2 H), 4.67−4.37 (m, 3 H), 4.29−3.85 (m, 5 H), 3.74 (m, 3 H), 2.91−2.71 (m, 3 H), 2.51−2.36 (m, 1 H), 2.26−1.99 (m, 3 H), 1.72−1.55 (m, 2 H), 1.04 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 544.3026 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 544.3017].</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({[methyl(4-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>14c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>14a</b> with 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-({[methyl(4-vinylbenzyl)amino]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (<b>12c</b>) provided <b>14c</b> (83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.45−7.31 (m, 2 H), 7.21 (d, <i>J</i> = 7.8 Hz, 1 H), 7.09 (d, <i>J</i> = 7.8 Hz, 1 H), 6.70 (dd, <i>J</i> = 17.6, 10.9 Hz, 1 H), 5.82−5.65 (m, 2 H), 5.42−5.27 (m, 2 H), 5.24 (d, <i>J</i> = 10.9 Hz, 1 H), 5.05−4.91 (m, 2 H), 4.69−4.37 (m, 2 H), 4.32−3.85 (m, 5 H), 3.80−3.71 (m, 4 H), 2.96−2.68 (m, 3 H), 2.52−2.37 (m, 1 H), 2.26−1.99 (m, 3 H), 1.69−1.56 (m, 2 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 544.3038 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 544.3017].</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-4-methyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatricyclo[20.2.1.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-23-carboxylate (<b>15a</b>)</h3><div class="NLM_p last">A solution of methyl 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({[methyl(2-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>14a</b>) (600 mg, 1.10 mmol) in DCE (180 mL) was degassed with nitrogen for 15 min. Zhan 1b catalyst<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (80 mg, 0.11 mmol) was added, and the reaction mixture was heated to 70 °C, stirred for 2 h, cooled, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 30−80% EtOAc in hexanes) to provide <b>15a</b> as a clear oil (420 mg, 74% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.50 (m, 1 H), 7.40−7.10 (m, 2 H), 7.00 (m, 1 H), 6.80−6.40 (m, 1 H), 6.20−5.90 (m, 1 H), 5.50−5.20 (m, 1 H), 4.72 (d, <i>J</i> = 17.1 Hz, 1 H), 4.52 (m, 1 H), 4.60−4.30 (m, 8 H), 2.97 (s, 3 H), 2.6−1.60 (m, 7 H), 1.04 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 516.2710 [(M + H)<sup>+</sup>; calcd for C<sub>27</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 516.2704].</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Methyl (6<i>R</i>,8<i>S</i>,11<i>S</i>,18<i>E</i>)-11-<i>tert</i>-Butyl-3-methyl-4,10,13-trioxo-5,14-dioxa-3,9,12-triazatricyclo[18.3.1.1<sup>6,9</sup>]pentacosa-1(24),18,20,22-tetraene-8-carboxylate (<b>15b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>15a</b> with methyl 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-({[methyl(3-vinylbenzyl)amino]carbonyl}oxy)-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>14b</b>) provided <b>15b</b> (68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42−7.20 (m, 1 H), 7.03−6.92 (m, 2 H), 6.43−5.93 (m, 2 H), 5.43−5.21 (m, 3 H), 4.86 (d, <i>J</i> = 14.9 Hz, 1 H), 4.70−4.52 (m, 1 H), 4.37−4.20 (m, 2 H), 4.08−3.93 (m, 2 H), 3.88−3.82 (m, 1 H), 3.80−3.71 (m, 4 H), 2.92−2.75 (m, 3 H), 2.50−2.14 (m, 4 H), 1.96−1.80 (m, 1 H), 1.68−1.62 (m, 1 H), 1.10−1.00 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 516.2711 [(M + H)<sup>+</sup>; calcd for C<sub>27</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 516.2704].</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-4-methyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatricyclo[20.2.1.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-23-carboxamide (<b>17a</b>)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-4-methyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatricyclo[20.2.1.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-23-carboxylate (<b>15a</b>) (200 mg, 0.39 mmol) in tetrahydrofuran (THF) (4 mL), MeOH (4 mL), and water (4 mL) was added LiOH (37.2 mg, 1.55 mmol) and the reaction mixture was stirred at 40 °C for 2 h. Upon complete hydrolysis, 3 N HCl (0.52 mL, 1.55 mmol) was added and the reaction mixture was concentrated to give (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-4-methyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatricyclo[20.2.1.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-23-carboxylic acid.</div><div class="NLM_p last">To a solution of the above crude carboxylic acid and (1<i>R</i>,2<i>S</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride (<b>16</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (128 mg, 0.48 mmol) in DMF (2 mL) at RT was added DMAP (24 mg, 0.20 mmol), DIPEA (0.21 mL, 1.20 mmol), and HATU (200 mg, 0.52 mmol). The reaction mixture was stirred for 18 h, diluted with water (30 mL), and the resulting solids were filtered and washed with water. The crude solids were purified by silica gel chromatography (gradient elution, 50% to 100% EtOAc in hexanes) to provide <b>17a</b> as a white solid (240 mg, 84% yield, 2 steps). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.20−8.80 (m, 1 H), 7.60−7.00 (m, 4 H), 6.51 (m, 1 H), 6.00 (m, 1 H), 5.72 (m, 1 H), 5.30 (m, 2 H), 5.12 (m, 1 H), 4.70−3.60 (m, 9 H), 3.00−1.60 (m, 13 H), 1.40 (m, 1 H), 1.21 (m, 2 H), 1.04 (m, 11 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 714.3194 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 714.3167]. Anal. (C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·1.5H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (6<i>R</i>,8<i>S</i>,11<i>S</i>,18<i>E</i>)-11-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3-methyl-4,10,13-trioxo-5,14-dioxa-3,9,12-triazatricyclo[18.3.1.1<sup>6,9</sup>]pentacosa-1(24),18,20,22-tetraene-8-carboxamide (<b>17b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>17a</b> with methyl (6<i>R</i>,8<i>S</i>,11<i>S</i>,18<i>E</i>)-11-<i>tert</i>-butyl-3-methyl-4,10,13-trioxo-5,14-dioxa-3,9,12-triazatricyclo[18.3.1.1<sup>6,9</sup>]pentacosa-1(24),18,20,22-tetraene-8-carboxylate (<b>15b</b>) provided <b>17b</b> (68% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.53−10.41 (m, 1 H), 9.04 (s, 1 H), 7.45−7.23 (m, 3 H), 7.21−6.95 (m, 4 H), 6.53−6.13 (m, 3 H), 5.63 (s, 1 H), 5.27−4.87 (m, 4 H), 4.38−3.72 (m, 7 H), 2.93 (s, 1 H), 2.82−2.67 (m, 3 H), 2.44−2.12 (m, 4 H), 1.90−1.62 (m, 3 H), 1.40−1.32 (m, 1 H), 1.12−0.83 (m, 11 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 714.3220 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 714.3167]. Anal. (C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·0.25 TFA) C, H, N.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> 8-Hydroxy-1,2,3,4-tetrahydroisoquinoline hydrobromide (<b>18c</b>)</h3><div class="NLM_p last">A mixture of 8-methoxy-1,2,3,4-tetrahydroisoquinoline hydrochloride (<b>18b</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (3.00 g, 15.0 mmol) and 48% aqueous HBr (45 mL) was heated at 120 °C for 18 h. The resulting brown suspension was filtered and dried to provide <b>18c</b> (2.8 g, 81% yield). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.89 (s, 1 H), 8.98 (s, 2 H), 7.08 (t, <i>J</i> = 7.8 Hz, 1 H), 6.72 (d, <i>J</i> = 7.8 Hz, 1 H), 6.66 (d, <i>J</i> = 7.8 Hz, 1 H), 4.07 (m, 2 H), 3.34 (m, 2 H), 2.94 (t, <i>J</i> = 6.14 Hz, 2 H). HRMS (ESI) <i>m</i>/<i>z</i> 150.0904 [(M + H)<sup>+</sup>; calcd for C<sub>9</sub>H<sub>12</sub>NO: 150.0913].</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> 1-<i>tert</i>-Butyl 2-Methyl (2<i>S</i>,4<i>R</i>)-4-{[(5-Vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (<b>19a</b>)</h3><div class="NLM_p last">Using the above procedure for <b>12a</b> with 5-bromo-1,2,3,4-tetrahydroisoquinoline (<b>18a</b>) provided <b>19a</b> (75% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.37 (d, <i>J</i> = 8.0 Hz, 1 H), 7.19 (t, <i>J</i> = 7.5 Hz, 1 H), 7.05 (m, 1 H), 6.89 (dd, <i>J</i> = 17.5, 11.0 Hz, 1 H), 5.63 (dd, <i>J</i> = 17.5, 1.0 Hz, 1 H), 5.33 (dd, <i>J</i> = 11.0, 1.0 Hz, 1 H), 5.29 (br s, 1 H), 4.6 (m, 2 H), 4.45 and 4.36 (2 × t, <i>J</i> = 7.5 Hz, 1 H), 3.75 (s, 3 H), 3.60 (m, 4 H), 2.86 (br s, 2 H), 2.41 (m, 1 H), 2.22 (m, 1 H), 1.46 and 1.43 (2 × s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 431.2179 [(M + H)<sup>+</sup>; calcd for C<sub>23</sub>H<sub>31</sub>N<sub>2</sub>O<sub>6</sub>: 431.2182].</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-<i>tert</i>-Butyl 2-Methyl (2<i>S</i>,4<i>R</i>)-4-{[(8-Vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (<b>19b</b>)</h3><div class="NLM_p">A mixture of CDI (0.176 g, 1.09 mmol) and 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidine-1,2-dicarboxylate (<b>11</b>) (0.21 g, 0.87 mmol) in DMF (5 mL) was stirred at RT for 45 min. 8-Hydroxy-1,2,3,4-tetrahydroisoquinoline hydrobromide (<b>18c</b>) (0.20 g, 0.87 mmol) and triethylamine (TEA) (0.18 g, 1.74 mmol) were added, and the resulting solution was heated at 50 °C for 2 h. The reaction mixture was poured onto aqueous saturated NH<sub>4</sub>Cl and extracted with EtOAc, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The residue was purified by column chromatography on silica gel (gradient elution, 10−80% EtOAc in hexanes) to give 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-{[(8-hydroxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (0.25 g, 0.60 mmol, 69% yield) as a colorless foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.04 (t, <i>J</i> = 7.8 Hz, 1 H), 6.72 (d, <i>J</i> = 7.8 Hz, 1 H), 6.64 (d, <i>J</i> = 7.8 Hz, 1 H), 5.62 (m, 1 H), 5.30 (m, 1 H), 4.50 (m, 2 H), 4.37 (m, 1 H), 3.75 (s, 3 H), 3.66 (m, 3 H), 2.83 (m, 2 H), 2.43 (m, 1 H), 2.21 (m, 1 H), 1.43 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 421.1990 [(M + H)<sup>+</sup>; calcd for C<sub>21</sub>H<sub>29</sub>N<sub>2</sub>O<sub>7</sub>: 421.1969].</div><div class="NLM_p">To a solution of the above coupled product (1.81 g, 4.30 mmol) and TEA (1.31 g, 12.90 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) at 0 °C was added trifluoromethanesulfonic anhydride (1.76 g, 6.24 mmol). The resulting mixture was stirred for 18 h and was poured onto saturated aqueous NaHCO<sub>3</sub> and extracted into CH<sub>2</sub>Cl<sub>2</sub>. The organic layer was washed with 10% citric acid solution, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The oil was purified by column chromatography on silica gel (gradient elution, 10−70% EtOAc in hexanes) to give 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-({[8-{[(trifluoromethyl)sulfonyl]oxy}-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl]carbonyl}oxy)pyrrolidine-1,2-dicarboxylate (1.65 g, 69% yield) as a yellow oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (m, 1 H), 7.18 (m, 2 H), 5.30 (s, 2 H), 4.65 (m, 2 H), 4.41 (m, 1 H), 3.77 (s, 3 H), 3.59 (m, 1 H), 2.91 (m, 2 H), 2.44 (m, 1 H), 2.22 (m, 1 H), 2.01 (s, 1 H), 1.55 (m, 1 H), 1.49 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 575.1303 [(M + Na)<sup>+</sup>; calcd for C<sub>22</sub>H<sub>27</sub>F<sub>3</sub>N<sub>2</sub>NaO<sub>9</sub>S: 575.1282].</div><div class="NLM_p last">A solution of the above triflate (1.74 g, 3.15 mmol), vinyltributyltin (1.10 g, 1.46 mmol), and lithium chloride (0.40 g, 9.45 mmol) in DMF (25 mL) was purged with nitrogen for 10 min. Bis(triphenylphosphine)palladium(II) chloride (0.22 g, 0.32 mmol) was added, and the mixture was stirred at RT under nitrogen for 18 h. The mixture was partitioned between EtOAc and saturated NaHCO<sub>3</sub>, the organic layer separated and washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The oil was purified by column chromatography on silica gel (gradient elution, 10 to 65% EtOAc in hexanes) to give <b>19b</b> (1.00 g, 74% yield) as a colorless oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (d, <i>J</i> = 7.6 Hz, 1 H), 7.18 (t, <i>J</i> = 7.4 Hz, 1 H), 7.08 (m, 1 H), 6.78−6.90 (m, 1 H), 5.65 (d, <i>J</i> = 7.2 Hz, 1 H), 5.36 (d, <i>J</i> = 10.4 Hz, 1 H), 5.30 (m, 1 H), 4.60 (m, 2 H), 4.39 (t, <i>J</i> = 7.9 Hz, 1 H), 3.75 (m, 5 H), 3.62 (m, 2 H), 2.85 (m, 2 H), 2.43 (m, 1 H), 2.21 (m, 1 H), 1.43 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 331.1669 [(M-Boc + H)<sup>+</sup>; calcd for C<sub>18</sub>H<sub>23</sub>N<sub>2</sub>O<sub>4</sub>: 331.1707 ].</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(5-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>20a</b>)</h3><div class="NLM_p last">Using the above procedure for <b>14a</b> with 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-{[(5-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (<b>19a</b>) provided <b>20a</b> (87% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (d, <i>J</i> = 7.2 Hz, 1 H), 7.18 (t, <i>J</i> = 7.2 Hz, 1 H), 7.06 (m, 1 H), 6.88 (dd, <i>J</i> = 17.0, 11.0 Hz, 1 H), 5.75 (br s, 1 H), 5.63 (d, <i>J</i> = 17.0 Hz, 1 H), 5.39 (br s, 1 H), 5.33 (d, <i>J</i> = 11.0 Hz, 2 H), 4.96 (m, 2 H), 4.65−4.52 (m, 3 H). 4.25 (d, <i>J</i> = 9.2 Hz, 1 H), 4.15−3.8 (m, 4 H), 3.75 (s, 3 H), 3.7−3.5 (m, 2 H), 2.87 (m, 2 H), 2.47 (m, 1 H), 2.19 (m, 1 H), 2.09 (m, 2 H), 1.64 (m, 2 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 556.3016 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 556.3017].</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(8-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>20b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>14a</b> with 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-{[(8-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (<b>19b</b>) provided <b>20b</b> (88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (d, <i>J</i> = 7.3 Hz, 1 H), 7.17 (t, <i>J</i> = 7.3 Hz, 1 H), 7.06 (m, 1 H), 6.84 (m, 1 H), 5.76 (m, 1 H), 5.64 (m, 1 H), 5.38 (m, 3 H), 4.99 (m, 2 H), 4.64 (m, 2 H), 4.26 (m, 1 H), 4.09 (m, 1 H), 3.92 (m, 2 H), 3.75 (s, 3 H), 3.62 (m, 2 H), 3.41 (m, 1 H), 2.82 (m, 2 H), 2.55 (m, 1 H), 2.23 (m, 1 H), 2.10 (m, 2 H), 1.81 (m, 1 H), 1.64 (m, 2 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 556.3042 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 556.3017].</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> Methyl (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-Butyl-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[20.3.1.1<sup>4,7</sup>.0<sup>18,23</sup>]heptacosa-16,18,20,22-tetraene-6-carboxylate (<b>21a</b>)</h3><div class="NLM_p last">Using the above procedure for <b>15a</b> with methyl 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(5-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>20a</b>) provided <b>21a</b> (67% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.21 (d, <i>J</i> = 7.5 Hz, 1 H), 7.11 (t, <i>J</i> = 7.5 Hz, 1 H), 6.97 (d, <i>J</i> = 7.5 Hz, 1 H), 6.45 (d, <i>J</i> = 16.0 Hz, 1 H), 5.90 (m, 1 H), 5.58 (t, <i>J</i> = 3.5 Hz, 1 H), 5.37 (d, <i>J</i> = 10.0 Hz, 1 H), 5.0 (d, <i>J</i> = 17.0 Hz, 1 H), 4.68 (dd, <i>J</i> = 10.7, 7.5 Hz, 1 H), 4.25 (d, <i>J</i> = 16.5 Hz, 1 H), 4.18 (d, <i>J</i> = 9.5 Hz, 1 H), 4.00 (m, 2 H), 3.92 (m, 1 H), 3.78−3.72 (m, 2 H), 3.77 (s, 3 H), 3.04 (m, 1 H), 2.77 (m, 1 H), 2.61 (m, 1 H), 2.48 (m, 1 H), 2.30 (m, 1 H), 2.20−2.10 (m, 2 H), 1.93 (m, 1 H), 1.65 (m, 1 H), 1.01 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 528.2704 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 528.2705].</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> Methyl (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-Butyl-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[16.6.2.1<sup>4,7</sup>.0<sup>22,26</sup>]heptacosa-16,18(26),19,21-tetraene-6-carboxylate (<b>21b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>15a</b> with methyl 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(8-vinyl-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>20b</b>) provided <b>21b</b> (82% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (t, <i>J</i> = 7.6 Hz, 1 H), 7.01 (t, <i>J</i> = 7.6 Hz, 1 H), 7.13 (d, <i>J</i> = 7.6 Hz, 1 H), 6.35 (d, <i>J</i> = 15.6 Hz, 1 H), 6.02 (m, 1 H), 5.44 (m, 1 H), 5.38 (m, 1 H), 4.61 (m, 2 H), 4.41 (m, 2 H), 4.30 (m, 2 H), 3.84 (m, 2 H), 3.81 (m, 2 H), 3.75 (s, 3 H), 3.52 (m, 1 H), 2.87 (m, 1 H), 2.60 (m, 1 H), 2.28 (m, 2 H), 2.19 (m, 1 H), 1.94 (m, 1 H), 1.62 (m, 1 H), 1.07 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 528.2729 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 528.2705].</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[20.3.1.1<sup>4,7</sup>.0<sup>18,23</sup>]heptacosa-16,18,20,22-tetraene-6-carboxamide (<b>22a</b>)</h3><div class="NLM_p last">Using the above procedure for <b>17a</b> with methyl (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-butyl-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[20.3.1.1<sup>4,7</sup>.0<sup>18,23</sup>]heptacosa-16,18,20,22-tetraene-6-carboxylate (<b>21a</b>) provided <b>22a</b> (45% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.35 (d, <i>J</i> = 8.0 Hz, 1 H), 7.11 (t, <i>J</i> = 7.5 Hz, 1 H), 7.01 (br d, <i>J</i> = 9.0 Hz, 1 H), 6.97 (d, <i>J</i> = 7.5 Hz, 1 H), 6.50 (d, <i>J</i> = 15.5 Hz, 1 H), 6.03 (m, 1 H), 5.78 (m, 1 H), 5.54 (br s, 1 H), 5.34 (d, <i>J</i> = 17.0 Hz, 1 H), 5.14 (d, <i>J</i> = 10.0 Hz, 1 H), 4.95 (d, <i>J</i> = 16.5 Hz, 1 H), 4.50 (dd, <i>J</i> = 11.5 Hz, 6.5 Hz, 1 H), 4.29 (d, <i>J</i> = 16.0 Hz, 1 H), 4.22 (m, 3 H), 3.90 (m, 3 H), 3.15 (m, 1 H), 2.94 (m, 1 H), 2.74 (m, 2 H), 2.38−2.10 (m, 6 H), 2.00 (m, 1 H), 1.85 (m, 1 H), 1.68 (m, 1 H), 1.48 (m, 1 H), 1.26 (m, 2 H), 1.08 (m, 2 H), 0.99 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 726.3151 [(M + H)<sup>+</sup>; calcd for C<sub>36</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 726.3167].</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[16.6.2.1<sup>4,7</sup>.0<sup>22,26</sup>]heptacosa-16,18(26),19,21-tetraene-6-carboxamide (<b>22b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>17a</b> with methyl (4<i>R</i>,6<i>S</i>,9<i>S</i>,16<i>E</i>)-9-<i>tert</i>-butyl-2,8,11-trioxo-3,12-dioxa-1,7,10-triazatetracyclo[16.6.2.1<sup>4,7</sup>.0<sup>22,26</sup>]heptacosa-16,18(26),19,21-tetraene-6-carboxylate (<b>21b</b>) and purification by reverse phase HPLC provided <b>22b</b> (56% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.30 (t, <i>J</i> = 7.4 Hz, 1 H), 7.14 (t, <i>J</i> = 7.4 Hz, 1 H), 7.01 (d, <i>J</i> = 7.4 Hz, 1 H), 6.42 (d, <i>J</i> = 15.2 Hz, 1 H), 5.98 (m, 1 H), 5.79 (m, 2 H), 5.19 (m, 2 H), 4.95 (m, 1 H), 4.59 (m, 2 H), 4.42 (m, 1 H), 4.31 (m, 1 H), 4.19 (m, 1 H), 3.90 (m, 1 H), 3.81 (m, 2 H), 3.77 (m, 1 H), 3.36 (m, 1 H), 2.90 (m, 1 H), 2.81 (m, 1 H), 2.59 (m, 1 H), 2.38 (m, 1 H), 2.22 (m, 2 H), 1.90 (m, 2 H), 1.73 (s, 9 H), 1.68 (m, 1 H), 1.03 (m, 8 H), 0.74 (m, 1 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 726.3169 [(M + H)<sup>+</sup>; calcd for C<sub>36</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 726.3167]. Anal. (C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·2.6H<sub>2</sub>O·0.9TFA) C, H, N.</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> 1-Bromo-2,3-bis(bromomethyl)benzene (<b>23</b>)</h3><div class="NLM_p last">A suspension of 3-bromo-<i>o</i>-xylene (196 g, 1.06 mol), <i>N-</i>bromosuccinimide (377 g, 2.15 mol), and benzoyl peroxide (0.26 g, 1.0 mmol) in carbon tetrachloride (1800 mL) was heated to reflux under nitrogen for 15 h. The contents of the reaction flask were cooled, filtered, and the filtrate evaporated. The crude material was distilled under high vacuum with major fractions collected between 88 and 152 °C to give <b>23</b> (108 g, 35% yield) and 182 g of 95% pure material (57% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.56 (d, <i>J</i> = 8.0 Hz, 1 H), 7.31 (d, <i>J</i> = 8.0 Hz, 1 H), 7.16 (t, <i>J</i> = 8.0 Hz, 1 H), 4.84 (s, 2 H), 4.64 (s, 2 H) ppm.</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-Vinylisoindoline (<b>24</b>)</h3><div class="NLM_p">Postassium bicarbonate (204 g, 2.04 mol) was suspended in acetonitrile (12 L), and the mixture was heated to 80 °C. Solutions of 1-bromo-2,3-bis(bromomethyl)benzene (<b>23</b>) (280 g, 0.82 mol) in acetonitrile (MeCN) (500 mL) and benzylamine (87.5 g, 0.82 mol) in MeCN (500 mL) were added concurrently via addition funnels over 1 h. The reaction mixture was stirred at 77 °C for 16 h, cooled to RT, and concentrated. The reaction mixture was partitioned between 1 M K<sub>2</sub>CO<sub>3</sub> and EtOAc. The organics were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Silica gel chromatography (gradient elution, heptane to 10% EtOAc in heptane) gave 2-benzyl-4-bromoisoindoline (118 g, 50% yield) as a pale oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39−7.31 (m, 4 H), 7.29−7.23 (m, 2 H), 7.07−7.02 (m, 2 H), 3.99 (s, 2 H), 3.94 (s, 2 H), 3.88 (s, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 288.0385 [(M + H)<sup>+</sup>; calcd for C<sub>15</sub>H<sub>15</sub>BrN: 288.0383]. Anal. (C<sub>15</sub>H<sub>14</sub>BrN·0.2H<sub>2</sub>O) C, H, N.</div><div class="NLM_p">A solution of 2-benzyl-4-bromoisoindoline (4.0 g, 13.9 mmol) and vinyltributyltin (4.9 mL, 16.7 mmol) in toluene (80 mL) was degassed with nitrogen for 15 min. Pd(PPh<sub>3</sub>)<sub>4</sub> (0.32 g, 0.28 mmol) was added, and the resulting solution was heated at 100 °C under nitrogen for 24 h. The reaction mixture was cooled, concentrated, and purified by silica gel chromatography (5% EtOAc in hexane) to give 2-benzyl-4-vinylisoindoline as a pale oil (2.7 g, 83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39 (m, 2 H), 7.33 (m, 2 H), 7.25 (m, 2 H), 7.14 (apparent t, <i>J</i> = 7.5 Hz, 1 H), 7.05 (d, <i>J</i> = 7.4 Hz, 1 H), 6.63 (dd, <i>J</i> = 17.6, 11.2 Hz, 1 H), 5.57 (d, <i>J</i> = 17.6 Hz, 1 H), 5.24 (d, <i>J</i> = 11.2 Hz, 1 H), 4.00 (s, 2 H), 3.91 (m, 4 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 236.1434 [(M + H)<sup>+</sup>; calcd for C<sub>17</sub>H<sub>18</sub>N: 236.1434].</div><div class="NLM_p last">To a solution of 2-benzyl-4-vinylisoindoline (2.9 g, 12.3 mmol) in 1,2-dichloroethane (50 mL) at 0 °C was added a solution of 1-chloroethyl chloroformate (2.11 g, 14.8 mmol) in 1,2-dichloroethane (10 mL) dropwise over 20 min, keeping the internal reaction temperature <5 °C. The reaction mixture was then warmed to RT, heated to reflux for 1 h, cooled, and concentrated. Methanol (50 mL) was added, and the reaction mixture was heated to reflux for 30 min, cooled, and concentrated and partitioned between EtOAc and water. The aqueous layer was basified with 2 N NaOH and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3×). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, CH<sub>2</sub>Cl<sub>2</sub> to 90:10:1 CH<sub>2</sub>Cl<sub>2</sub>:MeOH:NH<sub>4</sub>OH) to yield <b>24</b> as a brown oil (1.54 g, 86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.28 (d, <i>J</i> = 7.5 Hz, 1 H), 7.16 (apparent t, <i>J</i> = 7.4 Hz, 1 H), 7.12 (d, <i>J</i> = 7.3 Hz, 1 H), 6.67 (dd, <i>J</i> = 17.7, 11.1 Hz, 1 H), 5.61 (d, <i>J</i> = 17.7 Hz, 1 H), 5.28 (d, <i>J</i> = 11.1 Hz, 1 H), 4.27 (s, 2 H), 4.21 (s, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 146.0976 [(M + H)<sup>+</sup>; calcd for C<sub>10</sub>H<sub>12</sub>N: 146.0964]. Anal. (C<sub>10</sub>H<sub>11</sub>N·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (3<i>R</i>,5<i>S</i>)-5-(Methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate hydrochloride (<b>25</b>)</h3><div class="NLM_p">To a solution of 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-hydroxypyrrolidine-1,2-dicarboxylate (<b>11</b>) (10.1 g, 41.4 mmol) in DMF (90 mL) at 0 °C was added CDI (6.70 g, 41.4 mmol). The reaction mixture was warmed to RT and stirred for 2 h. A solution of 4-vinylisoindoline (<b>24</b>) (6.00 g, 41.4 mmol) in DMF (10 mL) was added, and the reaction mixture was heated at 60 °C for 2 h. The reaction mixture was cooled and poured into water and 5% potassium bisulfate and the resulting mixture was extracted with EtOAc (4 × 250 mL). The combined organics were washed with brine, dried with Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. Purification by silica gel chromatography (30% EtOAc in hexane) gave 1-<i>tert</i>-butyl 2-methyl (2<i>S</i>,4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}pyrrolidine-1,2-dicarboxylate (13.9 g, 81% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (m, 1 H), 7.23 (m, 1 H), 7.14−7.08 (m, 1 H), 6.62 (dd, <i>J</i> = 17.6, 11.2 Hz, 1 H), 5.66 (m, 1 H), 5.33 (d, <i>J</i> = 11.2 Hz, 1 H), 5.29 (br s, 1 H), 4.78−4.61 (m, 4 H), 4.50−4.32 (m, 1 H), 3.72 (s, 3 H), 3.72−3.58 (m, 2 H), 2.45 (m, 1 H), 2.20 (m, 1 H), 1.42−1.40 (m, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 417.2008 [(M + H)<sup>+</sup>; calcd for C<sub>22</sub>H<sub>29</sub>N<sub>2</sub>O<sub>6</sub>: 417.2020].</div><div class="NLM_p last">The above protected amine (15.0 g, 36.0 mmol) was dissolved in a solution of HCl in dioxane (4 M, 36.0 mL, 144 mmol), and the reaction mixture was stirred at RT for 2 h. The reaction mixture was concentrated, suspended in Et<sub>2</sub>O, and filtered to give <b>25</b> as a white solid (11.5 g, 90% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.40 (dd, <i>J</i> = 7.5, 3.03 Hz, 1 H), 7.27 (apparent t, <i>J</i> = 8.2 Hz, 1 H), 7.18 (apparent t, <i>J</i> = 9.0 Hz, 1 H), 6.70 (ddd, <i>J</i> = 17.6, 11.2, 3.4 Hz, 1 H), 5.70 (dd, <i>J</i> = 17.6, 10.3 Hz, 1 H), 5.41 (br s, 1 H), 5.33 (dd, <i>J</i> = 11.2. 3.0 Hz, 1 H), 4.82−4.70 (m, 5 H), 3.85 (s, 3 H), 3.70−3.58 (m, 2 H), 2.68 (m, 1 H), 2.43 (ddd, <i>J</i> = 14.8, 10.7, 4.9 Hz, 1 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 317.1497 [(M + H)<sup>+</sup>; calcd for C<sub>17</sub>H<sub>21</sub>N<sub>2</sub>O<sub>4</sub>: 317.1496]. Anal. (C<sub>17</sub>H<sub>20</sub>N<sub>2</sub>O<sub>4</sub>·HCl) C, H, N.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-[(Pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-norleucine (<b>26b</b>)</h3><div class="NLM_p">To a solution of 1-penten-4-ol (0.95 g, 11.0 mmol) in DMF (15 mL) at 0 °C was added CDI (1.79 g, 11.0 mmol). The reaction mixture was warmed to RT and stirred for 30 min. <span class="smallcaps smallerCapital">l</span>-Norleucine methyl ester hydrochloride (2.00 g, 11.0 mmol) was added, and the reaction mixture was heated to 50 °C and stirred for 15 min. Upon cooling, the reaction mixture was diluted with Et<sub>2</sub>O and washed twice with water. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 10 to 90% EtOAc in hexanes) to afford methyl <i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-norleucinate (2.10 g, 74% yield) as a clear oil.</div><div class="NLM_p last">To a stirred solution of methyl <i>N-</i>[(pent-4-enyloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-norleucinate (8.50 g, 33.0 mmol) in THF (20 mL) was added 1 N NaOH (20 mL). This reaction mixture was stirred at RT for 3 h and then acidified to pH 3 with 1 N HCl and extracted with EtOAc (3 × 250 mL). The combined EtOAc layer was washed with water, brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>26b</b> (7.09 g, 88% yield) as a clear oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.81 (m, 1 H), 5.12 (s, 1 H), 5.04 (d, <i>J</i> = 17.1 Hz, 1 H), 4.99 (d, <i>J</i> = 10.3 Hz, 1 H), 4.37 (q, <i>J</i> = 5.4 Hz, 1 H), 4.10 (m, 2 H), 2.12 (m, 2 H), 1.88 (s, 1 H), 1.73 (m, 3 H), 1.36 (m, 4 H), 0.91 (t, <i>J</i> = 7.4 Hz, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 244.1549 [(M + H)<sup>+</sup>; calcd for C<sub>12</sub>H<sub>22</sub>NO<sub>4</sub>: 244.1544].</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> <i>N</i>-[(Pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valine (<b>26c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>26b</b> with <span class="smallcaps smallerCapital">l</span>-valine methyl ester hydrochloride provided <b>26c</b> (80% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.00 (m, 1 H), 5.88−5.78 (m, 1 H), 5.06−4.95 (m, 2 H), 4.11−4.03 (m, 3 H), 2.17−2.12 (m, 3 H), 1.76−1.69 (m, 2 H), 0.99−0.93 (m, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 230.1396 [(M + H)<sup>+</sup>; calcd for C<sub>11</sub>H<sub>20</sub>NO<sub>4</sub>: 230.1387].</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (2<i>S</i>)-Cyclohexyl{[(pent-4-en-1-yloxy)carbonyl]amino}acetic Acid (<b>26d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>26b</b> with methyl (2<i>S</i>)-amino(cyclohexyl)acetate hydrochloride provided <b>26d</b> (75% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.01 (d, <i>J</i> = 8.4 Hz, 1 H), 5.88−5.77 (m, 1 H), 5.06−5.01 (m, 1 H), 4.98−4.95 (m, 1 H), 4.05−4.02 (m, 3 H), 3.74−3.70 (m, 1 H), 2.14 (dd, <i>J</i> = 15, 7.0 Hz, 2 H), 1.88−1.65 (m, 8 H), 1.34−1.09 (m, 5 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 270.1732 [(M + H)<sup>+</sup>; calcd for C<sub>14</sub>H<sub>24</sub>NO<sub>4</sub>: 270.1700].</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (2<i>S</i>)-(1-Methylcyclohexyl){[(pent-4-en-1-yloxy)carbonyl]amino}acetic Acid (<b>26e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>13</b> with (2<i>S</i>)-amino(1-methylcyclohexyl)acetic acid hydrochloride<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a> provided <b>26e</b> (30% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 6.89 (br d, <i>J</i> = 9.5 Hz, 1 H), 5.83 (m, 1 H), 5.05 (d, <i>J</i> = 17.0 Hz, 1 H), 4.95 (d, <i>J</i> = 10.0 Hz, 1 H), 4.23 (br s, 1 H), 4.04 (t, <i>J</i> = 6.5 Hz, 2 H), 2.14 (m, 2 H), 1.72 (m, 2 H), 1.61−1.30 (m, 10 H), 0.96 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 284.1854 [(M + H)<sup>+</sup>; calcd for C<sub>15</sub>H<sub>26</sub>NO<sub>4</sub>: 284.1862].</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (2<i>S</i>)-Cyclopentyl {[(Pent-4-en-1-yloxy)carbonyl]amino}acetic Acid (<b>26f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>26b</b> with methyl (2<i>S</i>)-amino(cyclopentyl)acetate hydrochloride provided <b>26f</b> (86% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 5.88−5.78 (m, 1 H), 5.06−4.95 (m, 2 H), 4.06−3.89 (m, 4 H), 2.29−2.11 (m, 2 H), 1.80−1.29 (m, 11 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 256.1542 [(M + H)<sup>+</sup>; calcd for C<sub>13</sub>H<sub>22</sub>NO<sub>4</sub>: 256.1471].</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> <i>N</i>-[(But-3-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>13</b> with but-3-en-1-ol provided <b>26g</b> (51% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.83−5.74 (m, 1 H), 5.24 (d, <i>J</i> = 9.2, 1 H), 5.14−5.06 (m, 2 H), 4.20−4.12 (m, 3 H), 2.42−2.36 (m, 2 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 230.1387 [(M + H)<sup>+</sup>; calcd for C<sub>11</sub>H<sub>20</sub>NO<sub>4</sub>: 230.1314].</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> <i>N</i>-[(Hex-5-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>13</b> with hex-5-en-1-ol provided <b>26h</b> (60% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.80 (m, 1 H), 5.25 (d, <i>J</i> = 9.5 Hz, 1 H), 5.02 (d, <i>J</i> = 17.1 Hz, 1 H), 4.96 (d, <i>J</i> = 9.3 Hz, 1 H), 4.19 (d, <i>J</i> = 9.5 Hz, 1 H), 4.08 (m, 2 H), 2.07 (m, 2 H), 1.64 (quint, <i>J</i> = 7.1 Hz, 2 H), 1.46 (quint, <i>J</i> = 7.4 Hz, 2 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 258.1709 [(M + H)<sup>+</sup>; calcd for C<sub>13</sub>H<sub>24</sub>NO<sub>4</sub>: 258.1700].</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> <i>N</i>-[(Hept-6-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>13</b> with hept-6-en-1-ol provided <b>26i</b> (68% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.81 (m, 1 H), 5.22 (m, 1 H), 5.02 (m, 1 H), 4.97 (m, 1 H), 4.18 (m, 1 H), 4.08 (m, 2 H), 2.11 (m, 2 H), 1.63 (m, 2 H), 1.39 (m, 4 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 272.1858 [(M + H)<sup>+</sup>; calcd for C<sub>14</sub>H<sub>26</sub>NO<sub>4</sub>: 272.1856].</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> Methyl 3-Methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27a</b>)</h3><div class="NLM_p last">To a solution of (3<i>R</i>,5<i>S</i>)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate hydrochloride (<b>25</b>) (200 mg, 0.57 mmol) and 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valine (<b>13</b>) (152 mg, 0.62 mmol) in DMF (5 mL) at RT was added DIPEA (0.30 mL, 1.70 mmol) and HATU (259 mg, 0.68 mmol). After 1 h, the reaction mixture was poured onto Et<sub>2</sub>O and extracted with 0.5 N HCl. The aqueous layer was back-extracted with Et<sub>2</sub>O, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 5% to 90% EtOAc in hexanes) to yield <b>27a</b> (290 mg, 94% yield) as a clear oil. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (apparent t, <i>J</i> = 7.3 Hz, 1 H), 7.23 (m, 1 H), 7.14−7.05 (m, 1 H), 6.62 (ddd, <i>J</i> = 17.6, 10.7, 10.7 Hz, 1 H), 5.70−5.63 (m, 2 H), 5.36−5.30 (m, 2 H), 5.23 (br d, <i>J</i> = 9.3 Hz, 1 H), 4.95−4.59 (m, 7 H), 4.21−4.14 (m, 2 H), 3.89−3.82 (m, 2 H), 3.73 (s, 3 H), 3.63 (m, 1 H), 2.48 (dd, <i>J</i> = 13.6, 7.9 Hz, 1 H), 2.19 (m, 1 H), 1.94 (m, 2 H), 1.50 (m, 2 H), 1.01 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 542.2853 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 542.2861].</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> Methyl <i>N</i>-[(Pent-4-enyloxy)carbonyl]-L-norleucyl-(4R)-4-{[(4-vinyl-1,3-dihydro-2H-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-norleucine (<b>26b</b>) provided <b>27b</b> (89% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.35 (apparent t, <i>J</i> = 7.1 Hz, 1 H), 7.25 (m, 1 H), 7.14−7.06 (m, 1 H), 6.62 (ddd, <i>J</i> = 17.5, 11.2, 6.1 Hz, 1 H), 5.75−5.63 (m, 2 H), 5.39 (m, 1 H), 5.35−5.31 (m, 2 H), 4.95−4.60 (m, 7 H), 4.40 (m, 1 H), 4.05 (m, 1 H), 3.92−3.75 (m, 3 H), 3.72 (s, 3 H), 2.48 (m, 1 H), 2.18 (m, 1 H), 1.98 (m, 2 H), 1.80−1.55 (m, 4 H), 1.40−1.27 (m, 4 H), 0.88 (t, <i>J</i> = 7.0 Hz, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 542.2851 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 542.2861].</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> Methyl <i>N</i>-[(Pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valine (<b>26c</b>) provided <b>27c</b> (77% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.45−7.41 (m, 1 H), 7.30−7.26 (m, 1 H), 7.23−7.15 (m, 1 H), 7.07 (d, <i>J</i> = 7.6 Hz, 1 H), 6.78−6.67 (m, 1 H), 5.72 (dd, <i>J</i> = 17.4, 3.8 Hz, 1 H), 5.68−5.62 (m, 1 H), 5.37−5.33 (m, 2 H), 4.94−4.82 (m, 3 H), 4.79−4.64 (m, 4 H), 4.50 (t, <i>J</i> = 10.4 Hz, 1 H), 3.97 (t, <i>J</i> = 8.4 Hz, 1 H), 3.83−3.78 (m, 1 H), 3.74 (s, 3 H), 3.66−3.62 (m, 1 H), 3.45−3.39 (m, 1 H), 2.60−2.55 (m, 1 H), 2.26−2.18 (m, 1 H), 2.00−1.95 (m, 1 H), 1.85 (m, 2 H), 1.41−1.37 (m, 2 H), 1.10−0.99 (m, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 528.2703 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 528.2705].</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (3<i>R</i>,5<i>S</i>)-1-((2<i>S</i>)-2-Cyclohexyl-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-Vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with (2<i>S</i>)-cyclohexyl{[(pent-4-en-1-yloxy)carbonyl]amino}acetic acid (<b>26d</b>) provided <b>27d</b> (73% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.39 (d, <i>J</i> = 7.2 Hz, 1 H), 7.29−7.24 (m, 1 H), 7.17−7.08 (m, 1 H), 6.70−6.60 (m, 1 H), 5.77−5.66 (m, 2 H), 5.42−5.34 (m, 2 H), 5.27−5.23 (m, 1 H), 4.99−4.59 (m, 7 H), 4.30−4.10 (m, 2 H), 3.93−3.84 (m, 2 H), 3.79−3.69 (m, 4 H), 2.54−2.48 (m, 1 H), 2.28−2.18 (m, 1 H), 2.01−1.95 (m, 2 H), 1.85−1.52 (m, 8 H), 1.28−1.00 (m, 5 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 568.3012 [(M + H)<sup>+</sup>; calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 568.3018].</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (3<i>R</i>,5<i>S</i>)-5-(Methoxycarbonyl)-1-((2<i>S</i>)-2-(1-methylcyclohexyl)-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)pyrrolidin-3-yl 4-Vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with (2<i>S</i>)-(1-methylcyclohexyl){[(pent-4-en-1-yloxy)carbonyl]amino}acetic acid (<b>26e</b>) provided <b>27e</b> (51% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.38 (m, 1 H), 7.27 (m, 1 H), 7.17 and 7.08 (2 × d, <i>J</i> = 7.5 Hz, 1 H), 6.64 (m, 1 H), 5.67 (m, 1 H), 5.36 (m, 2 H), 5.05−4.6 (m, 5 H), 4.24 (m, 1 H), 4.07 (m, 1 H), 3.88 (m, 2 H), 3.76 (s, 3 H), 3.65 (m, 1 H), 2.51 (m, 1 H), 2.21 (m, 1 H), 2.11 (m, 1 H), 1.95 (m, 1 H), 1.69 (m, 1 H), 1.62−1.30 (m, 14 H), 1.18 (m, 1 H), 1.04 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 582.3162 [(M + H)<sup>+</sup>; calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 582.3179].</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (3<i>R</i>,5<i>S</i>)-1-((2<i>S</i>)-2-Cyclopentyl-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with (2<i>S</i>)-cyclopentyl {[(pent-4-en-1-yloxy)carbonyl]amino}acetic acid (<b>26f</b>) provided <b>27f</b> (86% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (m, 1 H), 7.17 (d, <i>J</i> = 7.2 Hz, 1 H), 7.10 (d, <i>J</i> = 7.6 Hz, 1 H), 6.70−6.61 (m, 2 H), 5.75−5.65 (m, 2 H), 5.37 (m, 1 H), 5.29 (m, 1 H), 4.99−4.59 (m, 8 H), 4.31−4.24 (m, 3 H), 3.95−3.82 (m, 2 H), 3.74 (m, 1 H), 2.73 (br s, 1 H), 2.56−2.51 (m, 1 H), 2.26−2.16 (m, 1 H), 1.94 (m, 1 H), 1.83−1.48 (m, 10 H), 1.35 (m, 1 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 554.2888 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 554.2788].</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> Methyl <i>N</i>-[(But-3-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-[(but-3-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26g</b>) provided <b>27g</b> (96% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40−7.37 (m, 1 H), 7.29−7.24 (m, 1 H), 7.18−1.08 (m, 1 H), 6.70−6.61 (m, 1 H), 5.69 (dd, <i>J</i> = 17.6 Hz, 4.8 Hz, 1 H), 5.60 (m, 1 H), 5.40−5.31 (m, 3 H), 5.03−4.98 (m, 2 H), 4.88−4.59 (m, 5 H), 4.25−4.19 (m, 2 H), 3.98−3.64 (m, 5 H), 2.55−2.50 (m, 1 H), 2.26−2.18 (m, 4 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 528.2704 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 528.2632].</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> Methyl <i>N</i>-[(Hex-5-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-[(hex-5-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26h</b>) provided <b>27h</b> (82% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.42 (t, <i>J</i> = 8.2 Hz, 1 H), 7.28 (sext, <i>J</i> = 3.8 Hz, 1 H), 7.18 (2 × d, <i>J</i> = 7.3 Hz, 1 H), 6.77−6.66 (m, 1 H), 5.72 (m, 2 H), 5.36 (t, <i>J</i> = 9.9 Hz, 1 H), 5.32 (m, 1 H), 4.91 (m, 2 H), 4.79−4.65 (m, 5 H), 4.42 (t, <i>J</i> = 11.1 Hz, 1 H), 4.17 (s, 1 H), 3.79 (m, 1 H), 3.74 (s, 3 H), 3.60 (m, 1 H), 3.35 (m, 1 H), 2.58 (m, 1 H), 2.21 (m, 1 H), 1.89 (q, <i>J</i> = 5.9 Hz, 2 H), 1.28 (m, 2 H), 1.16 (m, 2 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 556.3063 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 556.3018].</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> Methyl <i>N</i>-[(Hept-6-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-[(hept-6-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>26i</b>) provided <b>27i</b> (83% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (t, <i>J</i> = 7.4 Hz, 1 H), 7.25 (t, <i>J</i> = 7.4 Hz, 1 H), 7.10 (2 × d, <i>J</i> = 7.4 Hz, 1 H), 6.63 (m, 1 H), 5.79 (m, 1 H), 5.69 (dd, <i>J</i> = 17.7, 4.4 Hz, 1 H), 5.37 (m, 2 H), 5.29 (m, 1 H), 4.94 (m, 2 H), 4.82−4.68 (m, 3 H), 4.64−4.56 (m, 2 H), 4.23 (d, <i>J</i> = 4.7 Hz, 2 H), 3.89 (m, 2 H), 3.76 (s, 3 H), 3.81 (m, 1 H), 2.52 (m, 1 H), 2.21 (m, 1 H), 2.00 (m, 2 H), 1.42 (m, 2 H), 1.31 (m, 2 H), 1.14 (m, 2 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 570.3174 [(M + H)<sup>+</sup>; calcd for C<sub>31</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 570.3174].</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28a</b>)</h3><div class="NLM_p last">A solution of methyl 3-methyl-<i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27a</b>) (230 mg, 0.43 mmol) in DCE (85 mL) was degassed with N<sub>2</sub> for 15 min. The Zhan 1b catalyst<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (31 mg, 0.042 mmol) was added, and the reaction mixture was heated to 75 °C for 1 h. The reaction mixture was concentrated and the crude product was purified by silica gel chromatography (gradient elution, 10−90% EtOAc/hexane) to provide <b>28a</b> (198 mg, 91% yield) as an off-white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26−7.18 (m, 2 H), 7.07 (d, <i>J</i> = 7.3 Hz, 1 H), 6.24 (d, <i>J</i> = 15.9 Hz, 1 H), 5.97 (ddd, <i>J</i> = 15.9, 8.0, 5.9 Hz, 1 H), 5.40−5.36 (m, 2 H), 4.68−4.50 (m, 5 H), 4.36 (d, <i>J</i> = 9.8 Hz, 1 H), 4.27 (dd, <i>J</i> = 11.5, 1.8 Hz, 1 H), 4.21 (dd, <i>J</i> = 10.9, 4.6 Hz, 1 H), 3.85 (m, 1 H), 3.73 (s, 3 H), 3.69 (dd, <i>J</i> = 11.5, 3.1 Hz, 1 H), 2.58 (ddd, <i>J</i> = 14.2, 8.1, 1.6 Hz, 1 H), 2.33−2.25 (m, 2 H), 2.09 (ddd, <i>J</i> = 14.0, 10.1, 3.8 Hz, 1 H), 1.95 (m, 1 H), 1.63, 1 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 514.2546 [(M + H)<sup>+</sup>; calcd for C<sub>27</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub>: 514.2548].</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-[(pent-4-enyloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-norleucyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2H-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27b</b>) provided <b>28b</b> (78% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.24−7.17 (m, 2 H), 7.07 (d, <i>J</i> = 7.2 Hz, 1 H), 6.28 (d, <i>J</i> = 16.1 Hz, 1 H), 5.98 (ddd, <i>J</i> = 16.1, 7.4, 6.0 Hz, 1 H), 5.37 (apparent t, <i>J</i> = 3.3 Hz, 1 H), 5.16 (d, <i>J</i> = 8.9 Hz, 1 H), 4.68−4.38 (m, 6 H), 4.27 (m, 1 H), 3.84 (m, 1 H), 3.72 (s, 3 H), 3.71 (m, 1 H), 2.60 (ddd, <i>J</i> = 14.1, 7.9, 1.6 Hz, 1 H), 2.31−2.23 (m, 2 H), 2.10 (ddd, <i>J</i> = 14.0, 10.1, 3.8 Hz, 1 H), 1.92 (m, 1 H), 1.78 (m, 1 H), 1.70−1.59 (m, 3 H), 1.43−1.30 (m, 4 H), 0.90 (t, <i>J</i> = 6.9 Hz, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 514.2545 [(M + H)<sup>+</sup>; calcd for C<sub>27</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub>: 514.2548].</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Isopropyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-[(pent-4-en-1-yloxy)carbonyl]-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27c</b>) provided <b>28c</b> (84% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.31−7.29 (m, 1 H), 7.26−7.22 (m, 1 H), 7.16−7.14 (m, 1 H), 6.44−6.40 (m, 1 H), 6.15−6.07 (m, 1 H), 5.34 (m, 1 H), 4.77−4.73 (m, 1 H), 4.68 (m, 3 H), 4.63−4.57 (m, 1 H), 4.51−4.48 (m, 1 H), 4.33−4.26 (m, 1 H), 4.16−4.13 (m, 1 H), 3.92−3.87 (m, 1 H), 3.81−3.79 (m, 1 H), 3.73 (s, 3 H), 2.63−2.58 (m, 1 H), 2.40−2.21 (m, 2 H), 2.20−2.14 (m, 1 H), 2.05−1.90 (m, 2 H), 1.80−1.68 (m, 1 H), 1.05 (d, <i>J</i> = 6.8 Hz, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 500.2380 [(M + H)<sup>+</sup>; calcd for C<sub>26</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub>: 500.2392].</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Cyclohexyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with (3<i>R</i>,5<i>S</i>)-1-((2<i>S</i>)-2-cyclohexyl-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27d</b>) provided <b>28d</b> (84% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.29 (d, <i>J</i> = 7.6 Hz, 1 H), 7.23 (t, <i>J</i> = 7.6 Hz, 1 H), 7.14 (d, <i>J</i> = 7.6 Hz, 1 H), 6.40 (d, <i>J</i> = 16.0 Hz, 1 H), 6.10 (dt, <i>J</i> = 16.0, 6.5 Hz, 1 H), 5.32 (t, <i>J</i> = 3.0 Hz, 1 H), 4.74−4.55 (m, 5 H), 4.47 (d, <i>J</i> = 11.6 Hz, 1 H), 4.29−4.24 (m, 1 H), 4.20 (d, <i>J</i> = 9.6 Hz, 1 H), 3.91−3.85 (m, 1 H), 3.78 (dd, <i>J</i> = 11.6, 2.8 Hz, 1 H), 3.72 (s, 3 H), 2.62−2.56 (m, 1 H), 2.40−2.22 (m, 2 H), 2.16 (ddd, <i>J</i> = 14.2, 10.4, 3.8 Hz, 1 H), 2.02−1.90 (m, 3 H), 1.82−1.66 (m, 5 H), 1.34−1.22 (m, 3 H), 1.12−1.00 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 540.2689 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 540.2705].</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-(1-Methylcyclohexyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with (3<i>R</i>,5<i>S</i>)-5-(methoxycarbonyl)-1-((2<i>S</i>)-2-(1-methylcyclohexyl)-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27e</b>) provided <b>28e</b> (90% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.25 (m, 2 H), 7.11 (d, <i>J</i> = 7.5 Hz, 1 H), 6.26 (d, <i>J</i> = 15.5 Hz, 1 H), 5.98 (m, 1 H), 5.45 (d, <i>J</i> = 10.0 Hz, 1 H), 5.42 (t, <i>J</i> = 3.5 Hz, 1 H), 4.7 (m, 3 H), 4.6 (m, 2 H), 4.42 (d, <i>J</i> = 10.0 Hz, 1 H), 4.32 (dd, <i>J</i> = 11.5, 2.0 Hz, 1 H), 4.24 (dt, <i>J</i> = 11.0, 4.5 Hz, 1 H), 3.88 (m, 1 H), 3.76 (s, 3 H), 3.74 (m, 1 H), 2.60 (m, 1 H), 2.3 (m, 2 H), 2.12 (m, 1 H), 1.97 (m, 1 H), 1.67−1.35 (m, 11 H), 1.07 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 554.2846 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 554.2866].</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> Methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Cyclopentyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with (3<i>R</i>,5<i>S</i>)-1-((2<i>S</i>)-2-cyclopentyl-2-{[(pent-4-en-1-yloxy)carbonyl]amino}acetyl)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>27f</b>) provided <b>28f</b> (81% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.27−7.21 (m, 2 H), 7.12 (d, <i>J</i> = 6.8 Hz, 1 H), 6.31 (d, <i>J</i> = 16.0 Hz, 1 H), 6.03−5.96 (m, 1 H), 5.40 (t, <i>J</i> = 3.2 Hz, 1 H), 5.24 (d, <i>J</i> = 8.8 Hz, 1 H), 4.76−4.64 (m, 4 H), 4.59−4.55 (m, 1 H), 4.47 (dd, <i>J</i> = 11.4 Hz, 1.8 Hz, 1 H), 4.34−4.25 (m, 2 H), 3.90−3.85 (m, 1 H), 3.79−3.75 (m, 4 H), 2.67−2.62 (m, 1 H), 2.35−2.21 (m, 2 H), 2.17−2.11 (m, 1 H), 1.99−1.93 (m, 1 H), 1.87−1.83 (m, 2 H), 1.72−1.57 (m, 6 H), 1.44−1.26 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 526.2563 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>36</sub>N<sub>3</sub>O<sub>7</sub>: 526.2475].</div></div><div id="sec5_51" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> Methyl (1<i>R</i>,12<i>E</i>,19<i>S</i>,22<i>S</i>)-19-<i>tert</i>-Butyl-3,17,20-trioxo-2,16-dioxa-4,18,21-triazatetracyclo[19.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-22-carboxylate (<b>28g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-[(but-3-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27g</b>) provided <b>28g</b> (64% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23 (d, <i>J</i> = 7.6 Hz, 1 H), 7.11 (t, <i>J</i> = 7.0 Hz, 2 H), 6.41 (d, <i>J</i> = 16.8 Hz, 1 H), 5.96−5.90 (m, 1 H), 5.59 (d, <i>J</i> = 9.6 Hz, 1 H), 5.28 (t, <i>J</i> = 3.4 Hz, 1 H), 4.84−4.68 (m, 5 H), 4.57 (d, <i>J</i> = 15.2 Hz, 1 H), 4.49 (d, <i>J</i> = 9.6 Hz, 1 H), 4.32 (dd, <i>J</i> = 11.6, 2.0 Hz, 1 H), 3.91 (dt, <i>J</i> = 11.0, 3.3 Hz, 1 H), 3.76−3.71 (m, 4 H), 2.81−2.75 (m, 1 H), 2.67 (m, 1 H), 2.39 (m, 1 H), 2.19−2.12 (m, 1 H), 1.07 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 500.2409 [(M + H)<sup>+</sup>; calcd for C<sub>26</sub>H<sub>34</sub>N<sub>3</sub>O<sub>7</sub>: 500.2319].</div></div><div id="sec5_52" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> Methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-Butyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>28h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-[(hex-5-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27h</b>) provided <b>28h</b> (80% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.23 (m, 2 H), 7.15 (dd, <i>J</i> = 5.9, 2.7 Hz, 1 H), 6.38 (d, <i>J</i> = 16.0 Hz, 1 H), 6.08 (dt, <i>J</i> = 16.1, 6.3 Hz, 1 H), 5.39 (t, <i>J</i> = 3.8 Hz, 1 H), 4.75 (m, 1 H), 4.69 (d, <i>J</i> = 1.2 Hz, 2 H), 4.58 (m, 3 H), 4.39 (s, 1 H), 4.25 (d, <i>J</i> = 12.0 Hz, 1 H), 3.91 (dd, <i>J</i> = 12.0, 4.0 Hz, 1 H), 3.77 (m, 1 H), 3.72 (s, 3 H), 2.64 (m, 1 H), 2.23 (m, 3 H), 1.70 (m, 2 H), 1.54 (m, 2 H), 1.06 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 528.2688 [(M + H)<sup>+</sup>; calcd for C<sub>28</sub>H<sub>38</sub>N<sub>3</sub>O<sub>7</sub>: 528.2705].</div></div><div id="sec5_53" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> Methyl (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-<i>tert</i>-Butyl-3,20,23-trioxo-2,19-dioxa-4,21,24-triazatetracyclo[22.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]octacosa-6,8,10,12-tetraene-25-carboxylate (<b>28i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-[(hept-6-en-1-yloxy)carbonyl]-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>27i</b>) provided <b>28i</b> (67% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.34 (t, <i>J</i> = 7.4 Hz, 1 H), 7.23 (t, <i>J</i> = 7.4 Hz, 1 H), 7.11 (d, <i>J</i> = 7.4 Hz, 1 H), 6.25 (d, <i>J</i> = 15.8 Hz, 1 H), 6.10 (m, 1 H), 5.63 (t, <i>J</i> = 3.6 Hz, 1 H), 5.33 (d, <i>J</i> = 9.5 Hz, 1 H), 4.73 (m, 2 H), 4.61 (m, 3 H), 4.33 (m, 2 H), 4.22 (m, 1 H), 3.86 (dd, <i>J</i> = 11.5, 3.8 Hz, 1 H), 3.77 (s, 3 H), 3.74 (m, 1 H), 2.57 (m, 1 H), 2.34 (m, 1 H), 2.24−2.19 (m, 2 H), 1.71 (m, 1 H), 1.48 (m, 3 H), 1.29 (m, 2 H), 1.07 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 542.2884 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 542.2861].</div></div><div id="sec5_54" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29a</b>)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28a</b>) (460 mg, 0.90 mmol) in THF (10 mL), MeOH (2.5 mL), and water (5 mL) was added LiOH (215 mg, 8.96 mmol). The reaction mixture was heated to 40 °C and stirred for 1 h. The mixture was then diluted with 0.5 N HCl and EtOAc, and the layers were separated. The organic layer was dried over Na<sub>2</sub>CO<sub>3</sub>, filtered, and concentrated to give (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylic acid (440 mg, 98% yield).</div><div class="NLM_p last">To a solution of the above crude acid (55 mg, 0.11 mmol) in DMF (1 mL) was added (1<i>R</i>,2<i>S</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-vinylcyclopropanecarboxamide hydrochloride (<b>16</b>)<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> (42 mg, 0.15 mmol), HATU (59 mg, 0.15 mmol), and DIPEA (0.06 mL, 0.33 mmol). The reaction mixture was stirred at RT for 2 h and then directly purified by reverse phase HPLC [Waters SunFire Prep C18 OBD 5 μm, 30 mm × 100 mm column, 5−95% MeCN/0.15% trifluoroacetic acid (TFA) in water]. The fractions containing product were concentrated to give <b>29a</b> as a white solid (42 mg, 54% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.89 (br s, 1 H), 7.29−7.22 (m, 2 H), 7.17−7.11 (m, 2 H), 6.29 (d, <i>J</i> = 16.0 Hz, 1 H), 6.03 (ddd, <i>J</i> = 16.0, 6.1, 6.1 Hz, 1 H), 5.73 (m, 1 H), 5.46−5.44 (m, 2 H), 5.27 (d, <i>J</i> = 17.0 Hz, 1 H), 5.14 (d, <i>J</i> = 10.3 Hz, 1 H), 4.75−4.65 (m, 3 H), 4.53 (d, <i>J</i> = 15.0 Hz, 1 H), 4.46 (dd, <i>J</i> = 9.7, 7.7 Hz, 1 H), 4.37 (apparent t, <i>J</i> = 9.6 Hz, 2 H), 4.25 (m, 1 H), 3.91 (m, 1 H), 3.73 (dd, <i>J</i> = 11.6, 3.1 Hz, 1 H), 2.91 (m, 1 H), 2.47−2.41 (m, 2 H), 2.34−2.29 (m, 2 H), 2.10−1.95 (m, 5 H), 1.71 (m, 1 H), 1.44 (dd, <i>J</i> = 9.3, 5.8 Hz, 1 H), 1.39−1.35 (m, 2 H), 1.07 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 712.3041 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>46</sub>N<sub>5</sub>O<sub>9</sub>S: 712.3011]. Anal. (C<sub>35</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S·0.5TFA) C, H, N.</div></div><div id="sec5_55" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29b</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28b</b>) provided <b>29b</b> (44% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 10.00 (s, 1 H), 7.29−7.22 (m, 2 H), 7.12 (d, <i>J</i> = 7.2 Hz, 1 H), 7.07 (s, 1 H), 6.39 (d, <i>J</i> = 16.1 Hz, 1 H), 6.08 (ddd, <i>J</i> = 16.1, 6.2, 6.2 Hz, 1 H), 5.77 (m, 1 H), 5.43 (apparent t, <i>J</i> = 2.7 Hz, 1 H), 5.38 (d, <i>J</i> = 8.3 Hz, 1 H), 5.25 (d, <i>J</i> = 17.0 Hz, 1 H), 5.13 (d, <i>J</i> = 10.3 Hz, 1 H), 4.80−4.67 (m, 3 H), 4.59 (d, <i>J</i> = 15.2 Hz, 1 H), 4.46−4.35 (m, 3 H), 4.29 (m, 1 H), 3.94 (m, 1 H), 3.77 (dd, <i>J</i> = 11.4, 3.1 Hz, 1 H), 2.94 (m, 1 H), 2.52−2.36 (m, 2 H), 2.31−2.25 (m, 2 H), 2.10−1.70 (m, 8 H), 1.39−1.24 (m, 5 H), 1.04 (m, 2 H), 0.92 (m, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 712.3028 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>46</sub>N<sub>5</sub>O<sub>9</sub>S: 712.3011]. Anal. (C<sub>35</sub>H<sub>45</sub>N<sub>5</sub>O<sub>9</sub>S·0.6TFA) C, H, N.</div></div><div id="sec5_56" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-20-isopropyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-isopropyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28c</b>) provided <b>29c</b> (78% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.26 (s, 1 H), 7.34−7.24 (m, 2 H), 7.17−7.15 (m, 1 H), 6.43−6.39 (m, 1 H), 6.13−6.10 (m, 1 H), 5.80−5.72 (m, 1 H), 5.37−5.29 (m, 2 H), 5.12 (d, <i>J</i> = 10.0 Hz, 1 H), 4.80−4.65 (m, 4 H), 4.54−4.48 (m, 1 H), 4.42−4.37 (m, 1 H), 4.36−4.30 (m, 1 H), 4.08−4.03 (m, 1 H), 3.91−3.82 (m, 2 H), 2.99−2.93 (m, 1 H), 2.47−2.42 (m, 1 H), 2.37−2.06 (m, 5 H), 1.99−1.94 (m, 1 H), 1.92−1.86 (m, 1 H), 1.78−1.70 (m, 1 H), 1.42−1.37 (m, 1 H), 1.31−1.16 (m, 3 H), 1.09−0.96 (m, 8 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 698.2858 [(M + H)<sup>+</sup>; calcd for C<sub>34</sub>H<sub>44</sub>N<sub>5</sub>O<sub>9</sub>S: 698.2854]. Anal. (C<sub>34</sub>H<sub>43</sub>N<sub>5</sub>O<sub>9</sub>S·0.25H<sub>2</sub>O·1.2EtOAc) C, H, N.</div></div><div id="sec5_57" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-cyclohexyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28d</b>) provided <b>29d</b> (79% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.24 (s, 1 H), 7.30 (d, <i>J</i> = 7.5 Hz, 1 H), 7.25 (t, <i>J</i> = 7.5 Hz, 1 H), 7.16 (d, <i>J</i> = 7.0 Hz, 1 H), 6.42 (d, <i>J</i> = 16.0 Hz, 1 H), 6.11 (dt, <i>J</i> = 16.0, 6.6 Hz, 1 H), 5.76 (m, 1 H), 5.35 (s, 1 H), 5.30 (m, 2 H), 5.12 (dd, <i>J</i> = 10.5, 1.5 Hz, 1 H), 4.79−4.63 (m, 4 H), 4.49 (d, <i>J</i> = 11.5 Hz, 1 H), 4.39 (dd, <i>J</i> = 10.5, 6.5 Hz, 1 H), 4.32 (sext, <i>J</i> = 5.3 Hz, 1 H), 4.15 (d, <i>J</i> = 10.5 Hz, 1 H), 3.90−3.86 (m, 1 H), 3.84 (dd, <i>J</i> = 11.5, 3.0 Hz, 1 H), 2.98−2.93 (m, 1 H), 2.44 (dd, <i>J</i> = 13.7, 7.2 Hz, 1 H), 2.39−2.14 (m, 4 H), 1.98−1.66 (m, 9 H), 1.40 (dd, <i>J</i> = 9.2, 5.2 Hz, 1 H), 1.31−1.21 (m, 5 H), 1.10−1.02 (m, 4 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 738.3176 [(M + H)<sup>+</sup>; calcd for C<sub>37</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 738.3167]. Anal. (C<sub>37</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·1.8H<sub>2</sub>O·0.55EtOAc) C, H, N.</div></div><div id="sec5_58" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-20-(1-methylcyclohexyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-(1-methylcyclohexyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28e</b>) provided <b>29e</b> (83% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.32 (d, <i>J</i> = 7.5 Hz, 1 H), 7.25 (t, <i>J</i> = 8.0 Hz, 1 H), 7.17 (d, <i>J</i> = 7.5 Hz, 1 H), 7.15 (d, <i>J</i> = 9.5 Hz, 1 H), 6.37 (d, <i>J</i> = 16.0 Hz, 1 H), 6.10 (m, 1 H), 5.72 (m, 1 H), 5.37 (s, 1 H), 5.28 (dd, <i>J</i> = 17.0, 1.5 Hz, 1 H), 5.12 (dd, <i>J</i> = 10.0, 1.5 Hz, 1 H), 4.67 (m, 4 H), 4.42 (m, 3 H), 4.28 (m, 1 H), 3.87 (m, 2 H), 2.93 (m, 1 H), 2.40 (m, 2 H), 2.31 (m, 1 H), 2.22 (m, 1 H), 2.12 (m, 1 H), 2.0 (m, 1 H), 1.88 (dd, <i>J</i> = 8.3, 5.5 Hz, 1 H), 1.71 (m, 1 H), 1.63−1.36 (m, 10 H), 1.30−1.19 (m, 4 H), 1.09 (s, 3 H), 1.08 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 752.3303 [(M + H)<sup>+</sup>; calcd for C<sub>38</sub>H<sub>50</sub>N<sub>5</sub>O<sub>9</sub>S: 752.3329].</div></div><div id="sec5_59" class="NLM_sec NLM_sec_level_2"><div id="ac_i67" class="anchor-spacer"></div><h3 class="article-section__title" id="_i67"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-Cyclopentyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>29f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-cyclopentyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28f</b>) provided <b>29f</b> (98% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.29−7.12 (m, 3 H), 6.40 (d, <i>J</i> = 16.0 Hz, 1 H), 6.10 (m, 1 H), 5.57 (br s, 1 H), 5.31−5.07 (m, 3 H), 4.79−4.14 (m, 10 H), 3.86 (m, 2 H), 2.95 (br s, 1 H), 2.42−2.22 (m, 6 H), 1.91−1.58 (m, 8 H), 1.38−1.04 (m, 8 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 724.3029 [(M + H)<sup>+</sup>; calcd for C<sub>36</sub>H<sub>46</sub>N<sub>5</sub>O<sub>9</sub>S: 724.3011].</div></div><div id="sec5_60" class="NLM_sec NLM_sec_level_2"><div id="ac_i68" class="anchor-spacer"></div><h3 class="article-section__title" id="_i68"> (1<i>R</i>,12<i>E</i>,19<i>S</i>,22<i>S</i>)-19-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,17,20-trioxo-2,16-dioxa-4,18,21-triazatetracyclo[19.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-22-carboxamide (<b>29g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,19<i>S</i>,22<i>S</i>)-19-<i>tert</i>-butyl-3,17,20-trioxo-2,16-dioxa-4,18,21-triazatetracyclo[19.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]pentacosa-6,8,10,12-tetraene-22-carboxylate (<b>28g</b>) provided <b>29g</b> (91% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.23 (m, 1 H), 7.13 (m, 2 H), 6.48 (d, <i>J</i> = 16.4 Hz, 1 H), 6.00 (m, 1 H), 5.80 (br s, 1 H), 5.24 (m, 2 H), 5.05 (m, 1 H), 4.79−4.57 (m, 5 H), 4.51 (s, 1 H), 4.42 (br s, 1 H), 4.33 (d, <i>J</i> = 12.0 Hz, 1 H), 3.99−3.83 (m, 2 H), 2.84 (br s, 1 H), 2.70−2.63 (m, 2 H), 2.44−2.40 (m, 1 H), 2.29−2.10 (m, 2 H), 1.83 (m, 1 H), 1.39−0.90 (m, 16 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 698.2854 [(M + H)<sup>+</sup>; calcd for C<sub>34</sub>H<sub>44</sub>N<sub>5</sub>O<sub>9</sub>S: 698.2781].</div></div><div id="sec5_61" class="NLM_sec NLM_sec_level_2"><div id="ac_i69" class="anchor-spacer"></div><h3 class="article-section__title" id="_i69"> (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxamide (<b>29h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-butyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>28h</b>) provided <b>29h</b> (70% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.25 (t, <i>J</i> = 7.5 Hz, 1 H), 7.22 (d, <i>J</i> = 7.0 Hz, 1 H), 7.15 (d, <i>J</i> = 6.5 Hz, 1 H), 6.37 (d, <i>J</i> = 16.0 Hz, 1 H), 6.07 (dt, <i>J</i> = 16.0, 6.4 Hz, 1 H), 5.77 (dt, <i>J</i> = 17.0, 9.0 Hz, 1 H), 5.37 (m, 1 H), 5.28 (d, <i>J</i> = 17.5 Hz, 1 H), 5.11 (d, <i>J</i> = 10.5 Hz, 1 H), 4.75 (d, <i>J</i> = 14.3 Hz, 1 H), 4.66 (m, 5 H), 4.41 (s, 1 H), 4.37 (dd, <i>J</i> = 10.7, 6.8 Hz, 1 H), 4.23 (d, <i>J</i> = 11.5 Hz, 1 H), 3.95 (dd, <i>J</i> = 12.0, 4.0 Hz, 1 H), 3.77 (quint, <i>J</i> = 5.6 Hz, 1 H), 2.93 (m, 1 H), 2.51 (dd, <i>J</i> = 14.0, 6.5 Hz, 1 H), 2.23 (m, 4 H), 1.86 (dd, <i>J</i> = 8.2, 5.7 Hz, 1 H), 1.68 (m, 2 H), 1.53 (quint, <i>J</i> = 7.2 Hz, 2 H), 1.44 (dd, <i>J</i> = 9.2, 5.8 Hz, 1 H); 1.24 (m, 3 H); 1.06 (m, 2 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 726.3137 [(M + H)<sup>+</sup>; calcd for C<sub>36</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 726.3167]. Anal. (C<sub>36</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_62" class="NLM_sec NLM_sec_level_2"><div id="ac_i70" class="anchor-spacer"></div><h3 class="article-section__title" id="_i70"> (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,20,23-trioxo-2,19-dioxa-4,21,24-triazatetracyclo[22.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]octacosa-6,8,10,12-tetraene-25-carboxamide (<b>29i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>29a</b> with methyl (1<i>R</i>,12<i>E</i>,22<i>S</i>,25<i>S</i>)-22-<i>tert</i>-butyl-3,20,23-trioxo-2,19-dioxa-4,21,24-triazatetracyclo[22.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]octacosa-6,8,10,12-tetraene-25-carboxylate (<b>28i</b>) provided <b>29i</b> (61% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.35 (t, <i>J</i> = 7.7 Hz, 1 H), 7.25 (t, <i>J</i> = 7.7 Hz, 1 H), 7.11 (d, <i>J</i> = 7.7 Hz, 1 H), 6.26 (d, <i>J</i> = 15.6 Hz, 1 H), 6.11 (m, 1 H), 5.82 (m, 1 H), 5.48 (m, 1 H), 5.27 (m, 1 H), 4.91 (m, 1 H), 4.89−4.60 (m, 5 H), 4.36−4.13 (m, 4 H), 3.79 (m, 2 H), 2.58 (m, 1 H), 2.26 (m, 2 H), 2.19 (m, 1 H), 2.03 (s, 3 H), 1.83 (m, 2 H), 1.69 (m, 1 H), 1.49 (m, 3 H), 1.33 (m, 2 H), 1.21 (m, 2 H), 1.02 (s, 9 H), 0.79 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 740.3320 [(M + H)<sup>+</sup>; calcd for C<sub>37</sub>H<sub>50</sub>N<sub>5</sub>O<sub>9</sub>S: 740.3324]. Anal. (C<sub>37</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S·3.8H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_63" class="NLM_sec NLM_sec_level_2"><div id="ac_i71" class="anchor-spacer"></div><h3 class="article-section__title" id="_i71"> (1<i>R</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>S</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10-triene-23-carboxamide (<b>31a</b>)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28a</b>) (100 mg, 0.20 mmol) in EtOAc (7 mL) was added 10% palladium on carbon (10 mg). The reaction mixture was stirred under a balloon of hydrogen for 5 h at RT. The reaction mixture was filtered through celite and the filtrate evaporated to give methyl (1<i>R</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10-triene-23-carboxylate (90 mg, 90% yield), which was used with no further purification.</div><div class="NLM_p last">Using the procedure for <b>29a</b> with the above crude ester provided <b>31a</b> (28% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 9.14 (s, 1 H), 7.23 (t, <i>J</i> = 7.4 Hz, 1 H), 7.13 (d, <i>J</i> = 7.2 Hz, 1 H), 7.10 (d, <i>J</i> = 7.2 Hz, 1 H), 5.75 (m, 1 H), 5.53 (s, 1 H), 5.30 (d, <i>J</i> = 16.8 Hz, 1 H), 5.12 (d, <i>J</i> = 10.0 Hz, 1 H), 4.75−4.59 (m, 4 H), 4.42 (m, 2 H), 4.34 (s, 1 H), 4.30 (d, <i>J</i> = 12.0 Hz, 1 H), 3.88 (d, <i>J</i> = 9.5 Hz, 1 H), 3.75 (m, 1 H), 3.60 (q, <i>J</i> = 6.9 Hz, 2 H), 2.95 (sept, <i>J</i> = 4.6 Hz, 1 H), 2.63 (m, 1 H), 2.41 (m, 2 H), 2.23 (q, <i>J</i> = 8.9 Hz, 1 H), 2.15 (m, 1 H), 1.88 (m, 1 H), 1.79 (m, 1 H), 1.56 (m, 3 H), 1.41 (m, 3 H), 1.25 (m, 2 H), 1.17 (t, <i>J</i> = 7.0 Hz, 2 H), 1.06 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 714.3188 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 714.3167]. Anal. (C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·2H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_64" class="NLM_sec NLM_sec_level_2"><div id="ac_i72" class="anchor-spacer"></div><h3 class="article-section__title" id="_i72"> (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxamide (<b>31b</b>)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28a</b>) (60 mg, 0.12 mmol) in THF (1 mL), MeOH (0.5 mL) and water (0.5 mL) was added LiOH (28 mg, 1.17 mmol). The reaction mixture was heated to 40 °C and stirred for 1 h. The reaction mixture was then diluted with 0.5 N HCl and EtOAc, and the layers were separated. The organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylic acid (51 mg, 87% yield).</div><div class="NLM_p last">To a solution of the above carboxylic acid (51 mg, 0.10 mmol) in DMF (1 mL) was added (1<i>R</i>,2<i>R</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-ethylcyclopropanecarboxamide hydrochloride (<b>30</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (32 mg, 0.12 mmol), HATU (48 mg, 0.15 mmol), and DIPEA (0.04 mL, 0.25 mmol). The reaction mixture was stirred at RT for 2 h and then directly purified by reverse phase HPLC [Waters SunFire Prep C18 OBD 5 μm, 30 mm × 100 mm column, 5−95% MeCN/0.15% TFA in water]. The fractions containing product were concentrated to give <b>31b</b> as a white solid (55 mg, 77% yield). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.33 (d, <i>J</i> = 7.2 Hz, 1 H), 7.26 (t, <i>J</i> = 7.6 Hz, 1 H), 7.16 (d, <i>J</i> = 8.0 Hz, 1 H), 6.39 (d, <i>J</i> = 15.7 Hz, 1 H), 6.13 (m, 1 H), 5.37 (s, 1 H), 4.69 (m, 5 H), 4.47−4.28 (m, 5 H), 3.89 (m, 1 H), 3.83 (d, <i>J</i> = 11.6 Hz, 1 H), 2.98 (m, 1 H), 2.40 (m, 2 H), 2.31 (m, 1 H), 2.10 (t, <i>J</i> = 12.0 Hz, 1 H), 1.99 (s, 1 H), 1.73 (m, 1 H), 1.60 (m, 2 H), 1.52 (m, 1 H), 1.29−1.15 (m, 4 H), 1.08 (s, 9 H), 0.98 (m, 4 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 714.3189 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>48</sub>N<sub>5</sub>O<sub>9</sub>S: 714.3167]. Anal. (C<sub>35</sub>H<sub>47</sub>N<sub>5</sub>O<sub>9</sub>S·0.60TFA) C, H, N.</div></div><div id="sec5_65" class="NLM_sec NLM_sec_level_2"><div id="ac_i73" class="anchor-spacer"></div><h3 class="article-section__title" id="_i73"> (1<i>R</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10-triene-23-carboxamide (<b>31c</b>)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10,12-tetraene-23-carboxylate (<b>28a</b>) (100 mg, 0.20 mmol) in EtOAc (7 mL) was added 10% palladium on carbon (10 mg). The reaction mixture was stirred under a balloon of hydrogen for 5 h at RT. The reaction mixture was filtered through celite and the filtrate evaporated to give methyl (1<i>R</i>,20<i>S</i>,23<i>S</i>)-20-<i>tert</i>-butyl-3,18,21-trioxo-2,17-dioxa-4,19,22-triazatetracyclo[20.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]hexacosa-6,8,10-triene-23-carboxylate (90 mg, 90% yield), which was used with no further purification.</div><div class="NLM_p last">Using the procedure for <b>31b</b> with the above crude ester provided <b>31c</b> (82% yield, 3 steps). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.23 (t, <i>J</i> = 7.5 Hz, 1 H), 7.13 (d, <i>J</i> = 7.5 Hz, 1 H), 7.10 (d, <i>J</i> = 7.5 Hz, 1 H), 7.02 (d, <i>J</i> = 9.0 Hz, 1 H), 5.52 (s, 1 H), 4.74−4.60 (m, 5 H), 4.48−4.30 (m, 4 H), 3.88 (d, <i>J</i> = 11.5 Hz, 1 H), 3.75 (m, 1 H), 2.99 (sept, <i>J</i> = 4.3 Hz, 1 H), 2.62 (m, 1 H), 2.41 (m, 2 H), 2.14 (m, 1 H), 1.79 (m, 1 H), 1.65−1.51 (m, 7 H), 1.47−1.19 (m, 6 H), 1.10 (m, 1 H), 1.07 (s, 9 H), 0.99 (t, <i>J</i> = 6.8 Hz, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 716.3321 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>50</sub>N<sub>5</sub>O<sub>9</sub>S: 716.3324]. Anal. (C<sub>35</sub>H<sub>49</sub>N<sub>5</sub>O<sub>9</sub>S·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_66" class="NLM_sec NLM_sec_level_2"><div id="ac_i74" class="anchor-spacer"></div><h3 class="article-section__title" id="_i74"> <i>N</i>-{[(2,2-Dimethylhex-5-enyl)oxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32b</b>)</h3><div class="NLM_p last">To a stirred solution of 2,2-dimethylhex-5-en-1-ol<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a> (10.8 g, 83.9 mmol) in anhydrous 1,4-dioxane (100 mL), at 0 °C and under nitrogen, was added triphosgene (13.7 g, 46.1 mmol) and DIPEA (14.6 mL, 83.9 mmol) cautiously. The reaction mixture was stirred at RT for 1 h, cooled to 0 °C, and 1 N NaOH (83.9 mL, 83.9 mmol) was added slowly. <span class="smallcaps smallerCapital">l</span>-<i>tert</i>-Leucine (11.0 g, 83.9 mmol) was then added, and the reaction mixture was stirred at RT for 20 h. The reaction solution was basified to pH 10 with 1 N NaOH, washed with CH<sub>2</sub>Cl<sub>2</sub> (3 × 100 mL), acidified to pH 5 with 1 N HCl, and extracted with CH<sub>2</sub>Cl<sub>2</sub> (3 × 150 mL). The combined CH<sub>2</sub>Cl<sub>2</sub> layer was washed with water, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>32b</b> (20.3 g, 85% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 8.50 (br s, 1 H), 5.85−5.76 (m, 1 H), 5.25−5.23 (m, 1 H), 5.04−4.99 (m, 1 H), 4.95−4.92 (m, 1 H), 4.23−4.20 (m, 1 H), 3.89−3.79 (m, 2 H), 2.05−2.00 (m, 2 H), 1.38−1.34 (m, 2 H), 1.05 (s, 9 H), 0.93 (s, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 286.2014 [(M + H)<sup>+</sup>; calcd for C<sub>15</sub>H<sub>28</sub>NO<sub>4</sub>: 286.2013]. Anal. (C<sub>15</sub>H<sub>27</sub>NO<sub>4</sub>·0.65H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_67" class="NLM_sec NLM_sec_level_2"><div id="ac_i75" class="anchor-spacer"></div><h3 class="article-section__title" id="_i75"> <i>N</i>-{[(1-But-3-en-1-ylcyclopropyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32c</b>)</h3><div class="NLM_p">To a stirred solution of 1 M lithium aluminum hydride (LAH) in ether (65.4 mL, 65.4 mmol), at 0 °C and under nitrogen, was added a solution of ethyl 1-but-3-en-1-ylcyclopropanecarboxylate<a onclick="showRef(event, 'ref36'); return false;" href="javascript:void(0);" class="ref ref36">(36)</a> (5.0 g, 29.7 mmol) in anhydrous ether (25 mL) dropwise over 1 h. The reaction solution was then stirred at RT for 15 h, carefully quenched at 0 °C with water (3 mL), 1 M NaOH (11 mL), and water (9 mL). The resulting mixture was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give (1-but-3-en-1-ylcyclopropyl)methanol (3.45 g, 92% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.84 (m, 1 H), 5.05−4.92 (m, 2 H), 3.43 (br s, 2 H), 2.17 (m, 2 H), 1.50 (m, 2 H), 0.37 (m, 4 H) ppm.</div><div class="NLM_p last">Using the above procedure for <b>13</b> with (1-but-3-en-1-ylcyclopropyl)methanol provided <b>32c</b> (64% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.81 (m, 1 H), 5.29 (m, 1 H), 5.01 (d, <i>J</i> = 15.5 Hz, 1 H), 4.93 (d, <i>J</i> = 10.5 Hz, 1 H), 4.19 (d, <i>J</i> = 9.5 Hz, 1 H), 3.97 (d, <i>J</i> = 11.0 Hz, 1 H), 3.89 (d, <i>J</i> = 11.5 Hz, 1 H), 2.15 (m, 2 H), 2.07 (m, 1 H), 1.45 (m, 2 H), 1.03 (s, 9 H), 0.48 (t, <i>J</i> = 5.0 Hz, 1 H), 0.39 (t, <i>J</i> = 5.3 Hz, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 284.1767 [(M + H)<sup>+</sup>; calcd for C<sub>15</sub>H<sub>26</sub>NO<sub>4</sub>: 284.1817].</div></div><div id="sec5_68" class="NLM_sec NLM_sec_level_2"><div id="ac_i76" class="anchor-spacer"></div><h3 class="article-section__title" id="_i76"> <i>N</i>-{[(1-But-3-en-1-ylcyclobutyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32d</b>)</h3><div class="NLM_p">To a stirred solution of DIPEA (12.1 mL, 85.8 mmol) in anhydrous THF (50 mL), at −70 °C under nitrogen, was slowly added a solution of <i>n</i>-BuLi (2.5 M in hexane, 33.1 mL, 82.7 mmol). The reaction mixture was stirred for 20 min, and a solution of ethyl cyclobutanecarboxylate (10.8 mL, 78.0 mmol) in THF (50 mL) was added dropwise over 30 min. The reaction mixture was warmed to 0 °C and recooled to −70 °C, and then a solution of 4-bromobut-1-ene (8.87 mL, 87.4 mmol) in HMPA (20 mL) was added dropwise. The reaction mixture was slowly warmed to RT and stirred for 2 h and then quenched with water (100 mL). The aqueous layer was extracted with ether, and the combined organic layers were washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by silica gel chromatography (gradient elution, 0 to 25% EtOAc in hexane) to give ethyl 1-but-3-en-1-ylcyclobutanecarboxylate (6.11 g, 43% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.84−5.76 (m, 1 H), 5.01 (m, 1 H), 4.91 (m, 1 H), 4.51 (q, <i>J</i> = 7.2 Hz, 2 H), 2.42 (m, 2 H), 1.94 (m, 2 H), 1.89 (m, 6 H), 1.26 (t, <i>J</i> = 7.0 Hz, 3 H) ppm. LRMS (ESI) <i>m</i>/<i>z</i> 183.3 [(M + H)<sup>+</sup>; calcd for C<sub>11</sub>H<sub>19</sub>O<sub>2</sub>: 183.1].</div><div class="NLM_p">To a stirred solution of ethyl 1-but-3-en-1-ylcyclobutanecarboxylate (6.00 g, 32.9 mmol) in Et<sub>2</sub>O (50 mL), at −75 °C was added a solution of LAH (1 M in Et<sub>2</sub>O, 72.4 mL, 72.4 mmol) over 1 h. The reaction mixture was stirred at RT for 3 h and then cooled to −75 °C and quenched with successive slow additions of water (3 mL), 1 M NaOH (11 mL), and water (9 mL). The mixture was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give (1-but-3-en-1-ylcyclobutyl)methanol (3.92 g, 85% yield) as a clear oil. <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.89−5.81 (m, 1 H), 5.02 (m, 1 H), 4.95 (m, 1 H), 3.56 (d, <i>J</i> = 6.0 Hz, 2 H), 2.00 (m, 2 H), 1.87 (m, 2 H), 1.77 (m, 4 H), 1.60 (m, 2 H) ppm.</div><div class="NLM_p last">Using the above procedure for <b>13</b> with (1-but-3-en-1-ylcyclobutyl)methanol provided <b>32d</b> (47% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.82 (m, 1 H), 5.26 (d, <i>J</i> = 9.5 Hz, 1 H), 5.02 (d, <i>J</i> = 17.0 Hz, 1 H), 4.94 (d, <i>J</i> = 9.0 Hz, 1 H), 4.21 (d, <i>J</i> = 9.5 Hz, 1 H), 4.09 (d, <i>J</i> = 11.0 Hz, 1 H), 4.02 (d, <i>J</i> = 11.0 Hz, 1 H), 1.99 (m, 2 H), 1.86 (m, 4 H), 1.78 (m, 2 H), 1.58 (m, 2 H), 1.04 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 298.2015 [(M + H)<sup>+</sup>; calcd for C<sub>16</sub>H<sub>28</sub>NO<sub>4</sub>: 298.2013].</div></div><div id="sec5_69" class="NLM_sec NLM_sec_level_2"><div id="ac_i77" class="anchor-spacer"></div><h3 class="article-section__title" id="_i77"> <i>N</i>-{[(1-But-3-en-1-ylcyclopentyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>32d</b> methyl cyclopentanecarboxylate provided <b>32e</b> (42% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.82 (m, 1 H), 5.26 (d, <i>J</i> = 9.5 Hz, 1 H), 5.00 (d, <i>J</i> = 17.5 Hz, 1 H), 4.92 (d, <i>J</i> = 10.0 Hz, 1 H), 4.20 (d, <i>J</i> = 9.5 Hz, 1 H), 3.94 (d, <i>J</i> = 11.0 Hz, 1 H), 3.85 (d, <i>J</i> = 10.5 Hz, 1 H), 2.02 (m, 2 H), 1.60 (m, 4 H), 1.47 (m, 4 H), 1.39 (m, 2 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 312.2172 [(M + H)<sup>+</sup>; calcd for C<sub>17</sub>H<sub>30</sub>NO<sub>4</sub>: 312.2169].</div></div><div id="sec5_70" class="NLM_sec NLM_sec_level_2"><div id="ac_i78" class="anchor-spacer"></div><h3 class="article-section__title" id="_i78"> <i>N</i>-{[(1-But-3-en-1-ylcyclohexyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>32d</b> with methyl cyclohexanecarboxylate provided <b>32f</b> (47% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.80 (m, 1 H), 5.22 (d, <i>J</i> = 9.5 Hz, 1 H), 5.01 (dq, <i>J</i> = 15.0, 1.7 Hz, 1 H), 4.92 (d, <i>J</i> = 10.0 Hz, 1 H), 4.21 (d, <i>J</i> = 10.0 Hz, 1 H), 3.98 (d, <i>J</i> = 11.0 Hz, 1 H), 3.90 (d, <i>J</i> = 10.5 Hz, 1 H), 1.97 (m, 2 H), 1.44 (m, 8 H), 1.33 (m, 4 H), 1.03 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 326.2326 [(M + H)<sup>+</sup>; calcd for C<sub>18</sub>H<sub>32</sub>NO<sub>4</sub>: 326.2326].</div></div><div id="sec5_71" class="NLM_sec NLM_sec_level_2"><div id="ac_i79" class="anchor-spacer"></div><h3 class="article-section__title" id="_i79"> (2<i>S</i>)-Cyclohexyl({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino)acetic Acid (<b>32g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>26b</b> with 2,2-dimethylhex-5-en-1-ol and methyl (2<i>S</i>)-amino(cyclohexyl)acetate hydrochloride provided <b>32g</b> (99% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.88−5.74 (m, 1 H), 5.18 (d, <i>J</i> = 8.9 Hz, 1 H), 5.01 (d, <i>J</i> = 17.2 Hz, 1 H), 4.93 (d, <i>J</i> = 10.2 Hz, 1 H), 4.31 (dd, <i>J</i> = 9.0, 4.9 Hz, 1 H), 3.81 (s, 2 H), 2.11−1.61 (m, 8 H), 1.42−1.08 (m, 7 H), 0.92 (d, <i>J</i> = 6.1 Hz, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 312.2167 [(M + H)<sup>+</sup>; calcd for C<sub>17</sub>H<sub>30</sub>NO<sub>4</sub>: 312.2169].</div></div><div id="sec5_72" class="NLM_sec NLM_sec_level_2"><div id="ac_i80" class="anchor-spacer"></div><h3 class="article-section__title" id="_i80"> (2<i>S</i>)-({[(2,2-Dimethylhex-5-en-1-yl)oxy]carbonyl}amino)(1-methylcyclohexyl)acetic Acid (<b>32h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>13</b> with 2,2-dimethylhex-5-en-1-ol and (2<i>S</i>)-amino(1-methylcyclohexyl)acetic acid hydrochloride provided <b>32h</b> (97% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 5.81 (m, 1 H), 5.20 (d, <i>J</i> = 12.0 Hz, 1 H), 5.01 (m, 1 H), 4.93 (d, <i>J</i> = 12.5 Hz, 1 H), 4.37 (d, <i>J</i> = 12.0 Hz, 1 H), 3.83 (m, 2 H), 2.02 (m, 2 H), 1.58−1.33 (m, 12 H), 0.97 (s, 3 H), 0.92 (s, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 326.2331 [(M + H)<sup>+</sup>; calcd for C<sub>18</sub>H<sub>32</sub>NO<sub>4</sub>: 326.2326].</div></div><div id="sec5_73" class="NLM_sec NLM_sec_level_2"><div id="ac_i81" class="anchor-spacer"></div><h3 class="article-section__title" id="_i81"> <i>O</i>-(<i>tert</i>-Butyl)-<i>N</i>-{[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}-<span class="smallcaps smallerCapital">l</span>-serine (<b>32i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>26b</b> with 2,2-dimethylhex-5-en-1-ol and methyl <i>O</i>-(<i>tert</i>-butyl)-<span class="smallcaps smallerCapital">l</span>-serinate hydrochloride provided <b>32i</b> (61% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 5.75−5.86 (m, 1 H), 4.90−5.04 (m, 2 H), 4.02 (m, 1 H), 3.57−3.90 (m, 4 H), 1.98−2.05 (m, 2 H), 1.27−1.36 (m, 2 H), 1.14 (s, 9 H), 1.01 (d, <i>J</i> = 6.5 Hz, 1 H), 6.09 (s, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 316.2114 [(M + H)<sup>+</sup>; calcd for C<sub>16</sub>H<sub>30</sub>NO<sub>5</sub>: 316.2118].</div></div><div id="sec5_74" class="NLM_sec NLM_sec_level_2"><div id="ac_i82" class="anchor-spacer"></div><h3 class="article-section__title" id="_i82"> Methyl <i>N</i>-{[(2,2-Dimethylhex-5-en-1-yl)oxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33b</b>)</h3><div class="NLM_p last">To a solution of (3<i>R</i>,5<i>S</i>)-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate hydrochloride (<b>25</b>) (400 mg, 1.13 mmol) and acid <b>32b</b> (324 mg, 1.13 mmol) in DMF (10 mL) at RT was added DIPEA (0.59 mL, 3.40 mmol) and HATU (604 mg, 1.59 mmol). After 18 h of stirring, the reaction mixture was poured into aqueous NaHCO<sub>3</sub> and extracted with EtOAc three times. The combined organic portions were washed with water and brine, dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified by silica gel chromatography (gradient elution, 5% to 90% EtOAc in hexanes) to yield <b>33b</b> (600 mg, 91% yield) as a white foam. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.40−7.36 (m, 1 H), 7.29−7.24 (m, 1 H), 7.17−7.08 (m, 1 H), 6.70−6.60 (m, 1 H), 5.82−5.66 (m, 2 H), 5.44−5.34 (m, 2 H), 5.29−5.27 (m, 1 H), 4.99−4.59 (m, 7 H), 4.26−4.19 (m, 2 H), 3.92−3.85 (m, 1 H), 3.76 (m, 3 H), 3.66−3.63 (m, 1 H), 3.31 (t, <i>J</i> = 11.0 Hz, 1 H), 2.55−2.50 (m, 1 H), 2.28−2.15 (m, 1 H), 1.95−1.85 (m, 2 H), 1.22−1.17 (m, 2 H), 1.05−1.02 (m, 9 H), 0.76−0.74 (m, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 584.3332 [(M + H)<sup>+</sup>; calcd for C<sub>32</sub>H<sub>46</sub>N<sub>3</sub>O<sub>7</sub>: 584.3331]. Anal. (C<sub>32</sub>H<sub>45</sub>N<sub>3</sub>O<sub>7</sub>·0.7H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_75" class="NLM_sec NLM_sec_level_2"><div id="ac_i83" class="anchor-spacer"></div><h3 class="article-section__title" id="_i83"> Methyl <i>N</i>-{[(1-But-3-en-1-ylcyclopropyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-{[(1-but-3-en-1-ylcyclopropyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32c</b>) provided <b>33c</b> (89% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.43 (t, <i>J</i> = 6.5 Hz, 1 H), 7.30−7.26 (2 × d, <i>J</i> = 7.8 Hz, 1 H), 7.22−7.13 (2 × d, <i>J</i> = 7.5 Hz, 1 H), 6.73 (m, 1 H), 5.72 (m, 1 H), 5.37 (t, <i>J</i> = 11.0 Hz, 1 H), 5.30 (m, 1 H), 4.92 (d, <i>J</i> = 17.5 Hz, 2 H), 4.71 (m, 5 H), 4.43 (t, <i>J</i> = 11.5 Hz, 1 H), 4.17 (s, 1 H), 3.78 (m, 1 H), 3.74 (s, 3 H), 3.54 (dd, <i>J</i> = 11.5, 5.0 Hz, 1 H), 3.08 (dd, <i>J</i> = 17.5, 11.5 Hz, 1 H), 2.56 (m, 1 H), 2.20 (m, 2 H), 1.92 (m, 2 H), 1.26 (m, 3 H), 1.05 (s, 9 H), 1.04 (m, 1 H), 0.13 (m, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 582.3160 [(M + H)<sup>+</sup>; calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 582.3170].</div></div><div id="sec5_76" class="NLM_sec NLM_sec_level_2"><div id="ac_i84" class="anchor-spacer"></div><h3 class="article-section__title" id="_i84"> Methyl <i>N</i>-{[(1-But-3-en-1-ylcyclobutyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-{[(1-but-3-en-1-ylcyclobutyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32d</b>) provided <b>33d</b> (79% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.42 (t, <i>J</i> = 8.5 Hz, 1 H), 7.28 (m, 1 H), 7.23−7.15 (2 × d, <i>J</i> = 7.8, Hz, 1 H), 6.72 (m, 1 H), 5.72 (dd, <i>J</i> = 17.5, 5.5 Hz, 1 H), 5.36 (dd, <i>J</i> = 15.5, 11.5 Hz, 1 H), 5.31 (m, 1 H), 4.93 (m, 1 H), 4.87 (m, 1 H), 4.73 (m, 4 H), 4.46 (t, <i>J</i> = 11.0 Hz, 1 H), 4.19 (d, <i>J</i> = 4.0 Hz, 1 H), 3.80 (m, 1 H), 3.74 (s, 3 H), 3.69 (dd, <i>J</i> = 11.0, 5.0 Hz, 1 H), 3.23 (t, <i>J</i> = 11.0 Hz, 1 H), 2.58 (m, 1 H), 2.22 (m, 1 H), 1.90 (s, 1 H), 1.73 (m, 5 H), 1.55 (m, 4 H), 1.38 (t, <i>J</i> = 7.7 Hz, 2 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 596.3330 [(M + H)<sup>+</sup>; calcd for C<sub>33</sub>H<sub>46</sub>N<sub>3</sub>O<sub>7</sub>: 596.3330].</div></div><div id="sec5_77" class="NLM_sec NLM_sec_level_2"><div id="ac_i85" class="anchor-spacer"></div><h3 class="article-section__title" id="_i85"> Methyl <i>N</i>-{[(1-But-3-en-1-ylcyclopentyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-{[(1-but-3-en-1-ylcyclopentyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32e</b>) provided <b>33e</b> (85% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.38 (t, <i>J</i> = 8.5 Hz, 1 H), 7.27 (m, 1 H), 7.17−7.08 (2 × d, <i>J</i> = 7.0 Hz, 1 H), 6.65 (dt, <i>J</i> = 17.5, 12.3 Hz, 1 H), 5.76 (m, 1 H), 5.69 (dd, <i>J</i> = 17.5, 5.5 Hz, 1 H), 5.38 (m, 2 H), 5.29 (m, 1 H), 4.96 (d, <i>J</i> = 17.0 Hz, 1 H), 4.89 (m, 2 H), 4.84−4.62 (m, 4 H), 4.24 (m, 1 H), 3.89 (m, 1 H), 3.76 (s, 3 H), 3.74 (m, 1 H), 3.35 (dd, <i>J</i> = 13.5, 10.5 Hz, 1 H), 2.52 (dd, <i>J</i> = 14.0, 8.0 Hz, 1 H), 2.22 (m, 1 H), 2.01 (m, 1 H), 1.88 (m, 1 H), 1.48 (m, 5 H), 1.34 (m, 3 H), 1.25 (m, 3 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 610.3511 [(M + H)<sup>+</sup>; calcd for C<sub>34</sub>H<sub>48</sub>N<sub>3</sub>O<sub>7</sub>: 610.3487].</div></div><div id="sec5_78" class="NLM_sec NLM_sec_level_2"><div id="ac_i86" class="anchor-spacer"></div><h3 class="article-section__title" id="_i86"> Methyl <i>N</i>-{[(1-But-3-en-1-ylcyclohexyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>N</i>-{[(1-but-3-en-1-ylcyclohexyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valine (<b>32f</b>) provided <b>33f</b> (76% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.38 (t, <i>J</i> = 9.0 Hz, 1 H), 7.27 (m, 1 H), 7.18−7.09 (2 × d, <i>J</i> = 7.2 Hz, 1 H), 6.66 (dt, <i>J</i> = 17.5, 11.3 Hz, 1 H), 5.76 (m, 1 H), 5.69 (dd, <i>J</i> = 17.5, 4.0 Hz, 1 H), 5.40 (s, 1 H), 5.37 (dd, <i>J</i> = 11.3, 2.8 Hz, 1 H), 5.27 (d, <i>J</i> = 9.5 Hz, 1 H), 4.99−4.62 (m, 6 H), 4.25 (d, <i>J</i> = 10.0 Hz, 1 H), 4.21 (t, <i>J</i> = 11.8 Hz, 1 H), 3.90 (m, 2 H), 3.82 (dd, <i>J</i> = 10.8, 8.2 Hz, 1 H), 3.77 (s, 3 H), 3.41 (dd, <i>J</i> = 10.8, 5.8 Hz, 1 H), 2.52 (dd, <i>J</i> = 13.5, 8.0 Hz, 1 H), 2.22 (m, 1 H), 1.85 (m, 2 H), 1.32 (m, 9 H), 1.17 (m, 3 H), 1.05 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 624.3631 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>50</sub>N<sub>3</sub>O<sub>7</sub>: 624.3643].</div></div><div id="sec5_79" class="NLM_sec NLM_sec_level_2"><div id="ac_i87" class="anchor-spacer"></div><h3 class="article-section__title" id="_i87"> (3<i>R</i>,5<i>S</i>)-1-[(2<i>S</i>)-2-Cyclohexyl-2-({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino)acetyl]-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>33g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with (2<i>S</i>)-cyclohexyl({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino)acetic acid (<b>32g</b>) provided <b>33g</b> (81% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.43−7.35 (m, 1 H), 7.17 (d, <i>J</i> = 7.6 Hz, 1 H), 7.10 (d, <i>J</i> = 7.6 Hz, 1 H), 6.71−6.58 (m, 2 H), 5.82−5.65 (m, 4 H), 5.45−5.22 (m, 3 H), 5.01−4.82 (m, 2 H), 4.85−4.57 (m, 4 H), 4.28−4.17 (m, 2 H), 3.90 (m, 1 H), 3.82−3.68 (m, 3 H), 3.67 (dd, <i>J</i> = 10.5, 4.4 Hz, 1 H), 3.39 (dd, J = 17.1, 10.4 Hz, 1 H), 2.53 (dd, <i>J</i> = 13.6, 8.0 Hz, 1 H), 2.28−2.16 (m, 1 H), 1.96−1.49 (m, 7 H), 1.25−0.82 (m, 6 H), 0.77 (d, <i>J</i> = 3.4 Hz, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 610.3481 [(M + H)<sup>+</sup>; calcd for C<sub>34</sub>H<sub>48</sub>N<sub>3</sub>O<sub>7</sub>: 610.3487].</div></div><div id="sec5_80" class="NLM_sec NLM_sec_level_2"><div id="ac_i88" class="anchor-spacer"></div><h3 class="article-section__title" id="_i88"> (3<i>R</i>,5<i>S</i>)-1-[(2<i>S</i>)-2-({[(2,2-Dimethylhex-5-en-1-yl)oxy]carbonyl}amino)-2-(1-methylcyclohexyl)acetyl]-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>33h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with (2<i>S</i>)-({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino) (1-methylcyclohexyl)acetic acid (<b>32h</b>) provided <b>33h</b> (89% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.38 (t, <i>J</i> = 10.0 Hz, 1 H), 7.26 (m, 1 H), 7.18−7.08 (2 × d, <i>J</i> = 9.5 Hz, 1 H), 6.65 (2 × t, <i>J</i> = 14.7 Hz, 1 H), 5.76 (m, 1 H), 5.69 (2 × d, <i>J</i> = 4.5 Hz, 1 H), 5.37 (m, 2 H), 5.29 (d, <i>J</i> = 10.5 Hz, 1 H), 4.99−4.61 (m, 7 H), 4.25 (m, 2 H), 3.90 (m, 1 H), 3.77 (s, 3 H), 3.63 (m, 1 H), 3.28 (t, <i>J</i> = 14.3 Hz, 1 H), 2.51 (m, 1 H), 2.19 (m, 1 H), 1.88 (m, 2 H), 1.55 (s, 6 H), 1.47 (m, 7 H), 1.18 (m, 2 H), 1.05 (s, 2 H), 0.74 (m, 4 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 624.3686 [(M + H)<sup>+</sup>; calcd for C<sub>35</sub>H<sub>50</sub>N<sub>3</sub>O<sub>7</sub>: 624.3643].</div></div><div id="sec5_81" class="NLM_sec NLM_sec_level_2"><div id="ac_i89" class="anchor-spacer"></div><h3 class="article-section__title" id="_i89"> Methyl <i>O</i>-(<i>tert</i>-Butyl)-<i>N</i>-{[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}-<span class="smallcaps smallerCapital">l</span>-seryl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>27a</b> with <i>O</i>-(<i>tert</i>-butyl)-<i>N</i>-{[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}-<span class="smallcaps smallerCapital">l</span>-serine (<b>32i</b>) provided <b>33i</b> (79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.42−7.35 (m, 1 H), 7.30−7.35 (m, 1 H), 7.20−7.05 (m, 1 H), 6.72−6.57 (m, 1 H), 5.84−5.65 (m, 2 H), 5.50 (m, 1 H), 5.44−5.33 (m, 2 H), 5.05−4.87 (m, 2 H), 4.80 (br s, 1 H), 4.76−4.53 (m, 5 H), 4.10−3.91 (m, 1 H), 3.83−3.68 (m, 5 H), 3.64−3.55 (m, 2 H), 3.55−3.37 (m, 1 H), 2.53−2.41 (m, 1 H), 2.31−2.19 (m, 1 H), 2.04−1.90 (m, 2 H), 1.37−1.29 (m, 1 H), 1.22−1.13 (m, 9 H), 1.09 (s, 1 H), 1.00−0.73 (m, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 614.3448 [(M + H)<sup>+</sup>; calcd for C<sub>33</sub>H<sub>48</sub>N<sub>3</sub>O<sub>8</sub>: 614.3436].</div></div><div id="sec5_82" class="NLM_sec NLM_sec_level_2"><div id="ac_i90" class="anchor-spacer"></div><h3 class="article-section__title" id="_i90"> Methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-Butyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34b</b>)</h3><div class="NLM_p last">A solution of methyl <i>N</i>-{[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33b</b>) (4.70 g, 8.05 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (1.4 L) was degassed with nitrogen for 15 min. Zhan 1b catalyst<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> (0.59 g, 0.81 mmol) was added, and the mixture was stirred at RT under a nitrogen atmosphere for 19 h. The reaction was complete, DMSO (57 μL, 0.805 mmol) was added, and the mixture was stirred for 2 h and concentrated. The crude product was then directly purified by silica gel chromatography (gradient elution, 0−50% EtOAc in hexanes) to yield <b>34b</b> (4.40 g, 98% yield) as a light-green oil. <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 7.25−7.12 (m, 3 H), 6.79 (d, <i>J</i> = 9.2 Hz, 1 H), 6.33 (d, <i>J</i> = 16.0 Hz, 1 H), 6.05−5.99 (m, 1 H), 5.31−5.29 (m, 1 H), 4.72−4.55 (m, 6 H), 4.47 (d, <i>J</i> = 9.6 Hz, 1 H), 4.20−4.17 (m, 1 H), 3.89 (dd, <i>J</i> = 12.0, 3.6 Hz, 1 H), 3.72 (s, 3 H), 3.35 (d, <i>J</i> = 10.8 Hz, 1 H), 2.71−2.66 (m, 1 H), 2.30−2.10 (m, 3 H), 1.44−1.28 (m, 2 H), 1.06 (s, 9 H), 1.03 (s, 3 H), 0.89 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 556.3023 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 556.3018]. Anal. (C<sub>30</sub>H<sub>41</sub>N<sub>3</sub>O<sub>7</sub>·0.7 H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_83" class="NLM_sec NLM_sec_level_2"><div id="ac_i91" class="anchor-spacer"></div><h3 class="article-section__title" id="_i91"> Methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopropane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-{[(1-but-3-en-1-ylcyclopropyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33c</b>) provided <b>34c</b> (78% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.25 (t, <i>J</i> = 7.7 Hz, 1 H), 7.17 (d, <i>J</i> = 7.5 Hz, 1 H), 7.15 (d, <i>J</i> = 7.0 Hz, 1 H), 6.42 (d, <i>J</i> = 16.0 Hz, 1 H), 6.04 (dt, <i>J</i> = 16.0, 7.3 Hz, 1 H), 5.36 (t, <i>J</i> = 3.8 Hz, 1 H), 5.06 (d, <i>J</i> = 11.0 Hz, 1 H), 4.89 (d, <i>J</i> = 15.0 Hz, 1 H), 4.68 (m, 3 H), 4.61 (dd, <i>J</i> = 10.3, 7.8 Hz, 1 H), 4.42 (s, 1 H), 4.26 (d, <i>J</i> = 12.5 Hz, 1 H), 3.89 (dd, <i>J</i> = 12.3, 3.8 Hz, 1 H), 3.73 (s, 3 H), 3.05 (d, <i>J</i> = 11.0 Hz, 1 H), 2.70 (dd, <i>J</i> = 14.0, 7.5 Hz, 1 H), 2.40 (m, 1 H), 2.21 (m, 2 H), 1.84 (m, 1 H), 1.29 (s, 1 H), 1.11 (m, 1 H), 1.07 (s, 9 H), 0.90 (m, 1 H), 0.51 (m, 1 H), 0.43 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 554.2881 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>40</sub>N<sub>3</sub>O<sub>7</sub>: 554.2861].</div></div><div id="sec5_84" class="NLM_sec NLM_sec_level_2"><div id="ac_i92" class="anchor-spacer"></div><h3 class="article-section__title" id="_i92"> Methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclobutane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-{[(1-but-3-en-1-ylcyclobutyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33d</b>) provided <b>34d</b> (87% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 7.24 (t, <i>J</i> = 7.8 Hz, 1 H), 7.16 (d, <i>J</i> = 7.5 Hz, 1 H), 7.10 (d, <i>J</i> = 7.5 Hz, 1 H), 6.32 (d, <i>J</i> = 16.5 Hz, 1 H), 5.93 (dt, <i>J</i> = 16.0, 6.8 Hz, 1 H), 5.54 (d, <i>J</i> = 9.5 Hz, 1 H), 5.32 (t, <i>J</i> = 3.7 Hz, 1 H), 4.76- 4.56 (m, 6 H), 4.40 (d, <i>J</i> = 9.5 Hz, 1 H), 4.15 (d, <i>J</i> = 11.5 Hz, 1 H), 3.83 (dd, <i>J</i> = 12.0, 3.5 Hz, 1 H), 3.76 (s, 3 H), 3.72 (d, <i>J</i> = 11.5 Hz, 1 H), 2.75 (dd, <i>J</i> = 14.8, 7.8 Hz, 1 H), 2.28 (sept, <i>J</i> = 7.1 Hz, 1 H), 2.17 (m, 2 H), 2.00 (m, 1 H), 1.86 (s, 4 H), 1.65 (m, 1 H), 1.51 (t, <i>J</i> = 8.2 Hz, 2 H), 1.07 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 568.3040 [(M+H)<sup>+</sup>; calcd for C<sub>31</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 568.3017].</div></div><div id="sec5_85" class="NLM_sec NLM_sec_level_2"><div id="ac_i93" class="anchor-spacer"></div><h3 class="article-section__title" id="_i93"> Methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopentane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-{[(1-but-3-en-1-ylcyclopentyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33e</b>) provided <b>34e</b> (81% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.24 (t, <i>J</i> = 7.5 Hz, 1 H), 7.17 (d, <i>J</i> = 7.5 Hz, 1 H), 7.14 (d, <i>J</i> = 7.5 Hz, 1 H), 6.37 (d, <i>J</i> = 16.0 Hz, 1 H), 5.98 (dt, <i>J</i> = 16.0, 6.9 Hz, 1 H), 5.29 (t, <i>J</i> = 3.7 Hz, 1 H), 4.76 (d, <i>J</i> = 15.0 Hz, 1 H), 4.65 (m, 4 H), 4.58 (dd, <i>J</i> = 10.3, 7.7 Hz, 1 H), 4.46 (s, 1 H), 4.22 (dd, <i>J</i> = 12.0, 1.5 Hz, 1 H), 3.89 (dd, <i>J</i> = 12.3, 3.8 Hz, 1 H), 3.72 (s, 3 H), 3.45 (d, <i>J</i> = 11.0 Hz, 1 H), 2.71 (dd, <i>J</i> = 14.3, 7.8 Hz, 1 H), 2.32 (m, 1 H), 2.17 (m, 2 H), 1.82 (m, 1 H), 1.66 (m, 4 H), 1.52 (m, 2 H), 1.41 (m, 2 H), 1.29 (m, 2 H), 1.06 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 582.3195 [(M + H)<sup>+</sup>; calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 582.3174].</div></div><div id="sec5_86" class="NLM_sec NLM_sec_level_2"><div id="ac_i94" class="anchor-spacer"></div><h3 class="article-section__title" id="_i94"> Methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclohexane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>N</i>-{[(1-but-3-en-1-ylcyclohexyl)methoxy]carbonyl}-3-methyl-<span class="smallcaps smallerCapital">l</span>-valyl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33f</b>) provided <b>34f</b> (86% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.24 (t, <i>J</i> = 7.7 Hz, 1 H), 7.15 (d, <i>J</i> = 6.5 Hz, 1 H), 7.14 (d, <i>J</i> = 6.0 Hz, 1 H), 6.39 (d, <i>J</i> = 16.0 Hz, 1 H), 5.91 (m, 1 H), 5.27 (t, <i>J</i> = 3.5 Hz, 1 H), 4.78 (m, 1 H), 4.66 (m, 3 H), 4.58 (d, <i>J</i> = 11.0 Hz, 2 H), 4.47 (s, 1 H), 4.23 (d, <i>J</i> = 12.0 Hz, 1 H), 3.88 (dd, <i>J</i> = 12.0, 3.5 Hz, 1 H), 3.72 (s, 3 H), 3.58 (d, <i>J</i> = 11.0 Hz, 1 H), 2.73 (dd, <i>J</i> = 14.2, 8.2 Hz, 1 H), 2.29 (m, 1 H), 2.20 (m, 1 H), 2.09 (m, 1 H), 1.47 (m, 9 H), 1.24 (m, 3 H), 1.06 (s, 9 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 596.3304 [(M + H)<sup>+</sup>; calcd for C<sub>33</sub>H<sub>46</sub>N<sub>3</sub>O<sub>7</sub>: 596.3331].</div></div><div id="sec5_87" class="NLM_sec NLM_sec_level_2"><div id="ac_i95" class="anchor-spacer"></div><h3 class="article-section__title" id="_i95"> Methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-Cyclohexyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with (3<i>R</i>,5<i>S</i>)-1-[(2<i>S</i>)-2-cyclohexyl-2-({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino)acetyl]-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>33g</b>) provided <b>34g</b> (65% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.26−7.06 (m, 3 H), 6.32−6.20 (m, 1 H), 6.00−5.88 (m, 1 H), 5.54 (d, <i>J</i> = 8.9 Hz, 1 H), 5.34−5.25 (m, 1 H), 4.74−4.42 (m, 7 H), 4.18−4.06 (m, 2 H), 3.82 (dd, <i>J</i> = 11.6, 3.5 Hz, 1 H), 3.76 (s, 3 H), 3.37−3.25 (m, 1 H), 2.76 (dd, <i>J</i> = 14.4, 7.7 Hz, 1 H), 2.30−2.10 (m, 3 H), 1.94−1.83 (m, 1 H), 1.85−1.64 (m, 4 H), 1.36−1.19 (m, 5 H), 1.24−1.01 (m, 4 H), 0.98 (s, 2 H), 0.86 (s, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 582.3187 [(M + H)<sup>+</sup>; calcd for C<sub>32</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 582.3174].</div></div><div id="sec5_88" class="NLM_sec NLM_sec_level_2"><div id="ac_i96" class="anchor-spacer"></div><h3 class="article-section__title" id="_i96"> Methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-16,16-Dimethyl-21-(1-methylcyclohexyl)-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with (3<i>R</i>,5<i>S</i>)-1-[(2<i>S</i>)-2-({[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}amino)-2-(1-methylcyclohexyl)acetyl]-5-(methoxycarbonyl)pyrrolidin-3-yl 4-vinyl-1,3-dihydro-2<i>H</i>-isoindole-2-carboxylate (<b>33h</b>) provided <b>34h</b> (79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.23 (d, <i>J</i> = 9.5 Hz, 1 H), 7.16 (d, <i>J</i> = 9.5 Hz, 1 H), 7.10 (d, <i>J</i> = 9.5 Hz, 1 H), 6.28 (d, <i>J</i> = 20.5 Hz, 1 H), 5.95 (dt, <i>J</i> = 20.0, 7.9 Hz, 1 H), 5.57 (d, <i>J</i> = 12.0 Hz, 1 H), 5.31 (t, <i>J</i> = 4.5 Hz, 1 H), 4.72−4.56 (m, 5 H), 4.41 (d, <i>J</i> = 12.0 Hz, 1 H), 4.13 (m, 1 H), 3.87 (dd, <i>J</i> = 14.8, 4.8 Hz, 1 H), 3.76 (s, 3 H), 3.29 (d, <i>J</i> = 13.5 Hz, 1 H), 2.73 (dd, <i>J</i> = 17.7, 9.2 Hz, 1 H), 2.16 (m, 3 H), 1.62 (m, 1 H), 1.57 (s, 6 H), 1.48−1.31 (m, 6 H), 1.05 (s, 3 H), 0.99 (s, 3 H), 0.86 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 596.3323 [(M + H)<sup>+</sup>; calcd for C<sub>33</sub>H<sub>46</sub>N<sub>3</sub>O<sub>7</sub>: 596.3330].</div></div><div id="sec5_89" class="NLM_sec NLM_sec_level_2"><div id="ac_i97" class="anchor-spacer"></div><h3 class="article-section__title" id="_i97"> Methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-(<i>tert</i>-Butoxymethyl)-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>28a</b> with methyl <i>O</i>-(<i>tert</i>-butyl)-<i>N</i>-{[(2,2-dimethylhex-5-en-1-yl)oxy]carbonyl}-<span class="smallcaps smallerCapital">l</span>-seryl-(4<i>R</i>)-4-{[(4-vinyl-1,3-dihydro-2<i>H</i>-isoindol-2-yl)carbonyl]oxy}-<span class="smallcaps smallerCapital">l</span>-prolinate (<b>33i</b>) provided <b>34i</b> (88% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 7.21 (m, 2 H), 7.10 (d, <i>J</i> = 7.1 Hz, 1 H), 6.23 (d, <i>J</i> = 16.1 Hz, 1 H), 6.01 (dt, <i>J</i> = 16.1, 6.1 Hz, 1 H), 5.66 (d, <i>J</i> = 8.2 Hz, 1 H), 5.29 (m, 1 H), 4.85−4.77 (m, 1 H), 4.79−4.47 (m, 3 H), 4.16−4.08 (m, 2 H), 3.82 (m, 1 H), 3.83−3.67 (m, 3 H), 3.66−3.55 (m, 1 H), 3.48 (t, <i>J</i> = 8.6 Hz, 1 H), 3.27 (d, <i>J</i> = 10.9 Hz, 1 H), 2.73 (dd, <i>J</i> = 14.6, 8.0 Hz, 1 H), 2.30−2.06 (m, 3 H), 1.20 (s, 9 H), 1.17 (s, 1 H), 0.98 (s, 3 H), 0.93−0.82 (m, 6 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 586.3127 [(M + H)<sup>+</sup>; calcd for C<sub>31</sub>H<sub>44</sub>N<sub>3</sub>O<sub>8</sub>: 586.3123].</div></div><div id="sec5_90" class="NLM_sec NLM_sec_level_2"><div id="ac_i98" class="anchor-spacer"></div><h3 class="article-section__title" id="_i98"> (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxamide (<b>35a</b>)</h3><div class="NLM_p last">Using the above procedure for <b>31c</b> with methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-butyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>28h</b>) provided <b>35a</b> (71% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.23 (t, <i>J</i> = 7.5 Hz, 1 H), 7.14 (d, <i>J</i> = 7.5 Hz, 1 H), 7.09 (d, <i>J</i> = 7.5 Hz, 1 H), 7.02 (d, <i>J</i> = 9.5 Hz, 1 H), 5.36 (s, 1 H), 4.71 (m, 3 H), 4.64 (m, 1 H), 4.56 (sext, <i>J</i> = 4.9 Hz, 1 H), 4.40 (m, 2 H), 4.24 (d, <i>J</i> = 11.5 Hz, 1 H), 3.96 (dd, <i>J</i> = 12.0, 3.5 Hz, 1 H), 3.72 (m, 1 H), 2.98 (sept, <i>J</i> = 4.2 Hz, 1 H), 2.58 (m, 1 H), 2.49 (m, 2 H), 2.15 (m, 1 H), 1.69−1.19 (m, 16 H), 1.09 (m, 2 H), 1.06 (s, 9 H), 0.98 (t, <i>J</i> = 7.0 Hz, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 730.3478 [(M + H)<sup>+</sup>; calcd for C<sub>36</sub>H<sub>52</sub>N<sub>5</sub>O<sub>9</sub>S: 730.3480]. Anal. (C<sub>36</sub>H<sub>51</sub>N<sub>5</sub>O<sub>9</sub>S·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_91" class="NLM_sec NLM_sec_level_2"><div id="ac_i99" class="anchor-spacer"></div><h3 class="article-section__title" id="_i99"> (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxamide (Vaniprevir, 35b)</h3><div class="NLM_p">To a solution of methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-butyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34b</b>) (17.8 g, 32.0 mmol) in ethanol (EtOH) (800 mL) and EtOAc (160 mL) was added 10% Pd/C (1.7 g, 1.60 mmol). The reaction mixture was then placed under balloon pressure hydrogen and stirred for 18 h. The reaction mixture was filtered through celite, and the filtrate was concentrated to give methyl (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-butyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxylate (17.9 g), which was used with no further purification. LRMS (ESI) <i>m</i>/<i>z</i> 558.4 [(M + H)<sup>+</sup>; calcd for C<sub>30</sub>H<sub>44</sub>N<sub>3</sub>O<sub>7</sub>: 558.3].</div><div class="NLM_p">To a solution of the above ester (17.9 g, 32.0 mmol) in THF (300 mL), MeOH (75 mL), and water (150 mL) at RT was added LiOH·H<sub>2</sub>O (13.4 g, 320 mmol). The reaction mixture was stirred at RT for 1 h, concentrated to half volume, and diluted with Et<sub>2</sub>O. The layers were separated, and the aqueous layer was acidified with 2 N HCl and then extracted with EtOAc three times. The combined organic layer was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to yield (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-<i>tert</i>-butyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxylic acid (17.4 g), which was used with no further purification. LRMS (ESI) <i>m</i>/<i>z</i> 544.4 [(M + H)<sup>+</sup>; calcd for C<sub>29</sub>H<sub>42</sub>N<sub>3</sub>O<sub>7</sub>: 544.3].</div><div class="NLM_p last">To a solution of the above carboxylic acid (17.4 g, 32.0 mmol) and (1<i>R</i>,2<i>R</i>)-1-amino-<i>N</i>-(cyclopropylsulfonyl)-2-ethylcyclopropanecarboxamide hydrochloride (<b>30</b>)<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> (10.3 g, 38.4 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (800 mL) was added DIPEA (16.8 mL, 96 mmol), DMAP (0.08 g, 0.02 mmol), and HATU (14.6 g, 38.4 mmol). The reaction mixture was stirred at RT for 20 h and then concentrated and partitioned between EtOAc and 1 N HCl. The organic layer was washed with water and brine, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. The crude material was then purified by silica gel chromatography (gradient elution, 40−100% EtOAc in hexanes) to yield <b>35b</b> (22.1 g, 91% yield, 3 steps) as a white powder. <sup>1</sup>H NMR (500 MHz, ppm, CD<sub>3</sub>OD) δ 9.07 (s, 1 H), 7.23 (t, <i>J</i> = 7.5 Hz, 1 H), 7.14 (d, <i>J</i> = 7.5 Hz, 1 H), 7.09 (d, <i>J</i> = 7.0 Hz, 1 H), 5.53 (s, 1 H), 4.75−4.56 (m, 4 H), 4.44−4.36 (m, 3 H), 4.19 (d, <i>J</i> = 11.7 Hz, 1 H), 3.92 (dd, <i>J</i> = 11.8, 3.3 Hz, 1 H), 3.33−3.27 (m, 2 H), 2.99−2.96 (m, 1 H), 2.60−2.42 (m, 3 H), 2.17−2.08 (m, 1 H), 1.68−1.48 (m, 6 H), 1.37−1.16 (m, 8 H), 1.13−0.94 (m, 17 H), 0.80 (s, 3 H). HRMS (ESI) <i>m</i>/<i>z</i> 758.3844 [(M + H)<sup>+</sup>; calcd for C<sub>38</sub>H<sub>56</sub>N<sub>5</sub>O<sub>9</sub>S: 758.3793]. Anal. (C<sub>38</sub>H<sub>55</sub>N<sub>5</sub>O<sub>9</sub>S·0.55H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_92" class="NLM_sec NLM_sec_level_2"><div id="ac_i100" class="anchor-spacer"></div><h3 class="article-section__title" id="_i100"> (1′<i>R</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopropane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′-triene-24′-carboxamide (<b>35c</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopropane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34c</b>) provided <b>35c</b> (73% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.21 (t, <i>J</i> = 7.5 Hz, 1 H), 7.14 (d, <i>J</i> = 7.6 Hz, 1 H), 7.06 (d, <i>J</i> = 7.6 Hz, 1 H), 7.05 (d, <i>J</i> = 9.8 Hz, 1 H), 5.36 (m, 1 H), 4.86 (m, 1 H), 4.75−4.59 (m, 4 H), 4.45 (m, 1 H), 4.36 (d, <i>J</i> = 9.5 Hz, 1 H), 4.22 (d, <i>J</i> = 11.2 Hz, 1 H), 3.90 (dd, <i>J</i> = 12.0, 3.4 Hz, 1 H), 2.97 (sept, <i>J</i> = 4.0 Hz, 1 H), 2.86 (d, <i>J</i> = 11.5 Hz, 1 H), 2.54 (m, 3 H), 2.14 (m, 1 H), 1.74 (m, 1 H), 1.64−1.52 (m, 6 H), 1.45−1.19 (m, 6 H), 1.11−0.89 (m, 14 H), 0.55 (m, 1 H), 0.36 (m, 1 H), 0.30 (m, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 756.3630 [(M + H)<sup>+</sup>; calcd for C<sub>38</sub>H<sub>54</sub>N<sub>5</sub>O<sub>9</sub>S: 756.3637]. Anal. (C<sub>38</sub>H<sub>53</sub>N<sub>5</sub>O<sub>9</sub>S·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_93" class="NLM_sec NLM_sec_level_2"><div id="ac_i101" class="anchor-spacer"></div><h3 class="article-section__title" id="_i101"> (1′<i>R</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclobutane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′-triene-24′-carboxamide (<b>35d</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclobutane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34d</b>) provided <b>35d</b> (74% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.21 (t, <i>J</i> = 7.5 Hz, 1 H), 7.13 (d, <i>J</i> = 7.3 Hz, 1 H), 7.07 (d, <i>J</i> = 7.1 Hz, 1 H), 7.06 (d, <i>J</i> = 10.3 Hz, 1 H), 5.35 (m, 1 H), 4.71 (m, 1 H), 4.66−4.57 (m, 3 H), 4.44−4.33 (m, 3 H), 4.21 (d, <i>J</i> = 11.0 Hz, 1 H), 3.89 (dd, <i>J</i> = 11.7, 3.2 Hz, 1 H), 3.68 (d, <i>J</i> = 10.7 Hz, 1 H), 2.96 (sept, <i>J</i> = 4.3 Hz, 1 H), 2.54 (m, 3 H), 2.13 (m, 1 H), 2.04 (m, 1 H), 1.85 (m, 2 H), 1.76 (q, <i>J</i> = 8.8 Hz, 2 H), 1.65−1.39 (m, 9 H), 1.32−1.16 (m, 5 H), 1.12−0.87 (m, 14 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 770.3807 [(M + H)<sup>+</sup>; calcd for C<sub>39</sub>H<sub>56</sub>N<sub>5</sub>O<sub>9</sub>S: 770.3793]. Anal. (C<sub>39</sub>H<sub>55</sub>N<sub>5</sub>O<sub>9</sub>S·0.75H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_94" class="NLM_sec NLM_sec_level_2"><div id="ac_i102" class="anchor-spacer"></div><h3 class="article-section__title" id="_i102"> (1′<i>R</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopentane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′-triene-24′-carboxamide (<b>35e</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclopentane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34e</b>) provided <b>35e</b> (97% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 9.08 (s, 1 H), 7.23 (t, <i>J</i> = 7.3 Hz, 1 H), 7.15 (d, <i>J</i> = 7.3 Hz, 1 H), 7.09 (d, <i>J</i> = 7.1 Hz, 1 H), 5.36 (s, 1 H), 4.75−4.58 (m, 5 H), 4.43 (m, 2 H), 4.34 (d, <i>J</i> = 10.5 Hz, 1 H), 4.21 (d, <i>J</i> = 11.7 Hz, 1 H), 3.91 (d, <i>J</i> = 10.0 Hz, 1 H), 3.35 (m, 1 H), 2.98 (br s, 1 H), 2.59−2.49 (m, 3 H), 2.14 (m, 1 H), 1.82 (m, 1 H), 1.62−0.94 (m, 34 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 784.3944 [(M + H)<sup>+</sup>; calcd for C<sub>40</sub>H<sub>58</sub>N<sub>5</sub>O<sub>9</sub>S: 784.3950]. Anal. (C<sub>40</sub>H<sub>57</sub>N<sub>5</sub>O<sub>9</sub>S·1.50H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_95" class="NLM_sec NLM_sec_level_2"><div id="ac_i103" class="anchor-spacer"></div><h3 class="article-section__title" id="_i103"> (1′<i>R</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-Butyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclohexane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′-triene-24′-carboxamide (<b>35f</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1′<i>R</i>,12′<i>E</i>,21′<i>S</i>,24′<i>S</i>)-21′-<i>tert</i>-butyl-3′,19′,22′-trioxo-2′,18′-dioxa-4′,20′,23′-triazaspiro[cyclohexane-1,16′-tetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosane]-6′,8′,10′,12′-tetraene-24′-carboxylate (<b>34f</b>) provided <b>35f</b> (81% yield). <sup>1</sup>H NMR (500 MHz, CD<sub>3</sub>OD) δ 7.22 (t, <i>J</i> = 7.4 Hz, 1 H), 7.14 (d, <i>J</i> = 7.6 Hz, 1 H), 7.08 (d, <i>J</i> = 8.1 Hz, 1 H), 5.34 (s, 1 H), 4.74−4.57 (m, 4 H), 4.43 (m, 2 H), 4.26−4.18 (m, 2 H), 3.90 (d, <i>J</i> = 9.3 Hz, 1 H), 3.53 (d, <i>J</i> = 10.8 Hz, 1 H), 2.98 (m, 1 H), 2.62−2.46 (m, 3 H), 2.13 (m, 1 H), 1.64 (m, 2 H), 1.56−1.36 (m, 12 H), 1.30−1.23 (m, 9 H), 1.09 (m, 3 H), 1.05 (s, 9 H), 0.97 (m, 4 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 798.4089 [(M + H)<sup>+</sup>; calcd for C<sub>41</sub>H<sub>60</sub>N<sub>5</sub>O<sub>9</sub>S: 798.4106]. Anal. (C<sub>41</sub>H<sub>59</sub>N<sub>5</sub>O<sub>9</sub>S·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_96" class="NLM_sec NLM_sec_level_2"><div id="ac_i104" class="anchor-spacer"></div><h3 class="article-section__title" id="_i104"> (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-Cyclohexyl-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxamide (<b>35g</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-cyclohexyl-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34g</b>) provided <b>35g</b> (83% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.13 (s, 1 H), 7.22 (t, <i>J</i> = 7.5 Hz, 1 H), 7.10 (d, <i>J</i> = 7.5 Hz, 1 H), 7.05 (d, <i>J</i> = 7.5 Hz, 1 H), 6.73 (s, 1 H), 5.40 (d, <i>J</i> = 9.5 Hz, 1 H), 5.36 (m, 1 H), 4.67−4.76 (m, 2 H), 4.55 (d, <i>J</i> = 15.5 Hz, 1 H), 4.44 (d, <i>J</i> = 14.5 Hz, 1 H), 4.41 (d, <i>J</i> = 11.0 Hz, 1 H), 4.29−4.39 (m, 2 H), 4.16 (d, <i>J</i> = 11.0 Hz, 1 H), 3.85−3.82 (dd, <i>J</i> = 11.5, 3.5 Hz, 1 H), 3.25 (d, <i>J</i> = 11.0 Hz, 1 H), 2.95 (m, 1 H), 2.59−2.51 (m, 2 H), 2.44−2.36 (m, 2 H), 1.76−1.00 (m, 26 H), 0.99−0.90 (m, 6 H), 0.79 (br s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 784.3950 [(M + H)<sup>+</sup>; calcd for C<sub>40</sub>H<sub>58</sub>N<sub>5</sub>O<sub>9</sub>S: 784.3911].</div></div><div id="sec5_97" class="NLM_sec NLM_sec_level_2"><div id="ac_i105" class="anchor-spacer"></div><h3 class="article-section__title" id="_i105"> (1<i>R</i>,21<i>S</i>,24<i>S</i>)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(Cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-16,16-dimethyl-21-(1-methylcyclohexyl)-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxamide (<b>35h</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-16,16-dimethyl-21-(1-methylcyclohexyl)-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34h</b>) provided <b>35h</b> (79% yield). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.97 (s, 1 H), 7.22 (m, 1 H), 7.09 (d, <i>J</i> = 7.5 Hz, 1 H), 7.06 (d, <i>J</i> = 7.3 Hz, 1 H), 6.70 (s, 1 H), 5.52 (d, <i>J</i> = 9.7 Hz, 1 H), 5.34 (m, 1 H), 4.72 (m, 2 H), 4.51−4.38 (m, 3 H), 4.31 (m, 1 H), 4.18 (d, <i>J</i> = 12.0 Hz, 1 H), 3.87 (dd, <i>J</i> = 11.8, 3.4 Hz, 1 H), 3.48 (q, <i>J</i> = 7.0 Hz, 2 H), 3.25 (d, <i>J</i> = 10.7 Hz, 1 H), 2.93 (m, 1 H), 2.63−2.50 (m, 2 H), 2.47−2.28 (m, 2 H), 1.64−1.33 (m, 13 H), 1.32−1.14 (m, 3 H), 1.11−1.08 (m, 11 H), 1.06 (s, 3 H), 0.96 (s, 3 H), 0.79 (s, 3 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 798.4129[(M + H)<sup>+</sup>; calcd for C<sub>41</sub>H<sub>60</sub>N<sub>5</sub>O<sub>9</sub>S: 798.4106]. Anal. (C<sub>41</sub>H<sub>59</sub>N<sub>5</sub>O<sub>9</sub>S·H<sub>2</sub>O) C, H, N.</div></div><div id="sec5_98" class="NLM_sec NLM_sec_level_2"><div id="ac_i106" class="anchor-spacer"></div><h3 class="article-section__title" id="_i106"> (1<i>R</i>,21<i>S</i>,24<i>S</i>)-21-(<i>tert</i>-Butoxymethyl)-<i>N</i>-((1<i>R</i>,2<i>R</i>)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-ethylcyclopropyl)-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10-triene-24-carboxamide (<b>35i</b>)</h3><div class="NLM_p last">Using the above procedure for <b>35b</b> with methyl (1<i>R</i>,12<i>E</i>,21<i>S</i>,24<i>S</i>)-21-(<i>tert</i>-butoxymethyl)-16,16-dimethyl-3,19,22-trioxo-2,18-dioxa-4,20,23-triazatetracyclo[21.2.1.1<sup>4,7</sup>.0<sup>6,11</sup>]heptacosa-6,8,10,12-tetraene-24-carboxylate (<b>34i</b>) provided <b>35i</b> (76% yield). <sup>1</sup>H NMR (500 MHz, CDCl<sub>3</sub>) δ 10.00 (s, 1 H), 7.20 (t, <i>J</i> = 7.5 Hz, 1 H), 7.10 (d, <i>J</i> = 8.0 Hz, 1 H), 7.05 (d, <i>J</i> = 8.5 Hz, 1 H), 6.82 (s, 1 H), 5.75 (m, 1 H), 5.54 (d, <i>J</i> = 9.5 Hz, 1 H), 5.31 (m, 1 H), 5.20−5.10 (m, 1 H), 4.80 (m, 1 H), 4.68−7.76 (m, 2 H), 4.45−4.56 (m, 4 H), 4.17 (d, <i>J</i> = 11.5 Hz, 1 H), 3.78 (m, 1 H), 3.68−3.70 (m, 1 H), 3.58 (t, <i>J</i> = 9.0 Hz, 1 H), 3.25 (d, <i>J</i> = 11.0 Hz, 1 H), 2.95−2.98 (m, 1 H), 2.71−2.75 (m, 1 H), 2.49−2.51 (m, 1 H), 2.37−2.42 (m, 1 H), 1.64−1.71 (m, 3 H), 1.54 (s, 9 H), 1.45−1.33 (m, 3 H), 1.26−1.33 (m, 5 H), 1.20 (s, 6 H), 1.00 (t, <i>J</i> = 7.0 Hz, 2 H), 0.96 (s, 2 H), 0.80 (br s, 2 H) ppm. HRMS (ESI) <i>m</i>/<i>z</i> 788.4011 [(M + H)<sup>+</sup>; calcd for C<sub>39</sub>H<sub>58</sub>N<sub>5</sub>O<sub>10</sub>S: 788.3860].</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i108"><a href="/doi/suppl/10.1021/jm9015526">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_24170" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_24170" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR spectra and elemental analysis data for selected compounds. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9015526/suppl_file/jm9015526_si_001.pdf">jm9015526_si_001.pdf (2.51 MB)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm9015526" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_57561" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_57561" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John A. McCauley</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#600a0f080e3f0d030301150c0519200d0512030b4e030f0d"><span class="__cf_email__" data-cfemail="2b41444345744648484a5e474e526b464e59484005484446">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles J. McIntyre</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael T. Rudd</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin T. Nguyen</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph J. Romano</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John W. Butcher</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kevin F. Gilbert</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kimberly J. Bush</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">M. Katharine Holloway</span> - <span class="hlFld-Affiliation affiliation">Department of Molecular Systems</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John Swestock</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Bang-Lin Wan</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven S. Carroll</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jillian M. DiMuzio</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Donald J. Graham</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven W. Ludmerer</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shi-Shan Mao</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark W. Stahlhut</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine M. Fandozzi</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nicole Trainor</span> - <span class="hlFld-Affiliation affiliation">Department of Drug Metabolism</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David B. Olsen</span> - <span class="hlFld-Affiliation affiliation">Department of Antiviral Research</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Joseph P. Vacca</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nigel J. Liverton</span> - <span class="hlFld-Affiliation affiliation">Department of Medicinal Chemistry</span></div></li></ul></li><li></li><li></li><li></li></ul></div><div class="ack"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i107">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85423" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85423" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Dr. Charles W. Ross, III, and Joan S. Murphy for determination of high-resolution mass spectra, and Sandor L. Varga for interpretation of NMR spectral data.</p></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 36 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span> </span><span class="NLM_article-title">Hepatitis C—global prevalence (update)</span>.  <span class="citation_source-journal">WHO Wkly. Epidemiol. Rec.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span>− <span class="NLM_lpage">427</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=10645164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%E2%80%94global+prevalence+%28update%29.+WHO+Wkly.+Epidemiol.+Rec.%2C+1999%2C+74%2C+425%E2%88%92427."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DHepatitis%2520C%25E2%2580%2594global%2520prevalence%2520%2528update%2529%26jtitle%3DWHO%2520Wkly.%2520Epidemiol.%2520Rec.%26date%3D1999%26volume%3D74%26spage%3D425%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C−associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C%E2%88%92associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C%25E2%2588%2592associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Salmon-Ceron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bévilacqua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jougla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héripret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chêne, G.</span><span> </span><span class="NLM_article-title">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.jhep.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=15973779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=799-805&author=D.+Salmon-Ceronauthor=C.+Lewdenauthor=P.+Morlatauthor=S.+B%C3%A9vilacquaauthor=E.+Jouglaauthor=F.+Bonnetauthor=L.+H%C3%A9ripretauthor=D.+Costagliolaauthor=T.+Mayauthor=G.+Ch%C3%AAne&title=Liver+disease+as+a+major+cause+of+death+among+HIV+infected+patients%3A+role+of+hepatitis+C+and+B+viruses+and+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span></div><div class="casAuthors">Salmon-Ceron, Dominique; Lewden, Charlotte; Morlat, Philippe; Bevilacqua, Sibylle; Jougla, Eric; Bonnet, Fabrice; Heripret, Laurence; Costagliola, Dominique; May, Thierry; Chene, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-805</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We analyzed the characteristics of HIV-infected patients who died from liver disease, focusing on hepatitis virus co-infection.  One-hundred and eighty-five French hospital departments involved in HIV/AIDS management prospectively notified all deaths occurring in 2000.  Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg pos.), both HCV and HBV, or neither HCV nor HBV.  Among 822 HIV infected patients, 29% were infected by HCV alone, 8% by HBV alone, and 4% by both HCV and HBV.  The most frequent causes of death were liver disease (31% of cases) and AIDS (29%) among HIV-HCV co-infected patients, and AIDS (38%) and liver disease (22%) among HIV-HBV co-infected patients.  Liver disease was a more frequent cause of death among patients co-infected by both HCV and HBV (44% of cases).  Hepatocellular carcinoma was present in 15% of patients who died from liver disease, and was assocd. with HBV co-infection.  Nearly half the patients who died from liver disease had more than 200 CD4/mm3.  Liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause of death among HIV-HBV co-infected patients.  The risk of death from liver disease is highest in patients co-infected by both HCV and HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiRIxXPw237Vg90H21EOLACvtfcHk0liB4Qi7vnyUhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D&md5=dcedbbba9e185f1783e680b6da3fa4ce</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon-Ceron%26aufirst%3DD.%26aulast%3DLewden%26aufirst%3DC.%26aulast%3DMorlat%26aufirst%3DP.%26aulast%3DB%25C3%25A9vilacqua%26aufirst%3DS.%26aulast%3DJougla%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DF.%26aulast%3DH%25C3%25A9ripret%26aufirst%3DL.%26aulast%3DCostagliola%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DCh%25C3%25AAne%26aufirst%3DG.%26atitle%3DLiver%2520disease%2520as%2520a%2520major%2520cause%2520of%2520death%2520among%2520HIV%2520infected%2520patients%253A%2520role%2520of%2520hepatitis%2520C%2520and%2520B%2520viruses%2520and%2520alcohol%26jtitle%3DJ.%2520Hepatol.%26date%3D2005%26volume%3D42%26spage%3D799%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hadziyannis, S. J.; Sette, H.; Morgan, T. R.; Balan, V.; Diago, M.; Marcellin, P.</span><span class="NLM_contrib-group">PEGASYS International Study Group</span><span class="NLM_contrib-group"></span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</span>.  <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span>− <span class="NLM_lpage">355</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.7326%2F0003-4819-140-5-200403020-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=14996676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2004&pages=346-355&author=S.+J.+Hadziyannis&author=H.+Sette&author=T.+R.+Morgan&author=V.+Balan&author=M.+Diago&author=P.+Marcellinauthor=PEGASYS+International+Study+Group&title=Peginterferon-alpha2a+and+ribavirin+combination+therapy+in+chronic+hepatitis+C%3A+a+randomized+study+of+treatment+duration+and+ribavirin+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose</span></div><div class="casAuthors">Hadziyannis, Stephanos J.; Sette, Hoel, Jr.; Morgan, Timothy R.; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry, Jr.; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; Pockros, Paul J.; Lin, Amy; Ackrill, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">Treatment with pegylated interferon (peginterferon) and ribavirin for 48 wk is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.  Objective: To assess the efficacy and safety of 24 or 48 wk of treatment with peginterferon-α2a plus a low or std. dose of ribavirin.  Design: Randomized, double-blind trial.  Setting: 99 international centers.  Patients: 1311 patients with chronic hepatitis C.  Intervention: Peginterferon-α2a, 180 μg/wk, for 24 or 48 wk plus a low-dose (800 mg/d) or std. wt.-based dose (1000 or 1200 mg/d) of ribavirin.  Measurement: Sustained virol. response: undetectable HCV RNA concn. at the end of treatment and during 12 to 24 wk of follow-up.  Results: Overall and in patients infected with HCV genotype 1, 48 wk of treatment was statistically superior to 24 wk and std.-dose ribavirin was statistically superior to low-dose ribavirin.  In patients with HCV genotype 1, abs. differences in sustained virol. response rates between 48 and 24 wk of treatment were 11.2% (95% CI, 3.6% to 18.9%) and 11.9% (CI, 4.7% to 18.9%), resp., between std.- and low-dose ribavirin.  Sustained virol. response rates for peginterferon-α2a and std.-dose ribavirin for 48 wk were 63% (CI, 59% to 68%) overall and 52% (CI, 46% to 58%) in patients with HCV genotype 1.  In patients with HCV genotypes 2 or 3, the sustained virol. response rates in the 4 treatment groups were not statistically significantly different.  Conclusion: Treatment with peginterferon-α2a and ribavirin may be individualized by genotype.  Patients with HCV genotype 1 require treatment for 48 wk and a std. dose of ribavirin; those with HCV genotypes 2 or 3 seem to be adequately treated with a low dose of ribavirin for 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDnDyBicuGj7Vg90H21EOLACvtfcHk0liB4Qi7vnyUhQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D&md5=0e5ff18b054a10ab2051ba6c094626d0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-140-5-200403020-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-140-5-200403020-00010%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26aulast%3D%26aulast%3D%26atitle%3DPeginterferon-alpha2a%2520and%2520ribavirin%2520combination%2520therapy%2520in%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520study%2520of%2520treatment%2520duration%2520and%2520ribavirin%2520dose%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2004%26volume%3D140%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=958-965&author=M.+P.+Mannsauthor=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=V.+K.+Rustgiauthor=M.+Shiffmanauthor=R.+Reindollarauthor=Z.+D.+Goodmanauthor=K.+Kouryauthor=M.+Lingauthor=J.+K.+Albrecht&title=Peginterferon+alfa-2b+plus+ribavirin+compared+with+interferon+alfa-2b+plus+ribavirin+for+initial+treatment+of+chronic+hepatitis+C%3A+a+randomized+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DPeginterferon%2520alfa-2b%2520plus%2520ribavirin%2520compared%2520with%2520interferon%2520alfa-2b%2520plus%2520ribavirin%2520for%2520initial%2520treatment%2520of%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520trial%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D958%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusti, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1056%2FNEJM199811193392101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=9819446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1485-1492&author=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=E.+R.+Schiffauthor=M.+L.+Shiffmanauthor=W.+M.+Leeauthor=V.+K.+Rustiauthor=Z.+D.+Goodmanauthor=M.+H.+Lingauthor=S.+Cortauthor=J.+K.+Albrecht&title=Interferon+alfa-2b+alone+or+in+combination+with+ribavirin+as+initial+treatment+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span></div><div class="casAuthors">Mchutchison, John G.; Gordon, Stuart C.; Schiff, Eugene R.; Shiffman, Mitchell L.; Lee, William M.; Rustgi, Vinod K.; Goodman, Zachary D.; Ling, Mei-Hsiu; Cort, Susannah; Albrecht, Janice K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1485-1492</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virol. response to interferon therapy.  We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of patients with chronic hepatitis C.  We randomly assigned 912 patients with chronic hepatitis C to receive std.-dose interferon alfa-2b alone or in combination with ribavirin (1000 or 1200 mg orally per day, depending on body wt.) for 24 or 48 wk.  Efficacy was assessed by measurements of serum hepatitis C virus (HCV) RNA and serum aminotransferases and by liver biopsy.  The rate of sustained virol. response (defined as an undetectable serum HCV RNA level 24 wk after treatment was completed) was higher among patients who received combination therapy for either 24 wk (70 of 228 patients, 31 percent) or 48 wk (87 of 228 patients, 38 percent) than among patients who received interferon alone for either 24 wk (13 of 231 patients, 6 percent) or 48 wk (29 of 225 patients, 13 percent) (P<0.001 for the comparison of interferon alone with both 24 wk and 48 wk of combination treatment).  Among patients with HCV genotype 1 infection, the best response occurred in those who were treated for 48 wk with interferon and ribavirin.  Histol. improvement was more common in patients who were treated with combination therapy for either 24 wk (57 percent) or 48 wk (61 percent) than in those who were treated with interferon alone for either 24 wk (44 percent) or 48 wk (41 percent).  The drug doses had to be reduced and treatment discontinued more often in patients who were treated with combination therapy.  In patients with chronic hepatitis C, initial therapy with interferon and ribavirin was more effective than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9oxTyHQud7LVg90H21EOLACvtfcHk0lhjWxDZ4IDqQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D&md5=41f8d301b8b7eddddda610cb71755cb2</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392101%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DRusti%26aufirst%3DV.%2BK.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DLing%26aufirst%3DM.%2BH.%26aulast%3DCort%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DInterferon%2520alfa-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520as%2520initial%2520treatment%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1485%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Gordon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Control of hepatitis C: a medicinal chemistry perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0400101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1-20&author=C.+P.+Gordonauthor=P.+A.+Keller&title=Control+of+hepatitis+C%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0400101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0400101%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DControl%2520of%2520hepatitis%2520C%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">For recent reviews see:</p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0lhjWxDZ4IDqQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=606-617&author=J.+A.+Thomsonauthor=R.+B.+Perni&title=Hepatitis+C+virus+NS3-4A+protease+inhibitors%3A+countering+viral+subversion+in+vitro+and+showing+promise+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520protease%2520inhibitors%253A%2520countering%2520viral%2520subversion%2520in%2520vitro%2520and%2520showing%2520promise%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D606%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chen, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span><span> </span><span class="NLM_article-title">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F0929867054864769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16181135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2317-2342&author=S.-H.+Chenauthor=S.-L.+Tan&title=Discovery+of+small-molecule+inhibitors+of+HCV+NS3-4A+protease+as+potential+therapeutic+agents+against+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span></div><div class="casAuthors">Chen, Shu-Hui; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2317-2342</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis C virus (HCV) is assocd. with liver cirrhosis that often leads to hepatic failure and hepatocellular carcinoma (HCC).  HCV infection has become a global health threat and the main cause of adult liver transplants in developed nations.  Current approved anti-HCV therapies (interferon and pegylated interferon alone or in combination with ribavirin) are not effective in eliminating the viral infection in a significant population of patients (e.g., those infected with HCV genotype 1).  Furthermore, these therapies are plagued with many undesirable side effects.  Therefore, the HCV epidemic represents a huge unmet medical need that has triggered intensive research efforts towards the development of more effective drugs.  Given its essential role in the process of HCV replication, the viral NS3/4A serine protease is arguably the most thoroughly characterized HCV enzyme and the most intensively pursued anti-HCV target for drug development.  This is further fueled by the successful use of small-mol. inhibitors of the human immunodeficiency virus (HIV) viral protease, which have had an impressive effect on HIV-related morbidity and mortality, offering hope that analogous drugs might also have a similar impact against HCV.  Here, we review the recent progress and development of small-mol. inhibitors of the HCV NS3/4A protease.  In particular, we focus on the discovery of VX-950, the latest HCV NS3-4A protease inhibitor to be advanced to clin. studies.  While the challenges of designing potent inhibitors of the viral protease have been solved, as highlighted by BILN 2061 and VX-950, it is still too early to det. whether these efforts will eventually yield promising drug candidates.  For the emerging small-mol. HCV inhibitors, viral resistance will likely be a big problem.  Thus, combination therapy of different drugs with different targets/mechanisms will be necessary to effectively inhibit HCV replication.  It is also hoped that a detail characterization of how the resistance mutations that affect NS3 inhibitor binding may provide useful information for the design of inhibitors with the potential to treat resistant viruses that may arise during chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPS11RNEtD9LVg90H21EOLACvtfcHk0lgIP1NWBvVIsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN&md5=5c255f47a40c7db2fa951f8727c5a21c</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.2174%2F0929867054864769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054864769%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.-H.%26aulast%3DTan%26aufirst%3DS.-L.%26atitle%3DDiscovery%2520of%2520small-molecule%2520inhibitors%2520of%2520HCV%2520NS3-4A%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520against%2520HCV%2520infection%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2317%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lgIP1NWBvVIsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhéaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Ma%C3%AEtreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rh%C3%A9aumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRh%25C3%25A9aume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F187152606776056706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16787300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=3-16&author=C.+Linauthor=A.+D.+Kwongauthor=R.+B.+Perni&title=Discovery+and+development+of+VX-950%2C+a+novel%2C+covalent%2C+and+reversible+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3•4A serine protease</span></div><div class="casAuthors">Lin, C.; Kwong, A. D.; Perni, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) NS3•4A protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel anti-HCV therapies.  However, discovery of potent and selective small-mol. inhibitors of HCV NS3•4A protease as oral drug candidates has been hampered by the shallow substrate-binding groove of the protease.  Serine trap warheads have been used to covalently anchor inhibitor scaffolds and to increase their affinity to the protease.  This review will examine the evolution of covalent inhibitors of the HCV NS3•4A protease from early aldehyde mols. to α-ketoamide inhibitors.  Kinetic and structural studies of α-ketoacid and α-ketoamide inhibitors revealed an unusual mechanism of binding in the catalytic site.  Optimization of α-ketoamide scaffolds by scientists at Vertex and Eli Lilly led to the discovery of VX-950, a novel, potent, selective inhibitor of HCV NS3•4A protease.  VX-950 possesses excellent antiviral activity in both HCV replicon cells and human fetal hepatocytes infected with HCV-pos. patient sera.  In addn., VX-950 exhibits a favorable pharmacokinetic profile in several animal species and demonstrates potent inhibition of the HCV NS3•4A protease activity in a mouse model.  In a recent phase 1b clin. trial, VX-950 was able to rapidly reduce the plasma viral load of patients chronically infected with genotype 1 HCV by a mean ∼3 log10 in 2 days.  The median viral load redn. was 4.4 log10 for the best dose group after 14 days of dosing.  The preclin. profile and early clin. data of VX-950 will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOA6Gspx5Jv7Vg90H21EOLACvtfcHk0lhIe6r1LkyT4A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D&md5=dbf5706a5d351aabf722d88216d88b78</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2174%2F187152606776056706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056706%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520and%2520development%2520of%2520VX-950%252C%2520a%2520novel%252C%2520covalent%252C%2520and%2520reversible%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034). Key Steps in Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.-S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+Protease+Inhibitor+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29.+Key+Steps+in+Structure-Based+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529.%2520Key%2520Steps%2520in%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical Characteristics of the Hepatitis C virus NS3/4A Protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+Characteristics+of+the+Hepatitis+C+virus+NS3%2F4A+Protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520Characteristics%2520of%2520the%2520Hepatitis%2520C%2520virus%2520NS3%252F4A%2520Protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rajagopalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span> </span><span class="NLM_article-title">Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2559</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900038p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2559-2568&author=R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=D.+G.+Myszkaauthor=B.+J.+Brandhuberauthor=J.+A.+Ballardauthor=S.+W.+Andrewsauthor=S.+D.+Seiwertauthor=K.+Kossen&title=Inhibition+and+Binding+Kinetics+of+the+Hepatitis+C+Virus+NS3+Protease+Inhibitor+ITMN-191+Reveals+Tight+Binding+and+Slow+Dissociative+Behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior</span></div><div class="casAuthors">Rajagopalan, Ravi; Misialek, Shawn; Stevens, Sarah K.; Myszka, David G.; Brandhuber, Barbara J.; Ballard, Joshua A.; Andrews, Steven W.; Seiwert, Scott D.; Kossen, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2559-2568</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protease activity of hepatitis C virus nonstructural protein 3 (NS3) is essential for viral replication.  ITMN-191, a macrocyclic inhibitor of the NS3 protease active site, promotes rapid, multilog viral load redns. in chronic HCV patients.  Here, ITMN-191 is shown to be a potent inhibitor of NS3 with a two-step binding mechanism.  Progress curves are consistent with the formation of an initial collision complex (EI) that isomerizes to a highly stable complex (EI*) from which ITMN-191 dissocs. very slowly.  Ki, the dissocn. const. of EI, is 100 nM, and the rate const. for conversion of EI to EI* is 6.2 × 10-2 s-1.  Binding expts. using protein fluorescence confirm this isomerization rate.  From progress curve anal., the rate const. for dissocn. of ITMN-191 from the EI* complex is 3.8 × 10-5 s-1 with a calcd. complex half-life of ∼5 h and a true biochem. potency (Ki*) of ∼62 pM.  Surface plasmon resonance studies and assessment of enzyme reactivation following diln. of the EI* complex confirm slow dissocn. and suggest that the half-life may be considerably longer.  Abrogation of the tight binding and slow dissociative properties of ITMN-191 is obsd. with proteases that carry the R155K or D168A substitution, each of which is likely in drug resistant mutants.  Slow dissocn. is not obsd. with closely related macrocyclic inhibitors of NS3, suggesting that members of this class may display distinct binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOY26vXOrtJrVg90H21EOLACvtfcHk0lgYG6Go5PqjYg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFems7k%253D&md5=5e985737f2627bd314b517f93b938336</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fbi900038p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900038p%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DBallard%26aufirst%3DJ.%2BA.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DKossen%26aufirst%3DK.%26atitle%3DInhibition%2520and%2520Binding%2520Kinetics%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%2520ITMN-191%2520Reveals%2520Tight%2520Binding%2520and%2520Slow%2520Dissociative%2520Behavior%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D2559%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blatt, L. M.; Wenglowsky, S. M.; Andrews, S. W.; Jiang, Y.; Kennedy, A. L.; Condroski, K. R.; Josey, J. A.; Stengel, P. J.; Madduru, M. R.; Doherty, G. A.; Woodard, B. T.</span><span> </span><span class="NLM_article-title">Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication</span>. PCT Int. Appl. WO 2005/037214,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+M.+Blatt&author=S.+M.+Wenglowsky&author=S.+W.+Andrews&author=Y.+Jiang&author=A.+L.+Kennedy&author=K.+R.+Condroski&author=J.+A.+Josey&author=P.+J.+Stengel&author=M.+R.+Madduru&author=G.+A.+Doherty&author=B.+T.+Woodard&title=Macrocyclic+carboxylic+acids+and+acylsulfonamides+as+inhibitors+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DMacrocyclic%2520carboxylic%2520acids%2520and%2520acylsulfonamides%2520as%2520inhibitors%2520of%2520HCV%2520replication%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=A.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+Vitro+Activity+and+Preclinical+Profile+of+TMC435350%2C+a+Potent+Hepatitis+C+Virus+Protease+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Preclinical%2520Profile%2520of%2520TMC435350%252C%2520a%2520Potent%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wähling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Biog. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.bmcl.2008.07.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=18678486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+W%C3%A4hlingauthor=K.+Wickstr%C3%B6mauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span></div><div class="casAuthors">Raboisson, Pierre; de Kock, Herman; Rosenquist, Asa; Nilsson, Magnus; Salvador-Oden, Lourdes; Lin, Tse-I.; Roue, Natalie; Ivanov, Vladimir; Wahling, Horst; Wickstrom, Kristina; Hamelink, Elizabeth; Edlund, Michael; Vrang, Lotta; Vendeville, Sandrine; Van de Vreken, Wim; McGowan, David; Tahri, Abdellah; Hu, Lili; Boutton, Carlo; Lenz, Oliver; Delouvroy, Frederic; Pille, Geert; Surleraux, Dominique; Wigerinck, Piet; Samuelsson, Bertil; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">SAR anal. performed with a limited set of cyclopentane-contg. macrocycles led to the identification of TMC435350 (I) as a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).  TMC435350 also displayed low in vitro clearance and high permeability, which were confirmed by in vivo pharmacokinetic studies.  TMC435350 is currently being evaluated in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbRb8GhLBkJ7Vg90H21EOLACvtfcHk0lihe4Eri7KCFw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE&md5=001abd8307658a926479ff77496b6ff9</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.088%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DW%25C3%25A4hling%26aufirst%3DH.%26aulast%3DWickstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBiog.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raboisson, P.; De Kock, H.; Hu, L.; Vendeville, S.; Tahri, A.; Surleraux, D.; Simmen, K.; Nilsson, K.; Samuelsson, B.; Rosenquist, A.; Ivanov, V.; Pelcman, M.; Belfrage, A.; Johansson, P.-O.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of hepatitis C virus</span>. PCT Int. Appl. WO 2007/014926,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Raboisson&author=H.+De+Kock&author=L.+Hu&author=S.+Vendeville&author=A.+Tahri&author=D.+Surleraux&author=K.+Simmen&author=K.+Nilsson&author=B.+Samuelsson&author=A.+Rosenquist&author=V.+Ivanov&author=M.+Pelcman&author=A.+Belfrage&author=P.-O.+Johansson&title=Macrocyclic+inhibitors+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1353-1363&author=N.+Yaoauthor=P.+Reichertauthor=S.+S.+Taremiauthor=W.+W.+Prosiseauthor=P.+C.+Weber&title=Molecular+views+of+viral+polyprotein+processing+revealed+by+the+crystal+structure+of+the+hepatitis+C+virus+bifunctional+protease-helicase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DN.%26aulast%3DReichert%26aufirst%3DP.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DMolecular%2520views%2520of%2520viral%2520polyprotein%2520processing%2520revealed%2520by%2520the%2520crystal%2520structure%2520of%2520the%2520hepatitis%2520C%2520virus%2520bifunctional%2520protease-helicase%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1353%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">McPhee, F.; Campbell, J. A.; Li, W.; D'Andrea, S.; Zheng, Z. B.; Good, A. C.; Carini, D. J.; Johnson, B. L.; Scola, P. M.</span><span> </span><span class="NLM_article-title">Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus</span>. PCT Int. Appl. WO 2004/094452,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=F.+McPhee&author=J.+A.+Campbell&author=W.+Li&author=S.+D%27Andrea&author=Z.+B.+Zheng&author=A.+C.+Good&author=D.+J.+Carini&author=B.+L.+Johnson&author=P.+M.+Scola&title=Macrocyclic+isoquinoline+peptide+inhibitors+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26atitle%3DMacrocyclic%2520isoquinoline%2520peptide%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Ripka, A.; Campbell, J. A.; Good, A. C.; Scola, P. M.; Sin, N.; Venables, B.</span><span> </span><span class="NLM_article-title">Hepatitis C virus inhibitors</span>. U.S. Pat. Appl. US 2004048802,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+Ripka&author=J.+A.+Campbell&author=A.+C.+Good&author=P.+M.+Scola&author=N.+Sin&author=B.+Venables&title=Hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRipka%26aufirst%3DA.%26atitle%3DHepatitis%2520C%2520virus%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin Metathesis</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7117</span><span class="NLM_x">–</span> <span class="NLM_lpage">7140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.tet.2004.05.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVWhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=7117-7140&author=R.+H.+Grubbs&title=Olefin+Metathesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin metathesis</span></div><div class="casAuthors">Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7117-7140</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Olefin metathesis has become a tool for synthetic org. and polymer chemists.  Well-defined, functional group-tolerant catalysts have allowed these advances.  A discussion of the evolution of mechanistic understanding and early catalyst developments is followed by a description of recent advances in ruthenium-based olefin metathesis catalysts.  Catalysts improvements have led to new applications in ring closing metathesis, cross metathesis and materials synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp17ME4BMlFQbVg90H21EOLACvtfcHk0lheEQDt33eGHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVWhtrg%253D&md5=efc9586c24a39fab1f4e5a1bb029c2aa</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.05.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.05.124%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520Metathesis%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D7117%26epage%3D7140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin metathesis catalysts for the preparation of molecules and materials (Nobel Lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3760</span><span class="NLM_x">–</span> <span class="NLM_lpage">3765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3760-3765&author=R.+H.+Grubbs&title=Olefin+metathesis+catalysts+for+the+preparation+of+molecules+and+materials+%28Nobel+Lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520metathesis%2520catalysts%2520for%2520the%2520preparation%2520of%2520molecules%2520and%2520materials%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D3760%26epage%3D3765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hoveyda, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhugralin, A. R.</span><span> </span><span class="NLM_article-title">The remarkable metal-catalysed olefin metathesis reaction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1038%2Fnature06351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=17994091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yntrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=243-251&author=A.+H.+Hoveydaauthor=A.+R.+Zhugralin&title=The+remarkable+metal-catalysed+olefin+metathesis+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">The remarkable metal-catalysed olefin metathesis reaction</span></div><div class="casAuthors">Hoveyda, Amir H.; Zhugralin, Adil R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7167</span>),
    <span class="NLM_cas:pages">243-251</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Catalytic olefin metathesis-through which pairs of C:C bonds are reorganized-transforms simple mols. to those that are complex and precious.  This class of reactions has noticeably enriched chem. synthesis, which is the art of prepg. scarce mols. with highly desirable properties (for example, medicinal agents or polymeric materials).  Research in the past two decades has yielded structurally well-defined catalysts for olefin metathesis that are used to synthesize an array of mols. with unprecedented efficiency.  Nonetheless, the full potential of olefin metathesis will be realized only when addnl. catalysts are discovered that are truly practical and afford exceptional selectivity for a significantly broader range of reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo43N1xT7HQq7Vg90H21EOLACvtfcHk0lheEQDt33eGHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yntrvN&md5=8f2f724c75f88ee6b1745e3512600db3</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1038%2Fnature06351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06351%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DA.%2BH.%26aulast%3DZhugralin%26aufirst%3DA.%2BR.%26atitle%3DThe%2520remarkable%2520metal-catalysed%2520olefin%2520metathesis%2520reaction%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="note"><p class="first last">For the synthesis of biologically active macrocycles via RCM:</p></div><div class="NLM_citation" id="cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van de Weghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eustache, J.</span><span> </span><span class="NLM_article-title">The application of olefin metathesis to the synthesis of biologically active macrocyclic agents</span> <span class="citation_source-journal">Curr. Topics Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F156802605775009748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16378489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1495-1519&author=P.+Van+de+Wegheauthor=J.+Eustache&title=The+application+of+olefin+metathesis+to+the+synthesis+of+biologically+active+macrocyclic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The application of olefin metathesis to the synthesis of biologically active macrocyclic agents</span></div><div class="casAuthors">Van de Weghe, Pierre; Eustache, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1495-1519</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent developments of the metathesis reaction in the area of biol. active mols. are presented.  Scope and limitations of ring-closing metathesis to form medium and large rings are discussed and illustrated by the epothilone synthesis.  Applications of the metathesis reaction related to medicinal chem., including solid phase synthesis and combinatorial chem. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxjKJDDdMXbVg90H21EOLACvtfcHk0lheEQDt33eGHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVylug%253D%253D&md5=05cc6be9e0aa009cfafb8bc4087be67f</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F156802605775009748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009748%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWeghe%26aufirst%3DP.%26aulast%3DEustache%26aufirst%3DJ.%26atitle%3DThe%2520application%2520of%2520olefin%2520metathesis%2520to%2520the%2520synthesis%2520of%2520biologically%2520active%2520macrocyclic%2520agents%26jtitle%3DCurr.%2520Topics%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1495%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gradillas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castells, J.</span><span> </span><span class="NLM_article-title">Macrocyclization by ring-closing metathesis in the total synthesis of natural products: reaction conditions and limitations</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">6086</span><span class="NLM_x">–</span> <span class="NLM_lpage">6101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1002%2Fanie.200600641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWnsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6086-6101&author=A.+Gradillasauthor=J.+Perez-Castells&title=Macrocyclization+by+ring-closing+metathesis+in+the+total+synthesis+of+natural+products%3A+reaction+conditions+and+limitations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclization by ring-closing metathesis in the total synthesis of natural products: reaction conditions and limitations</span></div><div class="casAuthors">Gradillas, Ana; Perez-Castells, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6086-6101</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The construction of macrocycles by ring-closing metathesis (RCM) is often used as the key step in the synthesis of natural products contg. large rings.  This reaction is attractive because of its high functional group compatibility and the possibility for further transformations.  The finding of suitable reaction conditions is crit. for the success of the synthesis.  This review summarizes the efficient RCM reactions of the total synthesis of natural macrocyclic products and should reduce the time-consuming phase of the optimization of the reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YDIbEWf4ALVg90H21EOLACvtfcHk0lheEQDt33eGHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWnsr3P&md5=b1430b45488e86d48f29848cd4b2f725</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200600641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200600641%26sid%3Dliteratum%253Aachs%26aulast%3DGradillas%26aufirst%3DA.%26aulast%3DPerez-Castells%26aufirst%3DJ.%26atitle%3DMacrocyclization%2520by%2520ring-closing%2520metathesis%2520in%2520the%2520total%2520synthesis%2520of%2520natural%2520products%253A%2520reaction%2520conditions%2520and%2520limitations%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D6086%26epage%3D6101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, A Potent and Selective Inhibitor of Hepatitis C Virus NS3/4a Protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+J.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+A+Potent+and+Selective+Inhibitor+of+Hepatitis+C+Virus+NS3%2F4a+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520A%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%252F4a%2520Protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; McCauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; McIntyre, C. J.</span><span> </span><span class="NLM_article-title">HCV NS3 Protease Inhibitors</span> U.S. Patent 7,470,664,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+McCauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+McIntyre&title=HCV+NS3+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DHCV%2520NS3%2520Protease%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Compound <b>11</b> is available from Aldrich, catalog number 639737.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="note"><p class="first last">The Zhan 1b catalyst [1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene[2-(<i>i</i>-propoxy)-5-(<i>N</i>,<i>N</i>-dimethylaminosulfonyl)phenyl] methyleneruthenium (II) dichloride] is available from Strem, catalog number 44-0082.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0001.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="note"><p class="first last">For development of related catalysts:</p></div><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weskamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattenmann, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, W. A.</span><span> </span><span class="NLM_article-title">A novel class of ruthenium catalysts for olefin metathesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2490-2493&author=T.+Weskampauthor=W.+C.+Schattenmannauthor=M.+Spieglerauthor=W.+A.+Herrmann&title=A+novel+class+of+ruthenium+catalysts+for+olefin+metathesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeskamp%26aufirst%3DT.%26aulast%3DSchattenmann%26aufirst%3DW.%2BC.%26aulast%3DSpiegler%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DW.%2BA.%26atitle%3DA%2520novel%2520class%2520of%2520ruthenium%2520catalysts%2520for%2520olefin%2520metathesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1998%26volume%3D37%26spage%3D2490%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scholl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trnka, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligands</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2FS0040-4039%2899%2900217-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=2247-2250&author=M.+Schollauthor=T.+M.+Trnkaauthor=J.+P.+Morganauthor=R.+H.+Grubbs&title=Increased+ring+closing+metathesis+activity+of+ruthenium-based+olefin+metathesis+catalysts+coordinated+with+imidazolin-2-ylidene+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligands</span></div><div class="casAuthors">Scholl, Matthias; Trnka, Tina M.; Morgan, John P.; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2250</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel air and water tolerant, imidazolinylidene-substituted ruthenium-based complex, has been prepd. starting from RuCl2(=CHPh)(PCy3)2 and shown to exhibit increased ring-closing metathesis activity at elevated temp. compared to that of the parent complex.  Di-, tri-, and even tetra-substituted cycloolefins were successfully prepd. from corresponding diene precursors using this new catalyst in moderate to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqMSfMaJx9uLVg90H21EOLACvtfcHk0lhyNsnfyBR1Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVeitbc%253D&md5=5ed07583753f2c0d5ca41aed4a8dbaef</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2900217-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252900217-8%26sid%3Dliteratum%253Aachs%26aulast%3DScholl%26aufirst%3DM.%26aulast%3DTrnka%26aufirst%3DT.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%2BP.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DIncreased%2520ring%2520closing%2520metathesis%2520activity%2520of%2520ruthenium-based%2520olefin%2520metathesis%2520catalysts%2520coordinated%2520with%2520imidazolin-2-ylidene%2520ligands%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D2247%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. L.</span><span> </span><span class="NLM_article-title">Olefin metathesis—active ruthenium complexes bearing nucleophilic carbene ligand</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9831352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=2674-2678&author=J.+Huangauthor=E.+D.+Stevensauthor=S.+P.+Nolanauthor=J.+L.+Petersen&title=Olefin+metathesis%E2%80%94active+ruthenium+complexes+bearing+nucleophilic+carbene+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fja9831352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9831352%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DE.%2BD.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26aulast%3DPetersen%26aufirst%3DJ.%2BL.%26atitle%3DOlefin%2520metathesis%25E2%2580%2594active%2520ruthenium%2520complexes%2520bearing%2520nucleophilic%2520carbene%2520ligand%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D2674%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Garber, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoveyda, A. H.</span><span> </span><span class="NLM_article-title">Efficient and recyclable monomeric and dendritic Ru-based metathesis catalysts</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">8168</span><span class="NLM_x">–</span> <span class="NLM_lpage">8179</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja001179g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=8168-8179&author=S.+B.+Garberauthor=J.+S.+Kingsburyauthor=B.+L.+Grayauthor=A.+H.+Hoveyda&title=Efficient+and+recyclable+monomeric+and+dendritic+Ru-based+metathesis+catalysts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Recyclable Monomeric and Dendritic Ru-Based Metathesis Catalysts</span></div><div class="casAuthors">Garber, Steven B.; Kingsbury, Jason S.; Gray, Brian L.; Hoveyda, Amir H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8168-8179</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several highly active, recoverable and recyclable Ru-based metathesis catalysts are presented.  The crystal structure of the Ru complex (I) bearing a 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene and styrenyl ether ligand is disclosed.  The heterocyclic ligand significantly enhances the catalytic activity, and the styrenyl ether allows for the easy recovery of the Ru complex.  Catalyst I promotes ring-closing metathesis (RCM) and the efficient formation of various trisubstituted olefins at ambient temp. in high yield within 2 h; the catalyst is obtained in >95% yield after silica gel chromatog. and can be used directly in subsequent reactions.  Tetrasubstituted olefins can also be synthesized by RCM reactions catalyzed by I.  In addn., the synthesis and catalytic activities of two dendritic and recyclable Ru-based complexes are disclosed.  Examples involving catalytic ring-closing, ring-opening, and cross metatheses are presented where, unlike monomer I, the dendritic catalyst can be readily recovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNDsVV1SIp7Vg90H21EOLACvtfcHk0lhyNsnfyBR1Gw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFKltLw%253D&md5=d24a933fff4df0d8ee160f0d6f014aae</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1021%2Fja001179g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001179g%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DS.%2BB.%26aulast%3DKingsbury%26aufirst%3DJ.%2BS.%26aulast%3DGray%26aufirst%3DB.%2BL.%26aulast%3DHoveyda%26aufirst%3DA.%2BH.%26atitle%3DEfficient%2520and%2520recyclable%2520monomeric%2520and%2520dendritic%2520Ru-based%2520metathesis%2520catalysts%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D8168%26epage%3D8179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Inhibitors</span>. U.S. Patent 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=X.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Hepatitis+C+Virus+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHepatitis%2520C%2520Virus%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">8-Methoxyisoquinoline derivatives through ortho-selective metalation of 2-(3-methoxyphenyl)ethylamine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1965-1966&author=M.+Schlosserauthor=G.+Simig&title=8-Methoxyisoquinoline+derivatives+through+ortho-selective+metalation+of+2-%283-methoxyphenyl%29ethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D8-Methoxyisoquinoline%2520derivatives%2520through%2520ortho-selective%2520metalation%2520of%25202-%25283-methoxyphenyl%2529ethylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1965%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Yatsunami, T.; Yazaki, A.; Inoue, S.; Yamamoto, H.; Yokomoto, M.; Nomiyama, J.; Noda, S.</span><span> </span><span class="NLM_article-title">Preparation of 7-(2-isoindolinyl)-1,4-dihydro-4-oxoquinoline- and 1,8-naphthyridine-3-carboxylic acid derivatives as antibacterials</span>. Eur. Pat. Appl. EP 343560,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=T.+Yatsunami&author=A.+Yazaki&author=S.+Inoue&author=H.+Yamamoto&author=M.+Yokomoto&author=J.+Nomiyama&author=S.+Noda&title=Preparation+of+7-%282-isoindolinyl%29-1%2C4-dihydro-4-oxoquinoline-+and+1%2C8-naphthyridine-3-carboxylic+acid+derivatives+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYatsunami%26aufirst%3DT.%26atitle%3DPreparation%2520of%25207-%25282-isoindolinyl%2529-1%252C4-dihydro-4-oxoquinoline-%2520and%25201%252C8-naphthyridine-3-carboxylic%2520acid%2520derivatives%2520as%2520antibacterials%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Yang, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Rourke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Mild and Selective Debenzylation of Tertiary Amines Using alpha-Chloroethyl Chloroformate</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=195-196&author=B.+V.+Yangauthor=D.+O%27Rourkeauthor=J.+Li&title=Mild+and+Selective+Debenzylation+of+Tertiary+Amines+Using+alpha-Chloroethyl+Chloroformate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BV.%26aulast%3DO%2527Rourke%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMild%2520and%2520Selective%2520Debenzylation%2520of%2520Tertiary%2520Amines%2520Using%2520alpha-Chloroethyl%2520Chloroformate%26jtitle%3DSynlett%26date%3D1993%26spage%3D195%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; McCauley, J. A.; Rudd, M. T.; Vacca, J. P.; Ludmerer, S. W.; Olsen, D. B.</span><span> </span><span class="NLM_article-title">Macrocyclic peptides as HCV NS3 protease inhibitors</span>. PCT Int. Appl. WO 2007/016441,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=J.+A.+McCauley&author=M.+T.+Rudd&author=J.+P.+Vacca&author=S.+W.+Ludmerer&author=D.+B.+Olsen&title=Macrocyclic+peptides+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DMacrocyclic%2520peptides%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span> </span><span class="NLM_article-title">A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=1-8&author=S.-S.+Maoauthor=J.+DiMuzioauthor=C.+McHaleauthor=C.+Burleinauthor=D.+Olsenauthor=S.+S.+Carroll&title=A+time-resolved%2C+internally+quenched+fluorescence+assay+to+characterize+inhibition+of+hepatitis+C+virus+nonstructural+protein+3-4A+protease+at+low+enzyme+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DA%2520time-resolved%252C%2520internally%2520quenched%2520fluorescence%2520assay%2520to%2520characterize%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520nonstructural%2520protein%25203-4A%2520protease%2520at%2520low%2520enzyme%2520concentrations%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Bossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=R.+De+Francescoauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+resistance+to+non-obligate+chain-terminating+ribonucleoside+analogs+that+inhibit+hepatitis+C+virus+replication+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0licJVCCjFvG9g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520resistance%2520to%2520non-obligate%2520chain-terminating%2520ribonucleoside%2520analogs%2520that%2520inhibit%2520hepatitis%2520C%2520virus%2520replication%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0ljncuPC7Sy1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furusaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokushige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakita, T.</span><span> </span><span class="NLM_article-title">Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1817</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=1808-1817&author=T.+Katoauthor=T.+Dateauthor=M.+Miyamotoauthor=A.+Furusakaauthor=K.+Tokushigeauthor=M.+Mizokamiauthor=T.+Wakita&title=Efficient+replication+of+the+genotype+2a+hepatitis+C+virus+subgenomic+replicon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DFurusaka%26aufirst%3DA.%26aulast%3DTokushige%26aufirst%3DK.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DWakita%26aufirst%3DT.%26atitle%3DEfficient%2520replication%2520of%2520the%2520genotype%25202a%2520hepatitis%2520C%2520virus%2520subgenomic%2520replicon%26jtitle%3DGastroenterology%26date%3D2003%26volume%3D125%26spage%3D1808%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">8-Methoxyisoquinoline derivatives through ortho-selective metalation of 2-(3-methoxyphenyl)ethylamine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1965-1966&author=M.+Schlosserauthor=G.+Simig&title=8-Methoxyisoquinoline+derivatives+through+ortho-selective+metalation+of+2-%283-methoxyphenyl%29ethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D8-Methoxyisoquinoline%2520derivatives%2520through%2520ortho-selective%2520metalation%2520of%25202-%25283-methoxyphenyl%2529ethylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1965%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Practical and efficient method for amino acid derivatives containing β-quaternary center: Application toward synthesis of hepatitis C virus NS3 serine protease inhibitors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6343</span><span class="NLM_x">–</span> <span class="NLM_lpage">6347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6343-6347&author=A.+Arasappanauthor=S.+Venkatramanauthor=A.+I.+Padillaauthor=W.+Wuauthor=T.+Mengauthor=Y.+Jinauthor=J.+Wongauthor=A.+Prongayauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Practical+and+efficient+method+for+amino+acid+derivatives+containing+%CE%B2-quaternary+center%3A+Application+toward+synthesis+of+hepatitis+C+virus+NS3+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPadilla%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DPractical%2520and%2520efficient%2520method%2520for%2520amino%2520acid%2520derivatives%2520containing%2520%25CE%25B2-quaternary%2520center%253A%2520Application%2520toward%2520synthesis%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6343%26epage%3D6347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group">Ashby, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurumurthy, R.</span><span> </span><span class="NLM_article-title">Competing radical, carbanion, and carbene pathways in the reactions of hindered primary alkyl halides with lithium dialkylamides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00054a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK3sXotVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=424-437&author=E.+C.+Ashbyauthor=B.+Parkauthor=G.+S.+Patilauthor=K.+Gadruauthor=R.+Gurumurthy&title=Competing+radical%2C+carbanion%2C+and+carbene+pathways+in+the+reactions+of+hindered+primary+alkyl+halides+with+lithium+dialkylamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Competing radical, carbanion, and carbene pathways in the reactions of hindered primary alkyl halides with lithium dialkylamides</span></div><div class="casAuthors">Ashby, E. C.; Park, B.; Patil, G. S.; Gadru, K.; Gurumurthy, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-37</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A variety of methods were utilized to study the mechanism of reaction of 6-iodo-5,5-dimethyl-1-hexene and its bromo, chloro, and tosylate derivs. with LDA and several other lithium dialkylamides.  In the reaction of 6-iodo-5,5-dimethyl-1-hexene with LDA in THF, radical, carbanion, and carbene pathways occurred simultaneously.  However, when the corresponding bromide was allowed to react with LDA, the radical pathway was minor and when the corresponding chloride or tosylate was allowed to react with LDA, no evidence for radical products was obsd.  This is the first time that competing radical, carbanion, and carbene pathways have been detected in the reaction of a primary alkyl halide with any nucleophile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ch1NAy0vdLVg90H21EOLACvtfcHk0ljncuPC7Sy1ZA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXotVChug%253D%253D&md5=33ea9584436ae69759a7f77a8346d1c0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00054a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00054a028%26sid%3Dliteratum%253Aachs%26aulast%3DAshby%26aufirst%3DE.%2BC.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DPatil%26aufirst%3DG.%2BS.%26aulast%3DGadru%26aufirst%3DK.%26aulast%3DGurumurthy%26aufirst%3DR.%26atitle%3DCompeting%2520radical%252C%2520carbanion%252C%2520and%2520carbene%2520pathways%2520in%2520the%2520reactions%2520of%2520hindered%2520primary%2520alkyl%2520halides%2520with%2520lithium%2520dialkylamides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D424%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englard, S.</span><span> </span><span class="NLM_article-title">Inhibition of γ-butyrobetaine hydroxylase by cyclopropyl-substituted γ-butyrobetaines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3088</span><span class="NLM_x">–</span> <span class="NLM_lpage">3097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00297a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=3088-3097&author=R.+C.+Petterauthor=S.+Banerjeeauthor=S.+Englard&title=Inhibition+of+%CE%B3-butyrobetaine+hydroxylase+by+cyclopropyl-substituted+%CE%B3-butyrobetaines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00297a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00297a025%26sid%3Dliteratum%253Aachs%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DEnglard%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520%25CE%25B3-butyrobetaine%2520hydroxylase%2520by%2520cyclopropyl-substituted%2520%25CE%25B3-butyrobetaines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D3088%26epage%3D3097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5a','cit5b','cit5c'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d'],'ref9':['cit9a','cit9b'],'ref10':['cit10a','cit10b'],'ref11':['cit11a','cit11b','cit11c'],'ref12':['cit12a','cit12b','cit12c'],'ref13':['cit13a','cit13b','cit13c'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18a','cit18b','cit18c'],'ref19':['cit19a','cit19b'],'ref20':['cit20a','cit20b'],'ref21':[],'ref22':[],'ref23':['cit23a','cit23b','cit23c','cit23d'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 121 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Ashley N. Matthew, Florian Leidner, Gordon J. Lockbaum, Mina Henes, Jacqueto Zephyr, Shurong Hou, Desaboini Nageswara Rao, Jennifer Timm, Linah N. Rusere, Debra A. Ragland, Janet L. Paulsen, Kristina Prachanronarong, Djade I. Soumana, Ellen A. Nalivaika, Nese Kurt Yilmaz, Akbar Ali, <span class="NLM_string-name hlFld-ContribAuthor">Celia A. Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Design Strategies to Avoid Resistance in Direct-Acting Antivirals and Beyond. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2021,</strong> <em>121 </em>
                                    (6)
                                     , 3238-3270. <a href="https://doi.org/10.1021/acs.chemrev.0c00648" title="DOI URL">https://doi.org/10.1021/acs.chemrev.0c00648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.chemrev.0c00648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.chemrev.0c00648%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DDrug%252BDesign%252BStrategies%252Bto%252BAvoid%252BResistance%252Bin%252BDirect-Acting%252BAntivirals%252Band%252BBeyond%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22062020%26date%3D07012021%26volume%3D121%26issue%3D6%26spage%3D3238%26epage%3D3270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor "> Feng    Xu    </span><span class="hlFld-ContribAuthor "> John A.    McCauley </span>. </span><span class="cited-content_cbyCitation_article-title">Discovery and Chemical Development of Grazoprevir: An HCV NS3/4a Protease Inhibitor for the Treatment of the Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 285-312. <a href="https://doi.org/10.1021/bk-2020-1369.ch009" title="DOI URL">https://doi.org/10.1021/bk-2020-1369.ch009</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/bk-2020-1369.ch009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fbk-2020-1369.ch009%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Band%252BChemical%252BDevelopment%252Bof%252BGrazoprevir%25253A%252BAn%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252Bthe%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DXu%26aufirst%3DFeng%26date%3D2020%26date%3D2020%26spage%3D285%26epage%3D312%26atitle%3DComplete%252BAccounts%252Bof%252BIntegrated%252BDrug%252BDiscovery%252Band%252BDevelopment%25253A%252BRecent%252BExamples%252Bfrom%252Bthe%252BPharmaceutical%252BIndustry%252BVolume%252B3%26aulast%3DPesti%26aufirst%3DJaan%2BA.%26date%3D2020%26date%3D2020%26volume%3D1369" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Maxwell D. Cummings, <span class="NLM_string-name hlFld-ContribAuthor">Sivakumar Sekharan</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-Based Macrocycle Design in Small-Molecule Drug Discovery and Simple Metrics To Identify Opportunities for Macrocyclization of Small-Molecule Ligands. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (15)
                                     , 6843-6853. <a href="https://doi.org/10.1021/acs.jmedchem.8b01985" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01985</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01985&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01985%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructure-Based%252BMacrocycle%252BDesign%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%252Band%252BSimple%252BMetrics%252BTo%252BIdentify%252BOpportunities%252Bfor%252BMacrocyclization%252Bof%252BSmall-Molecule%252BLigands%26aulast%3DCummings%26aufirst%3DMaxwell%2BD.%26date%3D2019%26date%3D2019%26date%3D2018%26date%3D18122018%26date%3D22032019%26date%3D12032019%26volume%3D62%26issue%3D15%26spage%3D6843%26epage%3D6853" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Robert J. Young, <span class="NLM_string-name hlFld-ContribAuthor">Paul D. Leeson</span>. </span><span class="cited-content_cbyCitation_article-title">Mapping the Efficiency and Physicochemical Trajectories of Successful Optimizations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (15)
                                     , 6421-6467. <a href="https://doi.org/10.1021/acs.jmedchem.8b00180" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00180</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00180&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00180%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMapping%252Bthe%252BEfficiency%252Band%252BPhysicochemical%252BTrajectories%252Bof%252BSuccessful%252BOptimizations%26aulast%3DYoung%26aufirst%3DRobert%2BJ.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D03022018%26date%3D25042018%26date%3D05042018%26volume%3D61%26issue%3D15%26spage%3D6421%26epage%3D6467" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="NLM_string-name hlFld-ContribAuthor">Kira A. Armacost</span>. </span><span class="cited-content_cbyCitation_article-title">The Transition from Academia: Overcoming the Barrier to a Career in the Drug Discovery Industry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2018,</strong> <em>58 </em>
                                    (6)
                                     , 1161-1163. <a href="https://doi.org/10.1021/acs.jcim.8b00262" title="DOI URL">https://doi.org/10.1021/acs.jcim.8b00262</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.8b00262&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.8b00262%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DThe%252BTransition%252Bfrom%252BAcademia%25253A%252BOvercoming%252Bthe%252BBarrier%252Bto%252Ba%252BCareer%252Bin%252Bthe%252BDrug%252BDiscovery%252BIndustry%26aulast%3DArmacost%26aufirst%3DKira%2BA.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D30042018%26date%3D18052018%26date%3D04052018%26volume%3D58%26issue%3D6%26spage%3D1161%26epage%3D1163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Jacqueto  Zephyr</span>, <span class="hlFld-ContribAuthor ">Caitlin. J.  Hill</span>, <span class="hlFld-ContribAuthor ">Muhammad  Jahangir</span>, <span class="hlFld-ContribAuthor ">Alicia  Newton</span>, <span class="hlFld-ContribAuthor ">Christos J.  Petropoulos</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Nese  Kurt-Yilmaz</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>, and <span class="hlFld-ContribAuthor ">Akbar  Ali</span>  . </span><span class="cited-content_cbyCitation_article-title">Hepatitis C Virus NS3/4A Protease Inhibitors Incorporating Flexible P2 Quinoxalines Target Drug Resistant Viral Variants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5699-5716. <a href="https://doi.org/10.1021/acs.jmedchem.7b00426" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00426%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252BInhibitors%252BIncorporating%252BFlexible%252BP2%252BQuinoxalines%252BTarget%252BDrug%252BResistant%252BViral%252BVariants%26aulast%3DMatthew%26aufirst%3DAshley%2BN.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D16032017%26date%3D19062017%26date%3D13072017%26date%3D08062017%26volume%3D60%26issue%3D13%26spage%3D5699%26epage%3D5716" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark A. T.  Blaskovich</span>  . </span><span class="cited-content_cbyCitation_article-title">Unusual Amino Acids in Medicinal Chemistry. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (24)
                                     , 10807-10836. <a href="https://doi.org/10.1021/acs.jmedchem.6b00319" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00319%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DUnusual%252BAmino%252BAcids%252Bin%252BMedicinal%252BChemistry%26aulast%3DBlaskovich%26aufirst%3DMark%2BA.%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D02032016%26date%3D30092016%26date%3D22122016%26date%3D02092016%26volume%3D59%26issue%3D24%26spage%3D10807%26epage%3D10836" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tanaji T.  Talele</span>  . </span><span class="cited-content_cbyCitation_article-title">The “Cyclopropyl Fragment” is a Versatile Player that Frequently Appears in Preclinical/Clinical Drug Molecules. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (19)
                                     , 8712-8756. <a href="https://doi.org/10.1021/acs.jmedchem.6b00472" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00472</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00472&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00472%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252B%2525E2%252580%25259CCyclopropyl%252BFragment%2525E2%252580%25259D%252Bis%252Ba%252BVersatile%252BPlayer%252Bthat%252BFrequently%252BAppears%252Bin%252BPreclinical%25252FClinical%252BDrug%252BMolecules%26aulast%3DTalele%26aufirst%3DTanaji%2BT.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D30032016%26date%3D30062016%26date%3D13102016%26date%3D14062016%26volume%3D59%26issue%3D19%26spage%3D8712%26epage%3D8756" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Eric  Mull</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Qian  Zhao</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Arvind  Mathur</span>, <span class="hlFld-ContribAuthor ">Richard  Rampulla</span>, <span class="hlFld-ContribAuthor ">Bang-Chi  Chen</span>, <span class="hlFld-ContribAuthor ">Theerthagiri  Palani</span>, <span class="hlFld-ContribAuthor ">Sivakumar  Ganesan</span>, <span class="hlFld-ContribAuthor ">Pirama Nayagam  Arunachalam</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Alicia  Ng</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Hua  Fang</span>, <span class="hlFld-ContribAuthor ">Mark I.  Cockett</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, and <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily Dosing. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (17)
                                     , 8042-8060. <a href="https://doi.org/10.1021/acs.jmedchem.6b00821" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00821%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPotent%252BAcyclic%25252C%252BTripeptidic%25252C%252BAcyl%252BSulfonamide%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%252BProtease%252Bas%252Ba%252BBack-up%252Bto%252BAsunaprevir%252Bwith%252Bthe%252BPotential%252Bfor%252BOnce-Daily%252BDosing%26aulast%3DSun%26aufirst%3DLi-Qiang%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D01062016%26date%3D26082016%26date%3D08092016%26volume%3D59%26issue%3D17%26spage%3D8042%26epage%3D8060" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brett A.  Hopkins</span>, <span class="hlFld-ContribAuthor ">Graham F.  Smith</span>, and <span class="hlFld-ContribAuthor ">Nunzio  Sciammetta</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cyclic Peptidomimetics via a Pd-Catalyzed Macroamination Reaction. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2016,</strong> <em>18 </em>
                                    (16)
                                     , 4072-4075. <a href="https://doi.org/10.1021/acs.orglett.6b01961" title="DOI URL">https://doi.org/10.1021/acs.orglett.6b01961</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.6b01961&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.6b01961%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BCyclic%252BPeptidomimetics%252Bvia%252Ba%252BPd-Catalyzed%252BMacroamination%252BReaction%26aulast%3DHopkins%26aufirst%3DBrett%2BA.%26date%3D2016%26date%3D2016%26date%3D2016%26date%3D06072016%26date%3D10082016%26date%3D19082016%26volume%3D18%26issue%3D16%26spage%3D4072%26epage%3D4075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiajing  Tan</span> and <span class="hlFld-ContribAuthor ">Nobuyoshi  Yasuda</span>  . </span><span class="cited-content_cbyCitation_article-title">Contemporary Asymmetric Phase Transfer Catalysis: Large-Scale Industrial Applications. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2015,</strong> <em>19 </em>
                                    (11)
                                     , 1731-1746. <a href="https://doi.org/10.1021/acs.oprd.5b00304" title="DOI URL">https://doi.org/10.1021/acs.oprd.5b00304</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.oprd.5b00304&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.oprd.5b00304%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DContemporary%252BAsymmetric%252BPhase%252BTransfer%252BCatalysis%25253A%252BLarge-Scale%252BIndustrial%252BApplications%26aulast%3DTan%26aufirst%3DJiajing%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D25092015%26date%3D27102015%26date%3D20112015%26date%3D29092015%26volume%3D19%26issue%3D11%26spage%3D1731%26epage%3D1746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marialucia  Lanzillotto</span>, <span class="hlFld-ContribAuthor ">Laure  Konnert</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, and <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>  . </span><span class="cited-content_cbyCitation_article-title">Mechanochemical 1,1′-Carbonyldiimidazole-Mediated Synthesis of Carbamates. </span><span class="cited-content_cbyCitation_journal-name">ACS Sustainable Chemistry & Engineering</span><span> <strong>2015,</strong> <em>3 </em>
                                    (11)
                                     , 2882-2889. <a href="https://doi.org/10.1021/acssuschemeng.5b00819" title="DOI URL">https://doi.org/10.1021/acssuschemeng.5b00819</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acssuschemeng.5b00819&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facssuschemeng.5b00819%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Sustainable%2520Chemistry%2520%2526%2520Engineering%26atitle%3DMechanochemical%252B1%25252C1%2525E2%252580%2525B2-Carbonyldiimidazole-Mediated%252BSynthesis%252Bof%252BCarbamates%26aulast%3DLanzillotto%26aufirst%3DMarialucia%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D05082015%26date%3D05092015%26date%3D07102015%26date%3D02112015%26date%3D29092015%26volume%3D3%26issue%3D11%26spage%3D2882%26epage%3D2889" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vedanjali  Gogineni</span>, <span class="hlFld-ContribAuthor ">Raymond F.  Schinazi</span>, and <span class="hlFld-ContribAuthor ">Mark T.  Hamann</span>  . </span><span class="cited-content_cbyCitation_article-title">Role of Marine Natural Products in the Genesis of Antiviral Agents. </span><span class="cited-content_cbyCitation_journal-name">Chemical Reviews</span><span> <strong>2015,</strong> <em>115 </em>
                                    (18)
                                     , 9655-9706. <a href="https://doi.org/10.1021/cr4006318" title="DOI URL">https://doi.org/10.1021/cr4006318</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cr4006318&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcr4006318%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Reviews%26atitle%3DRole%252Bof%252BMarine%252BNatural%252BProducts%252Bin%252Bthe%252BGenesis%252Bof%252BAntiviral%252BAgents%26aulast%3DGogineni%26aufirst%3DVedanjali%26date%3D2015%26date%3D2015%26date%3D2013%26date%3D02112013%26date%3D28082015%26date%3D23092015%26volume%3D115%26issue%3D18%26spage%3D9655%26epage%3D9706" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">K. C.  Nicolaou</span>, <span class="hlFld-ContribAuthor ">Christian  Nilewski</span>, <span class="hlFld-ContribAuthor ">Christopher R. H.  Hale</span>, <span class="hlFld-ContribAuthor ">Christopher F.  Ahles</span>, <span class="hlFld-ContribAuthor ">Chiao An  Chiu</span>, <span class="hlFld-ContribAuthor ">Christian  Ebner</span>, <span class="hlFld-ContribAuthor ">Abdelatif  ElMarrouni</span>, <span class="hlFld-ContribAuthor ">Lifeng  Yang</span>, <span class="hlFld-ContribAuthor ">Katherine  Stiles</span>, and <span class="hlFld-ContribAuthor ">Deepak  Nagrath</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis and Biological Evaluation of Dimeric Furanoid Macroheterocycles: Discovery of New Anticancer Agents. </span><span class="cited-content_cbyCitation_journal-name">Journal of the American Chemical Society</span><span> <strong>2015,</strong> <em>137 </em>
                                    (14)
                                     , 4766-4770. <a href="https://doi.org/10.1021/jacs.5b00141" title="DOI URL">https://doi.org/10.1021/jacs.5b00141</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jacs.5b00141&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjacs.5b00141%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520the%2520American%2520Chemical%2520Society%26atitle%3DSynthesis%252Band%252BBiological%252BEvaluation%252Bof%252BDimeric%252BFuranoid%252BMacroheterocycles%25253A%252BDiscovery%252Bof%252BNew%252BAnticancer%252BAgents%26aulast%3DNicolaou%26aufirst%3DK.%2BC.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09012015%26date%3D01042015%26date%3D15042015%26volume%3D137%26issue%3D14%26spage%3D4766%26epage%3D4770" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Jeremy P.  Scott</span>, <span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>, <span class="hlFld-ContribAuthor ">Michel  Journet</span>, <span class="hlFld-ContribAuthor ">Kevin  Belyk</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells</span>, <span class="hlFld-ContribAuthor ">Birgit  Kosjek</span>, <span class="hlFld-ContribAuthor ">Carl A.  Baxter</span>, <span class="hlFld-ContribAuthor ">Gavin W.  Stewart</span>, <span class="hlFld-ContribAuthor ">Christopher  Wise</span>, <span class="hlFld-ContribAuthor ">Mahbub  Alam</span>, <span class="hlFld-ContribAuthor ">Zhiguo Jake  Song</span>, and <span class="hlFld-ContribAuthor ">Lushi  Tan</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Bis-Macrocyclic HCV Protease Inhibitor MK-6325 via Intramolecular sp2–sp3 Suzuki–Miyaura Coupling and Ring Closing Metathesis. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2015,</strong> <em>17 </em>
                                    (6)
                                     , 1533-1536. <a href="https://doi.org/10.1021/acs.orglett.5b00418" title="DOI URL">https://doi.org/10.1021/acs.orglett.5b00418</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.orglett.5b00418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.orglett.5b00418%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DSynthesis%252Bof%252BBis-Macrocyclic%252BHCV%252BProtease%252BInhibitor%252BMK-6325%252Bvia%252BIntramolecular%252Bsp2%2525E2%252580%252593sp3%252BSuzuki%2525E2%252580%252593Miyaura%252BCoupling%252Band%252BRing%252BClosing%252BMetathesis%26aulast%3DLi%26aufirst%3DHongmei%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09022015%26date%3D10032015%26date%3D20032015%26volume%3D17%26issue%3D6%26spage%3D1533%26epage%3D1536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Keith D.  Combrink</span>, <span class="hlFld-ContribAuthor ">Jeffrey A.  Campbell</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Min  Ding</span>, <span class="hlFld-ContribAuthor ">Jan  Thuring</span>, <span class="hlFld-ContribAuthor ">Jianqing  Li</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Min S.  Lee</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Wenying  Li</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Susan  Jenkins</span>, <span class="hlFld-ContribAuthor ">Christoph  Gesenberg</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Kenneth S.  Santone</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Eric  Hughes</span>, <span class="hlFld-ContribAuthor ">Caly  Chien</span>, <span class="hlFld-ContribAuthor ">Stephen  Adams</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Early Clinical Evaluation of BMS-605339, a Potent and Orally Efficacious Tripeptidic Acylsulfonamide NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1708-1729. <a href="https://doi.org/10.1021/jm401840s" title="DOI URL">https://doi.org/10.1021/jm401840s</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401840s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401840s%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BEarly%252BClinical%252BEvaluation%252Bof%252BBMS-605339%25252C%252Ba%252BPotent%252Band%252BOrally%252BEfficacious%252BTripeptidic%252BAcylsulfonamide%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D27112013%26date%3D20022014%26date%3D13032014%26volume%3D57%26issue%3D5%26spage%3D1708%26epage%3D1729" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Paul M.  Scola</span>, <span class="hlFld-ContribAuthor ">Li-Qiang  Sun</span>, <span class="hlFld-ContribAuthor ">Alan Xiangdong  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Chen</span>, <span class="hlFld-ContribAuthor ">Ny  Sin</span>, <span class="hlFld-ContribAuthor ">Brian L.  Venables</span>, <span class="hlFld-ContribAuthor ">Sing-Yuen  Sit</span>, <span class="hlFld-ContribAuthor ">Yan  Chen</span>, <span class="hlFld-ContribAuthor ">Anthony  Cocuzza</span>, <span class="hlFld-ContribAuthor ">Donna M.  Bilder</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D’Andrea</span>, <span class="hlFld-ContribAuthor ">Barbara  Zheng</span>, <span class="hlFld-ContribAuthor ">Piyasena  Hewawasam</span>, <span class="hlFld-ContribAuthor ">Yong  Tu</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Paul  Falk</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Steven  Levine</span>, <span class="hlFld-ContribAuthor ">Chaoqun  Chen</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Amy K.  Sheaffer</span>, <span class="hlFld-ContribAuthor ">Guangzhi  Zhai</span>, <span class="hlFld-ContribAuthor ">Diana  Barry</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Yong-Hae  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Schartman</span>, <span class="hlFld-ContribAuthor ">Maria  Donoso</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Michael W.  Sinz</span>, <span class="hlFld-ContribAuthor ">Tatyana  Zvyaga</span>, <span class="hlFld-ContribAuthor ">Andrew C.  Good</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kevin  Kish</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Tredup</span>, <span class="hlFld-ContribAuthor ">Herbert E.  Klei</span>, <span class="hlFld-ContribAuthor ">Qi  Gao</span>, <span class="hlFld-ContribAuthor ">Luciano  Mueller</span>, <span class="hlFld-ContribAuthor ">Richard J.  Colonno</span>, <span class="hlFld-ContribAuthor ">Dennis M.  Grasela</span>, <span class="hlFld-ContribAuthor ">Stephen P.  Adams</span>, <span class="hlFld-ContribAuthor ">James  Loy</span>, <span class="hlFld-ContribAuthor ">Paul C.  Levesque</span>, <span class="hlFld-ContribAuthor ">Huabin  Sun</span>, <span class="hlFld-ContribAuthor ">Hong  Shi</span>, <span class="hlFld-ContribAuthor ">Lucy  Sun</span>, <span class="hlFld-ContribAuthor ">William  Warner</span>, <span class="hlFld-ContribAuthor ">Danshi  Li</span>, <span class="hlFld-ContribAuthor ">Jialong  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, and <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of Asunaprevir (BMS-650032), An Orally Efficacious NS3 Protease Inhibitor for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (5)
                                     , 1730-1752. <a href="https://doi.org/10.1021/jm500297k" title="DOI URL">https://doi.org/10.1021/jm500297k</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500297k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500297k%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252BAsunaprevir%252B%252528BMS-650032%252529%25252C%252BAn%252BOrally%252BEfficacious%252BNS3%252BProtease%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DScola%26aufirst%3DPaul%2BM.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D24022014%26date%3D05032014%26date%3D13032014%26date%3D24022014%26volume%3D57%26issue%3D5%26spage%3D1730%26epage%3D1752" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Weiwei  Xue</span>, <span class="hlFld-ContribAuthor ">Yihe  Ban</span>, <span class="hlFld-ContribAuthor ">Huanxiang  Liu</span>, and <span class="hlFld-ContribAuthor ">Xiaojun  Yao</span>  . </span><span class="cited-content_cbyCitation_article-title">Computational Study on the Drug Resistance Mechanism against HCV NS3/4A Protease Inhibitors Vaniprevir and MK-5172 by the Combination Use of Molecular Dynamics Simulation, Residue Interaction Network, and Substrate Envelope Analysis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2014,</strong> <em>54 </em>
                                    (2)
                                     , 621-633. <a href="https://doi.org/10.1021/ci400060j" title="DOI URL">https://doi.org/10.1021/ci400060j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci400060j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci400060j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DComputational%252BStudy%252Bon%252Bthe%252BDrug%252BResistance%252BMechanism%252Bagainst%252BHCV%252BNS3%25252F4A%252BProtease%252BInhibitors%252BVaniprevir%252Band%252BMK-5172%252Bby%252Bthe%252BCombination%252BUse%252Bof%252BMolecular%252BDynamics%252BSimulation%25252C%252BResidue%252BInteraction%252BNetwork%25252C%252Band%252BSubstrate%252BEnvelope%252BAnalysis%26aulast%3DXue%26aufirst%3DWeiwei%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D25012013%26date%3D28062013%26date%3D24022014%26date%3D09062013%26volume%3D54%26issue%3D2%26spage%3D621%26epage%3D633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabrizio  Giordanetto</span> and <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>  . </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Drugs and Clinical Candidates: What Can Medicinal Chemists Learn from Their Properties?. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (2)
                                     , 278-295. <a href="https://doi.org/10.1021/jm400887j" title="DOI URL">https://doi.org/10.1021/jm400887j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm400887j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm400887j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMacrocyclic%252BDrugs%252Band%252BClinical%252BCandidates%25253A%252BWhat%252BCan%252BMedicinal%252BChemists%252BLearn%252Bfrom%252BTheir%252BProperties%25253F%26aulast%3DGiordanetto%26aufirst%3DFabrizio%26date%3D2014%26date%3D2013%26date%3D2013%26date%3D14062013%26date%3D17092013%26date%3D23012014%26date%3D28082013%26volume%3D57%26issue%3D2%26spage%3D278%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Woody  Sherman</span>, and <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>  . </span><span class="cited-content_cbyCitation_article-title">Improving the Resistance Profile of Hepatitis C NS3/4A Inhibitors: Dynamic Substrate Envelope Guided Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2013,</strong> <em>9 </em>
                                    (12)
                                     , 5693-5705. <a href="https://doi.org/10.1021/ct400603p" title="DOI URL">https://doi.org/10.1021/ct400603p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ct400603p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fct400603p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DImproving%252Bthe%252BResistance%252BProfile%252Bof%252BHepatitis%252BC%252BNS3%25252F4A%252BInhibitors%25253A%252BDynamic%252BSubstrate%252BEnvelope%252BGuided%252BDesign%26aulast%3D%25C3%2596zen%26aufirst%3DAy%25C5%259Feg%25C3%25BCl%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D11072013%26date%3D22112013%26date%3D10122013%26date%3D16102013%26volume%3D9%26issue%3D12%26spage%3D5693%26epage%3D5705" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph E.  Banning</span>, <span class="hlFld-ContribAuthor ">Jacob  Gentillon</span>, <span class="hlFld-ContribAuthor ">Pavel G.  Ryabchuk</span>, <span class="hlFld-ContribAuthor ">Anthony R.  Prosser</span>, <span class="hlFld-ContribAuthor ">Andrew  Rogers</span>, <span class="hlFld-ContribAuthor ">Andrew  Edwards</span>, <span class="hlFld-ContribAuthor ">Andrew  Holtzen</span>, <span class="hlFld-ContribAuthor ">Ivan A.  Babkov</span>, <span class="hlFld-ContribAuthor ">Marina  Rubina</span>, and <span class="hlFld-ContribAuthor ">Michael  Rubin</span>  . </span><span class="cited-content_cbyCitation_article-title">Formal Substitution of Bromocyclopropanes with Nitrogen Nucleophiles. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2013,</strong> <em>78 </em>
                                    (15)
                                     , 7601-7616. <a href="https://doi.org/10.1021/jo4011798" title="DOI URL">https://doi.org/10.1021/jo4011798</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo4011798&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo4011798%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DFormal%252BSubstitution%252Bof%252BBromocyclopropanes%252Bwith%252BNitrogen%252BNucleophiles%26aulast%3DBanning%26aufirst%3DJoseph%2BE.%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D29052013%26date%3D24072013%26date%3D02082013%26date%3D11072013%26volume%3D78%26issue%3D15%26spage%3D7601%26epage%3D7616" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akbar  Ali</span>, <span class="hlFld-ContribAuthor ">Cihan  Aydin</span>, <span class="hlFld-ContribAuthor ">Reinhold  Gildemeister</span>, <span class="hlFld-ContribAuthor ">Keith P.  Romano</span>, <span class="hlFld-ContribAuthor ">Hong  Cao</span>, <span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Djade  Soumana</span>, <span class="hlFld-ContribAuthor ">Alicia  Newton</span>, <span class="hlFld-ContribAuthor ">Christos J.  Petropoulos</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, and <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>  . </span><span class="cited-content_cbyCitation_article-title">Evaluating the Role of Macrocycles in the Susceptibility of Hepatitis C Virus NS3/4A Protease Inhibitors to Drug Resistance. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2013,</strong> <em>8 </em>
                                    (7)
                                     , 1469-1478. <a href="https://doi.org/10.1021/cb400100g" title="DOI URL">https://doi.org/10.1021/cb400100g</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/cb400100g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fcb400100g%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DEvaluating%252Bthe%252BRole%252Bof%252BMacrocycles%252Bin%252Bthe%252BSusceptibility%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252BInhibitors%252Bto%252BDrug%252BResistance%26aulast%3DAli%26aufirst%3DAkbar%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D2013%26date%3D09022013%26date%3D17042013%26date%3D01052013%26date%3D19072013%26date%3D17042013%26volume%3D8%26issue%3D7%26spage%3D1469%26epage%3D1478" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rima  Chaudhuri</span>, <span class="hlFld-ContribAuthor ">Hyun  Lee</span>, <span class="hlFld-ContribAuthor ">Lena  Truong</span>, <span class="hlFld-ContribAuthor ">Jaime  Torres</span>, <span class="hlFld-ContribAuthor ">Kavankumar  Patel</span>, and <span class="hlFld-ContribAuthor ">Michael E.  Johnson</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of Non-Macrocyclic Small Molecule Inhibitors against the NS3/4A Serine Protease of Hepatitis C Virus through in Silico Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2012,</strong> <em>52 </em>
                                    (8)
                                     , 2245-2256. <a href="https://doi.org/10.1021/ci300177p" title="DOI URL">https://doi.org/10.1021/ci300177p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ci300177p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fci300177p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DIdentification%252Bof%252BNon-Macrocyclic%252BSmall%252BMolecule%252BInhibitors%252Bagainst%252Bthe%252BNS3%25252F4A%252BSerine%252BProtease%252Bof%252BHepatitis%252BC%252BVirus%252Bthrough%252Bin%252BSilico%252BScreening%26aulast%3DChaudhuri%26aufirst%3DRima%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D04042012%26date%3D20072012%26date%3D27082012%26date%3D14062012%26volume%3D52%26issue%3D8%26spage%3D2245%26epage%3D2256" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jongrock  Kong</span>, <span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells-Padros</span>, <span class="hlFld-ContribAuthor ">Yang  Cao</span>, <span class="hlFld-ContribAuthor ">Robert F.  Dunn</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Dolman</span>, <span class="hlFld-ContribAuthor ">Jacob  Janey</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, and <span class="hlFld-ContribAuthor ">Michael J.  Zacuto</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of the HCV Protease Inhibitor Vaniprevir (MK-7009) Using Ring-Closing Metathesis Strategy. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2012,</strong> <em>77 </em>
                                    (8)
                                     , 3820-3828. <a href="https://doi.org/10.1021/jo3001595" title="DOI URL">https://doi.org/10.1021/jo3001595</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo3001595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo3001595%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252Bthe%252BHCV%252BProtease%252BInhibitor%252BVaniprevir%252B%252528MK-7009%252529%252BUsing%252BRing-Closing%252BMetathesis%252BStrategy%26aulast%3DKong%26aufirst%3DJongrock%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D20012012%26date%3D10042012%26date%3D20042012%26date%3D29032012%26volume%3D77%26issue%3D8%26spage%3D3820%26epage%3D3828" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Robert  Hamatake</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Lois L.  Wright</span>, <span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Richard L.  Jarvest</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Ji</span>, <span class="hlFld-ContribAuthor ">Joel P.  Cooper</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Tallant</span>, <span class="hlFld-ContribAuthor ">Renae M.  Crosby</span>, <span class="hlFld-ContribAuthor ">Katrina  Creech</span>, <span class="hlFld-ContribAuthor ">Amy  Wang</span>, <span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Suoming  Zhang</span>, <span class="hlFld-ContribAuthor ">Yong-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Charles Z.  Ding</span>, <span class="hlFld-ContribAuthor ">Yasheen  Zhou</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Baker</span>, <span class="hlFld-ContribAuthor ">Wei  Bu</span>, and <span class="hlFld-ContribAuthor ">Liang  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Urea-Based Hepatitis C Protease Inhibitors with High Potency against Protease-Inhibitor-Resistant Mutants. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (7)
                                     , 3021-3026. <a href="https://doi.org/10.1021/jm201278q" title="DOI URL">https://doi.org/10.1021/jm201278q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201278q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201278q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BNovel%252BUrea-Based%252BHepatitis%252BC%252BProtease%252BInhibitors%252Bwith%252BHigh%252BPotency%252Bagainst%252BProtease-Inhibitor-Resistant%252BMutants%26aulast%3DKazmierski%26aufirst%3DWieslaw%2BM.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D25092011%26date%3D03042012%26date%3D12042012%26volume%3D55%26issue%3D7%26spage%3D3021%26epage%3D3026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Marcello  DiFilippo</span>, <span class="hlFld-ContribAuthor ">Benedetta  Crescenzi</span>, <span class="hlFld-ContribAuthor ">Uwe  Koch</span>, <span class="hlFld-ContribAuthor ">Alessia  Petrocchi</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">Kimberly J.  Bush</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Emanuela  Nizi</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Carolyn M.  McHale</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Simona  Cianetti</span>, <span class="hlFld-ContribAuthor ">Claudio  Giuliano</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Pucci</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, and <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of MK-5172, a Macrocyclic Hepatitis C Virus NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>3 </em>
                                    (4)
                                     , 332-336. <a href="https://doi.org/10.1021/ml300017p" title="DOI URL">https://doi.org/10.1021/ml300017p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml300017p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml300017p%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-5172%25252C%252Ba%252BMacrocyclic%252BHepatitis%252BC%252BVirus%252BNS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DHarper%26aufirst%3DSteven%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D19012012%26date%3D26022012%26date%3D02032012%26date%3D12042012%26volume%3D3%26issue%3D4%26spage%3D332%26epage%3D336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pavel  Ryabchuk</span>, <span class="hlFld-ContribAuthor ">Marina  Rubina</span>, <span class="hlFld-ContribAuthor ">Jack  Xu</span>, and <span class="hlFld-ContribAuthor ">Michael  Rubin</span>  . </span><span class="cited-content_cbyCitation_article-title">Formal Nucleophilic Substitution of Bromocyclopropanes with Azoles. </span><span class="cited-content_cbyCitation_journal-name">Organic Letters</span><span> <strong>2012,</strong> <em>14 </em>
                                    (7)
                                     , 1752-1755. <a href="https://doi.org/10.1021/ol300352z" title="DOI URL">https://doi.org/10.1021/ol300352z</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ol300352z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fol300352z%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Letters%26atitle%3DFormal%252BNucleophilic%252BSubstitution%252Bof%252BBromocyclopropanes%252Bwith%252BAzoles%26aulast%3DRyabchuk%26aufirst%3DPavel%26date%3D2012%26date%3D2012%26date%3D2012%26date%3D13022012%26date%3D14032012%26date%3D06042012%26volume%3D14%26issue%3D7%26spage%3D1752%26epage%3D1755" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael J.  Sofia</span>, <span class="hlFld-ContribAuthor ">Wonsuk  Chang</span>, <span class="hlFld-ContribAuthor ">Phillip A.  Furman</span>, <span class="hlFld-ContribAuthor ">Ralph T.  Mosley</span>, and <span class="hlFld-ContribAuthor ">Bruce S.  Ross</span>  . </span><span class="cited-content_cbyCitation_article-title">Nucleoside, Nucleotide, and Non-Nucleoside Inhibitors of Hepatitis C Virus NS5B RNA-Dependent RNA-Polymerase. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2012,</strong> <em>55 </em>
                                    (6)
                                     , 2481-2531. <a href="https://doi.org/10.1021/jm201384j" title="DOI URL">https://doi.org/10.1021/jm201384j</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm201384j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm201384j%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNucleoside%25252C%252BNucleotide%25252C%252Band%252BNon-Nucleoside%252BInhibitors%252Bof%252BHepatitis%252BC%252BVirus%252BNS5B%252BRNA-Dependent%252BRNA-Polymerase%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2012%26date%3D2012%26date%3D2011%26date%3D13102011%26date%3D23012012%26date%3D22032012%26date%3D16122011%26volume%3D55%26issue%3D6%26spage%3D2481%26epage%3D2531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiguo J.  Song</span>, <span class="hlFld-ContribAuthor ">David M.  Tellers</span>, <span class="hlFld-ContribAuthor ">Michel  Journet</span>, <span class="hlFld-ContribAuthor ">Jeffrey T.  Kuethe</span>, <span class="hlFld-ContribAuthor ">David  Lieberman</span>, <span class="hlFld-ContribAuthor ">Guy  Humphrey</span>, <span class="hlFld-ContribAuthor ">Fei  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhihui  Peng</span>, <span class="hlFld-ContribAuthor ">Marjorie S.  Waters</span>, <span class="hlFld-ContribAuthor ">Daniel  Zewge</span>, <span class="hlFld-ContribAuthor ">Andrew  Nolting</span>, <span class="hlFld-ContribAuthor ">Dalian  Zhao</span>, <span class="hlFld-ContribAuthor ">Robert A.  Reamer</span>, <span class="hlFld-ContribAuthor ">Peter G.  Dormer</span>, <span class="hlFld-ContribAuthor ">Kevin M.  Belyk</span>, <span class="hlFld-ContribAuthor ">Ian W.  Davies</span>, <span class="hlFld-ContribAuthor ">Paul N.  Devine</span>, and <span class="hlFld-ContribAuthor ">David M.  Tschaen</span>  . </span><span class="cited-content_cbyCitation_article-title">Synthesis of Vaniprevir (MK-7009): Lactamization To Prepare a 22-Membered Macrocycle. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2011,</strong> <em>76 </em>
                                    (19)
                                     , 7804-7815. <a href="https://doi.org/10.1021/jo2011494" title="DOI URL">https://doi.org/10.1021/jo2011494</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jo2011494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjo2011494%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DSynthesis%252Bof%252BVaniprevir%252B%252528MK-7009%252529%25253A%252BLactamization%252BTo%252BPrepare%252Ba%252B22-Membered%252BMacrocycle%26aulast%3DSong%26aufirst%3DZhiguo%2BJ.%26date%3D2011%26date%3D2011%26date%3D2011%26date%3D04062011%26date%3D31082011%26date%3D07102011%26date%3D12082011%26volume%3D76%26issue%3D19%26spage%3D7804%26epage%3D7815" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric  Marsault</span> and <span class="hlFld-ContribAuthor ">Mark L.  Peterson</span>  . </span><span class="cited-content_cbyCitation_article-title">Macrocycles Are Great Cycles: Applications, Opportunities, and Challenges of Synthetic Macrocycles in Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2011,</strong> <em>54 </em>
                                    (7)
                                     , 1961-2004. <a href="https://doi.org/10.1021/jm1012374" title="DOI URL">https://doi.org/10.1021/jm1012374</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm1012374&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm1012374%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DMacrocycles%252BAre%252BGreat%252BCycles%25253A%252BApplications%25252C%252BOpportunities%25252C%252Band%252BChallenges%252Bof%252BSynthetic%252BMacrocycles%252Bin%252BDrug%252BDiscovery%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D23092010%26date%3D07032011%26date%3D14042011%26volume%3D54%26issue%3D7%26spage%3D1961%26epage%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Kimberly J.  Bush</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">John  Swestock</span>, <span class="hlFld-ContribAuthor ">Bang-Lin  Wan</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, and <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of  MK-1220: A Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease with Improved Preclinical Plasma Exposure. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2011,</strong> <em>2 </em>
                                    (3)
                                     , 207-212. <a href="https://doi.org/10.1021/ml1002426" title="DOI URL">https://doi.org/10.1021/ml1002426</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/ml1002426&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fml1002426%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252BMK-1220%25253A%252BA%252BMacrocyclic%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252Bwith%252BImproved%252BPreclinical%252BPlasma%252BExposure%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2011%26date%3D2011%26date%3D2010%26date%3D2010%26date%3D08102010%26date%3D24122010%26date%3D12012011%26date%3D10032011%26volume%3D2%26issue%3D3%26spage%3D207%26epage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin M.  Belyk</span>, <span class="hlFld-ContribAuthor ">Bangping  Xiang</span>, <span class="hlFld-ContribAuthor ">Paul G.  Bulger</span>, <span class="hlFld-ContribAuthor ">William R.  Leonard, Jr.</span>, <span class="hlFld-ContribAuthor ">Jaume  Balsells</span>, <span class="hlFld-ContribAuthor ">Jingjun  Yin</span> and <span class="hlFld-ContribAuthor ">Cheng-yi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Synthesis of (1R,2S)-1-Amino-2-vinylcyclopropanecarboxylic Acid Ethyl Ester (Vinyl-ACCA-OEt) by Asymmetric Phase-Transfer Catalyzed Cyclopropanation of (E)-N-Phenylmethyleneglycine Ethyl Ester. </span><span class="cited-content_cbyCitation_journal-name">Organic Process Research & Development</span><span> <strong>2010,</strong> <em>14 </em>
                                    (3)
                                     , 692-700. <a href="https://doi.org/10.1021/op100070d" title="DOI URL">https://doi.org/10.1021/op100070d</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/op100070d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fop100070d%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520Process%2520Research%2520%2526%2520Development%26atitle%3DEnantioselective%252BSynthesis%252Bof%252B%2525281R%25252C2S%252529-1-Amino-2-vinylcyclopropanecarboxylic%252BAcid%252BEthyl%252BEster%252B%252528Vinyl-ACCA-OEt%252529%252Bby%252BAsymmetric%252BPhase-Transfer%252BCatalyzed%252BCyclopropanation%252Bof%252B%252528E%252529-N-Phenylmethyleneglycine%252BEthyl%252BEster%26aulast%3DBelyk%26aufirst%3DKevin%2BM.%26date%3D2010%26date%3D2010%26date%3D2010%26date%3D12%252003%25202010%26date%3D07042010%26date%3D21052010%26volume%3D14%26issue%3D3%26spage%3D692%26epage%3D700" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dharma Rao  Tompa</span>, <span class="hlFld-ContribAuthor ">Aruldoss  Immanuel</span>, <span class="hlFld-ContribAuthor ">Srimari  Srikanth</span>, <span class="hlFld-ContribAuthor ">Saraboji  Kadhirvel</span>. </span><span class="cited-content_cbyCitation_article-title">Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2021,</strong> <em>172 </em>, 524-541. <a href="https://doi.org/10.1016/j.ijbiomac.2021.01.076" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2021.01.076</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2021.01.076&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2021.01.076%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DTrends%252Band%252Bstrategies%252Bto%252Bcombat%252Bviral%252Binfections%25253A%252BA%252Breview%252Bon%252BFDA%252Bapproved%252Bantiviral%252Bdrugs%26aulast%3DTompa%26aufirst%3DDharma%2BRao%26date%3D2021%26volume%3D172%26spage%3D524%26epage%3D541" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sjoerd  Slagman</span>, <span class="hlFld-ContribAuthor ">Wolf-Dieter  Fessner</span>. </span><span class="cited-content_cbyCitation_article-title">Biocatalytic routes to anti-viral agents and their synthetic intermediates. </span><span class="cited-content_cbyCitation_journal-name">Chemical Society Reviews</span><span> <strong>2021,</strong> <em>50 </em>
                                    (3)
                                     , 1968-2009. <a href="https://doi.org/10.1039/D0CS00763C" title="DOI URL">https://doi.org/10.1039/D0CS00763C</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0CS00763C&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0CS00763C%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Society%2520Reviews%26atitle%3DBiocatalytic%252Broutes%252Bto%252Banti-viral%252Bagents%252Band%252Btheir%252Bsynthetic%252Bintermediates%26aulast%3DSlagman%26aufirst%3DSjoerd%26date%3D2021%26date%3D2021%26volume%3D50%26issue%3D3%26spage%3D1968%26epage%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Gao</span>, <span class="hlFld-ContribAuthor ">Andrea L.  Webber</span>, <span class="hlFld-ContribAuthor ">Jill  Maxwell</span>, <span class="hlFld-ContribAuthor ">Melanie  Anderson</span>, <span class="hlFld-ContribAuthor ">Luzelena  Caro</span>, <span class="hlFld-ContribAuthor ">Chris  Chung</span>, <span class="hlFld-ContribAuthor ">André M.M.  Miltenburg</span>, <span class="hlFld-ContribAuthor ">Serghei  Popa</span>, <span class="hlFld-ContribAuthor ">Kristien  Van Dyck</span>, <span class="hlFld-ContribAuthor ">Larissa  Wenning</span>, <span class="hlFld-ContribAuthor ">Eric  Mangin</span>, <span class="hlFld-ContribAuthor ">Christine  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Radha  Railkar</span>, <span class="hlFld-ContribAuthor ">Norah J.  Shire</span>, <span class="hlFld-ContribAuthor ">Iain  Fraser</span>, <span class="hlFld-ContribAuthor ">Bonnie  Howell</span>, <span class="hlFld-ContribAuthor ">Andrew H.  Talal</span>, <span class="hlFld-ContribAuthor ">S. Aubrey  Stoch</span>. </span><span class="cited-content_cbyCitation_article-title">Fine‐Needle Aspiration for the Evaluation of Hepatic Pharmacokinetics of Vaniprevir: A Randomized Trial in Patients With Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name">Clinical Pharmacology & Therapeutics</span><span> <strong>2020,</strong> <em>107 </em>
                                    (6)
                                     , 1325-1333. <a href="https://doi.org/10.1002/cpt.1737" title="DOI URL">https://doi.org/10.1002/cpt.1737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cpt.1737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcpt.1737%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Pharmacology%2520%2526%2520Therapeutics%26atitle%3DFine%2525E2%252580%252590Needle%252BAspiration%252Bfor%252Bthe%252BEvaluation%252Bof%252BHepatic%252BPharmacokinetics%252Bof%252BVaniprevir%25253A%252BA%252BRandomized%252BTrial%252Bin%252BPatients%252BWith%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DGao%26aufirst%3DWei%26date%3D2020%26date%3D2020%26volume%3D107%26issue%3D6%26spage%3D1325%26epage%3D1333" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mohit  Tyagi</span>, <span class="hlFld-ContribAuthor ">Fabio  Begnini</span>, <span class="hlFld-ContribAuthor ">Vasanthanathan  Poongavanam</span>, <span class="hlFld-ContribAuthor ">Bradley C.  Doak</span>, <span class="hlFld-ContribAuthor ">Jan  Kihlberg</span>. </span><span class="cited-content_cbyCitation_article-title">Drug Syntheses Beyond the Rule of 5. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (1)
                                     , 49-88. <a href="https://doi.org/10.1002/chem.201902716" title="DOI URL">https://doi.org/10.1002/chem.201902716</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201902716&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201902716%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DDrug%252BSyntheses%252BBeyond%252Bthe%252BRule%252Bof%252B5%26aulast%3DTyagi%26aufirst%3DMohit%26date%3D2020%26date%3D2019%26volume%3D26%26issue%3D1%26spage%3D49%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rishitha  Gundala</span>, <span class="hlFld-ContribAuthor ">Himani  Balutia</span>, <span class="hlFld-ContribAuthor ">R.  Lavanya</span>, <span class="hlFld-ContribAuthor ">Ravichandiran  Velayutham</span>, <span class="hlFld-ContribAuthor ">Kuldeep K.  Roy</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3 serine protease as a drug target for the development of drugs against hepatocellular carcinoma (liver cancer). </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2020,</strong>,, 243-263. <a href="https://doi.org/10.1016/B978-0-12-818168-3.00009-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-818168-3.00009-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818168-3.00009-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818168-3.00009-7%26sid%3Dliteratum%253Aachs%26atitle%3DHCV%252BNS3%252Bserine%252Bprotease%252Bas%252Ba%252Bdrug%252Btarget%252Bfor%252Bthe%252Bdevelopment%252Bof%252Bdrugs%252Bagainst%252Bhepatocellular%252Bcarcinoma%252B%252528liver%252Bcancer%252529%26aulast%3DGundala%26aufirst%3DRishitha%26date%3D2020%26spage%3D243%26epage%3D263%26pub%3DElsevier%26atitle%3DCancer-Leading%252BProteases%26date%3D2020%26volume%3D60" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zebediah C.  Girvin</span>, <span class="hlFld-ContribAuthor ">Mary Katherine  Andrews</span>, <span class="hlFld-ContribAuthor ">Xinyu  Liu</span>, <span class="hlFld-ContribAuthor ">Samuel H.  Gellman</span>. </span><span class="cited-content_cbyCitation_article-title">Foldamer-templated catalysis of macrocycle formation. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2019,</strong> <em>366 </em>
                                    (6472)
                                     , 1528-1531. <a href="https://doi.org/10.1126/science.aax7344" title="DOI URL">https://doi.org/10.1126/science.aax7344</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aax7344&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aax7344%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DFoldamer-templated%252Bcatalysis%252Bof%252Bmacrocycle%252Bformation%26aulast%3DGirvin%26aufirst%3DZebediah%2BC.%26date%3D2019%26date%3D2019%26volume%3D366%26issue%3D6472%26spage%3D1528%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wenliang  Zhu</span>, <span class="hlFld-ContribAuthor ">Boya  Zhang</span>, <span class="hlFld-ContribAuthor ">Mengqi  Li</span>, <span class="hlFld-ContribAuthor ">Fan  Mo</span>, <span class="hlFld-ContribAuthor ">Tingwei  Mi</span>, <span class="hlFld-ContribAuthor ">Yihui  Wu</span>, <span class="hlFld-ContribAuthor ">Zhaoqian  Teng</span>, <span class="hlFld-ContribAuthor ">Qi  Zhou</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Baoyang  Hu</span>. </span><span class="cited-content_cbyCitation_article-title">Precisely controlling endogenous protein dosage in hPSCs and derivatives to model FOXG1 syndrome. </span><span class="cited-content_cbyCitation_journal-name">Nature Communications</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/s41467-019-08841-7" title="DOI URL">https://doi.org/10.1038/s41467-019-08841-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41467-019-08841-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41467-019-08841-7%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Communications%26atitle%3DPrecisely%252Bcontrolling%252Bendogenous%252Bprotein%252Bdosage%252Bin%252BhPSCs%252Band%252Bderivatives%252Bto%252Bmodel%252BFOXG1%252Bsyndrome%26aulast%3DZhu%26aufirst%3DWenliang%26date%3D2019%26date%3D2019%26volume%3D10%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jirayu  Kammarabutr</span>, <span class="hlFld-ContribAuthor ">Panupong  Mahalapbutr</span>, <span class="hlFld-ContribAuthor ">Bodee  Nutho</span>, <span class="hlFld-ContribAuthor ">Nawee  Kungwan</span>, <span class="hlFld-ContribAuthor ">Thanyada  Rungrotmongkol</span>. </span><span class="cited-content_cbyCitation_article-title">Low susceptibility of asunaprevir towards R155K and D168A point mutations in HCV NS3/4A protease: A molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2019,</strong> <em>89 </em>, 122-130. <a href="https://doi.org/10.1016/j.jmgm.2019.03.006" title="DOI URL">https://doi.org/10.1016/j.jmgm.2019.03.006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2019.03.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2019.03.006%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DLow%252Bsusceptibility%252Bof%252Basunaprevir%252Btowards%252BR155K%252Band%252BD168A%252Bpoint%252Bmutations%252Bin%252BHCV%252BNS3%25252F4A%252Bprotease%25253A%252BA%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DKammarabutr%26aufirst%3DJirayu%26date%3D2019%26volume%3D89%26spage%3D122%26epage%3D130" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Muhammad Usman  Ashraf</span>, <span class="hlFld-ContribAuthor ">Kanzal  Iman</span>, <span class="hlFld-ContribAuthor ">Muhammad Farhan  Khalid</span>, <span class="hlFld-ContribAuthor ">Hafiz Muhammad  Salman</span>, <span class="hlFld-ContribAuthor ">Talha  Shafi</span>, <span class="hlFld-ContribAuthor ">Momal  Rafi</span>, <span class="hlFld-ContribAuthor ">Nida  Javaid</span>, <span class="hlFld-ContribAuthor ">Rashid  Hussain</span>, <span class="hlFld-ContribAuthor ">Fayyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Syed  Shahzad‐Ul‐Hussan</span>, <span class="hlFld-ContribAuthor ">Shaper  Mirza</span>, <span class="hlFld-ContribAuthor ">Muhammad  Shafiq</span>, <span class="hlFld-ContribAuthor ">Samia  Afzal</span>, <span class="hlFld-ContribAuthor ">Sadia  Hamera</span>, <span class="hlFld-ContribAuthor ">Saima  Anwar</span>, <span class="hlFld-ContribAuthor ">Romena  Qazi</span>, <span class="hlFld-ContribAuthor ">Muhammad  Idrees</span>, <span class="hlFld-ContribAuthor ">Sohail A.  Qureshi</span>, <span class="hlFld-ContribAuthor ">Safee Ullah  Chaudhary</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of efficacious pangenotypic hepatitis C virus therapies. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2019,</strong> <em>39 </em>
                                    (3)
                                     , 1091-1136. <a href="https://doi.org/10.1002/med.21554" title="DOI URL">https://doi.org/10.1002/med.21554</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21554&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21554%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DEvolution%252Bof%252Befficacious%252Bpangenotypic%252Bhepatitis%252BC%252Bvirus%252Btherapies%26aulast%3DAshraf%26aufirst%3DMuhammad%2BUsman%26date%3D2019%26date%3D2018%26volume%3D39%26issue%3D3%26spage%3D1091%26epage%3D1136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin R.  Campos</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Juan C.  Alvarez</span>, <span class="hlFld-ContribAuthor ">Spencer D.  Dreher</span>, <span class="hlFld-ContribAuthor ">Robert M.  Garbaccio</span>, <span class="hlFld-ContribAuthor ">Nicholas K.  Terrett</span>, <span class="hlFld-ContribAuthor ">Richard D.  Tillyer</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Truppo</span>, <span class="hlFld-ContribAuthor ">Emma R.  Parmee</span>. </span><span class="cited-content_cbyCitation_article-title">The importance of synthetic chemistry in the pharmaceutical industry. </span><span class="cited-content_cbyCitation_journal-name">Science</span><span> <strong>2019,</strong> <em>363 </em>
                                    (6424)
                                     , eaat0805. <a href="https://doi.org/10.1126/science.aat0805" title="DOI URL">https://doi.org/10.1126/science.aat0805</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/science.aat0805&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscience.aat0805%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%26atitle%3DThe%252Bimportance%252Bof%252Bsynthetic%252Bchemistry%252Bin%252Bthe%252Bpharmaceutical%252Bindustry%26aulast%3DCampos%26aufirst%3DKevin%2BR.%26date%3D2019%26date%3D2019%26volume%3D363%26issue%3D6424%26spage%3Deaat0805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Kristina  Prachanronarong</span>, <span class="hlFld-ContribAuthor ">Ashley N.  Matthew</span>, <span class="hlFld-ContribAuthor ">Djade I.  Soumana</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>. </span><span class="cited-content_cbyCitation_article-title">Resistance outside the substrate envelope: hepatitis C NS3/4A protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Critical Reviews in Biochemistry and Molecular Biology</span><span> <strong>2019,</strong> <em>54 </em>
                                    (1)
                                     , 11-26. <a href="https://doi.org/10.1080/10409238.2019.1568962" title="DOI URL">https://doi.org/10.1080/10409238.2019.1568962</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10409238.2019.1568962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10409238.2019.1568962%26sid%3Dliteratum%253Aachs%26jtitle%3DCritical%2520Reviews%2520in%2520Biochemistry%2520and%2520Molecular%2520Biology%26atitle%3DResistance%252Boutside%252Bthe%252Bsubstrate%252Benvelope%25253A%252Bhepatitis%252BC%252BNS3%25252F4A%252Bprotease%252Binhibitors%26aulast%3D%25C3%2596zen%26aufirst%3DAy%25C5%259Feg%25C3%25BCl%26date%3D2019%26date%3D2019%26volume%3D54%26issue%3D1%26spage%3D11%26epage%3D26" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>. </span><span class="cited-content_cbyCitation_article-title">Evolution of HCV NS3/4a Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 231-259. <a href="https://doi.org/10.1007/7355_2018_39" title="DOI URL">https://doi.org/10.1007/7355_2018_39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_39%26sid%3Dliteratum%253Aachs%26atitle%3DEvolution%252Bof%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitors%26aulast%3DLiverton%26aufirst%3DNigel%2BJ.%26date%3D2019%26date%3D2019%26spage%3D231%26epage%3D259%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">The Invention of Grazoprevir: An HCV NS3/4a Protease Inhibitor. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 355-387. <a href="https://doi.org/10.1007/7355_2018_41" title="DOI URL">https://doi.org/10.1007/7355_2018_41</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2018_41&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2018_41%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BInvention%252Bof%252BGrazoprevir%25253A%252BAn%252BHCV%252BNS3%25252F4a%252BProtease%252BInhibitor%26aulast%3DMcCauley%26aufirst%3DJohn%2BA.%26date%3D2019%26date%3D2019%26spage%3D355%26epage%3D387%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DHCV%25253A%252BThe%252BJourney%252Bfrom%252BDiscovery%252Bto%252Ba%252BCure%26aulast%3DSofia%26aufirst%3DMichael%2BJ.%26date%3D2019%26volume%3D31" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ye  Che</span>. </span><span class="cited-content_cbyCitation_article-title">Design of Cyclic Peptides as Protein Recognition Motifs. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 97-106. <a href="https://doi.org/10.1007/978-1-4939-9504-2_6" title="DOI URL">https://doi.org/10.1007/978-1-4939-9504-2_6</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4939-9504-2_6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4939-9504-2_6%26sid%3Dliteratum%253Aachs%26atitle%3DDesign%252Bof%252BCyclic%252BPeptides%252Bas%252BProtein%252BRecognition%252BMotifs%26aulast%3DChe%26aufirst%3DYe%26date%3D2019%26date%3D2019%26spage%3D97%26epage%3D106%26pub%3DSpringer%2520New%2520York%26atitle%3DCyclic%252BPeptide%252BDesign%26aulast%3DGoetz%26aufirst%3DGilles%26date%3D2019%26volume%3D2001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Valerio  Sabatino</span>, <span class="hlFld-ContribAuthor ">Thomas R  Ward</span>. </span><span class="cited-content_cbyCitation_article-title">Aqueous olefin metathesis: recent developments and applications. </span><span class="cited-content_cbyCitation_journal-name">Beilstein Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>15 </em>, 445-468. <a href="https://doi.org/10.3762/bjoc.15.39" title="DOI URL">https://doi.org/10.3762/bjoc.15.39</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3762/bjoc.15.39&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3762%2Fbjoc.15.39%26sid%3Dliteratum%253Aachs%26jtitle%3DBeilstein%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DAqueous%252Bolefin%252Bmetathesis%25253A%252Brecent%252Bdevelopments%252Band%252Bapplications%26aulast%3DSabatino%26aufirst%3DValerio%26date%3D2019%26date%3D2019%26volume%3D15%26spage%3D445%26epage%3D468" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ayodeji A.  Agbowuro</span>, <span class="hlFld-ContribAuthor ">Wilhelmina M.  Huston</span>, <span class="hlFld-ContribAuthor ">Allan B.  Gamble</span>, <span class="hlFld-ContribAuthor ">Joel D. A.  Tyndall</span>. </span><span class="cited-content_cbyCitation_article-title">Proteases and protease inhibitors in infectious diseases. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2018,</strong> <em>38 </em>
                                    (4)
                                     , 1295-1331. <a href="https://doi.org/10.1002/med.21475" title="DOI URL">https://doi.org/10.1002/med.21475</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21475&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21475%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DProteases%252Band%252Bprotease%252Binhibitors%252Bin%252Binfectious%252Bdiseases%26aulast%3DAgbowuro%26aufirst%3DAyodeji%2BA.%26date%3D2018%26date%3D2017%26volume%3D38%26issue%3D4%26spage%3D1295%26epage%3D1331" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sulejman  Alihodžić</span>, <span class="hlFld-ContribAuthor ">Mirjana  Bukvić</span>, <span class="hlFld-ContribAuthor ">Ivaylo J.  Elenkov</span>, <span class="hlFld-ContribAuthor ">Antun  Hutinec</span>, <span class="hlFld-ContribAuthor ">Sanja  Koštrun</span>, <span class="hlFld-ContribAuthor ">Dijana  Pešić</span>, <span class="hlFld-ContribAuthor ">Gordon  Saxty</span>, <span class="hlFld-ContribAuthor ">Linda  Tomašković</span>, <span class="hlFld-ContribAuthor ">Dinko  Žiher</span>. </span><span class="cited-content_cbyCitation_article-title">Current Trends in Macrocyclic Drug Discovery and beyond -Ro5. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2018,</strong>,, 113-233. <a href="https://doi.org/10.1016/bs.pmch.2018.01.002" title="DOI URL">https://doi.org/10.1016/bs.pmch.2018.01.002</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.pmch.2018.01.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.pmch.2018.01.002%26sid%3Dliteratum%253Aachs%26atitle%3DCurrent%252BTrends%252Bin%252BMacrocyclic%252BDrug%252BDiscovery%252Band%252Bbeyond%252B-Ro5%26aulast%3DAlihod%25C5%25BEi%25C4%2587%26aufirst%3DSulejman%26date%3D2018%26spage%3D113%26epage%3D233%26pub%3DElsevier%26date%3D2018%26volume%3D57" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Bowsher</span>, <span class="hlFld-ContribAuthor ">Sheldon  Hiebert</span>, <span class="hlFld-ContribAuthor ">Rongti  Li</span>, <span class="hlFld-ContribAuthor ">Alan X.  Wang</span>, <span class="hlFld-ContribAuthor ">Jacques  Friborg</span>, <span class="hlFld-ContribAuthor ">Fei  Yu</span>, <span class="hlFld-ContribAuthor ">Dennis  Hernandez</span>, <span class="hlFld-ContribAuthor ">Ying-Kai  Wang</span>, <span class="hlFld-ContribAuthor ">Herbert  Klei</span>, <span class="hlFld-ContribAuthor ">Ramkumar  Rajamani</span>, <span class="hlFld-ContribAuthor ">Kathy  Mosure</span>, <span class="hlFld-ContribAuthor ">Jay O.  Knipe</span>, <span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Fiona  McPhee</span>, <span class="hlFld-ContribAuthor ">Paul M.  Scola</span>. </span><span class="cited-content_cbyCitation_article-title">The discovery and optimization of naphthalene-linked P2-P4 Macrocycles as inhibitors of HCV NS3 protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2018,</strong> <em>28 </em>
                                    (1)
                                     , 43-48. <a href="https://doi.org/10.1016/j.bmcl.2017.11.005" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.11.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.11.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.11.005%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bdiscovery%252Band%252Boptimization%252Bof%252Bnaphthalene-linked%252BP2-P4%252BMacrocycles%252Bas%252Binhibitors%252Bof%252BHCV%252BNS3%252Bprotease%26aulast%3DBowsher%26aufirst%3DMichael%26date%3D2018%26volume%3D28%26issue%3D1%26spage%3D43%26epage%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mariusz  Kędziorek</span>, <span class="hlFld-ContribAuthor ">Karol  Grela</span>. </span><span class="cited-content_cbyCitation_article-title">Metathesis. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1333-1364. <a href="https://doi.org/10.1002/9783527651733.ch24" title="DOI URL">https://doi.org/10.1002/9783527651733.ch24</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527651733.ch24&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527651733.ch24%26sid%3Dliteratum%253Aachs%26atitle%3DMetathesis%26aulast%3DK%25C4%2599dziorek%26aufirst%3DMariusz%26date%3D2017%26date%3D2017%26spage%3D1333%26epage%3D1364%26pub%3DWiley%26atitle%3DApplied%252BHomogeneous%252BCatalysis%252Bwith%252BOrganometallic%252BCompounds%26aulast%3DCornils%26aufirst%3DBoy%26date%3D2017%26date%3D2017%26volume%3D36" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jongrock  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Approaches Used in the Scale-Up of Macrocyclic Clinical Candidates. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 377-409. <a href="https://doi.org/10.1002/9781119092599.ch15" title="DOI URL">https://doi.org/10.1002/9781119092599.ch15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119092599.ch15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119092599.ch15%26sid%3Dliteratum%253Aachs%26atitle%3DSynthetic%252BApproaches%252BUsed%252Bin%252Bthe%252BScale-Up%252Bof%252BMacrocyclic%252BClinical%252BCandidates%26aulast%3DKong%26aufirst%3DJongrock%26date%3D2017%26date%3D2017%26spage%3D377%26epage%3D409%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPractical%252BMedicinal%252BChemistry%252Bwith%252BMacrocycles%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2017%26volume%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Silvia  Stotani</span>, <span class="hlFld-ContribAuthor ">Fabrizio  Giordanetto</span>. </span><span class="cited-content_cbyCitation_article-title">Overview of Macrocycles in Clinical Development and Clinically Used. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 411-499. <a href="https://doi.org/10.1002/9781119092599.ch16" title="DOI URL">https://doi.org/10.1002/9781119092599.ch16</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781119092599.ch16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781119092599.ch16%26sid%3Dliteratum%253Aachs%26atitle%3DOverview%252Bof%252BMacrocycles%252Bin%252BClinical%252BDevelopment%252Band%252BClinically%252BUsed%26aulast%3DStotani%26aufirst%3DSilvia%26date%3D2017%26date%3D2017%26spage%3D411%26epage%3D499%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DPractical%252BMedicinal%252BChemistry%252Bwith%252BMacrocycles%26aulast%3DMarsault%26aufirst%3DEric%26date%3D2017%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">L  Caro</span>, <span class="hlFld-ContribAuthor ">J  Hoon</span>, <span class="hlFld-ContribAuthor ">M  Depré</span>, <span class="hlFld-ContribAuthor ">C  Cilissen</span>, <span class="hlFld-ContribAuthor ">J  Miller</span>, <span class="hlFld-ContribAuthor ">W  Gao</span>, <span class="hlFld-ContribAuthor ">D  Panebianco</span>, <span class="hlFld-ContribAuthor ">Z  Guo</span>, <span class="hlFld-ContribAuthor ">SL  Troemel</span>, <span class="hlFld-ContribAuthor ">MS  Anderson</span>, <span class="hlFld-ContribAuthor ">N  Uemura</span>, <span class="hlFld-ContribAuthor ">J  Butterton</span>, <span class="hlFld-ContribAuthor ">J  Wagner</span>, <span class="hlFld-ContribAuthor ">DH  Wright</span>. </span><span class="cited-content_cbyCitation_article-title">Single‐Dose and Multiple‐Dose Pharmacokinetics of Vaniprevir in Healthy Men. </span><span class="cited-content_cbyCitation_journal-name">Clinical and Translational Science</span><span> <strong>2017,</strong> <em>10 </em>
                                    (6)
                                     , 480-486. <a href="https://doi.org/10.1111/cts.12482" title="DOI URL">https://doi.org/10.1111/cts.12482</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cts.12482&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcts.12482%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520and%2520Translational%2520Science%26atitle%3DSingle%2525E2%252580%252590Dose%252Band%252BMultiple%2525E2%252580%252590Dose%252BPharmacokinetics%252Bof%252BVaniprevir%252Bin%252BHealthy%252BMen%26aulast%3DCaro%26aufirst%3DL%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D6%26spage%3D480%26epage%3D486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guanghai  Jin</span>, <span class="hlFld-ContribAuthor ">Jisu  Lee</span>, <span class="hlFld-ContribAuthor ">Kyeong  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Chemical genetics-based development of small molecules targeting hepatitis C virus. </span><span class="cited-content_cbyCitation_journal-name">Archives of Pharmacal Research</span><span> <strong>2017,</strong> <em>40 </em>
                                    (9)
                                     , 1021-1036. <a href="https://doi.org/10.1007/s12272-017-0949-3" title="DOI URL">https://doi.org/10.1007/s12272-017-0949-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12272-017-0949-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12272-017-0949-3%26sid%3Dliteratum%253Aachs%26jtitle%3DArchives%2520of%2520Pharmacal%2520Research%26atitle%3DChemical%252Bgenetics-based%252Bdevelopment%252Bof%252Bsmall%252Bmolecules%252Btargeting%252Bhepatitis%252BC%252Bvirus%26aulast%3DJin%26aufirst%3DGuanghai%26date%3D2017%26date%3D2017%26volume%3D40%26issue%3D9%26spage%3D1021%26epage%3D1036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcin  Skoreński</span>, <span class="hlFld-ContribAuthor ">Magdalena  Pachota</span>, <span class="hlFld-ContribAuthor ">Krzysztof  Pyrć</span>, <span class="hlFld-ContribAuthor ">Marcin  Sieńczyk</span>, <span class="hlFld-ContribAuthor ">Józef  Oleksyszyn</span>. </span><span class="cited-content_cbyCitation_article-title">Novel peptidyl α-aminoalkylphosphonates as inhibitors of hepatitis C virus NS3/4A protease. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2017,</strong> <em>144 </em>, 286-298. <a href="https://doi.org/10.1016/j.antiviral.2017.06.020" title="DOI URL">https://doi.org/10.1016/j.antiviral.2017.06.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2017.06.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2017.06.020%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DNovel%252Bpeptidyl%252B%2525CE%2525B1-aminoalkylphosphonates%252Bas%252Binhibitors%252Bof%252Bhepatitis%252BC%252Bvirus%252BNS3%25252F4A%252Bprotease%26aulast%3DSkore%25C5%2584ski%26aufirst%3DMarcin%26date%3D2017%26volume%3D144%26spage%3D286%26epage%3D298" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Nelson  Hayes</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Chayama</span>. </span><span class="cited-content_cbyCitation_article-title">Why highly effective drugs are not enough: the need for an affordable solution to eliminating HCV. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2017,</strong> <em>10 </em>
                                    (6)
                                     , 583-594. <a href="https://doi.org/10.1080/17512433.2017.1313111" title="DOI URL">https://doi.org/10.1080/17512433.2017.1313111</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17512433.2017.1313111&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17512433.2017.1313111%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DWhy%252Bhighly%252Beffective%252Bdrugs%252Bare%252Bnot%252Benough%25253A%252Bthe%252Bneed%252Bfor%252Ban%252Baffordable%252Bsolution%252Bto%252Beliminating%252BHCV%26aulast%3DHayes%26aufirst%3DC.%2BNelson%26date%3D2017%26date%3D2017%26volume%3D10%26issue%3D6%26spage%3D583%26epage%3D594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Satya  P Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">HCV NS3/4A Protease and its Emerging Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Analytical & Pharmaceutical Research</span><span> <strong>2017,</strong> <em>4 </em>
                                    (4)
                                     <a href="https://doi.org/10.15406/japlr.2017.04.00108" title="DOI URL">https://doi.org/10.15406/japlr.2017.04.00108</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.15406/japlr.2017.04.00108&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.15406%2Fjaplr.2017.04.00108%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Analytical%2520%2526%2520Pharmaceutical%2520Research%26atitle%3DHCV%252BNS3%25252F4A%252BProtease%252Band%252Bits%252BEmerging%252BInhibitors%26aulast%3DP%2BGupta%26aufirst%3DSatya%26date%3D2017%26date%3D2017%26volume%3D4%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Frank K.  Brown</span>, <span class="hlFld-ContribAuthor ">Edward C.  Sherer</span>, <span class="hlFld-ContribAuthor ">Scott A.  Johnson</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Bradley S.  Sherborne</span>. </span><span class="cited-content_cbyCitation_article-title">The evolution of drug design at Merck Research Laboratories. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2017,</strong> <em>31 </em>
                                    (3)
                                     , 255-266. <a href="https://doi.org/10.1007/s10822-016-9993-1" title="DOI URL">https://doi.org/10.1007/s10822-016-9993-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-016-9993-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-016-9993-1%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DThe%252Bevolution%252Bof%252Bdrug%252Bdesign%252Bat%252BMerck%252BResearch%252BLaboratories%26aulast%3DBrown%26aufirst%3DFrank%2BK.%26date%3D2017%26date%3D2016%26volume%3D31%26issue%3D3%26spage%3D255%26epage%3D266" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">C. Nelson  Hayes</span>, <span class="hlFld-ContribAuthor ">Michio  Imamura</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Chayama</span>. </span><span class="cited-content_cbyCitation_article-title">The practical management of chronic hepatitis C infection in Japan - dual therapy of daclatasvir + asunaprevir. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Gastroenterology & Hepatology</span><span> <strong>2017,</strong> <em>11 </em>
                                    (2)
                                     , 103-113. <a href="https://doi.org/10.1080/17474124.2017.1270205" title="DOI URL">https://doi.org/10.1080/17474124.2017.1270205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/17474124.2017.1270205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F17474124.2017.1270205%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Gastroenterology%2520%2526%2520Hepatology%26atitle%3DThe%252Bpractical%252Bmanagement%252Bof%252Bchronic%252Bhepatitis%252BC%252Binfection%252Bin%252BJapan%252B-%252Bdual%252Btherapy%252Bof%252Bdaclatasvir%252B%25252B%252Basunaprevir%26aulast%3DHayes%26aufirst%3DC.%2BNelson%26date%3D2017%26date%3D2016%26volume%3D11%26issue%3D2%26spage%3D103%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">N.A.  Meanwell</span>. </span><span class="cited-content_cbyCitation_article-title">Direct-Acting Antiviral Agents for the Treatment of Hepatitis C Virus Infection. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 553-627. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12406-0" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12406-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12406-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12406-0%26sid%3Dliteratum%253Aachs%26atitle%3DDirect-Acting%252BAntiviral%252BAgents%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatitis%252BC%252BVirus%252BInfection%26aulast%3DMeanwell%26aufirst%3DN.A.%26date%3D2017%26spage%3D553%26epage%3D627%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S.  Venkatraman</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: Ketoamide-Derived HCV NS3 Serine Protease Inhibitors for the Treatment of Chronic Hepatitis C. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 583-608. <a href="https://doi.org/10.1016/B978-0-12-409547-2.12452-7" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.12452-7</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.12452-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.12452-7%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BKetoamide-Derived%252BHCV%252BNS3%252BSerine%252BProtease%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BChronic%252BHepatitis%252BC%26aulast%3DVenkatraman%26aufirst%3DS.%26date%3D2017%26spage%3D583%26epage%3D608%26pub%3DElsevier%26atitle%3DComprehensive%252BMedicinal%252BChemistry%252BIII%26date%3D2017%26volume%3D343" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Marcin  Drop</span>, <span class="hlFld-ContribAuthor ">Xavier  Bantreil</span>, <span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Gilbert Umuhire  Mahoro</span>, <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Gilles  Subra</span>, <span class="hlFld-ContribAuthor ">Pawel  Zajdel</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>. </span><span class="cited-content_cbyCitation_article-title">Continuous flow ring-closing metathesis, an environmentally-friendly route to 2,5-dihydro-1H-pyrrole-3-carboxylates. </span><span class="cited-content_cbyCitation_journal-name">Green Chemistry</span><span> <strong>2017,</strong> <em>19 </em>
                                    (7)
                                     , 1647-1652. <a href="https://doi.org/10.1039/C7GC00235A" title="DOI URL">https://doi.org/10.1039/C7GC00235A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C7GC00235A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC7GC00235A%26sid%3Dliteratum%253Aachs%26jtitle%3DGreen%2520Chemistry%26atitle%3DContinuous%252Bflow%252Bring-closing%252Bmetathesis%25252C%252Ban%252Benvironmentally-friendly%252Broute%252Bto%252B2%25252C5-dihydro-1H-pyrrole-3-carboxylates%26aulast%3DDrop%26aufirst%3DMarcin%26date%3D2017%26date%3D2017%26volume%3D19%26issue%3D7%26spage%3D1647%26epage%3D1652" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Katarzyna  Grychowska</span>, <span class="hlFld-ContribAuthor ">Bartłomiej  Kubica</span>, <span class="hlFld-ContribAuthor ">Marcin  Drop</span>, <span class="hlFld-ContribAuthor ">Evelina  Colacino</span>, <span class="hlFld-ContribAuthor ">Xavier  Bantreil</span>, <span class="hlFld-ContribAuthor ">Maciej  Pawłowski</span>, <span class="hlFld-ContribAuthor ">Jean  Martinez</span>, <span class="hlFld-ContribAuthor ">Gilles  Subra</span>, <span class="hlFld-ContribAuthor ">Paweł  Zajdel</span>, <span class="hlFld-ContribAuthor ">Frédéric  Lamaty</span>. </span><span class="cited-content_cbyCitation_article-title">Application of the ring-closing metathesis to the formation of 2-aryl-1H-pyrrole-3-carboxylates as building blocks for biologically active compounds. </span><span class="cited-content_cbyCitation_journal-name">Tetrahedron</span><span> <strong>2016,</strong> <em>72 </em>
                                    (47)
                                     , 7462-7469. <a href="https://doi.org/10.1016/j.tet.2016.09.059" title="DOI URL">https://doi.org/10.1016/j.tet.2016.09.059</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tet.2016.09.059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tet.2016.09.059%26sid%3Dliteratum%253Aachs%26jtitle%3DTetrahedron%26atitle%3DApplication%252Bof%252Bthe%252Bring-closing%252Bmetathesis%252Bto%252Bthe%252Bformation%252Bof%252B2-aryl-1H-pyrrole-3-carboxylates%252Bas%252Bbuilding%252Bblocks%252Bfor%252Bbiologically%252Bactive%252Bcompounds%26aulast%3DGrychowska%26aufirst%3DKatarzyna%26date%3D2016%26volume%3D72%26issue%3D47%26spage%3D7462%26epage%3D7469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">John A  McCauley</span>, <span class="hlFld-ContribAuthor ">Michael T  Rudd</span>. </span><span class="cited-content_cbyCitation_article-title">Hepatitis C virus NS3/4a protease inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2016,</strong> <em>30 </em>, 84-92. <a href="https://doi.org/10.1016/j.coph.2016.07.015" title="DOI URL">https://doi.org/10.1016/j.coph.2016.07.015</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2016.07.015&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2016.07.015%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DHepatitis%252BC%252Bvirus%252BNS3%25252F4a%252Bprotease%252Binhibitors%26aulast%3DMcCauley%26aufirst%3DJohn%2BA%26date%3D2016%26volume%3D30%26spage%3D84%26epage%3D92" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiromitsu  Kumada</span>, <span class="hlFld-ContribAuthor ">Satoshi  Mochida</span>, <span class="hlFld-ContribAuthor ">Fumitaka  Suzuki</span>, <span class="hlFld-ContribAuthor ">Kazuaki  Chayama</span>, <span class="hlFld-ContribAuthor ">Yoshiyasu  Karino</span>, <span class="hlFld-ContribAuthor ">Keisuke  Nakamura</span>, <span class="hlFld-ContribAuthor ">Go  Fujimoto</span>, <span class="hlFld-ContribAuthor ">Anita Y. M.  Howe</span>, <span class="hlFld-ContribAuthor ">Steve W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Niloufar  Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Vaniprevir plus peginterferon alfa‐2b and ribavirin in treatment‐experienced Japanese patients with hepatitis C virus genotype 1 (GT1b) infection: Phase 3 studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastroenterology and Hepatology</span><span> <strong>2016,</strong> <em>31 </em>
                                    (10)
                                     , 1674-1683. <a href="https://doi.org/10.1111/jgh.13328" title="DOI URL">https://doi.org/10.1111/jgh.13328</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/jgh.13328&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fjgh.13328%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastroenterology%2520and%2520Hepatology%26atitle%3DVaniprevir%252Bplus%252Bpeginterferon%252Balfa%2525E2%252580%2525902b%252Band%252Bribavirin%252Bin%252Btreatment%2525E2%252580%252590experienced%252BJapanese%252Bpatients%252Bwith%252Bhepatitis%252BC%252Bvirus%252Bgenotype%252B1%252B%252528GT1b%252529%252Binfection%25253A%252BPhase%252B3%252Bstudies%26aulast%3DKumada%26aufirst%3DHiromitsu%26date%3D2016%26date%3D2016%26volume%3D31%26issue%3D10%26spage%3D1674%26epage%3D1683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lin  Sun</span>, <span class="hlFld-ContribAuthor ">Ping  Gao</span>, <span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Pyrazolo[1,5-a]pyrimidine-based macrocycles as novel HIV-1 inhibitors: a patent evaluation of WO2015123182. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (9)
                                     , 979-986. <a href="https://doi.org/10.1080/13543776.2016.1210127" title="DOI URL">https://doi.org/10.1080/13543776.2016.1210127</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2016.1210127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2016.1210127%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DPyrazolo%25255B1%25252C5-a%25255Dpyrimidine-based%252Bmacrocycles%252Bas%252Bnovel%252BHIV-1%252Binhibitors%25253A%252Ba%252Bpatent%252Bevaluation%252Bof%252BWO2015123182%26aulast%3DSun%26aufirst%3DLin%26date%3D2016%26date%3D2016%26volume%3D26%26issue%3D9%26spage%3D979%26epage%3D986" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>, <span class="hlFld-ContribAuthor ">Guangdi  Li</span>. </span><span class="cited-content_cbyCitation_article-title">Approved Antiviral Drugs over the Past 50 Years. </span><span class="cited-content_cbyCitation_journal-name">Clinical Microbiology Reviews</span><span> <strong>2016,</strong> <em>29 </em>
                                    (3)
                                     , 695-747. <a href="https://doi.org/10.1128/CMR.00102-15" title="DOI URL">https://doi.org/10.1128/CMR.00102-15</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/CMR.00102-15&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FCMR.00102-15%26sid%3Dliteratum%253Aachs%26jtitle%3DClinical%2520Microbiology%2520Reviews%26atitle%3DApproved%252BAntiviral%252BDrugs%252Bover%252Bthe%252BPast%252B50%252BYears%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2016%26volume%3D29%26issue%3D3%26spage%3D695%26epage%3D747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Tomona  Hirano</span>, <span class="hlFld-ContribAuthor ">Stuart  Black</span>, <span class="hlFld-ContribAuthor ">Anita Y.M.  Howe</span>, <span class="hlFld-ContribAuthor ">Wei  Chang</span>, <span class="hlFld-ContribAuthor ">Akiko  Takase</span>, <span class="hlFld-ContribAuthor ">Keisuke  Nakamura</span>, <span class="hlFld-ContribAuthor ">Yoshiyuki  Tanaka</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Kumada</span>, <span class="hlFld-ContribAuthor ">Norio  Hayashi</span>, <span class="hlFld-ContribAuthor ">David  Nickle</span>. </span><span class="cited-content_cbyCitation_article-title">HCV evolutionary genetics of SVR versus virologic failure assessed from the vaniprevir phase III registration trials. </span><span class="cited-content_cbyCitation_journal-name">Antiviral Research</span><span> <strong>2016,</strong> <em>130 </em>, 118-129. <a href="https://doi.org/10.1016/j.antiviral.2016.03.004" title="DOI URL">https://doi.org/10.1016/j.antiviral.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.antiviral.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.antiviral.2016.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DAntiviral%2520Research%26atitle%3DHCV%252Bevolutionary%252Bgenetics%252Bof%252BSVR%252Bversus%252Bvirologic%252Bfailure%252Bassessed%252Bfrom%252Bthe%252Bvaniprevir%252Bphase%252BIII%252Bregistration%252Btrials%26aulast%3DLudmerer%26aufirst%3DSteven%2BW.%26date%3D2016%26volume%3D130%26spage%3D118%26epage%3D129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna Karin  Belfrage</span>, <span class="hlFld-ContribAuthor ">Eldar  Abdurakhmanov</span>, <span class="hlFld-ContribAuthor ">Eva  Åkerblom</span>, <span class="hlFld-ContribAuthor ">Peter  Brandt</span>, <span class="hlFld-ContribAuthor ">Anna  Oshalim</span>, <span class="hlFld-ContribAuthor ">Johan  Gising</span>, <span class="hlFld-ContribAuthor ">Anna  Skogh</span>, <span class="hlFld-ContribAuthor ">Johan  Neyts</span>, <span class="hlFld-ContribAuthor ">U. Helena  Danielson</span>, <span class="hlFld-ContribAuthor ">Anja  Sandström</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of pyrazinone based compounds that potently inhibit the drug-resistant enzyme variant R155K of the hepatitis C virus NS3 protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (12)
                                     , 2603-2620. <a href="https://doi.org/10.1016/j.bmc.2016.03.066" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.066</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.066%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bpyrazinone%252Bbased%252Bcompounds%252Bthat%252Bpotently%252Binhibit%252Bthe%252Bdrug-resistant%252Benzyme%252Bvariant%252BR155K%252Bof%252Bthe%252Bhepatitis%252BC%252Bvirus%252BNS3%252Bprotease%26aulast%3DBelfrage%26aufirst%3DAnna%2BKarin%26date%3D2016%26volume%3D24%26issue%3D12%26spage%3D2603%26epage%3D2620" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrew C.  Flick</span>, <span class="hlFld-ContribAuthor ">Hong X.  Ding</span>, <span class="hlFld-ContribAuthor ">Carolyn A.  Leverett</span>, <span class="hlFld-ContribAuthor ">Robert E.  Kyne</span>, <span class="hlFld-ContribAuthor ">Kevin K.-C.  Liu</span>, <span class="hlFld-ContribAuthor ">Sarah J.  Fink</span>, <span class="hlFld-ContribAuthor ">Christopher J.  O’Donnell</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic approaches to the 2014 new drugs. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2016,</strong> <em>24 </em>
                                    (9)
                                     , 1937-1980. <a href="https://doi.org/10.1016/j.bmc.2016.03.004" title="DOI URL">https://doi.org/10.1016/j.bmc.2016.03.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2016.03.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2016.03.004%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Bapproaches%252Bto%252Bthe%252B2014%252Bnew%252Bdrugs%26aulast%3DFlick%26aufirst%3DAndrew%2BC.%26date%3D2016%26volume%3D24%26issue%3D9%26spage%3D1937%26epage%3D1980" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norio  Hayashi</span>, <span class="hlFld-ContribAuthor ">Makoto  Nakamuta</span>, <span class="hlFld-ContribAuthor ">Tetsuo  Takehara</span>, <span class="hlFld-ContribAuthor ">Hiromitsu  Kumada</span>, <span class="hlFld-ContribAuthor ">Akiko  Takase</span>, <span class="hlFld-ContribAuthor ">Anita Yee Mei  Howe</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Niloufar  Mobashery</span>. </span><span class="cited-content_cbyCitation_article-title">Vaniprevir plus peginterferon alfa-2b and ribavirin in treatment-naive Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase III study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastroenterology</span><span> <strong>2016,</strong> <em>51 </em>
                                    (4)
                                     , 390-403. <a href="https://doi.org/10.1007/s00535-015-1120-x" title="DOI URL">https://doi.org/10.1007/s00535-015-1120-x</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00535-015-1120-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00535-015-1120-x%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastroenterology%26atitle%3DVaniprevir%252Bplus%252Bpeginterferon%252Balfa-2b%252Band%252Bribavirin%252Bin%252Btreatment-naive%252BJapanese%252Bpatients%252Bwith%252Bhepatitis%252BC%252Bvirus%252Bgenotype%252B1%252Binfection%25253A%252Ba%252Brandomized%252Bphase%252BIII%252Bstudy%26aulast%3DHayashi%26aufirst%3DNorio%26date%3D2016%26date%3D2015%26volume%3D51%26issue%3D4%26spage%3D390%26epage%3D403" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guorui  Cao</span>, <span class="hlFld-ContribAuthor ">Kun  Yang</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Longjiang  Huang</span>, <span class="hlFld-ContribAuthor ">Dawei  Teng</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Strategy and Anti-Tumor Activities of Macrocyclic Scaffolds Based on 4-Hydroxyproline. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2016,</strong> <em>21 </em>
                                    (2)
                                     , 212. <a href="https://doi.org/10.3390/molecules21020212" title="DOI URL">https://doi.org/10.3390/molecules21020212</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules21020212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules21020212%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DSynthetic%252BStrategy%252Band%252BAnti-Tumor%252BActivities%252Bof%252BMacrocyclic%252BScaffolds%252BBased%252Bon%252B4-Hydroxyproline%26aulast%3DCao%26aufirst%3DGuorui%26date%3D2016%26date%3D2016%26volume%3D21%26issue%3D2%26spage%3D212" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fangyuan  Shi</span>, <span class="hlFld-ContribAuthor ">Yingjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Wenfang  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a series of novel compounds with moderate anti-hepatitis C virus NS3 protease activity in vitro. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (17)
                                     , 5539-5545. <a href="https://doi.org/10.1016/j.bmc.2015.07.032" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.07.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.07.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.07.032%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252Bseries%252Bof%252Bnovel%252Bcompounds%252Bwith%252Bmoderate%252Banti-hepatitis%252BC%252Bvirus%252BNS3%252Bprotease%252Bactivity%252Bin%252Bvitro%26aulast%3DShi%26aufirst%3DFangyuan%26date%3D2015%26volume%3D23%26issue%3D17%26spage%3D5539%26epage%3D5545" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">François-René  Alexandre</span>, <span class="hlFld-ContribAuthor ">Guillaume  Brandt</span>, <span class="hlFld-ContribAuthor ">Catherine  Caillet</span>, <span class="hlFld-ContribAuthor ">Dominique  Chaves</span>, <span class="hlFld-ContribAuthor ">Thierry  Convard</span>, <span class="hlFld-ContribAuthor ">Michel  Derock</span>, <span class="hlFld-ContribAuthor ">Damien  Gloux</span>, <span class="hlFld-ContribAuthor ">Yann  Griffon</span>, <span class="hlFld-ContribAuthor ">Lisa  Lallos</span>, <span class="hlFld-ContribAuthor ">Frédéric  Leroy</span>, <span class="hlFld-ContribAuthor ">Michel  Liuzzi</span>, <span class="hlFld-ContribAuthor ">Anna-Giulia  Loi</span>, <span class="hlFld-ContribAuthor ">Laure  Moulat</span>, <span class="hlFld-ContribAuthor ">Chiara  Musiu</span>, <span class="hlFld-ContribAuthor ">Christophe  Parsy</span>, <span class="hlFld-ContribAuthor ">Houcine  Rahali</span>, <span class="hlFld-ContribAuthor ">Virginie  Roques</span>, <span class="hlFld-ContribAuthor ">Maria  Seifer</span>, <span class="hlFld-ContribAuthor ">David  Standring</span>, <span class="hlFld-ContribAuthor ">Dominique  Surleraux</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiviral evaluation of a novel series of homoserine-based inhibitors of the hepatitis C virus NS3/4A serine protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (18)
                                     , 3984-3991. <a href="https://doi.org/10.1016/j.bmcl.2015.07.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.07.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.07.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.07.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantiviral%252Bevaluation%252Bof%252Ba%252Bnovel%252Bseries%252Bof%252Bhomoserine-based%252Binhibitors%252Bof%252Bthe%252Bhepatitis%252BC%252Bvirus%252BNS3%25252F4A%252Bserine%252Bprotease%26aulast%3DAlexandre%26aufirst%3DFran%25C3%25A7ois-Ren%25C3%25A9%26date%3D2015%26volume%3D25%26issue%3D18%26spage%3D3984%26epage%3D3991" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Kimberly J.  Bush</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Marcello  DiFilippo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">John  Swestock</span>, <span class="hlFld-ContribAuthor ">Jeff  Fritzen</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Adam  Gates</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>, <span class="hlFld-ContribAuthor ">Stephanie  McClain</span>, <span class="hlFld-ContribAuthor ">Carolyn  McHale</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Stuart  Black</span>, <span class="hlFld-ContribAuthor ">Robert  Chase</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Christine M.  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Anne  Taylor</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>. </span><span class="cited-content_cbyCitation_article-title">P2-Quinazolinones and Bis-Macrocycles as New Templates for Next-Generation Hepatitis C Virus NS3/4a Protease Inhibitors: Discovery of MK-2748 and MK-6325. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2015,</strong> <em>10 </em>
                                    (4)
                                     , 727-735. <a href="https://doi.org/10.1002/cmdc.201402558" title="DOI URL">https://doi.org/10.1002/cmdc.201402558</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201402558&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201402558%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DP2-Quinazolinones%252Band%252BBis-Macrocycles%252Bas%252BNew%252BTemplates%252Bfor%252BNext-Generation%252BHepatitis%2525E2%252580%252585C%252BVirus%252BNS3%25252F4a%252BProtease%252BInhibitors%25253A%252BDiscovery%252Bof%252BMK-2748%252Band%252BMK-6325%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D4%26spage%3D727%26epage%3D735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nan  Yang</span>, <span class="hlFld-ContribAuthor ">Qiushi  Sun</span>, <span class="hlFld-ContribAuthor ">Zihua  Xu</span>, <span class="hlFld-ContribAuthor ">Xiuyun  Wang</span>, <span class="hlFld-ContribAuthor ">Xin  Zhao</span>, <span class="hlFld-ContribAuthor ">Yuqing  Cao</span>, <span class="hlFld-ContribAuthor ">Li  Chen</span>, <span class="hlFld-ContribAuthor ">Guorong  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">LC-ESI-MS/MS Analysis and Pharmacokinetics of GP205,  an Innovative Potent Macrocyclic Inhibitor of Hepatitis C Virus NS3/4A Protease in Rats. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (3)
                                     , 4319-4336. <a href="https://doi.org/10.3390/molecules20034319" title="DOI URL">https://doi.org/10.3390/molecules20034319</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules20034319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules20034319%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DLC-ESI-MS%25252FMS%252BAnalysis%252Band%252BPharmacokinetics%252Bof%252BGP205%25252C%252Ban%252BInnovative%252BPotent%252BMacrocyclic%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252Bin%252BRats%26aulast%3DYang%26aufirst%3DNan%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D3%26spage%3D4319%26epage%3D4336" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Norio  Hayashi</span>, <span class="hlFld-ContribAuthor ">Niloufar  Mobashery</span>, <span class="hlFld-ContribAuthor ">Namiki  Izumi</span>. </span><span class="cited-content_cbyCitation_article-title">Vaniprevir plus peginterferon alfa-2a and ribavirin in treatment-experienced Japanese patients with hepatitis C virus genotype 1 infection: a randomized phase II study. </span><span class="cited-content_cbyCitation_journal-name">Journal of Gastroenterology</span><span> <strong>2015,</strong> <em>50 </em>
                                    (2)
                                     , 238-248. <a href="https://doi.org/10.1007/s00535-014-0979-2" title="DOI URL">https://doi.org/10.1007/s00535-014-0979-2</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00535-014-0979-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00535-014-0979-2%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Gastroenterology%26atitle%3DVaniprevir%252Bplus%252Bpeginterferon%252Balfa-2a%252Band%252Bribavirin%252Bin%252Btreatment-experienced%252BJapanese%252Bpatients%252Bwith%252Bhepatitis%252BC%252Bvirus%252Bgenotype%252B1%252Binfection%25253A%252Ba%252Brandomized%252Bphase%252BII%252Bstudy%26aulast%3DHayashi%26aufirst%3DNorio%26date%3D2015%26date%3D2014%26volume%3D50%26issue%3D2%26spage%3D238%26epage%3D248" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dirk T. S.  Rijkers</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis of Cyclic Peptides and Peptidomimetics by Metathesis Reactions. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 191-244. <a href="https://doi.org/10.1007/7081_2015_142" title="DOI URL">https://doi.org/10.1007/7081_2015_142</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7081_2015_142&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7081_2015_142%26sid%3Dliteratum%253Aachs%26atitle%3DSynthesis%252Bof%252BCyclic%252BPeptides%252Band%252BPeptidomimetics%252Bby%252BMetathesis%252BReactions%26aulast%3DRijkers%26aufirst%3DDirk%2BT.%2BS.%26date%3D2015%26date%3D2015%26spage%3D191%26epage%3D244%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSynthesis%252Bof%252BHeterocycles%252Bby%252BMetathesis%252BReactions%26aulast%3DPrunet%26aufirst%3DJo%25C3%25ABlle%26date%3D2017%26volume%3D47" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tristan E.  Rose</span>, <span class="hlFld-ContribAuthor ">Kenneth V.  Lawson</span>, <span class="hlFld-ContribAuthor ">Patrick. G.  Harran</span>. </span><span class="cited-content_cbyCitation_article-title">Large ring-forming alkylations provide facile access to composite macrocycles. </span><span class="cited-content_cbyCitation_journal-name">Chemical Science</span><span> <strong>2015,</strong> <em>6 </em>
                                    (4)
                                     , 2219-2223. <a href="https://doi.org/10.1039/C4SC03848G" title="DOI URL">https://doi.org/10.1039/C4SC03848G</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4SC03848G&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4SC03848G%26sid%3Dliteratum%253Aachs%26jtitle%3DChemical%2520Science%26atitle%3DLarge%252Bring-forming%252Balkylations%252Bprovide%252Bfacile%252Baccess%252Bto%252Bcomposite%252Bmacrocycles%26aulast%3DRose%26aufirst%3DTristan%2BE.%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D4%26spage%3D2219%26epage%3D2223" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kiyoshi  Kinoshita</span>, <span class="hlFld-ContribAuthor ">Takashi  Iwasa</span>, <span class="hlFld-ContribAuthor ">Akiko  Takase</span>, <span class="hlFld-ContribAuthor ">Keisuke  Nakamura</span>. </span><span class="cited-content_cbyCitation_article-title">Preclinical and clinical properties of vaniprevir (VANIHEP® Capsules 150 mg), a novel therapeutic agent for hepatitis C. </span><span class="cited-content_cbyCitation_journal-name">Folia Pharmacologica Japonica</span><span> <strong>2015,</strong> <em>146 </em>
                                    (3)
                                     , 159-170. <a href="https://doi.org/10.1254/fpj.146.159" title="DOI URL">https://doi.org/10.1254/fpj.146.159</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1254/fpj.146.159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1254%2Ffpj.146.159%26sid%3Dliteratum%253Aachs%26jtitle%3DFolia%2520Pharmacologica%2520Japonica%26atitle%3DPreclinical%252Band%252Bclinical%252Bproperties%252Bof%252Bvaniprevir%252B%252528VANIHEP%2525C2%2525AE%252BCapsules%252B150%2525E2%252580%252585mg%252529%25252C%252Ba%252Bnovel%252Btherapeutic%252Bagent%252Bfor%252Bhepatitis%252BC%26aulast%3DKinoshita%26aufirst%3DKiyoshi%26date%3D2015%26volume%3D146%26issue%3D3%26spage%3D159%26epage%3D170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Anna  Lampa</span>, <span class="hlFld-ContribAuthor ">Hiba  Alogheli</span>, <span class="hlFld-ContribAuthor ">Angelica E.  Ehrenberg</span>, <span class="hlFld-ContribAuthor ">Eva  Åkerblom</span>, <span class="hlFld-ContribAuthor ">Richard  Svensson</span>, <span class="hlFld-ContribAuthor ">Per  Artursson</span>, <span class="hlFld-ContribAuthor ">U. Helena  Danielson</span>, <span class="hlFld-ContribAuthor ">Anders  Karlén</span>, <span class="hlFld-ContribAuthor ">Anja  Sandström</span>. </span><span class="cited-content_cbyCitation_article-title">Vinylated linear P2 pyrimidinyloxyphenylglycine based inhibitors of the HCV NS3/4A protease and corresponding macrocycles. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2014,</strong> <em>22 </em>
                                    (23)
                                     , 6595-6615. <a href="https://doi.org/10.1016/j.bmc.2014.10.010" title="DOI URL">https://doi.org/10.1016/j.bmc.2014.10.010</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2014.10.010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2014.10.010%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DVinylated%252Blinear%252BP2%252Bpyrimidinyloxyphenylglycine%252Bbased%252Binhibitors%252Bof%252Bthe%252BHCV%252BNS3%25252F4A%252Bprotease%252Band%252Bcorresponding%252Bmacrocycles%26aulast%3DLampa%26aufirst%3DAnna%26date%3D2014%26volume%3D22%26issue%3D23%26spage%3D6595%26epage%3D6615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Hill</span>, <span class="hlFld-ContribAuthor ">Nicholas E.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Frederik  Diness</span>, <span class="hlFld-ContribAuthor ">David P.  Fairlie</span>. </span><span class="cited-content_cbyCitation_article-title">Fixierung cyclischer Peptide: Mimetika von Proteinstrukturmotiven. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2014,</strong> <em>126 </em>
                                    (48)
                                     , 13234-13257. <a href="https://doi.org/10.1002/ange.201401058" title="DOI URL">https://doi.org/10.1002/ange.201401058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.201401058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.201401058%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DFixierung%252Bcyclischer%252BPeptide%25253A%252BMimetika%252Bvon%252BProteinstrukturmotiven%26aulast%3DHill%26aufirst%3DTimothy%2BA.%26date%3D2014%26date%3D2014%26volume%3D126%26issue%3D48%26spage%3D13234%26epage%3D13257" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Timothy A.  Hill</span>, <span class="hlFld-ContribAuthor ">Nicholas E.  Shepherd</span>, <span class="hlFld-ContribAuthor ">Frederik  Diness</span>, <span class="hlFld-ContribAuthor ">David P.  Fairlie</span>. </span><span class="cited-content_cbyCitation_article-title">Constraining Cyclic Peptides To Mimic Protein Structure Motifs. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2014,</strong> <em>53 </em>
                                    (48)
                                     , 13020-13041. <a href="https://doi.org/10.1002/anie.201401058" title="DOI URL">https://doi.org/10.1002/anie.201401058</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.201401058&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.201401058%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DConstraining%252BCyclic%252BPeptides%252BTo%252BMimic%252BProtein%252BStructure%252BMotifs%26aulast%3DHill%26aufirst%3DTimothy%2BA.%26date%3D2014%26date%3D2014%26volume%3D53%26issue%3D48%26spage%3D13020%26epage%3D13041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">S. Jack  Lin</span>, <span class="hlFld-ContribAuthor ">Ken C.  Dong</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Menno  van Lookeren Campagne</span>, <span class="hlFld-ContribAuthor ">Daniel  Kirchhofer</span>. </span><span class="cited-content_cbyCitation_article-title">Structures of Neutrophil Serine Protease 4 Reveal an Unusual Mechanism of Substrate Recognition by a Trypsin-Fold Protease. </span><span class="cited-content_cbyCitation_journal-name">Structure</span><span> <strong>2014,</strong> <em>22 </em>
                                    (9)
                                     , 1333-1340. <a href="https://doi.org/10.1016/j.str.2014.07.008" title="DOI URL">https://doi.org/10.1016/j.str.2014.07.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.str.2014.07.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.str.2014.07.008%26sid%3Dliteratum%253Aachs%26jtitle%3DStructure%26atitle%3DStructures%252Bof%252BNeutrophil%252BSerine%252BProtease%252B4%252BReveal%252Ban%252BUnusual%252BMechanism%252Bof%252BSubstrate%252BRecognition%252Bby%252Ba%252BTrypsin-Fold%252BProtease%26aulast%3DLin%26aufirst%3DS.%25C2%25A0Jack%26date%3D2014%26volume%3D22%26issue%3D9%26spage%3D1333%26epage%3D1340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manogna  Nookathota</span>, <span class="hlFld-ContribAuthor ">Sandeep  Mukherjee</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral therapy for chronic hepatitis C in 2014. </span><span class="cited-content_cbyCitation_journal-name">Expert Review of Clinical Pharmacology</span><span> <strong>2014,</strong> <em>7 </em>
                                    (4)
                                     , 499-505. <a href="https://doi.org/10.1586/17512433.2014.915737" title="DOI URL">https://doi.org/10.1586/17512433.2014.915737</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1586/17512433.2014.915737&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1586%2F17512433.2014.915737%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Review%2520of%2520Clinical%2520Pharmacology%26atitle%3DAntiviral%252Btherapy%252Bfor%252Bchronic%252Bhepatitis%252BC%252Bin%252B2014%26aulast%3DNookathota%26aufirst%3DManogna%26date%3D2014%26date%3D2014%26volume%3D7%26issue%3D4%26spage%3D499%26epage%3D505" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Shaihana  Abdulrahman Almatrrouk</span>, <span class="hlFld-ContribAuthor ">Anthony W  Oliver</span>, <span class="hlFld-ContribAuthor ">Lynne  Hampson</span>, <span class="hlFld-ContribAuthor ">Ian N  Hampson</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting gap junction intercellular communication as a potential therapy for HCV-related carcinogenesis. </span><span class="cited-content_cbyCitation_journal-name">Future Virology</span><span> <strong>2014,</strong> <em>9 </em>
                                    (7)
                                     , 679-692. <a href="https://doi.org/10.2217/fvl.14.50" title="DOI URL">https://doi.org/10.2217/fvl.14.50</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/fvl.14.50&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Ffvl.14.50%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Virology%26atitle%3DTargeting%252Bgap%252Bjunction%252Bintercellular%252Bcommunication%252Bas%252Ba%252Bpotential%252Btherapy%252Bfor%252BHCV-related%252Bcarcinogenesis%26aulast%3DAbdulrahman%2BAlmatrrouk%26aufirst%3DShaihana%26date%3D2014%26volume%3D9%26issue%3D7%26spage%3D679%26epage%3D692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jean–Michel  Pawlotsky</span>. </span><span class="cited-content_cbyCitation_article-title">New Hepatitis C Therapies: The Toolbox, Strategies, and Challenges. </span><span class="cited-content_cbyCitation_journal-name">Gastroenterology</span><span> <strong>2014,</strong> <em>146 </em>
                                    (5)
                                     , 1176-1192. <a href="https://doi.org/10.1053/j.gastro.2014.03.003" title="DOI URL">https://doi.org/10.1053/j.gastro.2014.03.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1053/j.gastro.2014.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1053%2Fj.gastro.2014.03.003%26sid%3Dliteratum%253Aachs%26jtitle%3DGastroenterology%26atitle%3DNew%252BHepatitis%252BC%252BTherapies%25253A%252BThe%252BToolbox%25252C%252BStrategies%25252C%252Band%252BChallenges%26aulast%3DPawlotsky%26aufirst%3DJean%25E2%2580%2593Michel%26date%3D2014%26volume%3D146%26issue%3D5%26spage%3D1176%26epage%3D1192" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xufen  Yu</span>, <span class="hlFld-ContribAuthor ">Dianqing  Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Macrocyclic Drugs and Synthetic Methodologies toward Macrocycles. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2013,</strong> <em>18 </em>
                                    (6)
                                     , 6230-6268. <a href="https://doi.org/10.3390/molecules18066230" title="DOI URL">https://doi.org/10.3390/molecules18066230</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules18066230&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules18066230%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DMacrocyclic%252BDrugs%252Band%252BSynthetic%252BMethodologies%252Btoward%252BMacrocycles%26aulast%3DYu%26aufirst%3DXufen%26date%3D2013%26date%3D2013%26volume%3D18%26issue%3D6%26spage%3D6230%26epage%3D6268" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nicholas A.  Meanwell</span>, <span class="hlFld-ContribAuthor ">Stanley V.  D'Andrea</span>, <span class="hlFld-ContribAuthor ">Christopher W.  Cianci</span>, <span class="hlFld-ContribAuthor ">Ira B.  Dicker</span>, <span class="hlFld-ContribAuthor ">Kap-Sun  Yeung</span>, <span class="hlFld-ContribAuthor ">Makonen  Belema</span>, <span class="hlFld-ContribAuthor ">Mark  Krystal</span>. </span><span class="cited-content_cbyCitation_article-title">Antiviral Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 439-515. <a href="https://doi.org/10.1002/9781118354483.ch11" title="DOI URL">https://doi.org/10.1002/9781118354483.ch11</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118354483.ch11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118354483.ch11%26sid%3Dliteratum%253Aachs%26atitle%3DAntiviral%252BDrug%252BDiscovery%26aulast%3DMeanwell%26aufirst%3DNicholas%2BA.%26date%3D2013%26date%3D2013%26spage%3D439%26epage%3D515%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DDrug%252BDiscovery%26aulast%3DLi%26aufirst%3DJie%2BJack%26date%3D2013%26volume%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vaishali M.  Patil</span>, <span class="hlFld-ContribAuthor ">Neeraj  Masand</span>, <span class="hlFld-ContribAuthor ">Satya Prakash  Gupta</span>. </span><span class="cited-content_cbyCitation_article-title">Role of Proteases in the Management of Hepatitis C Virus. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 335-360. <a href="https://doi.org/10.1007/978-1-4614-9233-7_20" title="DOI URL">https://doi.org/10.1007/978-1-4614-9233-7_20</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/978-1-4614-9233-7_20&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F978-1-4614-9233-7_20%26sid%3Dliteratum%253Aachs%26atitle%3DRole%252Bof%252BProteases%252Bin%252Bthe%252BManagement%252Bof%252BHepatitis%252BC%252BVirus%26aulast%3DPatil%26aufirst%3DVaishali%2BM.%26date%3D2013%26date%3D2013%26spage%3D335%26epage%3D360%26pub%3DSpringer%2520New%2520York%26atitle%3DProteases%252Bin%252BHealth%252Band%252BDisease%26aulast%3DChakraborti%26aufirst%3DSajal%26date%3D2013%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christian  Steinkühler</span>. </span><span class="cited-content_cbyCitation_article-title">Hepacivirin. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 3120-3130. <a href="https://doi.org/10.1016/B978-0-12-382219-2.00688-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-382219-2.00688-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-382219-2.00688-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-382219-2.00688-8%26sid%3Dliteratum%253Aachs%26atitle%3DHepacivirin%26aulast%3DSteink%25C3%25BChler%26aufirst%3DChristian%26date%3D2013%26spage%3D3120%26epage%3D3130%26pub%3DElsevier%26atitle%3DHandbook%252Bof%252BProteolytic%252BEnzymes%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandrine  Vendeville</span>, <span class="hlFld-ContribAuthor ">Maxwell D.  Cummings</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic Macrocycles in Small-Molecule Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 371-386. <a href="https://doi.org/10.1016/B978-0-12-417150-3.00023-5" title="DOI URL">https://doi.org/10.1016/B978-0-12-417150-3.00023-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-417150-3.00023-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-417150-3.00023-5%26sid%3Dliteratum%253Aachs%26atitle%3DSynthetic%252BMacrocycles%252Bin%252BSmall-Molecule%252BDrug%252BDiscovery%26aulast%3DVendeville%26aufirst%3DSandrine%26date%3D2013%26spage%3D371%26epage%3D386%26pub%3DElsevier%26date%3D2013%26volume%3D48" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">Kimberly  Bush</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Terry A.  Lyle</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Bang-Lin  Wan</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Adam  Gates</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Stephanie  McClain</span>, <span class="hlFld-ContribAuthor ">Carolyn  McHale</span>, <span class="hlFld-ContribAuthor ">Mark  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Christine  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Anne  Taylor</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>. </span><span class="cited-content_cbyCitation_article-title">Development of potent macrocyclic inhibitors of genotype 3a HCV NS3/4A protease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (23)
                                     , 7201-7206. <a href="https://doi.org/10.1016/j.bmcl.2012.08.106" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.08.106</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.08.106&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.08.106%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bpotent%252Bmacrocyclic%252Binhibitors%252Bof%252Bgenotype%252B3a%252BHCV%252BNS3%25252F4A%252Bprotease%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2012%26volume%3D22%26issue%3D23%26spage%3D7201%26epage%3D7206" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">Charles J.  McIntyre</span>, <span class="hlFld-ContribAuthor ">Joseph J.  Romano</span>, <span class="hlFld-ContribAuthor ">John W.  Butcher</span>, <span class="hlFld-ContribAuthor ">M. Katharine  Holloway</span>, <span class="hlFld-ContribAuthor ">Kimberly  Bush</span>, <span class="hlFld-ContribAuthor ">Kevin T.  Nguyen</span>, <span class="hlFld-ContribAuthor ">Kevin F.  Gilbert</span>, <span class="hlFld-ContribAuthor ">Terry A.  Lyle</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>, <span class="hlFld-ContribAuthor ">Bang-Lin  Wan</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Adam  Gates</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Qian  Huang</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">Stephanie  McClain</span>, <span class="hlFld-ContribAuthor ">Carolyn  McHale</span>, <span class="hlFld-ContribAuthor ">Mark  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Christine  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Anne  Taylor</span>, <span class="hlFld-ContribAuthor ">Nicole  Trainor</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>. </span><span class="cited-content_cbyCitation_article-title">Development of macrocyclic inhibitors of HCV NS3/4A protease with cyclic constrained P2–P4 linkers. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (23)
                                     , 7207-7213. <a href="https://doi.org/10.1016/j.bmcl.2012.09.061" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.09.061</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.09.061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.09.061%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDevelopment%252Bof%252Bmacrocyclic%252Binhibitors%252Bof%252BHCV%252BNS3%25252F4A%252Bprotease%252Bwith%252Bcyclic%252Bconstrained%252BP2%2525E2%252580%252593P4%252Blinkers%26aulast%3DRudd%26aufirst%3DMichael%2BT.%26date%3D2012%26volume%3D22%26issue%3D23%26spage%3D7207%26epage%3D7213" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xianfeng  Li</span>, <span class="hlFld-ContribAuthor ">Yang  Liu</span>, <span class="hlFld-ContribAuthor ">Yong-Kang  Zhang</span>, <span class="hlFld-ContribAuthor ">Jacob J.  Plattner</span>, <span class="hlFld-ContribAuthor ">Stephen J.  Baker</span>, <span class="hlFld-ContribAuthor ">Wei  Bu</span>, <span class="hlFld-ContribAuthor ">Liang  Liu</span>, <span class="hlFld-ContribAuthor ">Yasheen  Zhou</span>, <span class="hlFld-ContribAuthor ">Charles Z.  Ding</span>, <span class="hlFld-ContribAuthor ">Suoming  Zhang</span>, <span class="hlFld-ContribAuthor ">Wieslaw M.  Kazmierski</span>, <span class="hlFld-ContribAuthor ">Robert  Hamatake</span>, <span class="hlFld-ContribAuthor ">Maosheng  Duan</span>, <span class="hlFld-ContribAuthor ">Lois L.  Wright</span>, <span class="hlFld-ContribAuthor ">Gary K.  Smith</span>, <span class="hlFld-ContribAuthor ">Richard L.  Jarvest</span>, <span class="hlFld-ContribAuthor ">Jing-Jing  Ji</span>, <span class="hlFld-ContribAuthor ">Joel P.  Cooper</span>, <span class="hlFld-ContribAuthor ">Matthew D.  Tallant</span>, <span class="hlFld-ContribAuthor ">Renae M.  Crosby</span>, <span class="hlFld-ContribAuthor ">Katrina  Creech</span>, <span class="hlFld-ContribAuthor ">Amy  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and antiviral activity of novel HCV NS3 protease inhibitors with P4 capping groups. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2012,</strong> <em>22 </em>
                                    (24)
                                     , 7351-7356. <a href="https://doi.org/10.1016/j.bmcl.2012.10.075" title="DOI URL">https://doi.org/10.1016/j.bmcl.2012.10.075</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2012.10.075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2012.10.075%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bantiviral%252Bactivity%252Bof%252Bnovel%252BHCV%252BNS3%252Bprotease%252Binhibitors%252Bwith%252BP4%252Bcapping%252Bgroups%26aulast%3DLi%26aufirst%3DXianfeng%26date%3D2012%26volume%3D22%26issue%3D24%26spage%3D7351%26epage%3D7356" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Erik  De Clercq</span>. </span><span class="cited-content_cbyCitation_article-title">The race for interferon-free HCV therapies: a snapshot by the spring of 2012. </span><span class="cited-content_cbyCitation_journal-name">Reviews in Medical Virology</span><span> <strong>2012,</strong> <em>22 </em>
                                    (6)
                                     , 392-411. <a href="https://doi.org/10.1002/rmv.1727" title="DOI URL">https://doi.org/10.1002/rmv.1727</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/rmv.1727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Frmv.1727%26sid%3Dliteratum%253Aachs%26jtitle%3DReviews%2520in%2520Medical%2520Virology%26atitle%3DThe%252Brace%252Bfor%252Binterferon-free%252BHCV%252Btherapies%25253A%252Ba%252Bsnapshot%252Bby%252Bthe%252Bspring%252Bof%252B2012%26aulast%3DDe%2BClercq%26aufirst%3DErik%26date%3D2012%26date%3D2012%26volume%3D22%26issue%3D6%26spage%3D392%26epage%3D411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vincenzo  Summa</span>, <span class="hlFld-ContribAuthor ">Steven W.  Ludmerer</span>, <span class="hlFld-ContribAuthor ">John A.  McCauley</span>, <span class="hlFld-ContribAuthor ">Christine  Fandozzi</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Giuliano  Claudio</span>, <span class="hlFld-ContribAuthor ">Paul J.  Coleman</span>, <span class="hlFld-ContribAuthor ">Jillian M.  DiMuzio</span>, <span class="hlFld-ContribAuthor ">Marco  Ferrara</span>, <span class="hlFld-ContribAuthor ">Marcello  Di Filippo</span>, <span class="hlFld-ContribAuthor ">Adam T.  Gates</span>, <span class="hlFld-ContribAuthor ">Donald J.  Graham</span>, <span class="hlFld-ContribAuthor ">Steven  Harper</span>, <span class="hlFld-ContribAuthor ">Daria J.  Hazuda</span>, <span class="hlFld-ContribAuthor ">Carolyn  McHale</span>, <span class="hlFld-ContribAuthor ">Edith  Monteagudo</span>, <span class="hlFld-ContribAuthor ">Vincenzo  Pucci</span>, <span class="hlFld-ContribAuthor ">Michael  Rowley</span>, <span class="hlFld-ContribAuthor ">Michael T.  Rudd</span>, <span class="hlFld-ContribAuthor ">Aileen  Soriano</span>, <span class="hlFld-ContribAuthor ">Mark W.  Stahlhut</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Vacca</span>, <span class="hlFld-ContribAuthor ">David B.  Olsen</span>, <span class="hlFld-ContribAuthor ">Nigel J.  Liverton</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>. </span><span class="cited-content_cbyCitation_article-title">MK-5172, a Selective Inhibitor of Hepatitis C Virus NS3/4a Protease with Broad Activity across Genotypes and Resistant Variants. </span><span class="cited-content_cbyCitation_journal-name">Antimicrobial Agents and Chemotherapy</span><span> <strong>2012,</strong> <em>56 </em>
                                    (8)
                                     , 4161-4167. <a href="https://doi.org/10.1128/AAC.00324-12" title="DOI URL">https://doi.org/10.1128/AAC.00324-12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1128/AAC.00324-12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1128%2FAAC.00324-12%26sid%3Dliteratum%253Aachs%26jtitle%3DAntimicrobial%2520Agents%2520and%2520Chemotherapy%26atitle%3DMK-5172%25252C%252Ba%252BSelective%252BInhibitor%252Bof%252BHepatitis%252BC%252BVirus%252BNS3%25252F4a%252BProtease%252Bwith%252BBroad%252BActivity%252Bacross%252BGenotypes%252Band%252BResistant%252BVariants%26aulast%3DSumma%26aufirst%3DVincenzo%26date%3D2012%26date%3D2012%26volume%3D56%26issue%3D8%26spage%3D4161%26epage%3D4167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Keith P.  Romano</span>, <span class="hlFld-ContribAuthor ">Akbar  Ali</span>, <span class="hlFld-ContribAuthor ">Cihan  Aydin</span>, <span class="hlFld-ContribAuthor ">Djade  Soumana</span>, <span class="hlFld-ContribAuthor ">Ayşegül  Özen</span>, <span class="hlFld-ContribAuthor ">Laura M.  Deveau</span>, <span class="hlFld-ContribAuthor ">Casey  Silver</span>, <span class="hlFld-ContribAuthor ">Hong  Cao</span>, <span class="hlFld-ContribAuthor ">Alicia  Newton</span>, <span class="hlFld-ContribAuthor ">Christos J.  Petropoulos</span>, <span class="hlFld-ContribAuthor ">Wei  Huang</span>, <span class="hlFld-ContribAuthor ">Celia A.  Schiffer</span>, . </span><span class="cited-content_cbyCitation_article-title">The Molecular Basis of Drug Resistance against Hepatitis C Virus NS3/4A Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">PLoS Pathogens</span><span> <strong>2012,</strong> <em>8 </em>
                                    (7)
                                     , e1002832. <a href="https://doi.org/10.1371/journal.ppat.1002832" title="DOI URL">https://doi.org/10.1371/journal.ppat.1002832</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1371/journal.ppat.1002832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1371%2Fjournal.ppat.1002832%26sid%3Dliteratum%253Aachs%26jtitle%3DPLoS%2520Pathogens%26atitle%3DThe%252BMolecular%252BBasis%252Bof%252BDrug%252BResistance%252Bagainst%252BHepatitis%252BC%252BVirus%252BNS3%25252F4A%252BProtease%252BInhibitors%26aulast%3DRomano%26aufirst%3DKeith%2BP.%26date%3D2012%26date%3D2012%26volume%3D8%26issue%3D7%26spage%3De1002832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kevin X.  Chen</span>, <span class="hlFld-ContribAuthor ">F. George  Njoroge</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Boceprevir and Narlaprevir: The First and Second Generation of HCV NS3 Protease Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2012,</strong>,, 296-335. <a href="https://doi.org/10.1002/9781118219683.ch12" title="DOI URL">https://doi.org/10.1002/9781118219683.ch12</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118219683.ch12&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118219683.ch12%26sid%3Dliteratum%253Aachs%26atitle%3DDiscovery%252Bof%252BBoceprevir%252Band%252BNarlaprevir%25253A%252BThe%252BFirst%252Band%252BSecond%252BGeneration%252Bof%252BHCV%252BNS3%252BProtease%252BInhibitors%26aulast%3DChen%26aufirst%3DKevin%2BX.%26date%3D2012%26date%3D2012%26spage%3D296%26epage%3D335%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DCase%252BStudies%252Bin%252BModern%252BDrug%252BDiscovery%252Band%252BDevelopment%26aulast%3DHuang%26aufirst%3DXianhai%26date%3D2012%26volume%3D345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div><a href="#" data-source="/pb/widgets/cited-by?doi=10.1021%2Fjm9015526&amp;widgetId=9cf770f4-a9a2-46e0-bd29-3da15bcf4ae0&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3Barticle%3Aarticle%3A10.1021%2Fjm9015526%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text&amp;citedByCount=121&amp;pagesCount=2&amp;pageNumber=-1" title="Load all citations" class="button_primary float-right cited-by__see-more mb-5"><i aria-hidden="”true”" class="icon-angle-double-down"></i><span>Load all citations</span></a></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0010.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HCV NS3/4a protease inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. P2 substituents employed in representative HCV NS3/4a protease inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11</b>, carbonyldiimidazole, DMF; <b>10a</b>−<b>c</b>, DIPEA, 50 °C; (b) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C; (c) HCl, dioxane; (d) <b>13</b>, HATU, DIPEA, DMAP, DMF; (e) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼3 mM, 70 °C; (f) LiOH, THF, MeOH, H<sub>2</sub>O; (g) <b>16</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><figure data-id="sch2" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>11</b>, carbonyldiimidazole, DMF; <b>18a</b>, DIPEA, 50 °C; (b) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 75%; (c) HBr/H<sub>2</sub>O, 120 °C, 81%; (d) carbonyldiimidazole, DMF; <b>18c</b>, DIPEA, 50 °C, 69%; (e) Tf<sub>2</sub>O, TEA, CH<sub>2</sub>Cl<sub>2</sub>, 69%; (f) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, LiCl, toluene, 25 °C, 74%; (g) HCl, dioxane; (h) <b>13</b>, HATU, DIPEA, DMAP, DMF; (i) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼3 mM, 70 °C; (j) LiOH, THF, MeOH, H<sub>2</sub>O; (k) <b>16</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><figure data-id="sch3" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) NBS, benzoyl peroxide, CCl<sub>4</sub>, reflux, 92%; (b) K<sub>2</sub>CO<sub>3</sub>, benzylamine, MeCN, 77 °C, 50%; (c) Bu<sub>3</sub>SnCH═CH<sub>2</sub>, Pd(PPh<sub>3</sub>)<sub>4</sub>, toluene, 100 °C, 83%; (d) 1-chloroethyl chloroformate, DCE, reflux; MeOH, reflux, 86%; (e) <b>11</b>, carbonyldiimidazole, DMF; <b>24</b>, 60 °C, 81%; (f) HCl, dioxane, 90%; (g) <b>13</b>, <b>26b</b>−<b>i</b>, HATU, DIPEA, DMF; (h) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> DCE, ∼5 mM, 75 °C; (i) LiOH, THF, MeOH, H<sub>2</sub>O; (j) <b>16</b>, HATU, DIPEA, DMF.</p></p></figure><figure data-id="sch4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 4. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) H<sub>2</sub>, 10% Pd/C, EtOAc; (b) LiOH·H<sub>2</sub>O, THF, MeOH, H<sub>2</sub>O; (c) <b>16</b>, HATU, DIPEA, DMAP, DMF; (d) <b>30</b>, HATU, DIPEA, DMAP, DMF.</p></p></figure><figure data-id="sch5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 5. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/large/jm-2009-015526_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm9015526&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (a) <b>26h</b>, <b>32b</b>−<b>i</b>, HATU, DIPEA, DMF; (b) Zhan 1b catalyst,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> CH<sub>2</sub>Cl<sub>2</sub>, ∼3 mM; (c) H<sub>2</sub>, 10% Pd/C, EtOH, EtOAc; (d) LiOH·H<sub>2</sub>O, THF, MeOH, H<sub>2</sub>O; (e) <b>30</b>, HATU, DIPEA, DMAP, CH<sub>2</sub>Cl<sub>2</sub>.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i109">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_44877" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_44877" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 36 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span> </span><span class="NLM_article-title">Hepatitis C—global prevalence (update)</span>.  <span class="citation_source-journal">WHO Wkly. Epidemiol. Rec.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">425</span>− <span class="NLM_lpage">427</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=10645164" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Hepatitis+C%E2%80%94global+prevalence+%28update%29.+WHO+Wkly.+Epidemiol.+Rec.%2C+1999%2C+74%2C+425%E2%88%92427."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26atitle%3DHepatitis%2520C%25E2%2580%2594global%2520prevalence%2520%2528update%2529%26jtitle%3DWHO%2520Wkly.%2520Epidemiol.%2520Rec.%26date%3D1999%26volume%3D74%26spage%3D425%26epage%3D427" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Liang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heller, T.</span><span> </span><span class="NLM_article-title">Pathogenesis of hepatitis C−associated hepatocellular carcinoma</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">127</span><span class="NLM_x">, </span> <span class="NLM_fpage">S62</span><span class="NLM_x">–</span> <span class="NLM_lpage">S71</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2004&pages=S62-S71&author=T.+J.+Liangauthor=T.+Heller&title=Pathogenesis+of+hepatitis+C%E2%88%92associated+hepatocellular+carcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiang%26aufirst%3DT.%2BJ.%26aulast%3DHeller%26aufirst%3DT.%26atitle%3DPathogenesis%2520of%2520hepatitis%2520C%25E2%2588%2592associated%2520hepatocellular%2520carcinoma%26jtitle%3DGastroenterology%26date%3D2004%26volume%3D127%26spage%3DS62%26epage%3DS71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Salmon-Ceron, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lewden, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morlat, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bévilacqua, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jougla, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonnet, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Héripret, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Costagliola, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">May, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chêne, G.</span><span> </span><span class="NLM_article-title">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span> <span class="citation_source-journal">J. Hepatol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">799</span><span class="NLM_x">–</span> <span class="NLM_lpage">805</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.jhep.2005.01.022" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=15973779" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2005&pages=799-805&author=D.+Salmon-Ceronauthor=C.+Lewdenauthor=P.+Morlatauthor=S.+B%C3%A9vilacquaauthor=E.+Jouglaauthor=F.+Bonnetauthor=L.+H%C3%A9ripretauthor=D.+Costagliolaauthor=T.+Mayauthor=G.+Ch%C3%AAne&title=Liver+disease+as+a+major+cause+of+death+among+HIV+infected+patients%3A+role+of+hepatitis+C+and+B+viruses+and+alcohol"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol</span></div><div class="casAuthors">Salmon-Ceron, Dominique; Lewden, Charlotte; Morlat, Philippe; Bevilacqua, Sibylle; Jougla, Eric; Bonnet, Fabrice; Heripret, Laurence; Costagliola, Dominique; May, Thierry; Chene, Genevieve</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Hepatology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">799-805</span>CODEN:
                <span class="NLM_cas:coden">JOHEEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-8278</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">We analyzed the characteristics of HIV-infected patients who died from liver disease, focusing on hepatitis virus co-infection.  One-hundred and eighty-five French hospital departments involved in HIV/AIDS management prospectively notified all deaths occurring in 2000.  Patients whose hepatitis C (HCV) and hepatitis B (HBV) serostatus was known were classified as being infected by HCV alone, HBV alone (HBsAg pos.), both HCV and HBV, or neither HCV nor HBV.  Among 822 HIV infected patients, 29% were infected by HCV alone, 8% by HBV alone, and 4% by both HCV and HBV.  The most frequent causes of death were liver disease (31% of cases) and AIDS (29%) among HIV-HCV co-infected patients, and AIDS (38%) and liver disease (22%) among HIV-HBV co-infected patients.  Liver disease was a more frequent cause of death among patients co-infected by both HCV and HBV (44% of cases).  Hepatocellular carcinoma was present in 15% of patients who died from liver disease, and was assocd. with HBV co-infection.  Nearly half the patients who died from liver disease had more than 200 CD4/mm3.  Liver disease is now a leading cause of death among HIV-HCV co-infected patients and is becoming an important cause of death among HIV-HBV co-infected patients.  The risk of death from liver disease is highest in patients co-infected by both HCV and HBV.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqxiRIxXPw237Vg90H21EOLACvtfcHk0liWDjEZztdr0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktVGmtrk%253D&md5=dcedbbba9e185f1783e680b6da3fa4ce</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2Fj.jhep.2005.01.022&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jhep.2005.01.022%26sid%3Dliteratum%253Aachs%26aulast%3DSalmon-Ceron%26aufirst%3DD.%26aulast%3DLewden%26aufirst%3DC.%26aulast%3DMorlat%26aufirst%3DP.%26aulast%3DB%25C3%25A9vilacqua%26aufirst%3DS.%26aulast%3DJougla%26aufirst%3DE.%26aulast%3DBonnet%26aufirst%3DF.%26aulast%3DH%25C3%25A9ripret%26aufirst%3DL.%26aulast%3DCostagliola%26aufirst%3DD.%26aulast%3DMay%26aufirst%3DT.%26aulast%3DCh%25C3%25AAne%26aufirst%3DG.%26atitle%3DLiver%2520disease%2520as%2520a%2520major%2520cause%2520of%2520death%2520among%2520HIV%2520infected%2520patients%253A%2520role%2520of%2520hepatitis%2520C%2520and%2520B%2520viruses%2520and%2520alcohol%26jtitle%3DJ.%2520Hepatol.%26date%3D2005%26volume%3D42%26spage%3D799%26epage%3D805" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Brown, R. S.</span><span> </span><span class="NLM_article-title">Hepatitis C and liver transplantation</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">436</span><span class="NLM_x">, </span> <span class="NLM_fpage">973</span><span class="NLM_x">–</span> <span class="NLM_lpage">978</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=436&publication_year=2005&pages=973-978&author=R.+S.+Brown&title=Hepatitis+C+and+liver+transplantation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBrown%26aufirst%3DR.%2BS.%26atitle%3DHepatitis%2520C%2520and%2520liver%2520transplantation%26jtitle%3DNature%26date%3D2005%26volume%3D436%26spage%3D973%26epage%3D978" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Hadziyannis, S. J.; Sette, H.; Morgan, T. R.; Balan, V.; Diago, M.; Marcellin, P.</span><span class="NLM_contrib-group">PEGASYS International Study Group</span><span class="NLM_contrib-group"></span><span class="NLM_etal"></span><span> </span><span class="NLM_article-title">Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose</span>.  <span class="citation_source-journal">Ann. Intern. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">140</span><span class="NLM_x">, </span> <span class="NLM_fpage">346</span>− <span class="NLM_lpage">355</span>.</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.7326%2F0003-4819-140-5-200403020-00010" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=14996676" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=140&publication_year=2004&pages=346-355&author=S.+J.+Hadziyannis&author=H.+Sette&author=T.+R.+Morgan&author=V.+Balan&author=M.+Diago&author=P.+Marcellinauthor=PEGASYS+International+Study+Group&title=Peginterferon-alpha2a+and+ribavirin+combination+therapy+in+chronic+hepatitis+C%3A+a+randomized+study+of+treatment+duration+and+ribavirin+dose"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5aR"><div class="casContent"><span class="casTitleNuber">5a</span><div class="casTitle"><span class="NLM_cas:atitle">Peginterferon-α2a and ribavirin combination therapy in chronic hepatitis C: A randomized study of treatment duration and ribavirin dose</span></div><div class="casAuthors">Hadziyannis, Stephanos J.; Sette, Hoel, Jr.; Morgan, Timothy R.; Balan, Vijayan; Diago, Moises; Marcellin, Patrick; Ramadori, Giuliano; Bodenheimer, Henry, Jr.; Bernstein, David; Rizzetto, Mario; Zeuzem, Stefan; Pockros, Paul J.; Lin, Amy; Ackrill, Andrew M.</div><div class="citationInfo"><span class="NLM_cas:title">Annals of Internal Medicine</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">140</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">346-355</span>CODEN:
                <span class="NLM_cas:coden">AIMEAS</span>;
        ISSN:<span class="NLM_cas:issn">0003-4819</span>.
    
            (<span class="NLM_cas:orgname">American College of Physicians-American Society of Internal Medicine</span>)
        </div><div class="casAbstract">Treatment with pegylated interferon (peginterferon) and ribavirin for 48 wk is more effective than conventional interferon and ribavirin in patients with chronic hepatitis C.  Objective: To assess the efficacy and safety of 24 or 48 wk of treatment with peginterferon-α2a plus a low or std. dose of ribavirin.  Design: Randomized, double-blind trial.  Setting: 99 international centers.  Patients: 1311 patients with chronic hepatitis C.  Intervention: Peginterferon-α2a, 180 μg/wk, for 24 or 48 wk plus a low-dose (800 mg/d) or std. wt.-based dose (1000 or 1200 mg/d) of ribavirin.  Measurement: Sustained virol. response: undetectable HCV RNA concn. at the end of treatment and during 12 to 24 wk of follow-up.  Results: Overall and in patients infected with HCV genotype 1, 48 wk of treatment was statistically superior to 24 wk and std.-dose ribavirin was statistically superior to low-dose ribavirin.  In patients with HCV genotype 1, abs. differences in sustained virol. response rates between 48 and 24 wk of treatment were 11.2% (95% CI, 3.6% to 18.9%) and 11.9% (CI, 4.7% to 18.9%), resp., between std.- and low-dose ribavirin.  Sustained virol. response rates for peginterferon-α2a and std.-dose ribavirin for 48 wk were 63% (CI, 59% to 68%) overall and 52% (CI, 46% to 58%) in patients with HCV genotype 1.  In patients with HCV genotypes 2 or 3, the sustained virol. response rates in the 4 treatment groups were not statistically significantly different.  Conclusion: Treatment with peginterferon-α2a and ribavirin may be individualized by genotype.  Patients with HCV genotype 1 require treatment for 48 wk and a std. dose of ribavirin; those with HCV genotypes 2 or 3 seem to be adequately treated with a low dose of ribavirin for 24 wk.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDnDyBicuGj7Vg90H21EOLACvtfcHk0lgrgwhnSxoD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXitlOktrg%253D&md5=0e5ff18b054a10ab2051ba6c094626d0</span></div><a href="/servlet/linkout?suffix=cit5a&amp;dbid=16384&amp;doi=10.7326%2F0003-4819-140-5-200403020-00010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7326%252F0003-4819-140-5-200403020-00010%26sid%3Dliteratum%253Aachs%26aulast%3DHadziyannis%26aufirst%3DS.%2BJ.%26aulast%3D%26aulast%3D%26atitle%3DPeginterferon-alpha2a%2520and%2520ribavirin%2520combination%2520therapy%2520in%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520study%2520of%2520treatment%2520duration%2520and%2520ribavirin%2520dose%26jtitle%3DAnn.%2520Intern.%2520Med.%26date%3D2004%26volume%3D140%26spage%3D346%26epage%3D355" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Manns, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rustgi, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reindollar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koury, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial</span> <span class="citation_source-journal">Lancet</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">358</span><span class="NLM_x">, </span> <span class="NLM_fpage">958</span><span class="NLM_x">–</span> <span class="NLM_lpage">965</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=358&publication_year=2001&pages=958-965&author=M.+P.+Mannsauthor=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=V.+K.+Rustgiauthor=M.+Shiffmanauthor=R.+Reindollarauthor=Z.+D.+Goodmanauthor=K.+Kouryauthor=M.+Lingauthor=J.+K.+Albrecht&title=Peginterferon+alfa-2b+plus+ribavirin+compared+with+interferon+alfa-2b+plus+ribavirin+for+initial+treatment+of+chronic+hepatitis+C%3A+a+randomized+trial"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DRustgi%26aufirst%3DV.%2BK.%26aulast%3DShiffman%26aufirst%3DM.%26aulast%3DReindollar%26aufirst%3DR.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DKoury%26aufirst%3DK.%26aulast%3DLing%26aufirst%3DM.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DPeginterferon%2520alfa-2b%2520plus%2520ribavirin%2520compared%2520with%2520interferon%2520alfa-2b%2520plus%2520ribavirin%2520for%2520initial%2520treatment%2520of%2520chronic%2520hepatitis%2520C%253A%2520a%2520randomized%2520trial%26jtitle%3DLancet%26date%3D2001%26volume%3D358%26spage%3D958%26epage%3D965" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit5c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">McHutchison, J. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gordon, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schiff, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shiffman, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rusti, V. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goodman, Z. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ling, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cort, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Albrecht, J. K.</span><span> </span><span class="NLM_article-title">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">1485</span><span class="NLM_x">–</span> <span class="NLM_lpage">1492</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1056%2FNEJM199811193392101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=9819446" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5c&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1998&pages=1485-1492&author=J.+G.+McHutchisonauthor=S.+C.+Gordonauthor=E.+R.+Schiffauthor=M.+L.+Shiffmanauthor=W.+M.+Leeauthor=V.+K.+Rustiauthor=Z.+D.+Goodmanauthor=M.+H.+Lingauthor=S.+Cortauthor=J.+K.+Albrecht&title=Interferon+alfa-2b+alone+or+in+combination+with+ribavirin+as+initial+treatment+for+chronic+hepatitis+C"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5cR"><div class="casContent"><span class="casTitleNuber">5c</span><div class="casTitle"><span class="NLM_cas:atitle">Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C</span></div><div class="casAuthors">Mchutchison, John G.; Gordon, Stuart C.; Schiff, Eugene R.; Shiffman, Mitchell L.; Lee, William M.; Rustgi, Vinod K.; Goodman, Zachary D.; Ling, Mei-Hsiu; Cort, Susannah; Albrecht, Janice K.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">1998</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">1485-1492</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Only 15 to 20 percent of patients with chronic hepatitis C have a sustained virol. response to interferon therapy.  We compared the efficacy and safety of recombinant interferon alfa-2b alone with those of a combination of interferon alfa-2b and ribavirin for the initial treatment of patients with chronic hepatitis C.  We randomly assigned 912 patients with chronic hepatitis C to receive std.-dose interferon alfa-2b alone or in combination with ribavirin (1000 or 1200 mg orally per day, depending on body wt.) for 24 or 48 wk.  Efficacy was assessed by measurements of serum hepatitis C virus (HCV) RNA and serum aminotransferases and by liver biopsy.  The rate of sustained virol. response (defined as an undetectable serum HCV RNA level 24 wk after treatment was completed) was higher among patients who received combination therapy for either 24 wk (70 of 228 patients, 31 percent) or 48 wk (87 of 228 patients, 38 percent) than among patients who received interferon alone for either 24 wk (13 of 231 patients, 6 percent) or 48 wk (29 of 225 patients, 13 percent) (P<0.001 for the comparison of interferon alone with both 24 wk and 48 wk of combination treatment).  Among patients with HCV genotype 1 infection, the best response occurred in those who were treated for 48 wk with interferon and ribavirin.  Histol. improvement was more common in patients who were treated with combination therapy for either 24 wk (57 percent) or 48 wk (61 percent) than in those who were treated with interferon alone for either 24 wk (44 percent) or 48 wk (41 percent).  The drug doses had to be reduced and treatment discontinued more often in patients who were treated with combination therapy.  In patients with chronic hepatitis C, initial therapy with interferon and ribavirin was more effective than treatment with interferon alone.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9oxTyHQud7LVg90H21EOLACvtfcHk0lgrgwhnSxoD2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1cXnslGmtbs%253D&md5=41f8d301b8b7eddddda610cb71755cb2</span></div><a href="/servlet/linkout?suffix=cit5c&amp;dbid=16384&amp;doi=10.1056%2FNEJM199811193392101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJM199811193392101%26sid%3Dliteratum%253Aachs%26aulast%3DMcHutchison%26aufirst%3DJ.%2BG.%26aulast%3DGordon%26aufirst%3DS.%2BC.%26aulast%3DSchiff%26aufirst%3DE.%2BR.%26aulast%3DShiffman%26aufirst%3DM.%2BL.%26aulast%3DLee%26aufirst%3DW.%2BM.%26aulast%3DRusti%26aufirst%3DV.%2BK.%26aulast%3DGoodman%26aufirst%3DZ.%2BD.%26aulast%3DLing%26aufirst%3DM.%2BH.%26aulast%3DCort%26aufirst%3DS.%26aulast%3DAlbrecht%26aufirst%3DJ.%2BK.%26atitle%3DInterferon%2520alfa-2b%2520alone%2520or%2520in%2520combination%2520with%2520ribavirin%2520as%2520initial%2520treatment%2520for%2520chronic%2520hepatitis%2520C%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D1998%26volume%3D339%26spage%3D1485%26epage%3D1492" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group">Fried, M. W.</span><span> </span><span class="NLM_article-title">Side effects of therapy of hepatitis C and their management</span> <span class="citation_source-journal">Hepatology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">S237</span><span class="NLM_x">–</span> <span class="NLM_lpage">244</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2002&pages=S237-244&author=M.+W.+Fried&title=Side+effects+of+therapy+of+hepatitis+C+and+their+management"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFried%26aufirst%3DM.%2BW.%26atitle%3DSide%2520effects%2520of%2520therapy%2520of%2520hepatitis%2520C%2520and%2520their%2520management%26jtitle%3DHepatology%26date%3D2002%26volume%3D36%26spage%3DS237%26epage%3D244" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Gordon, C. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Keller, P. A.</span><span> </span><span class="NLM_article-title">Control of hepatitis C: a medicinal chemistry perspective</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">20</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0400101" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=1-20&author=C.+P.+Gordonauthor=P.+A.+Keller&title=Control+of+hepatitis+C%3A+a+medicinal+chemistry+perspective"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm0400101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0400101%26sid%3Dliteratum%253Aachs%26aulast%3DGordon%26aufirst%3DC.%2BP.%26aulast%3DKeller%26aufirst%3DP.%2BA.%26atitle%3DControl%2520of%2520hepatitis%2520C%253A%2520a%2520medicinal%2520chemistry%2520perspective%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D1%26epage%3D20" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">For recent reviews see:</p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Chen, K. X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">A review of HCV protease inhibitors</span> <span class="citation_source-journal">Curr. Opin. Invest. Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">821</span><span class="NLM_x">–</span> <span class="NLM_lpage">837</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2009&pages=821-837&author=K.+X.+Chenauthor=F.+G.+Njoroge&title=A+review+of+HCV+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DK.%2BX.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DA%2520review%2520of%2520HCV%2520protease%2520inhibitors%26jtitle%3DCurr.%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D10%26spage%3D821%26epage%3D837" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of HCV NS3 protease</span> <span class="citation_source-journal">Expert Opin. Ther. Patents</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">1277</span><span class="NLM_x">–</span> <span class="NLM_lpage">1303</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1517%2F13543770903044994" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=19563268" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=1277-1303&author=S.+Venkatramanauthor=F.+G.+Njoroge&title=Macrocyclic+inhibitors+of+HCV+NS3+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8bR"><div class="casContent"><span class="casTitleNuber">8b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclic inhibitors of HCV NS3 protease</span></div><div class="casAuthors">Venkatraman, Srikanth; Njoroge, F. George</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1277-1303</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  HCV NS3 is a serine protease that plays a pivotal role in catalyzing the cleavage of the single polyprotein encoded by HCV after infection of hepatocytes.  Anal. of the X-ray crystal structure of the enzyme reveals a shallow catalytic site located on the surface of the protein, which has made development of inhibitors a formidable task.  Attempts to discover leads by a traditional approach of screening of compd. libraries have proved futile and, therefore, researchers have adopted a structure-based drug design.  Anal. of the X-ray structure of NS3 protease reveals close proximity of S1-S3 and S2-S4 pockets.  Various novel approaches have been used to design preorganized, depeptidized macrocyclic inhibitors linking the P2-P4 groups and P1-P3 residues.  The article summarizes efforts by various groups to develop inhibitors that bind to the active site and inhibit viral replication.  Review of recent patents and scientific literature.  Macrocyclization has proved to be an effective tool for depeptidization of peptidic inhibitors with improved binding and pharmacokinetic properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodbzHliWVL17Vg90H21EOLACvtfcHk0lhkp3EFC2iDbQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtVWitL%252FI&md5=4081e78be8e92b762d50501ca8fcb97c</span></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1517%2F13543770903044994&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770903044994%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520HCV%2520NS3%2520protease%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Patents%26date%3D2009%26volume%3D19%26spage%3D1277%26epage%3D1303" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Hepatitis C virus NS3-4A protease inhibitors: countering viral subversion in vitro and showing promise in the clinic</span> <span class="citation_source-journal">Curr. Opin. Drug Discovery Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">606</span><span class="NLM_x">–</span> <span class="NLM_lpage">617</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2006&pages=606-617&author=J.+A.+Thomsonauthor=R.+B.+Perni&title=Hepatitis+C+virus+NS3-4A+protease+inhibitors%3A+countering+viral+subversion+in+vitro+and+showing+promise+in+the+clinic"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DHepatitis%2520C%2520virus%2520NS3-4A%2520protease%2520inhibitors%253A%2520countering%2520viral%2520subversion%2520in%2520vitro%2520and%2520showing%2520promise%2520in%2520the%2520clinic%26jtitle%3DCurr.%2520Opin.%2520Drug%2520Discovery%2520Dev.%26date%3D2006%26volume%3D9%26spage%3D606%26epage%3D617" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Chen, S.-H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, S.-L.</span><span> </span><span class="NLM_article-title">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span> <span class="citation_source-journal">Curr. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">2317</span><span class="NLM_x">–</span> <span class="NLM_lpage">2342</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F0929867054864769" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16181135" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8d&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2005&pages=2317-2342&author=S.-H.+Chenauthor=S.-L.+Tan&title=Discovery+of+small-molecule+inhibitors+of+HCV+NS3-4A+protease+as+potential+therapeutic+agents+against+HCV+infection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8dR"><div class="casContent"><span class="casTitleNuber">8d</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of small-molecule inhibitors of HCV NS3-4A protease as potential therapeutic agents against HCV infection</span></div><div class="casAuthors">Chen, Shu-Hui; Tan, Seng-Lai</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">2317-2342</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Chronic infection with hepatitis C virus (HCV) is assocd. with liver cirrhosis that often leads to hepatic failure and hepatocellular carcinoma (HCC).  HCV infection has become a global health threat and the main cause of adult liver transplants in developed nations.  Current approved anti-HCV therapies (interferon and pegylated interferon alone or in combination with ribavirin) are not effective in eliminating the viral infection in a significant population of patients (e.g., those infected with HCV genotype 1).  Furthermore, these therapies are plagued with many undesirable side effects.  Therefore, the HCV epidemic represents a huge unmet medical need that has triggered intensive research efforts towards the development of more effective drugs.  Given its essential role in the process of HCV replication, the viral NS3/4A serine protease is arguably the most thoroughly characterized HCV enzyme and the most intensively pursued anti-HCV target for drug development.  This is further fueled by the successful use of small-mol. inhibitors of the human immunodeficiency virus (HIV) viral protease, which have had an impressive effect on HIV-related morbidity and mortality, offering hope that analogous drugs might also have a similar impact against HCV.  Here, we review the recent progress and development of small-mol. inhibitors of the HCV NS3/4A protease.  In particular, we focus on the discovery of VX-950, the latest HCV NS3-4A protease inhibitor to be advanced to clin. studies.  While the challenges of designing potent inhibitors of the viral protease have been solved, as highlighted by BILN 2061 and VX-950, it is still too early to det. whether these efforts will eventually yield promising drug candidates.  For the emerging small-mol. HCV inhibitors, viral resistance will likely be a big problem.  Thus, combination therapy of different drugs with different targets/mechanisms will be necessary to effectively inhibit HCV replication.  It is also hoped that a detail characterization of how the resistance mutations that affect NS3 inhibitor binding may provide useful information for the design of inhibitors with the potential to treat resistant viruses that may arise during chronic HCV infection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoPS11RNEtD9LVg90H21EOLACvtfcHk0lhH9YQB2LCsSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVWks7jN&md5=5c255f47a40c7db2fa951f8727c5a21c</span></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.2174%2F0929867054864769&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F0929867054864769%26sid%3Dliteratum%253Aachs%26aulast%3DChen%26aufirst%3DS.-H.%26aulast%3DTan%26aufirst%3DS.-L.%26atitle%3DDiscovery%2520of%2520small-molecule%2520inhibitors%2520of%2520HCV%2520NS3-4A%2520protease%2520as%2520potential%2520therapeutic%2520agents%2520against%2520HCV%2520infection%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2005%26volume%3D12%26spage%3D2317%26epage%3D2342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lamarre, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Anderson, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beaulieu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bonneau, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bös, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cameron, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cartier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cordingley, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goudreau, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kawai, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kukolj, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lagacé, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaPlante, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narjes, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poupart, M.-A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rancourt, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sentjens, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. George, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simoneau, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinmann, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thibeault, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weldon, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yong, C.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span> </span><span class="NLM_article-title">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">426</span><span class="NLM_x">, </span> <span class="NLM_fpage">186</span><span class="NLM_x">–</span> <span class="NLM_lpage">189</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1038%2Fnature02099" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=14578911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=426&publication_year=2003&pages=186-189&author=D.+Lamarreauthor=P.+C.+Andersonauthor=M.+Baileyauthor=P.+Beaulieuauthor=G.+Bolgerauthor=P.+Bonneauauthor=M.+B%C3%B6sauthor=D.+R.+Cameronauthor=M.+Cartierauthor=M.+G.+Cordingleyauthor=A.-M.+Faucherauthor=N.+Goudreauauthor=S.+H.+Kawaiauthor=G.+Kukoljauthor=L.+Lagac%C3%A9author=S.+R.+LaPlanteauthor=H.+Narjesauthor=M.-A.+Poupartauthor=J.+Rancourtauthor=R.+E.+Sentjensauthor=R.+St.+Georgeauthor=B.+Simoneauauthor=G.+Steinmannauthor=D.+Thibeaultauthor=Y.+S.+Tsantrizosauthor=S.+M.+Weldonauthor=C.-L.+Yongauthor=M.+Llin%C3%A0s-Brunet&title=An+NS3+protease+inhibitor+with+antiviral+effects+in+humans+infected+with+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9aR"><div class="casContent"><span class="casTitleNuber">9a</span><div class="casTitle"><span class="NLM_cas:atitle">An NS3 protease inhibitor with antiviral effects in humans infected with hepatitis C virus</span></div><div class="casAuthors">Lamarre, Daniel; Anderson, Paul C.; Bailey, Murray; Beaulieu, Pierre; Bolger, Gordon; Bonneau, Pierre; Boes, Michael; Cameron, Dale R.; Cartier, Mireille; Cordingley, Michael G.; Faucher, Anne-Marie; Goudreau, Nathalie; Kawai, Stephen H.; Kukolj, George; Lagace, Lisette; LaPlante, Steven R.; Narjes, Hans; Poupart, Marc-Andre; Rancourt, Jean; Sentjens, Roel E.; St. George, Roger; Simoneau, Bruno; Steinmann, Gerhard; Thibeault, Diane; Tsantrizos, Youla S.; Weldon, Steven M.; Yong, Chan-Loi; Llinas-Brunet, Montse</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">426</span>
        (<span class="NLM_cas:issue">6963</span>),
    <span class="NLM_cas:pages">186-189</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Hepatitis C virus (HCV) infection is a serious cause of chronic liver disease worldwide with more than 170 million infected individuals at risk of developing significant morbidity and mortality.  Current interferon-based therapies are suboptimal esp. in patients infected with HCV genotype 1, and they are poorly tolerated, highlighting the unmet medical need for new therapeutics.  The HCV-encoded NS3 protease is essential for viral replication and has long been considered an attractive target for therapeutic intervention in HCV-infected patients.  Here we identify a class of specific and potent NS3 protease inhibitors and report the evaluation of BILN 2061, a small mol. inhibitor biol. available through oral ingestion and the first of its class in human trials.  Administration of BILN 2061 to patients infected with HCV genotype 1 for 2 days resulted in an impressive redn. of HCV RNA plasma levels, and established proof-of-concept in humans for an HCV NS3 protease inhibitor.  Our results further illustrate the potential of the viral-enzyme-targeted drug discovery approach for the development of new HCV therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPnVapDO21RLVg90H21EOLACvtfcHk0lhH9YQB2LCsSg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXovVKmtbw%253D&md5=36db818d5af257d3ebeef1a061ca68cb</span></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1038%2Fnature02099&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature02099%26sid%3Dliteratum%253Aachs%26aulast%3DLamarre%26aufirst%3DD.%26aulast%3DAnderson%26aufirst%3DP.%2BC.%26aulast%3DBailey%26aufirst%3DM.%26aulast%3DBeaulieu%26aufirst%3DP.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBonneau%26aufirst%3DP.%26aulast%3DB%25C3%25B6s%26aufirst%3DM.%26aulast%3DCameron%26aufirst%3DD.%2BR.%26aulast%3DCartier%26aufirst%3DM.%26aulast%3DCordingley%26aufirst%3DM.%2BG.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DGoudreau%26aufirst%3DN.%26aulast%3DKawai%26aufirst%3DS.%2BH.%26aulast%3DKukolj%26aufirst%3DG.%26aulast%3DLagac%25C3%25A9%26aufirst%3DL.%26aulast%3DLaPlante%26aufirst%3DS.%2BR.%26aulast%3DNarjes%26aufirst%3DH.%26aulast%3DPoupart%26aufirst%3DM.-A.%26aulast%3DRancourt%26aufirst%3DJ.%26aulast%3DSentjens%26aufirst%3DR.%2BE.%26aulast%3DSt.%2BGeorge%26aufirst%3DR.%26aulast%3DSimoneau%26aufirst%3DB.%26aulast%3DSteinmann%26aufirst%3DG.%26aulast%3DThibeault%26aufirst%3DD.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DWeldon%26aufirst%3DS.%2BM.%26aulast%3DYong%26aufirst%3DC.-L.%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26atitle%3DAn%2520NS3%2520protease%2520inhibitor%2520with%2520antiviral%2520effects%2520in%2520humans%2520infected%2520with%2520hepatitis%2520C%2520virus%26jtitle%3DNature%26date%3D2003%26volume%3D426%26spage%3D186%26epage%3D189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Llinàs-Brunet, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bolger, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brochu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Faucher, A.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ferland, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garneau, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghiro, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gorys, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grand-Maître, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Halmos, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lapeyre-Paquette, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liard, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poirier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rhéaume, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsantrizos, Y. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamarre, D.</span><span> </span><span class="NLM_article-title">Structure−Activity Study on a Novel Series of Macrocyclic Inhibitors of the Hepatitis C Virus NS3 Protease Leading to the Discovery of BILN 2061</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">1605</span><span class="NLM_x">–</span> <span class="NLM_lpage">1608</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm0342414" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=1605-1608&author=M.+Llin%C3%A0s-Brunetauthor=M.+D.+Baileyauthor=G.+Bolgerauthor=C.+Brochuauthor=A.-M.+Faucherauthor=J.+M.+Ferlandauthor=M.+Garneauauthor=E.+Ghiroauthor=V.+Gorysauthor=C.+Grand-Ma%C3%AEtreauthor=T.+Halmosauthor=N.+Lapeyre-Paquetteauthor=F.+Liardauthor=M.+Poirierauthor=M.+Rh%C3%A9aumeauthor=Y.+S.+Tsantrizosauthor=D.+Lamarre&title=Structure%E2%88%92Activity+Study+on+a+Novel+Series+of+Macrocyclic+Inhibitors+of+the+Hepatitis+C+Virus+NS3+Protease+Leading+to+the+Discovery+of+BILN+2061"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm0342414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0342414%26sid%3Dliteratum%253Aachs%26aulast%3DLlin%25C3%25A0s-Brunet%26aufirst%3DM.%26aulast%3DBailey%26aufirst%3DM.%2BD.%26aulast%3DBolger%26aufirst%3DG.%26aulast%3DBrochu%26aufirst%3DC.%26aulast%3DFaucher%26aufirst%3DA.-M.%26aulast%3DFerland%26aufirst%3DJ.%2BM.%26aulast%3DGarneau%26aufirst%3DM.%26aulast%3DGhiro%26aufirst%3DE.%26aulast%3DGorys%26aufirst%3DV.%26aulast%3DGrand-Ma%25C3%25AEtre%26aufirst%3DC.%26aulast%3DHalmos%26aufirst%3DT.%26aulast%3DLapeyre-Paquette%26aufirst%3DN.%26aulast%3DLiard%26aufirst%3DF.%26aulast%3DPoirier%26aufirst%3DM.%26aulast%3DRh%25C3%25A9aume%26aufirst%3DM.%26aulast%3DTsantrizos%26aufirst%3DY.%2BS.%26aulast%3DLamarre%26aufirst%3DD.%26atitle%3DStructure%25E2%2588%2592Activity%2520Study%2520on%2520a%2520Novel%2520Series%2520of%2520Macrocyclic%2520Inhibitors%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Leading%2520to%2520the%2520Discovery%2520of%2520BILN%25202061%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D1605%26epage%3D1608" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Perni, R. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almquist, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Byrn, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandorkar, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chaturvedi, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Courtney, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Decker, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinehart, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gates, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harbeson, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heiser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kalkeri, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kolaczkowski, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luong, Y.-P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rao, B. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, W. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tung, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wei, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, C.</span><span> </span><span class="NLM_article-title">Preclinical profile of VX-950, a potent, selective, and orally bioavailable inhibitor of hepatitis C virus NS3−4A serine protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">899</span><span class="NLM_x">–</span> <span class="NLM_lpage">909</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=899-909&author=R.+B.+Perniauthor=S.+J.+Almquistauthor=R.+A.+Byrnauthor=G.+Chandorkarauthor=P.+R.+Chaturvediauthor=L.+F.+Courtneyauthor=C.+J.+Deckerauthor=K.+Dinehartauthor=C.+A.+Gatesauthor=S.+L.+Harbesonauthor=A.+Heiserauthor=G.+Kalkeriauthor=E.+Kolaczkowskiauthor=K.+Linauthor=Y.-P.+Luongauthor=B.+G.+Raoauthor=W.+P.+Taylorauthor=J.+A.+Thomsonauthor=R.+D.+Tungauthor=Y.+Weiauthor=A.+D.+Kwongauthor=C.+Lin&title=Preclinical+profile+of+VX-950%2C+a+potent%2C+selective%2C+and+orally+bioavailable+inhibitor+of+hepatitis+C+virus+NS3%E2%88%924A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPerni%26aufirst%3DR.%2BB.%26aulast%3DAlmquist%26aufirst%3DS.%2BJ.%26aulast%3DByrn%26aufirst%3DR.%2BA.%26aulast%3DChandorkar%26aufirst%3DG.%26aulast%3DChaturvedi%26aufirst%3DP.%2BR.%26aulast%3DCourtney%26aufirst%3DL.%2BF.%26aulast%3DDecker%26aufirst%3DC.%2BJ.%26aulast%3DDinehart%26aufirst%3DK.%26aulast%3DGates%26aufirst%3DC.%2BA.%26aulast%3DHarbeson%26aufirst%3DS.%2BL.%26aulast%3DHeiser%26aufirst%3DA.%26aulast%3DKalkeri%26aufirst%3DG.%26aulast%3DKolaczkowski%26aufirst%3DE.%26aulast%3DLin%26aufirst%3DK.%26aulast%3DLuong%26aufirst%3DY.-P.%26aulast%3DRao%26aufirst%3DB.%2BG.%26aulast%3DTaylor%26aufirst%3DW.%2BP.%26aulast%3DThomson%26aufirst%3DJ.%2BA.%26aulast%3DTung%26aufirst%3DR.%2BD.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DLin%26aufirst%3DC.%26atitle%3DPreclinical%2520profile%2520of%2520VX-950%252C%2520a%2520potent%252C%2520selective%252C%2520and%2520orally%2520bioavailable%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%25E2%2588%25924A%2520serine%2520protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D899%26epage%3D909" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit10b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lin, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kwong, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perni, R. B.</span><span> </span><span class="NLM_article-title">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3-4A serine protease</span> <span class="citation_source-journal">Infect. Disord.: Drug Targets</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">3</span><span class="NLM_x">–</span> <span class="NLM_lpage">16</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F187152606776056706" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16787300" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2006&pages=3-16&author=C.+Linauthor=A.+D.+Kwongauthor=R.+B.+Perni&title=Discovery+and+development+of+VX-950%2C+a+novel%2C+covalent%2C+and+reversible+inhibitor+of+hepatitis+C+virus+NS3-4A+serine+protease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10bR"><div class="casContent"><span class="casTitleNuber">10b</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of VX-950, a novel, covalent, and reversible inhibitor of hepatitis C virus NS3•4A serine protease</span></div><div class="casAuthors">Lin, C.; Kwong, A. D.; Perni, R. B.</div><div class="citationInfo"><span class="NLM_cas:title">Infectious Disorders: Drug Targets</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">3-16</span>CODEN:
                <span class="NLM_cas:coden">IDDTAD</span>;
        ISSN:<span class="NLM_cas:issn">1871-5265</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The hepatitis C virus (HCV) NS3•4A protease, which is essential for viral replication, is considered one of the most attractive targets for developing novel anti-HCV therapies.  However, discovery of potent and selective small-mol. inhibitors of HCV NS3•4A protease as oral drug candidates has been hampered by the shallow substrate-binding groove of the protease.  Serine trap warheads have been used to covalently anchor inhibitor scaffolds and to increase their affinity to the protease.  This review will examine the evolution of covalent inhibitors of the HCV NS3•4A protease from early aldehyde mols. to α-ketoamide inhibitors.  Kinetic and structural studies of α-ketoacid and α-ketoamide inhibitors revealed an unusual mechanism of binding in the catalytic site.  Optimization of α-ketoamide scaffolds by scientists at Vertex and Eli Lilly led to the discovery of VX-950, a novel, potent, selective inhibitor of HCV NS3•4A protease.  VX-950 possesses excellent antiviral activity in both HCV replicon cells and human fetal hepatocytes infected with HCV-pos. patient sera.  In addn., VX-950 exhibits a favorable pharmacokinetic profile in several animal species and demonstrates potent inhibition of the HCV NS3•4A protease activity in a mouse model.  In a recent phase 1b clin. trial, VX-950 was able to rapidly reduce the plasma viral load of patients chronically infected with genotype 1 HCV by a mean ∼3 log10 in 2 days.  The median viral load redn. was 4.4 log10 for the best dose group after 14 days of dosing.  The preclin. profile and early clin. data of VX-950 will be discussed in this review.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOA6Gspx5Jv7Vg90H21EOLACvtfcHk0lhDUli3VyIMTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xkt1Ggu7k%253D&md5=dbf5706a5d351aabf722d88216d88b78</span></div><a href="/servlet/linkout?suffix=cit10b&amp;dbid=16384&amp;doi=10.2174%2F187152606776056706&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187152606776056706%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DC.%26aulast%3DKwong%26aufirst%3DA.%2BD.%26aulast%3DPerni%26aufirst%3DR.%2BB.%26atitle%3DDiscovery%2520and%2520development%2520of%2520VX-950%252C%2520a%2520novel%252C%2520covalent%252C%2520and%2520reversible%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3-4A%2520serine%2520protease%26jtitle%3DInfect.%2520Disord.%253A%2520Drug%2520Targets%26date%3D2006%26volume%3D6%26spage%3D3%26epage%3D16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Malcolm, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lahser, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Belanger, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gheyas, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hesk, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Skelton, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">SCH 503034, a mechanism-based inhibitor of hepatitis C virus NS3 protease, suppresses polyprotein maturation and enhances the antiviral activity of alpha interferon in replicon cells</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">1013</span><span class="NLM_x">–</span> <span class="NLM_lpage">1020</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2006&pages=1013-1020&author=B.+A.+Malcolmauthor=R.+Liuauthor=F.+Lahserauthor=S.+Agrawalauthor=B.+Belangerauthor=N.+Butkiewiczauthor=R.+Chaseauthor=F.+Gheyasauthor=A.+Hartauthor=D.+Heskauthor=P.+Ingravalloauthor=C.+Jiangauthor=R.+Kongauthor=J.+Luauthor=J.+Pichardoauthor=A.+Prongayauthor=A.+Skeltonauthor=X.+Tongauthor=S.+Venkatramanauthor=E.+Xiaauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=SCH+503034%2C+a+mechanism-based+inhibitor+of+hepatitis+C+virus+NS3+protease%2C+suppresses+polyprotein+maturation+and+enhances+the+antiviral+activity+of+alpha+interferon+in+replicon+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMalcolm%26aufirst%3DB.%2BA.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DLahser%26aufirst%3DF.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DBelanger%26aufirst%3DB.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DGheyas%26aufirst%3DF.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DHesk%26aufirst%3DD.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DJiang%26aufirst%3DC.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DSkelton%26aufirst%3DA.%26aulast%3DTong%26aufirst%3DX.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DXia%26aufirst%3DE.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DSCH%2520503034%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520protease%252C%2520suppresses%2520polyprotein%2520maturation%2520and%2520enhances%2520the%2520antiviral%2520activity%2520of%2520alpha%2520interferon%2520in%2520replicon%2520cells%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2006%26volume%3D50%26spage%3D1013%26epage%3D1020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrata, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parekh, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pinto, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Popov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pike, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruan, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Santhanam, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vibulbhan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butkiewicz, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chase, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Agrawal, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingravallo, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kong, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baroudy, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Broske, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cui, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, K.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hsieh, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brisson, J.-M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prelusky, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korfmacher, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">White, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogdanowich-Knipp, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pavlovsky, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bradley, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ganguly, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Piwinski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Discovery of (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(<i>S</i>)-carboxamide (SCH 503034), a Selective, Potent, Orally Bioavailable Hepatitis C Virus NS3 Protease Inhibitor: A Potential Therapeutic Agent for the Treatment of Hepatitis C Infection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">49</span><span class="NLM_x">, </span> <span class="NLM_fpage">6074</span><span class="NLM_x">–</span> <span class="NLM_lpage">6086</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060325b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=2006&pages=6074-6086&author=S.+Venkatramanauthor=S.+L.+Bogenauthor=A.+Arasappanauthor=F.+Bennettauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+Loveyauthor=S.+Hendrataauthor=Y.+Huangauthor=W.+Panauthor=T.+Parekhauthor=P.+Pintoauthor=V.+Popovauthor=R.+Pikeauthor=S.+Ruanauthor=B.+Santhanamauthor=B.+Vibulbhanauthor=W.+Wuauthor=W.+Yangauthor=J.+Kongauthor=X.+Liangauthor=J.+Wongauthor=R.+Liuauthor=N.+Butkiewiczauthor=R.+Chaseauthor=A.+Hartauthor=S.+Agrawalauthor=P.+Ingravalloauthor=J.+Pichardoauthor=R.+Kongauthor=B.+Baroudyauthor=B.+Malcolmauthor=Z.+Guoauthor=A.+Prongayauthor=V.+Madisonauthor=L.+Broskeauthor=X.+Cuiauthor=K.-C.+Chengauthor=Y.+Hsiehauthor=J.-M.+Brissonauthor=D.+Preluskyauthor=W.+Korfmacherauthor=R.+Whiteauthor=S.+Bogdanowich-Knippauthor=A.+Pavlovskyauthor=P.+Bradleyauthor=A.+K.+Saksenaauthor=A.+Gangulyauthor=J.+Piwinskiauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Discovery+of+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29%2C+a+Selective%2C+Potent%2C+Orally+Bioavailable+Hepatitis+C+Virus+NS3+Protease+Inhibitor%3A+A+Potential+Therapeutic+Agent+for+the+Treatment+of+Hepatitis+C+Infection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1021%2Fjm060325b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060325b%26sid%3Dliteratum%253Aachs%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%26aulast%3DHendrata%26aufirst%3DS.%26aulast%3DHuang%26aufirst%3DY.%26aulast%3DPan%26aufirst%3DW.%26aulast%3DParekh%26aufirst%3DT.%26aulast%3DPinto%26aufirst%3DP.%26aulast%3DPopov%26aufirst%3DV.%26aulast%3DPike%26aufirst%3DR.%26aulast%3DRuan%26aufirst%3DS.%26aulast%3DSanthanam%26aufirst%3DB.%26aulast%3DVibulbhan%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DW.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DLiang%26aufirst%3DX.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DLiu%26aufirst%3DR.%26aulast%3DButkiewicz%26aufirst%3DN.%26aulast%3DChase%26aufirst%3DR.%26aulast%3DHart%26aufirst%3DA.%26aulast%3DAgrawal%26aufirst%3DS.%26aulast%3DIngravallo%26aufirst%3DP.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DKong%26aufirst%3DR.%26aulast%3DBaroudy%26aufirst%3DB.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DMadison%26aufirst%3DV.%26aulast%3DBroske%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DK.-C.%26aulast%3DHsieh%26aufirst%3DY.%26aulast%3DBrisson%26aufirst%3DJ.-M.%26aulast%3DPrelusky%26aufirst%3DD.%26aulast%3DKorfmacher%26aufirst%3DW.%26aulast%3DWhite%26aufirst%3DR.%26aulast%3DBogdanowich-Knipp%26aufirst%3DS.%26aulast%3DPavlovsky%26aufirst%3DA.%26aulast%3DBradley%26aufirst%3DP.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DGanguly%26aufirst%3DA.%26aulast%3DPiwinski%26aufirst%3DJ.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DDiscovery%2520of%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529%252C%2520a%2520Selective%252C%2520Potent%252C%2520Orally%2520Bioavailable%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%253A%2520A%2520Potential%2520Therapeutic%2520Agent%2520for%2520the%2520Treatment%2520of%2520Hepatitis%2520C%2520Infection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2006%26volume%3D49%26spage%3D6074%26epage%3D6086" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Prongay, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guo, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pichardo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischmann, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strickland, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myers, J.,  Jr.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beyer, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ingram, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ramanathan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yarosh-Tomaine, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Senior, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, R.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Malcolm, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bennett, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bogen, S. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jao, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Y.-T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lovey, R. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Saksena, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Madison, V.</span><span> </span><span class="NLM_article-title">Discovery of the HCV NS3/4A Protease Inhibitor (1<i>R</i>,5<i>S</i>)-<i>N</i>-[3-Amino-1-(cyclobutylmethyl)-2,3-dioxopropyl]-3-[2(<i>S</i>)-[[[(1,1-dimethylethyl)amino]carbonyl]amino]-3,3-dimethyl-1-oxobutyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2(S)-carboxamide (SCH 503034). Key Steps in Structure-Based Optimization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">2310</span><span class="NLM_x">–</span> <span class="NLM_lpage">2318</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060173k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=2310-2318&author=A.+J.+Prongayauthor=Z.+Guoauthor=N.+Yaoauthor=J.+Pichardoauthor=T.+Fischmannauthor=C.+Stricklandauthor=J.+Myersauthor=P.+C.+Weberauthor=B.+M.+Beyerauthor=R.+Ingramauthor=Z.+Hongauthor=W.+W.+Prosiseauthor=L.+Ramanathanauthor=S.+S.+Taremiauthor=T.+Yarosh-Tomaineauthor=R.+Zhangauthor=M.+Seniorauthor=R.-S.+Yangauthor=B.+Malcolmauthor=A.+Arasappanauthor=F.+Bennettauthor=S.+L.+Bogenauthor=K.+Chenauthor=E.+Jaoauthor=Y.-T.+Liuauthor=R.+G.+Loveyauthor=A.+K.+Saksenaauthor=S.+Venkatramanauthor=V.+Girijavallabhanauthor=F.+G.+Njorogeauthor=V.+Madison&title=Discovery+of+the+HCV+NS3%2F4A+Protease+Inhibitor+%281R%2C5S%29-N-%5B3-Amino-1-%28cyclobutylmethyl%29-2%2C3-dioxopropyl%5D-3-%5B2%28S%29-%5B%5B%5B%281%2C1-dimethylethyl%29amino%5Dcarbonyl%5Damino%5D-3%2C3-dimethyl-1-oxobutyl%5D-6%2C6-dimethyl-3-azabicyclo%5B3.1.0%5Dhexan-2%28S%29-carboxamide+%28SCH+503034%29.+Key+Steps+in+Structure-Based+Optimization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11c&amp;dbid=16384&amp;doi=10.1021%2Fjm060173k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060173k%26sid%3Dliteratum%253Aachs%26aulast%3DProngay%26aufirst%3DA.%2BJ.%26aulast%3DGuo%26aufirst%3DZ.%26aulast%3DYao%26aufirst%3DN.%26aulast%3DPichardo%26aufirst%3DJ.%26aulast%3DFischmann%26aufirst%3DT.%26aulast%3DStrickland%26aufirst%3DC.%26aulast%3DMyers%26aufirst%3DJ.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26aulast%3DBeyer%26aufirst%3DB.%2BM.%26aulast%3DIngram%26aufirst%3DR.%26aulast%3DHong%26aufirst%3DZ.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DRamanathan%26aufirst%3DL.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DYarosh-Tomaine%26aufirst%3DT.%26aulast%3DZhang%26aufirst%3DR.%26aulast%3DSenior%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DR.-S.%26aulast%3DMalcolm%26aufirst%3DB.%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DBennett%26aufirst%3DF.%26aulast%3DBogen%26aufirst%3DS.%2BL.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DJao%26aufirst%3DE.%26aulast%3DLiu%26aufirst%3DY.-T.%26aulast%3DLovey%26aufirst%3DR.%2BG.%26aulast%3DSaksena%26aufirst%3DA.%2BK.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26aulast%3DMadison%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520the%2520HCV%2520NS3%252F4A%2520Protease%2520Inhibitor%2520%25281R%252C5S%2529-N-%255B3-Amino-1-%2528cyclobutylmethyl%2529-2%252C3-dioxopropyl%255D-3-%255B2%2528S%2529-%255B%255B%255B%25281%252C1-dimethylethyl%2529amino%255Dcarbonyl%255Damino%255D-3%252C3-dimethyl-1-oxobutyl%255D-6%252C6-dimethyl-3-azabicyclo%255B3.1.0%255Dhexan-2%2528S%2529-carboxamide%2520%2528SCH%2520503034%2529.%2520Key%2520Steps%2520in%2520Structure-Based%2520Optimization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D2310%26epage%3D2318" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serebryany, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajagopalan, P. T. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stoycheva, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lim, S. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qin, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rieger, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Condroski, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Do, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemieux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hingorani, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hartley, D. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Beigelman, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blatt, L. M.</span><span> </span><span class="NLM_article-title">Preclinical Characteristics of the Hepatitis C virus NS3/4A Protease inhibitor ITMN-191 (R7227)</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">4432</span><span class="NLM_x">–</span> <span class="NLM_lpage">4441</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2008&pages=4432-4441&author=S.+D.+Seiwertauthor=S.+W.+Andrewsauthor=Y.+Jiangauthor=V.+Serebryanyauthor=H.+Tanauthor=K.+Kossenauthor=P.+T.+R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=A.+Stoychevaauthor=J.+Hongauthor=S.+R.+Limauthor=X.+Qinauthor=R.+Riegerauthor=K.+R.+Condroskiauthor=H.+Zhangauthor=M.+G.+Doauthor=C.+Lemieuxauthor=G.+P.+Hingoraniauthor=D.+P.+Hartleyauthor=J.+A.+Joseyauthor=L.+Panauthor=L.+Beigelmanauthor=L.+M.+Blatt&title=Preclinical+Characteristics+of+the+Hepatitis+C+virus+NS3%2F4A+Protease+inhibitor+ITMN-191+%28R7227%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DJiang%26aufirst%3DY.%26aulast%3DSerebryany%26aufirst%3DV.%26aulast%3DTan%26aufirst%3DH.%26aulast%3DKossen%26aufirst%3DK.%26aulast%3DRajagopalan%26aufirst%3DP.%2BT.%2BR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DStoycheva%26aufirst%3DA.%26aulast%3DHong%26aufirst%3DJ.%26aulast%3DLim%26aufirst%3DS.%2BR.%26aulast%3DQin%26aufirst%3DX.%26aulast%3DRieger%26aufirst%3DR.%26aulast%3DCondroski%26aufirst%3DK.%2BR.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DDo%26aufirst%3DM.%2BG.%26aulast%3DLemieux%26aufirst%3DC.%26aulast%3DHingorani%26aufirst%3DG.%2BP.%26aulast%3DHartley%26aufirst%3DD.%2BP.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DPan%26aufirst%3DL.%26aulast%3DBeigelman%26aufirst%3DL.%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DPreclinical%2520Characteristics%2520of%2520the%2520Hepatitis%2520C%2520virus%2520NS3%252F4A%2520Protease%2520inhibitor%2520ITMN-191%2520%2528R7227%2529%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2008%26volume%3D52%26spage%3D4432%26epage%3D4441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Rajagopalan, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Misialek, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Myszka, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brandhuber, B. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ballard, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seiwert, S. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kossen, K.</span><span> </span><span class="NLM_article-title">Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior</span> <span class="citation_source-journal">Biochemistry</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">2559</span><span class="NLM_x">–</span> <span class="NLM_lpage">2568</span></span><div class="citationLinks">[<a href="/doi/10.1021/bi900038p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1MXisFems7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2009&pages=2559-2568&author=R.+Rajagopalanauthor=S.+Misialekauthor=S.+K.+Stevensauthor=D.+G.+Myszkaauthor=B.+J.+Brandhuberauthor=J.+A.+Ballardauthor=S.+W.+Andrewsauthor=S.+D.+Seiwertauthor=K.+Kossen&title=Inhibition+and+Binding+Kinetics+of+the+Hepatitis+C+Virus+NS3+Protease+Inhibitor+ITMN-191+Reveals+Tight+Binding+and+Slow+Dissociative+Behavior"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition and Binding Kinetics of the Hepatitis C Virus NS3 Protease Inhibitor ITMN-191 Reveals Tight Binding and Slow Dissociative Behavior</span></div><div class="casAuthors">Rajagopalan, Ravi; Misialek, Shawn; Stevens, Sarah K.; Myszka, David G.; Brandhuber, Barbara J.; Ballard, Joshua A.; Andrews, Steven W.; Seiwert, Scott D.; Kossen, Karl</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2559-2568</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The protease activity of hepatitis C virus nonstructural protein 3 (NS3) is essential for viral replication.  ITMN-191, a macrocyclic inhibitor of the NS3 protease active site, promotes rapid, multilog viral load redns. in chronic HCV patients.  Here, ITMN-191 is shown to be a potent inhibitor of NS3 with a two-step binding mechanism.  Progress curves are consistent with the formation of an initial collision complex (EI) that isomerizes to a highly stable complex (EI*) from which ITMN-191 dissocs. very slowly.  Ki, the dissocn. const. of EI, is 100 nM, and the rate const. for conversion of EI to EI* is 6.2 × 10-2 s-1.  Binding expts. using protein fluorescence confirm this isomerization rate.  From progress curve anal., the rate const. for dissocn. of ITMN-191 from the EI* complex is 3.8 × 10-5 s-1 with a calcd. complex half-life of ∼5 h and a true biochem. potency (Ki*) of ∼62 pM.  Surface plasmon resonance studies and assessment of enzyme reactivation following diln. of the EI* complex confirm slow dissocn. and suggest that the half-life may be considerably longer.  Abrogation of the tight binding and slow dissociative properties of ITMN-191 is obsd. with proteases that carry the R155K or D168A substitution, each of which is likely in drug resistant mutants.  Slow dissocn. is not obsd. with closely related macrocyclic inhibitors of NS3, suggesting that members of this class may display distinct binding kinetics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqOY26vXOrtJrVg90H21EOLACvtfcHk0lhcZkhyA7ag4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXisFems7k%253D&md5=5e985737f2627bd314b517f93b938336</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1021%2Fbi900038p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi900038p%26sid%3Dliteratum%253Aachs%26aulast%3DRajagopalan%26aufirst%3DR.%26aulast%3DMisialek%26aufirst%3DS.%26aulast%3DStevens%26aufirst%3DS.%2BK.%26aulast%3DMyszka%26aufirst%3DD.%2BG.%26aulast%3DBrandhuber%26aufirst%3DB.%2BJ.%26aulast%3DBallard%26aufirst%3DJ.%2BA.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DSeiwert%26aufirst%3DS.%2BD.%26aulast%3DKossen%26aufirst%3DK.%26atitle%3DInhibition%2520and%2520Binding%2520Kinetics%2520of%2520the%2520Hepatitis%2520C%2520Virus%2520NS3%2520Protease%2520Inhibitor%2520ITMN-191%2520Reveals%2520Tight%2520Binding%2520and%2520Slow%2520Dissociative%2520Behavior%26jtitle%3DBiochemistry%26date%3D2009%26volume%3D48%26spage%3D2559%26epage%3D2568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Blatt, L. M.; Wenglowsky, S. M.; Andrews, S. W.; Jiang, Y.; Kennedy, A. L.; Condroski, K. R.; Josey, J. A.; Stengel, P. J.; Madduru, M. R.; Doherty, G. A.; Woodard, B. T.</span><span> </span><span class="NLM_article-title">Macrocyclic carboxylic acids and acylsulfonamides as inhibitors of HCV replication</span>. PCT Int. Appl. WO 2005/037214,<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=L.+M.+Blatt&author=S.+M.+Wenglowsky&author=S.+W.+Andrews&author=Y.+Jiang&author=A.+L.+Kennedy&author=K.+R.+Condroski&author=J.+A.+Josey&author=P.+J.+Stengel&author=M.+R.+Madduru&author=G.+A.+Doherty&author=B.+T.+Woodard&title=Macrocyclic+carboxylic+acids+and+acylsulfonamides+as+inhibitors+of+HCV+replication"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBlatt%26aufirst%3DL.%2BM.%26atitle%3DMacrocyclic%2520carboxylic%2520acids%2520and%2520acylsulfonamides%2520as%2520inhibitors%2520of%2520HCV%2520replication%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fanning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verbinnen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scholliers, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vermeiren, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">1377</span><span class="NLM_x">–</span> <span class="NLM_lpage">1385</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2009&pages=1377-1385&author=T.-I.+Linauthor=O.+Lenzauthor=G.+Fanningauthor=T.+Verbinnenauthor=F.+Delouvroyauthor=A.+Scholliersauthor=K.+Vermeirenauthor=A.+Rosenquistauthor=M.+Edlundauthor=B.+Samuelssonauthor=L.+Vrangauthor=H.+de+Kockauthor=P.+Wigerinckauthor=P.+Raboissonauthor=K.+Simmen&title=In+Vitro+Activity+and+Preclinical+Profile+of+TMC435350%2C+a+Potent+Hepatitis+C+Virus+Protease+Inhibitor"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DFanning%26aufirst%3DG.%26aulast%3DVerbinnen%26aufirst%3DT.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DScholliers%26aufirst%3DA.%26aulast%3DVermeiren%26aufirst%3DK.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DIn%2520Vitro%2520Activity%2520and%2520Preclinical%2520Profile%2520of%2520TMC435350%252C%2520a%2520Potent%2520Hepatitis%2520C%2520Virus%2520Protease%2520Inhibitor%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2009%26volume%3D53%26spage%3D1377%26epage%3D1385" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Raboisson, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Kock, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenquist, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvador-Oden, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, T.-I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roue, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ivanov, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wähling, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wickström, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamelink, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edlund, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vrang, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vendeville, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Van de Vreken, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGowan, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tahri, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boutton, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lenz, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Delouvroy, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pille, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Surleraux, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wigerinck, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Samuelsson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simmen, K.</span><span> </span><span class="NLM_article-title">Structure−activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span> <span class="citation_source-journal">Biog. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4853</span><span class="NLM_x">–</span> <span class="NLM_lpage">4858</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.bmcl.2008.07.088" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=18678486" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4853-4858&author=P.+Raboissonauthor=H.+de+Kockauthor=A.+Rosenquistauthor=M.+Nilssonauthor=L.+Salvador-Odenauthor=T.-I.+Linauthor=N.+Roueauthor=V.+Ivanovauthor=H.+W%C3%A4hlingauthor=K.+Wickstr%C3%B6mauthor=E.+Hamelinkauthor=M.+Edlundauthor=L.+Vrangauthor=S.+Vendevilleauthor=W.+Van+de+Vrekenauthor=D.+McGowanauthor=A.+Tahriauthor=L.+Huauthor=C.+Bouttonauthor=O.+Lenzauthor=F.+Delouvroyauthor=G.+Pilleauthor=D.+Surlerauxauthor=P.+Wigerinckauthor=B.+Samuelssonauthor=K.+Simmen&title=Structure%E2%88%92activity+relationship+study+on+a+novel+series+of+cyclopentane-containing+macrocyclic+inhibitors+of+the+hepatitis+C+virus+NS3%2F4A+protease+leading+to+the+discovery+of+TMC435350"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13bR"><div class="casContent"><span class="casTitleNuber">13b</span><div class="casTitle"><span class="NLM_cas:atitle">Structure-activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis C virus NS3/4A protease leading to the discovery of TMC435350</span></div><div class="casAuthors">Raboisson, Pierre; de Kock, Herman; Rosenquist, Asa; Nilsson, Magnus; Salvador-Oden, Lourdes; Lin, Tse-I.; Roue, Natalie; Ivanov, Vladimir; Wahling, Horst; Wickstrom, Kristina; Hamelink, Elizabeth; Edlund, Michael; Vrang, Lotta; Vendeville, Sandrine; Van de Vreken, Wim; McGowan, David; Tahri, Abdellah; Hu, Lili; Boutton, Carlo; Lenz, Oliver; Delouvroy, Frederic; Pille, Geert; Surleraux, Dominique; Wigerinck, Piet; Samuelsson, Bertil; Simmen, Kenneth</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4853-4858</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">SAR anal. performed with a limited set of cyclopentane-contg. macrocycles led to the identification of TMC435350 (I) as a potent inhibitor of HCV NS3/4A protease (Ki = 0.36 nM) and viral replication (replicon EC50 = 7.8 nM).  TMC435350 also displayed low in vitro clearance and high permeability, which were confirmed by in vivo pharmacokinetic studies.  TMC435350 is currently being evaluated in the clinics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbRb8GhLBkJ7Vg90H21EOLACvtfcHk0lhcZkhyA7ag4g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbvE&md5=001abd8307658a926479ff77496b6ff9</span></div><a href="/servlet/linkout?suffix=cit13b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.088&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.088%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26aulast%3Dde%2BKock%26aufirst%3DH.%26aulast%3DRosenquist%26aufirst%3DA.%26aulast%3DNilsson%26aufirst%3DM.%26aulast%3DSalvador-Oden%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DT.-I.%26aulast%3DRoue%26aufirst%3DN.%26aulast%3DIvanov%26aufirst%3DV.%26aulast%3DW%25C3%25A4hling%26aufirst%3DH.%26aulast%3DWickstr%25C3%25B6m%26aufirst%3DK.%26aulast%3DHamelink%26aufirst%3DE.%26aulast%3DEdlund%26aufirst%3DM.%26aulast%3DVrang%26aufirst%3DL.%26aulast%3DVendeville%26aufirst%3DS.%26aulast%3DVan%2Bde%2BVreken%26aufirst%3DW.%26aulast%3DMcGowan%26aufirst%3DD.%26aulast%3DTahri%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DL.%26aulast%3DBoutton%26aufirst%3DC.%26aulast%3DLenz%26aufirst%3DO.%26aulast%3DDelouvroy%26aufirst%3DF.%26aulast%3DPille%26aufirst%3DG.%26aulast%3DSurleraux%26aufirst%3DD.%26aulast%3DWigerinck%26aufirst%3DP.%26aulast%3DSamuelsson%26aufirst%3DB.%26aulast%3DSimmen%26aufirst%3DK.%26atitle%3DStructure%25E2%2588%2592activity%2520relationship%2520study%2520on%2520a%2520novel%2520series%2520of%2520cyclopentane-containing%2520macrocyclic%2520inhibitors%2520of%2520the%2520hepatitis%2520C%2520virus%2520NS3%252F4A%2520protease%2520leading%2520to%2520the%2520discovery%2520of%2520TMC435350%26jtitle%3DBiog.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4853%26epage%3D4858" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit13c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Raboisson, P.; De Kock, H.; Hu, L.; Vendeville, S.; Tahri, A.; Surleraux, D.; Simmen, K.; Nilsson, K.; Samuelsson, B.; Rosenquist, A.; Ivanov, V.; Pelcman, M.; Belfrage, A.; Johansson, P.-O.</span><span> </span><span class="NLM_article-title">Macrocyclic inhibitors of hepatitis C virus</span>. PCT Int. Appl. WO 2007/014926,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=P.+Raboisson&author=H.+De+Kock&author=L.+Hu&author=S.+Vendeville&author=A.+Tahri&author=D.+Surleraux&author=K.+Simmen&author=K.+Nilsson&author=B.+Samuelsson&author=A.+Rosenquist&author=V.+Ivanov&author=M.+Pelcman&author=A.+Belfrage&author=P.-O.+Johansson&title=Macrocyclic+inhibitors+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRaboisson%26aufirst%3DP.%26atitle%3DMacrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Butcher, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilbert, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Romano, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, B.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">Molecular modeling based approach to potent P2-P4 macrocyclic inhibitors of hepatitis C NS3/4a protease</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">130</span><span class="NLM_x">, </span> <span class="NLM_fpage">4607</span><span class="NLM_x">–</span> <span class="NLM_lpage">4609</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja711120r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=130&publication_year=2008&pages=4607-4609&author=N.+J.+Livertonauthor=M.+K.+Hollowayauthor=J.+A.+McCauleyauthor=M.+T.+Ruddauthor=J.+W.+Butcherauthor=S.+S.+Carrollauthor=J.+DiMuzioauthor=C.+Fandozziauthor=K.+F.+Gilbertauthor=S.-S.+Maoauthor=C.+J.+McIntyreauthor=K.+T.+Nguyenauthor=J.+J.+Romanoauthor=M.+Stahlhutauthor=B.-L.+Wanauthor=D.+B.+Olsenauthor=J.+P.+Vacca&title=Molecular+modeling+based+approach+to+potent+P2-P4+macrocyclic+inhibitors+of+hepatitis+C+NS3%2F4a+protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1021%2Fja711120r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja711120r%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DButcher%26aufirst%3DJ.%2BW.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGilbert%26aufirst%3DK.%2BF.%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DNguyen%26aufirst%3DK.%2BT.%26aulast%3DRomano%26aufirst%3DJ.%2BJ.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DWan%26aufirst%3DB.-L.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMolecular%2520modeling%2520based%2520approach%2520to%2520potent%2520P2-P4%2520macrocyclic%2520inhibitors%2520of%2520hepatitis%2520C%2520NS3%252F4a%2520protease%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2008%26volume%3D130%26spage%3D4607%26epage%3D4609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Yao, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reichert, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taremi, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prosise, W. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weber, P. C.</span><span> </span><span class="NLM_article-title">Molecular views of viral polyprotein processing revealed by the crystal structure of the hepatitis C virus bifunctional protease-helicase</span> <span class="citation_source-journal">Structure</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1353</span><span class="NLM_x">–</span> <span class="NLM_lpage">1363</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1999&pages=1353-1363&author=N.+Yaoauthor=P.+Reichertauthor=S.+S.+Taremiauthor=W.+W.+Prosiseauthor=P.+C.+Weber&title=Molecular+views+of+viral+polyprotein+processing+revealed+by+the+crystal+structure+of+the+hepatitis+C+virus+bifunctional+protease-helicase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYao%26aufirst%3DN.%26aulast%3DReichert%26aufirst%3DP.%26aulast%3DTaremi%26aufirst%3DS.%2BS.%26aulast%3DProsise%26aufirst%3DW.%2BW.%26aulast%3DWeber%26aufirst%3DP.%2BC.%26atitle%3DMolecular%2520views%2520of%2520viral%2520polyprotein%2520processing%2520revealed%2520by%2520the%2520crystal%2520structure%2520of%2520the%2520hepatitis%2520C%2520virus%2520bifunctional%2520protease-helicase%26jtitle%3DStructure%26date%3D1999%26volume%3D7%26spage%3D1353%26epage%3D1363" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">McPhee, F.; Campbell, J. A.; Li, W.; D'Andrea, S.; Zheng, Z. B.; Good, A. C.; Carini, D. J.; Johnson, B. L.; Scola, P. M.</span><span> </span><span class="NLM_article-title">Macrocyclic isoquinoline peptide inhibitors of hepatitis C virus</span>. PCT Int. Appl. WO 2004/094452,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=F.+McPhee&author=J.+A.+Campbell&author=W.+Li&author=S.+D%27Andrea&author=Z.+B.+Zheng&author=A.+C.+Good&author=D.+J.+Carini&author=B.+L.+Johnson&author=P.+M.+Scola&title=Macrocyclic+isoquinoline+peptide+inhibitors+of+hepatitis+C+virus"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcPhee%26aufirst%3DF.%26atitle%3DMacrocyclic%2520isoquinoline%2520peptide%2520inhibitors%2520of%2520hepatitis%2520C%2520virus%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Ripka, A.; Campbell, J. A.; Good, A. C.; Scola, P. M.; Sin, N.; Venables, B.</span><span> </span><span class="NLM_article-title">Hepatitis C virus inhibitors</span>. U.S. Pat. Appl. US 2004048802,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=A.+Ripka&author=J.+A.+Campbell&author=A.+C.+Good&author=P.+M.+Scola&author=N.+Sin&author=B.+Venables&title=Hepatitis+C+virus+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DRipka%26aufirst%3DA.%26atitle%3DHepatitis%2520C%2520virus%2520inhibitors%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin Metathesis</span> <span class="citation_source-journal">Tetrahedron</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">60</span><span class="NLM_x">, </span> <span class="NLM_fpage">7117</span><span class="NLM_x">–</span> <span class="NLM_lpage">7140</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2Fj.tet.2004.05.124" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2cXmtVWhtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=7117-7140&author=R.+H.+Grubbs&title=Olefin+Metathesis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18aR"><div class="casContent"><span class="casTitleNuber">18a</span><div class="casTitle"><span class="NLM_cas:atitle">Olefin metathesis</span></div><div class="casAuthors">Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">7117-7140</span>CODEN:
                <span class="NLM_cas:coden">TETRAB</span>;
        ISSN:<span class="NLM_cas:issn">0040-4020</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Olefin metathesis has become a tool for synthetic org. and polymer chemists.  Well-defined, functional group-tolerant catalysts have allowed these advances.  A discussion of the evolution of mechanistic understanding and early catalyst developments is followed by a description of recent advances in ruthenium-based olefin metathesis catalysts.  Catalysts improvements have led to new applications in ring closing metathesis, cross metathesis and materials synthesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp17ME4BMlFQbVg90H21EOLACvtfcHk0ljXM45TUusYQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXmtVWhtrg%253D&md5=efc9586c24a39fab1f4e5a1bb029c2aa</span></div><a href="/servlet/linkout?suffix=cit18a&amp;dbid=16384&amp;doi=10.1016%2Fj.tet.2004.05.124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tet.2004.05.124%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520Metathesis%26jtitle%3DTetrahedron%26date%3D2004%26volume%3D60%26spage%3D7117%26epage%3D7140" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Olefin metathesis catalysts for the preparation of molecules and materials (Nobel Lecture)</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">3760</span><span class="NLM_x">–</span> <span class="NLM_lpage">3765</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=3760-3765&author=R.+H.+Grubbs&title=Olefin+metathesis+catalysts+for+the+preparation+of+molecules+and+materials+%28Nobel+Lecture%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DOlefin%2520metathesis%2520catalysts%2520for%2520the%2520preparation%2520of%2520molecules%2520and%2520materials%2520%2528Nobel%2520Lecture%2529%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D3760%26epage%3D3765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit18c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hoveyda, A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhugralin, A. R.</span><span> </span><span class="NLM_article-title">The remarkable metal-catalysed olefin metathesis reaction</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">450</span><span class="NLM_x">, </span> <span class="NLM_fpage">243</span><span class="NLM_x">–</span> <span class="NLM_lpage">251</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1038%2Fnature06351" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=17994091" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18c&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1yntrvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=450&publication_year=2007&pages=243-251&author=A.+H.+Hoveydaauthor=A.+R.+Zhugralin&title=The+remarkable+metal-catalysed+olefin+metathesis+reaction"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18cR"><div class="casContent"><span class="casTitleNuber">18c</span><div class="casTitle"><span class="NLM_cas:atitle">The remarkable metal-catalysed olefin metathesis reaction</span></div><div class="casAuthors">Hoveyda, Amir H.; Zhugralin, Adil R.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">450</span>
        (<span class="NLM_cas:issue">7167</span>),
    <span class="NLM_cas:pages">243-251</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Catalytic olefin metathesis-through which pairs of C:C bonds are reorganized-transforms simple mols. to those that are complex and precious.  This class of reactions has noticeably enriched chem. synthesis, which is the art of prepg. scarce mols. with highly desirable properties (for example, medicinal agents or polymeric materials).  Research in the past two decades has yielded structurally well-defined catalysts for olefin metathesis that are used to synthesize an array of mols. with unprecedented efficiency.  Nonetheless, the full potential of olefin metathesis will be realized only when addnl. catalysts are discovered that are truly practical and afford exceptional selectivity for a significantly broader range of reactions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo43N1xT7HQq7Vg90H21EOLACvtfcHk0lipzjdlMxM3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1yntrvN&md5=8f2f724c75f88ee6b1745e3512600db3</span></div><a href="/servlet/linkout?suffix=cit18c&amp;dbid=16384&amp;doi=10.1038%2Fnature06351&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature06351%26sid%3Dliteratum%253Aachs%26aulast%3DHoveyda%26aufirst%3DA.%2BH.%26aulast%3DZhugralin%26aufirst%3DA.%2BR.%26atitle%3DThe%2520remarkable%2520metal-catalysed%2520olefin%2520metathesis%2520reaction%26jtitle%3DNature%26date%3D2007%26volume%3D450%26spage%3D243%26epage%3D251" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="note"><p class="first last">For the synthesis of biologically active macrocycles via RCM:</p></div><div class="NLM_citation" id="rightTab-cit19a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Van de Weghe, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eustache, J.</span><span> </span><span class="NLM_article-title">The application of olefin metathesis to the synthesis of biologically active macrocyclic agents</span> <span class="citation_source-journal">Curr. Topics Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1495</span><span class="NLM_x">–</span> <span class="NLM_lpage">1519</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.2174%2F156802605775009748" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=16378489" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19a&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28XhsVylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2005&pages=1495-1519&author=P.+Van+de+Wegheauthor=J.+Eustache&title=The+application+of+olefin+metathesis+to+the+synthesis+of+biologically+active+macrocyclic+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19aR"><div class="casContent"><span class="casTitleNuber">19a</span><div class="casTitle"><span class="NLM_cas:atitle">The application of olefin metathesis to the synthesis of biologically active macrocyclic agents</span></div><div class="casAuthors">Van de Weghe, Pierre; Eustache, Jacques</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1495-1519</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  Recent developments of the metathesis reaction in the area of biol. active mols. are presented.  Scope and limitations of ring-closing metathesis to form medium and large rings are discussed and illustrated by the epothilone synthesis.  Applications of the metathesis reaction related to medicinal chem., including solid phase synthesis and combinatorial chem. are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGojxjKJDDdMXbVg90H21EOLACvtfcHk0lipzjdlMxM3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhsVylug%253D%253D&md5=05cc6be9e0aa009cfafb8bc4087be67f</span></div><a href="/servlet/linkout?suffix=cit19a&amp;dbid=16384&amp;doi=10.2174%2F156802605775009748&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802605775009748%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2Bde%2BWeghe%26aufirst%3DP.%26aulast%3DEustache%26aufirst%3DJ.%26atitle%3DThe%2520application%2520of%2520olefin%2520metathesis%2520to%2520the%2520synthesis%2520of%2520biologically%2520active%2520macrocyclic%2520agents%26jtitle%3DCurr.%2520Topics%2520Med.%2520Chem.%26date%3D2005%26volume%3D5%26spage%3D1495%26epage%3D1519" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit19b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Gradillas, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perez-Castells, J.</span><span> </span><span class="NLM_article-title">Macrocyclization by ring-closing metathesis in the total synthesis of natural products: reaction conditions and limitations</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">6086</span><span class="NLM_x">–</span> <span class="NLM_lpage">6101</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1002%2Fanie.200600641" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVWnsr3P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6086-6101&author=A.+Gradillasauthor=J.+Perez-Castells&title=Macrocyclization+by+ring-closing+metathesis+in+the+total+synthesis+of+natural+products%3A+reaction+conditions+and+limitations"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19bR"><div class="casContent"><span class="casTitleNuber">19b</span><div class="casTitle"><span class="NLM_cas:atitle">Macrocyclization by ring-closing metathesis in the total synthesis of natural products: reaction conditions and limitations</span></div><div class="casAuthors">Gradillas, Ana; Perez-Castells, Javier</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">37</span>),
    <span class="NLM_cas:pages">6086-6101</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  The construction of macrocycles by ring-closing metathesis (RCM) is often used as the key step in the synthesis of natural products contg. large rings.  This reaction is attractive because of its high functional group compatibility and the possibility for further transformations.  The finding of suitable reaction conditions is crit. for the success of the synthesis.  This review summarizes the efficient RCM reactions of the total synthesis of natural macrocyclic products and should reduce the time-consuming phase of the optimization of the reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo8YDIbEWf4ALVg90H21EOLACvtfcHk0lipzjdlMxM3aA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVWnsr3P&md5=b1430b45488e86d48f29848cd4b2f725</span></div><a href="/servlet/linkout?suffix=cit19b&amp;dbid=16384&amp;doi=10.1002%2Fanie.200600641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200600641%26sid%3Dliteratum%253Aachs%26aulast%3DGradillas%26aufirst%3DA.%26aulast%3DPerez-Castells%26aufirst%3DJ.%26atitle%3DMacrocyclization%2520by%2520ring-closing%2520metathesis%2520in%2520the%2520total%2520synthesis%2520of%2520natural%2520products%253A%2520reaction%2520conditions%2520and%2520limitations%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2006%26volume%3D45%26spage%3D6086%26epage%3D6101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Liverton, N. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fandozzi, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Holloway, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCauley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McIntyre, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rudd, M. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vacca, J. P.</span><span> </span><span class="NLM_article-title">MK-7009, A Potent and Selective Inhibitor of Hepatitis C Virus NS3/4a Protease</span> <span class="citation_source-journal">Antimicrob. Agents Chemother.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">311</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2010&pages=305-311&author=N.+J.+Livertonauthor=S.+S.+Carrollauthor=J.+M.+DiMuzioauthor=C.+Fandozziauthor=D.+J.+Grahamauthor=D.+J.+Hazudaauthor=M.+K.+Hollowayauthor=S.+W.+Ludmererauthor=J.+A.+McCauleyauthor=C.+J.+McIntyreauthor=D.+B.+Olsenauthor=M.+T.+Ruddauthor=M.+Stahlhutauthor=J.+P.+Vacca&title=MK-7009%2C+A+Potent+and+Selective+Inhibitor+of+Hepatitis+C+Virus+NS3%2F4a+Protease"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLiverton%26aufirst%3DN.%2BJ.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DDiMuzio%26aufirst%3DJ.%2BM.%26aulast%3DFandozzi%26aufirst%3DC.%26aulast%3DGraham%26aufirst%3DD.%2BJ.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMcCauley%26aufirst%3DJ.%2BA.%26aulast%3DMcIntyre%26aufirst%3DC.%2BJ.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DRudd%26aufirst%3DM.%2BT.%26aulast%3DStahlhut%26aufirst%3DM.%26aulast%3DVacca%26aufirst%3DJ.%2BP.%26atitle%3DMK-7009%252C%2520A%2520Potent%2520and%2520Selective%2520Inhibitor%2520of%2520Hepatitis%2520C%2520Virus%2520NS3%252F4a%2520Protease%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2010%26volume%3D54%26spage%3D305%26epage%3D311" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit20b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; Ludmerer, S. W.; McCauley, J. A.; Olsen, D. B.; Rudd, M. T.; Vacca, J. P.; McIntyre, C. J.</span><span> </span><span class="NLM_article-title">HCV NS3 Protease Inhibitors</span> U.S. Patent 7,470,664,<span class="NLM_x"> </span><span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=M.+K.+Holloway&author=N.+J.+Liverton&author=S.+W.+Ludmerer&author=J.+A.+McCauley&author=D.+B.+Olsen&author=M.+T.+Rudd&author=J.+P.+Vacca&author=C.+J.+McIntyre&title=HCV+NS3+Protease+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DHCV%2520NS3%2520Protease%2520Inhibitors%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Compound <b>11</b> is available from Aldrich, catalog number 639737.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="note"><p class="first last">The Zhan 1b catalyst [1,3-bis(2,4,6-trimethylphenyl)-4,5-dihydroimidazol-2-ylidene[2-(<i>i</i>-propoxy)-5-(<i>N</i>,<i>N</i>-dimethylaminosulfonyl)phenyl] methyleneruthenium (II) dichloride] is available from Strem, catalog number 44-0082.<span class="NLM_inline-graphic"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2010/jmcmar.2010.53.issue-6/jm9015526/production/images/medium/jm-2009-015526_0001.tif.gif" alt="" /></img></span></p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="note"><p class="first last">For development of related catalysts:</p></div><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Weskamp, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schattenmann, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spiegler, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herrmann, W. A.</span><span> </span><span class="NLM_article-title">A novel class of ruthenium catalysts for olefin metathesis</span> <span class="citation_source-journal">Angew. Chem., Int. Ed. Engl.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">37</span><span class="NLM_x">, </span> <span class="NLM_fpage">2490</span><span class="NLM_x">–</span> <span class="NLM_lpage">2493</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=1998&pages=2490-2493&author=T.+Weskampauthor=W.+C.+Schattenmannauthor=M.+Spieglerauthor=W.+A.+Herrmann&title=A+novel+class+of+ruthenium+catalysts+for+olefin+metathesis"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWeskamp%26aufirst%3DT.%26aulast%3DSchattenmann%26aufirst%3DW.%2BC.%26aulast%3DSpiegler%26aufirst%3DM.%26aulast%3DHerrmann%26aufirst%3DW.%2BA.%26atitle%3DA%2520novel%2520class%2520of%2520ruthenium%2520catalysts%2520for%2520olefin%2520metathesis%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%2520Engl.%26date%3D1998%26volume%3D37%26spage%3D2490%26epage%3D2493" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Scholl, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trnka, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Morgan, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grubbs, R. H.</span><span> </span><span class="NLM_article-title">Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligands</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">2247</span><span class="NLM_x">–</span> <span class="NLM_lpage">2250</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1016%2FS0040-4039%2899%2900217-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1MXhvVeitbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=1999&pages=2247-2250&author=M.+Schollauthor=T.+M.+Trnkaauthor=J.+P.+Morganauthor=R.+H.+Grubbs&title=Increased+ring+closing+metathesis+activity+of+ruthenium-based+olefin+metathesis+catalysts+coordinated+with+imidazolin-2-ylidene+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligands</span></div><div class="casAuthors">Scholl, Matthias; Trnka, Tina M.; Morgan, John P.; Grubbs, Robert H.</div><div class="citationInfo"><span class="NLM_cas:title">Tetrahedron Letters</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2247-2250</span>CODEN:
                <span class="NLM_cas:coden">TELEAY</span>;
        ISSN:<span class="NLM_cas:issn">0040-4039</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A novel air and water tolerant, imidazolinylidene-substituted ruthenium-based complex, has been prepd. starting from RuCl2(=CHPh)(PCy3)2 and shown to exhibit increased ring-closing metathesis activity at elevated temp. compared to that of the parent complex.  Di-, tri-, and even tetra-substituted cycloolefins were successfully prepd. from corresponding diene precursors using this new catalyst in moderate to excellent yields.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoqMSfMaJx9uLVg90H21EOLACvtfcHk0lgNsEGF2hYodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXhvVeitbc%253D&md5=5ed07583753f2c0d5ca41aed4a8dbaef</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1016%2FS0040-4039%2899%2900217-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4039%252899%252900217-8%26sid%3Dliteratum%253Aachs%26aulast%3DScholl%26aufirst%3DM.%26aulast%3DTrnka%26aufirst%3DT.%2BM.%26aulast%3DMorgan%26aufirst%3DJ.%2BP.%26aulast%3DGrubbs%26aufirst%3DR.%2BH.%26atitle%3DIncreased%2520ring%2520closing%2520metathesis%2520activity%2520of%2520ruthenium-based%2520olefin%2520metathesis%2520catalysts%2520coordinated%2520with%2520imidazolin-2-ylidene%2520ligands%26jtitle%3DTetrahedron%2520Lett.%26date%3D1999%26volume%3D40%26spage%3D2247%26epage%3D2250" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Huang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stevens, E. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nolan, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Petersen, J. L.</span><span> </span><span class="NLM_article-title">Olefin metathesis—active ruthenium complexes bearing nucleophilic carbene ligand</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">121</span><span class="NLM_x">, </span> <span class="NLM_fpage">2674</span><span class="NLM_x">–</span> <span class="NLM_lpage">2678</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja9831352" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=1999&pages=2674-2678&author=J.+Huangauthor=E.+D.+Stevensauthor=S.+P.+Nolanauthor=J.+L.+Petersen&title=Olefin+metathesis%E2%80%94active+ruthenium+complexes+bearing+nucleophilic+carbene+ligand"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23c&amp;dbid=16384&amp;doi=10.1021%2Fja9831352&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja9831352%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DStevens%26aufirst%3DE.%2BD.%26aulast%3DNolan%26aufirst%3DS.%2BP.%26aulast%3DPetersen%26aufirst%3DJ.%2BL.%26atitle%3DOlefin%2520metathesis%25E2%2580%2594active%2520ruthenium%2520complexes%2520bearing%2520nucleophilic%2520carbene%2520ligand%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D1999%26volume%3D121%26spage%3D2674%26epage%3D2678" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Garber, S. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kingsbury, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gray, B. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoveyda, A. H.</span><span> </span><span class="NLM_article-title">Efficient and recyclable monomeric and dendritic Ru-based metathesis catalysts</span> <span class="citation_source-journal">J. Am. Chem. Soc.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">122</span><span class="NLM_x">, </span> <span class="NLM_fpage">8168</span><span class="NLM_x">–</span> <span class="NLM_lpage">8179</span></span><div class="citationLinks">[<a href="/doi/10.1021/ja001179g" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref23/cit23d&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3cXlsFKltLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2000&pages=8168-8179&author=S.+B.+Garberauthor=J.+S.+Kingsburyauthor=B.+L.+Grayauthor=A.+H.+Hoveyda&title=Efficient+and+recyclable+monomeric+and+dendritic+Ru-based+metathesis+catalysts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23dR"><div class="casContent"><span class="casTitleNuber">23d</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient and Recyclable Monomeric and Dendritic Ru-Based Metathesis Catalysts</span></div><div class="casAuthors">Garber, Steven B.; Kingsbury, Jason S.; Gray, Brian L.; Hoveyda, Amir H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">34</span>),
    <span class="NLM_cas:pages">8168-8179</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Several highly active, recoverable and recyclable Ru-based metathesis catalysts are presented.  The crystal structure of the Ru complex (I) bearing a 1,3-dimesityl-4,5-dihydroimidazol-2-ylidene and styrenyl ether ligand is disclosed.  The heterocyclic ligand significantly enhances the catalytic activity, and the styrenyl ether allows for the easy recovery of the Ru complex.  Catalyst I promotes ring-closing metathesis (RCM) and the efficient formation of various trisubstituted olefins at ambient temp. in high yield within 2 h; the catalyst is obtained in >95% yield after silica gel chromatog. and can be used directly in subsequent reactions.  Tetrasubstituted olefins can also be synthesized by RCM reactions catalyzed by I.  In addn., the synthesis and catalytic activities of two dendritic and recyclable Ru-based complexes are disclosed.  Examples involving catalytic ring-closing, ring-opening, and cross metatheses are presented where, unlike monomer I, the dendritic catalyst can be readily recovered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosNDsVV1SIp7Vg90H21EOLACvtfcHk0lgNsEGF2hYodw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXlsFKltLw%253D&md5=d24a933fff4df0d8ee160f0d6f014aae</span></div><a href="/servlet/linkout?suffix=cit23d&amp;dbid=16384&amp;doi=10.1021%2Fja001179g&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja001179g%26sid%3Dliteratum%253Aachs%26aulast%3DGarber%26aufirst%3DS.%2BB.%26aulast%3DKingsbury%26aufirst%3DJ.%2BS.%26aulast%3DGray%26aufirst%3DB.%2BL.%26aulast%3DHoveyda%26aufirst%3DA.%2BH.%26atitle%3DEfficient%2520and%2520recyclable%2520monomeric%2520and%2520dendritic%2520Ru-based%2520metathesis%2520catalysts%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2000%26volume%3D122%26spage%3D8168%26epage%3D8179" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Wang, X. A.; Sun, L.-Q.; Sit, S.-Y.; Sin, N.; Scola, P. M.; Hewawasam, P.; Good, A. C.; Chen, Y.; Campbell, J. A.</span><span> </span><span class="NLM_article-title">Hepatitis C Virus Inhibitors</span>. U.S. Patent 6,995,174,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=X.+A.+Wang&author=L.-Q.+Sun&author=S.-Y.+Sit&author=N.+Sin&author=P.+M.+Scola&author=P.+Hewawasam&author=A.+C.+Good&author=Y.+Chen&author=J.+A.+Campbell&title=Hepatitis+C+Virus+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DX.%2BA.%26atitle%3DHepatitis%2520C%2520Virus%2520Inhibitors%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">8-Methoxyisoquinoline derivatives through ortho-selective metalation of 2-(3-methoxyphenyl)ethylamine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1965-1966&author=M.+Schlosserauthor=G.+Simig&title=8-Methoxyisoquinoline+derivatives+through+ortho-selective+metalation+of+2-%283-methoxyphenyl%29ethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D8-Methoxyisoquinoline%2520derivatives%2520through%2520ortho-selective%2520metalation%2520of%25202-%25283-methoxyphenyl%2529ethylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1965%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Yatsunami, T.; Yazaki, A.; Inoue, S.; Yamamoto, H.; Yokomoto, M.; Nomiyama, J.; Noda, S.</span><span> </span><span class="NLM_article-title">Preparation of 7-(2-isoindolinyl)-1,4-dihydro-4-oxoquinoline- and 1,8-naphthyridine-3-carboxylic acid derivatives as antibacterials</span>. Eur. Pat. Appl. EP 343560,<span class="NLM_x"> </span><span class="NLM_year">1989</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1989&author=T.+Yatsunami&author=A.+Yazaki&author=S.+Inoue&author=H.+Yamamoto&author=M.+Yokomoto&author=J.+Nomiyama&author=S.+Noda&title=Preparation+of+7-%282-isoindolinyl%29-1%2C4-dihydro-4-oxoquinoline-+and+1%2C8-naphthyridine-3-carboxylic+acid+derivatives+as+antibacterials"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DYatsunami%26aufirst%3DT.%26atitle%3DPreparation%2520of%25207-%25282-isoindolinyl%2529-1%252C4-dihydro-4-oxoquinoline-%2520and%25201%252C8-naphthyridine-3-carboxylic%2520acid%2520derivatives%2520as%2520antibacterials%26date%3D1989" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Yang, B. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O'Rourke, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, J.</span><span> </span><span class="NLM_article-title">Mild and Selective Debenzylation of Tertiary Amines Using alpha-Chloroethyl Chloroformate</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_fpage">195</span><span class="NLM_x">–</span> <span class="NLM_lpage">196</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=1993&pages=195-196&author=B.+V.+Yangauthor=D.+O%27Rourkeauthor=J.+Li&title=Mild+and+Selective+Debenzylation+of+Tertiary+Amines+Using+alpha-Chloroethyl+Chloroformate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DB.%2BV.%26aulast%3DO%2527Rourke%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DJ.%26atitle%3DMild%2520and%2520Selective%2520Debenzylation%2520of%2520Tertiary%2520Amines%2520Using%2520alpha-Chloroethyl%2520Chloroformate%26jtitle%3DSynlett%26date%3D1993%26spage%3D195%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Holloway, M. K.; Liverton, N. J.; McCauley, J. A.; Rudd, M. T.; Vacca, J. P.; Ludmerer, S. W.; Olsen, D. B.</span><span> </span><span class="NLM_article-title">Macrocyclic peptides as HCV NS3 protease inhibitors</span>. PCT Int. Appl. WO 2007/016441,<span class="NLM_x"> </span><span class="NLM_year">2007</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2007&author=M.+K.+Holloway&author=N.+J.+Liverton&author=J.+A.+McCauley&author=M.+T.+Rudd&author=J.+P.+Vacca&author=S.+W.+Ludmerer&author=D.+B.+Olsen&title=Macrocyclic+peptides+as+HCV+NS3+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHolloway%26aufirst%3DM.%2BK.%26atitle%3DMacrocyclic%2520peptides%2520as%2520HCV%2520NS3%2520protease%2520inhibitors%26date%3D2007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Mao, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DiMuzio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McHale, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burlein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span> </span><span class="NLM_article-title">A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3-4A protease at low enzyme concentrations</span> <span class="citation_source-journal">Anal. Biochem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">373</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">8</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=373&publication_year=2008&pages=1-8&author=S.-S.+Maoauthor=J.+DiMuzioauthor=C.+McHaleauthor=C.+Burleinauthor=D.+Olsenauthor=S.+S.+Carroll&title=A+time-resolved%2C+internally+quenched+fluorescence+assay+to+characterize+inhibition+of+hepatitis+C+virus+nonstructural+protein+3-4A+protease+at+low+enzyme+concentrations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMao%26aufirst%3DS.-S.%26aulast%3DDiMuzio%26aufirst%3DJ.%26aulast%3DMcHale%26aufirst%3DC.%26aulast%3DBurlein%26aufirst%3DC.%26aulast%3DOlsen%26aufirst%3DD.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26atitle%3DA%2520time-resolved%252C%2520internally%2520quenched%2520fluorescence%2520assay%2520to%2520characterize%2520inhibition%2520of%2520hepatitis%2520C%2520virus%2520nonstructural%2520protein%25203-4A%2520protease%2520at%2520low%2520enzyme%2520concentrations%26jtitle%3DAnal.%2520Biochem.%26date%3D2008%26volume%3D373%26spage%3D1%26epage%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Migliaccio, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomassini, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, S. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomei, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altamura, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bhat, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartholomew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bosserman, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ceccacci, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Colwell, L. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cortese, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">De Francesco, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eldrup, A. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Getty, K. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">LaFemina, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ludmerer, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacCoss, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McMasters, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stahlhut, M. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olsen, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hazuda, D. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Flores, O. A.</span><span> </span><span class="NLM_article-title">Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in vitro</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">49164</span><span class="NLM_x">–</span> <span class="NLM_lpage">49170</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1074%2Fjbc.M305041200" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=12966103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=49164-49170&author=G.+Migliaccioauthor=J.+E.+Tomassiniauthor=S.+S.+Carrollauthor=L.+Tomeiauthor=S.+Altamuraauthor=B.+Bhatauthor=L.+Bartholomewauthor=M.+R.+Bossermanauthor=A.+Ceccacciauthor=L.+F.+Colwellauthor=R.+Corteseauthor=R.+De+Francescoauthor=A.+B.+Eldrupauthor=K.+L.+Gettyauthor=X.+S.+Houauthor=R.+L.+LaFeminaauthor=S.+W.+Ludmererauthor=M.+MacCossauthor=D.+R.+McMastersauthor=M.+W.+Stahlhutauthor=D.+B.+Olsenauthor=D.+J.+Hazudaauthor=O.+A.+Flores&title=Characterization+of+resistance+to+non-obligate+chain-terminating+ribonucleoside+analogs+that+inhibit+hepatitis+C+virus+replication+in+vitro"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of Resistance to Non-obligate Chain-terminating Ribonucleoside Analogs That Inhibit Hepatitis C Virus Replication in Vitro</span></div><div class="casAuthors">Migliaccio, Giovanni; Tomassini, Joanne E.; Carroll, Steven S.; Tomei, Licia; Altamura, Sergio; Bhat, Balkrishen; Bartholomew, Linda; Bosserman, Michele R.; Ceccacci, Alessandra; Colwell, Lawrence F.; Cortese, Riccardo; De Francesco, Raffaele; Eldrup, Anne B.; Getty, Krista L.; Hou, Xiaoli S.; LaFemina, Robert L.; Ludmerer, Steven W.; MacCoss, Malcolm; McMasters, Daniel R.; Stahlhut, Mark W.; Olsen, David B.; Hazuda, Daria J.; Flores, Osvaldo A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">278</span>
        (<span class="NLM_cas:issue">49</span>),
    <span class="NLM_cas:pages">49164-49170</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">The urgent need for efficacious drugs to treat chronic hepatitis C virus (HCV) infection requires a concerted effort to develop inhibitors specific for virally encoded enzymes.  We demonstrate that 2'-C-Me ribonucleosides are efficient chain-terminating inhibitors of HCV genome replication.  Characterization of drug-resistant HCV replicons defined a single S282T mutation within the active site of the viral polymerase that conferred loss of sensitivity to structurally related compds. in both replicon and isolated polymerase assays.  Biochem. analyses demonstrated that resistance at the level of the enzyme results from a combination of reduced affinity of the mutant polymerase for the drug and an increased ability to extend the incorporated nucleoside analog.  Importantly, the combination of these agents with interferon-α results in synergistic inhibition of HCV genome replication in cell culture.  Furthermore, 2'-C-methyl-substituted ribonucleosides also inhibited replication of genetically related viruses such as bovine diarrhea virus, yellow fever, and West African Nile viruses.  These observations, together with the finding that 2'-C-methyl-guanosine in particular has a favorable pharmacol. profile, suggest that this class of compds. may have broad utility in the treatment of HCV and other flavivirus infections.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7Zeuc5zFmbbVg90H21EOLACvtfcHk0lhx0nxXVVLn3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXptlGrsL4%253D&md5=a7183ce208fe008e48c7a1a83ef66e85</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M305041200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M305041200%26sid%3Dliteratum%253Aachs%26aulast%3DMigliaccio%26aufirst%3DG.%26aulast%3DTomassini%26aufirst%3DJ.%2BE.%26aulast%3DCarroll%26aufirst%3DS.%2BS.%26aulast%3DTomei%26aufirst%3DL.%26aulast%3DAltamura%26aufirst%3DS.%26aulast%3DBhat%26aufirst%3DB.%26aulast%3DBartholomew%26aufirst%3DL.%26aulast%3DBosserman%26aufirst%3DM.%2BR.%26aulast%3DCeccacci%26aufirst%3DA.%26aulast%3DColwell%26aufirst%3DL.%2BF.%26aulast%3DCortese%26aufirst%3DR.%26aulast%3DDe%2BFrancesco%26aufirst%3DR.%26aulast%3DEldrup%26aufirst%3DA.%2BB.%26aulast%3DGetty%26aufirst%3DK.%2BL.%26aulast%3DHou%26aufirst%3DX.%2BS.%26aulast%3DLaFemina%26aufirst%3DR.%2BL.%26aulast%3DLudmerer%26aufirst%3DS.%2BW.%26aulast%3DMacCoss%26aufirst%3DM.%26aulast%3DMcMasters%26aufirst%3DD.%2BR.%26aulast%3DStahlhut%26aufirst%3DM.%2BW.%26aulast%3DOlsen%26aufirst%3DD.%2BB.%26aulast%3DHazuda%26aufirst%3DD.%2BJ.%26aulast%3DFlores%26aufirst%3DO.%2BA.%26atitle%3DCharacterization%2520of%2520resistance%2520to%2520non-obligate%2520chain-terminating%2520ribonucleoside%2520analogs%2520that%2520inhibit%2520hepatitis%2520C%2520virus%2520replication%2520in%2520vitro%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D49164%26epage%3D49170" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Lohmann, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korner, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koch, J.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herian, U.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Theilmann, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bartenschlager, R.</span><span> </span><span class="NLM_article-title">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">285</span><span class="NLM_x">, </span> <span class="NLM_fpage">110</span><span class="NLM_x">–</span> <span class="NLM_lpage">113</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm9015526&amp;key=10.1126%2Fscience.285.5424.110" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm9015526&amp;key=10390360" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=285&publication_year=1999&pages=110-113&author=V.+Lohmannauthor=F.+Kornerauthor=J.-O.+Kochauthor=U.+Herianauthor=L.+Theilmannauthor=R.+Bartenschlager&title=Replication+of+subgenomic+hepatitis+C+virus+RNAs+in+a+hepatoma+cell+line"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line</span></div><div class="casAuthors">Lohmann, V.; Korner, F.; Koch, J.-O.; Herian, U.; Theilmann, L.; Bartenschlager, R.</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">285</span>
        (<span class="NLM_cas:issue">5424</span>),
    <span class="NLM_cas:pages">110-113</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">An estd. 170 million persons worldwide are infected with hepatitis C virus (HCV), a major cause of chronic liver disease.  Despite increasing knowledge of genome structure and individual viral proteins, studies on virus replication and pathogenesis have been hampered by the lack of reliable and efficient cell culture systems.  A full-length consensus genome was cloned from viral RNA isolated from an infected human liver and used to construct subgenomic selectable replicons.  Upon transfection into a human hepatoma cell line, these RNAs replicated to high levels, permitting metabolic radiolabeling of viral RNA and proteins.  This work defines the structure of HCV replicons functional in cell culture and provides the basis for a long-sought cellular system that should allow detailed mol. studies of HCV and the development of antiviral drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7X754RT8y1LVg90H21EOLACvtfcHk0lhx0nxXVVLn3w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXksVCqurk%253D&md5=b075621b316209ecf4498c9b5b33e4b5</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1126%2Fscience.285.5424.110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.285.5424.110%26sid%3Dliteratum%253Aachs%26aulast%3DLohmann%26aufirst%3DV.%26aulast%3DKorner%26aufirst%3DF.%26aulast%3DKoch%26aufirst%3DJ.-O.%26aulast%3DHerian%26aufirst%3DU.%26aulast%3DTheilmann%26aufirst%3DL.%26aulast%3DBartenschlager%26aufirst%3DR.%26atitle%3DReplication%2520of%2520subgenomic%2520hepatitis%2520C%2520virus%2520RNAs%2520in%2520a%2520hepatoma%2520cell%2520line%26jtitle%3DScience%26date%3D1999%26volume%3D285%26spage%3D110%26epage%3D113" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Kato, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Date, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miyamoto, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Furusaka, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tokushige, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mizokami, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wakita, T.</span><span> </span><span class="NLM_article-title">Efficient replication of the genotype 2a hepatitis C virus subgenomic replicon</span> <span class="citation_source-journal">Gastroenterology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">125</span><span class="NLM_x">, </span> <span class="NLM_fpage">1808</span><span class="NLM_x">–</span> <span class="NLM_lpage">1817</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=125&publication_year=2003&pages=1808-1817&author=T.+Katoauthor=T.+Dateauthor=M.+Miyamotoauthor=A.+Furusakaauthor=K.+Tokushigeauthor=M.+Mizokamiauthor=T.+Wakita&title=Efficient+replication+of+the+genotype+2a+hepatitis+C+virus+subgenomic+replicon"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKato%26aufirst%3DT.%26aulast%3DDate%26aufirst%3DT.%26aulast%3DMiyamoto%26aufirst%3DM.%26aulast%3DFurusaka%26aufirst%3DA.%26aulast%3DTokushige%26aufirst%3DK.%26aulast%3DMizokami%26aufirst%3DM.%26aulast%3DWakita%26aufirst%3DT.%26atitle%3DEfficient%2520replication%2520of%2520the%2520genotype%25202a%2520hepatitis%2520C%2520virus%2520subgenomic%2520replicon%26jtitle%3DGastroenterology%26date%3D2003%26volume%3D125%26spage%3D1808%26epage%3D1817" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Schlosser, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Simig, G.</span><span> </span><span class="NLM_article-title">8-Methoxyisoquinoline derivatives through ortho-selective metalation of 2-(3-methoxyphenyl)ethylamine</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1991</span><span class="NLM_x">, </span> <span class="NLM_volume">32</span><span class="NLM_x">, </span> <span class="NLM_fpage">1965</span><span class="NLM_x">–</span> <span class="NLM_lpage">1966</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1991&pages=1965-1966&author=M.+Schlosserauthor=G.+Simig&title=8-Methoxyisoquinoline+derivatives+through+ortho-selective+metalation+of+2-%283-methoxyphenyl%29ethylamine"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSchlosser%26aufirst%3DM.%26aulast%3DSimig%26aufirst%3DG.%26atitle%3D8-Methoxyisoquinoline%2520derivatives%2520through%2520ortho-selective%2520metalation%2520of%25202-%25283-methoxyphenyl%2529ethylamine%26jtitle%3DTetrahedron%2520Lett.%26date%3D1991%26volume%3D32%26spage%3D1965%26epage%3D1966" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group">Arasappan, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Venkatraman, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Padilla, A. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meng, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prongay, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Girijavallabhan, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Njoroge, F. G.</span><span> </span><span class="NLM_article-title">Practical and efficient method for amino acid derivatives containing β-quaternary center: Application toward synthesis of hepatitis C virus NS3 serine protease inhibitors</span> <span class="citation_source-journal">Tetrahedron Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">48</span><span class="NLM_x">, </span> <span class="NLM_fpage">6343</span><span class="NLM_x">–</span> <span class="NLM_lpage">6347</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2007&pages=6343-6347&author=A.+Arasappanauthor=S.+Venkatramanauthor=A.+I.+Padillaauthor=W.+Wuauthor=T.+Mengauthor=Y.+Jinauthor=J.+Wongauthor=A.+Prongayauthor=V.+Girijavallabhanauthor=F.+G.+Njoroge&title=Practical+and+efficient+method+for+amino+acid+derivatives+containing+%CE%B2-quaternary+center%3A+Application+toward+synthesis+of+hepatitis+C+virus+NS3+serine+protease+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DArasappan%26aufirst%3DA.%26aulast%3DVenkatraman%26aufirst%3DS.%26aulast%3DPadilla%26aufirst%3DA.%2BI.%26aulast%3DWu%26aufirst%3DW.%26aulast%3DMeng%26aufirst%3DT.%26aulast%3DJin%26aufirst%3DY.%26aulast%3DWong%26aufirst%3DJ.%26aulast%3DProngay%26aufirst%3DA.%26aulast%3DGirijavallabhan%26aufirst%3DV.%26aulast%3DNjoroge%26aufirst%3DF.%2BG.%26atitle%3DPractical%2520and%2520efficient%2520method%2520for%2520amino%2520acid%2520derivatives%2520containing%2520%25CE%25B2-quaternary%2520center%253A%2520Application%2520toward%2520synthesis%2520of%2520hepatitis%2520C%2520virus%2520NS3%2520serine%2520protease%2520inhibitors%26jtitle%3DTetrahedron%2520Lett.%26date%3D2007%26volume%3D48%26spage%3D6343%26epage%3D6347" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group">Ashby, E. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Park, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patil, G. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gadru, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gurumurthy, R.</span><span> </span><span class="NLM_article-title">Competing radical, carbanion, and carbene pathways in the reactions of hindered primary alkyl halides with lithium dialkylamides</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">58</span><span class="NLM_x">, </span> <span class="NLM_fpage">424</span><span class="NLM_x">–</span> <span class="NLM_lpage">437</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00054a028" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Fjm9015526&amp;key=1%3ACAS%3A528%3ADyaK3sXotVChug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=1993&pages=424-437&author=E.+C.+Ashbyauthor=B.+Parkauthor=G.+S.+Patilauthor=K.+Gadruauthor=R.+Gurumurthy&title=Competing+radical%2C+carbanion%2C+and+carbene+pathways+in+the+reactions+of+hindered+primary+alkyl+halides+with+lithium+dialkylamides"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Competing radical, carbanion, and carbene pathways in the reactions of hindered primary alkyl halides with lithium dialkylamides</span></div><div class="casAuthors">Ashby, E. C.; Park, B.; Patil, G. S.; Gadru, K.; Gurumurthy, R.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1993</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">424-37</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">A variety of methods were utilized to study the mechanism of reaction of 6-iodo-5,5-dimethyl-1-hexene and its bromo, chloro, and tosylate derivs. with LDA and several other lithium dialkylamides.  In the reaction of 6-iodo-5,5-dimethyl-1-hexene with LDA in THF, radical, carbanion, and carbene pathways occurred simultaneously.  However, when the corresponding bromide was allowed to react with LDA, the radical pathway was minor and when the corresponding chloride or tosylate was allowed to react with LDA, no evidence for radical products was obsd.  This is the first time that competing radical, carbanion, and carbene pathways have been detected in the reaction of a primary alkyl halide with any nucleophile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1ch1NAy0vdLVg90H21EOLACvtfcHk0lhwtUjWW1EyQA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK3sXotVChug%253D%253D&md5=33ea9584436ae69759a7f77a8346d1c0</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjo00054a028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00054a028%26sid%3Dliteratum%253Aachs%26aulast%3DAshby%26aufirst%3DE.%2BC.%26aulast%3DPark%26aufirst%3DB.%26aulast%3DPatil%26aufirst%3DG.%2BS.%26aulast%3DGadru%26aufirst%3DK.%26aulast%3DGurumurthy%26aufirst%3DR.%26atitle%3DCompeting%2520radical%252C%2520carbanion%252C%2520and%2520carbene%2520pathways%2520in%2520the%2520reactions%2520of%2520hindered%2520primary%2520alkyl%2520halides%2520with%2520lithium%2520dialkylamides%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1993%26volume%3D58%26spage%3D424%26epage%3D437" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group">Petter, R. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Englard, S.</span><span> </span><span class="NLM_article-title">Inhibition of γ-butyrobetaine hydroxylase by cyclopropyl-substituted γ-butyrobetaines</span> <span class="citation_source-journal">J. Org. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1990</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">3088</span><span class="NLM_x">–</span> <span class="NLM_lpage">3097</span></span><div class="citationLinks">[<a href="/doi/10.1021/jo00297a025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1990&pages=3088-3097&author=R.+C.+Petterauthor=S.+Banerjeeauthor=S.+Englard&title=Inhibition+of+%CE%B3-butyrobetaine+hydroxylase+by+cyclopropyl-substituted+%CE%B3-butyrobetaines"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1021%2Fjo00297a025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00297a025%26sid%3Dliteratum%253Aachs%26aulast%3DPetter%26aufirst%3DR.%2BC.%26aulast%3DBanerjee%26aufirst%3DS.%26aulast%3DEnglard%26aufirst%3DS.%26atitle%3DInhibition%2520of%2520%25CE%25B3-butyrobetaine%2520hydroxylase%2520by%2520cyclopropyl-substituted%2520%25CE%25B3-butyrobetaines%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1990%26volume%3D55%26spage%3D3088%26epage%3D3097" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i108"><a href="/doi/suppl/10.1021/jm9015526">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_66422"></div></div></div></div></div><hr /></hr><p class="last"><sup>1</sup>H NMR spectra and elemental analysis data for selected compounds. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm9015526/suppl_file/jm9015526_si_001.pdf">jm9015526_si_001.pdf (2.51 MB)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm9015526&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2010.53.issue-6%3Barticle%3Aarticle%3A10.1021%2Fjm9015526%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm9015526" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799a8aa3a1c2495","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
